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Abstract 
 
The aim of the project is to synthesise (–)-morphine utilising aziridine and metathesis 
chemistry. The thesis is divided into three chapters. 
 
Chapter 1 provides brief reviews on the subjects of total synthesis of morphine; ring-
rearrangement metathesis (RRM) and regioselective ring-opening of aziridines. 
 
Chapter 2 focuses on the research findings in the past three years. Two routes, A and B, 
were investigated in attempts to synthesise morphine (Scheme 1). In route A, sulfonyl 
cyclopentene II was prepared from ring-closing metathesis of a diene precursor, which 
was synthesised from lithiated cinnamylsulfone and butadiene monoxide. Subsequently, 
RRM reactions of several α-SO2Ph allyl derivatives of II were investigated and some 
interesting results were obtained. The synthesis of 2,3-trans vinylaziridine III was 
achieved in seven steps beginning with a Grignard reaction of (4-
methoxyphenyl)magnesium bromide with butadiene monoxide. Subsequently, some 
highly regioselective ring-opening reactions of III with sulfur-stabilised anionic 
nucleophiles were achieved. However, in an attempt to synthesise compound I from II 
and III, no reaction was observed. This led to the investigation of route B, in which five 
methods for the synthesis of compound IV were investigated. The practical approach 
deployed a novel Al-mediated substitution of the 4-tosyl group of the tosyl 
tetrahydropyridine counterpart of IV, prepared from V and III, with a phenylthio group.  
 
 
 
 
 
 
 
 
Scheme 1 
 
Chapter 3 provides the experimental details and characterisation data. 
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Abbreviations 
 
Ac                                acetyl 
acac                             acetylacetonate    
AcOH                          acetic acid 
ADDP                         1,1’-(azodicarbonyl)dipiperidine 
(aq.)                             aqueous 
Ar                                aryl 
Bn                                benzyl 
Boc                              tert-butyloxycarbonyl 
br                                 broad 
Bu                                butyl 
CI                                chemical ionisation 
d                                  doublet 
dba                              dibenzylideneacetone 
dd                                doublet of doublets 
ddd                              doublet of doublet of doublets 
diast.                            diastereomer 
dr                                 diastereomeric ratio 
dt                                 doublet of triplets 
DBU                            1,8-diazabicyclo[5.4.0]-undec-7-ene 
DEAD                         diethyl azodicarboxylate 
DIAD                          diisopropyl azodicarboxylate 
DIBAL-H                    diisobutylaluminium hydride          
DMAP                         N,N-dimethylaminopyridine 
DMDO                        dimethyldioxirane 
DMF                            N,N-dimethylformamide 
DMPU                         1,3-dimethyl-3,4,5,6-tetrahydro-2-pyrimidone 
DMSO                         dimethylsulfoxide 
ee                                 enantiomeric excess 
ESI                               electrospray ionisation 
equiv                            equivalent(s) 
Et                                 ethyl  
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Et2O                             diethyl ether 
EtOAc                          ethyl acetate 
Et3N                             triethylamine 
g                                   gram(s) 
h                                   hour(s) 
HMPA                          hexamethylphosphoramide 
IBX                               o-iodoxybenzoic acid 
Lit.                                literature 
KHMDS                       potassium hexamethyldisilazide 
m                                  multiplet 
maj.                              major (spectroscopic; in reference to diastereoisomers) 
m-CPBA                       m-chloroperoxybenzoic acid 
Me                                methyl 
min                               minute(s) 
min.                              minor (spectroscopic; in reference to diastereoisomers) 
MOM                           methoxymethyl 
mp                                melting point 
MS                                mass spectrum 
Ms                                methanesulfonyl (mesyl) 
NADP+                         nicotinamide adenine dinucleotide phosphate 
NADPH                        reduced form of NADP 
NBS                              N-bromosuccinimide 
NCS                              N-chlorosuccinimide 
NIS                               N-iodosuccinimide 
NMO                            N-methylmorpholine-N-oxide 
NMR                            nuclear magnetic resonance      
Ns                                 nitrophenylsulfonyl 
PCC                             pyridinium chlorochromate 
PDC                             pyridinium dichromate 
Ph                                 phenyl 
PMB                             para-methoxybenzyl 
PTAB                           phenyltrimethylammonium tribromide 
q Ar                              quaternary aromatic 
q                                   quartet 
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rt                                   room temperature 
RRM                             ring-rearrangement metathesis 
SES                              2-(trimethylsilyl)ethylsulfonyl 
SM                               starting material 
SN1                               unimolecular nucleophilic substitution 
SN2                               bimolecular nucleophilic substitution 
t                                    triplet 
TBDMS                        tert-butyldimethylsilyl 
TES                              triethylsilyl 
TFA                              trifluoroacetic acid 
THF                              tetrahydrofuran 
TLC                              thin layer chromatography 
TMEDA                       N,N,N′,N′-tetramethyl-1,2-ethylenediamine 
Ts                                  p-toluenesulfonyl 
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Stereochemical Notation 
 
Throughout this report, to aid rapid visual identification of relative and absolute 
stereochemical configuration, the Maehr convention has been adopted.1 Thus, solid and 
broken lines denote racemates, whilst solid and broken wedges imply absolute 
configurations. For the latter, narrowing of both solid and broken wedges denotes 
increasing distance from viewer. 
 
 
 
          Racemate                                  Single enantiomer
Relative stereochemistry              Absolute stereochemistry  
 
 
 
Morphine Numbering 
 
In this report, the following morphine numbering system is adopted. 
 
3
4
12
11
1
2
HO
5
6
7
8
14
13
HO
10
9 NMe
15 16O
H H
 
(–)-morphine 
 
 
 
 
 10
1. Introduction 
 
1.1 Historical Aspects of Morphine  
 
Morphine, the active principle of opium, was the first alkaloid discovered. 2 , 3  Its 
isolation from opium poppy, Papaver somniferum, was attempted by a number of 
scientists.4 At the beginning of the 19th century Séguin in France and Sertürner in 
Germany both independently completed the isolation of morphine.5  However, since 
Séguin’s work was not published until 1814, the discovery of morphine is generally 
attributed to Sertürner in the year 1805.2,4,5 Sertürner named the white crystalline 
powder morphinum, after Morpheus, the Greek god of dreams. He realised that 
morphinmum, or morphine as we know it, belonged to a group of previously unknown 
natural products. The term alkaloid, vegetable alkali, was adopted for this family of 
compounds.6 
 
Subsequently, explanations of the molecular structure of morphine caused great 
controversy. Intensive investigation was carried out but it remained unsolved for a long 
period.2,4,5 In 1847 Laurent correctly deduced the empirical formula of morphine as 
C17H19NO3.
2,3 Further progress was made by Knorr and Hörlein whose conclusion was 
published in 1907 (1 in Figure 1).2,3 They believed that C-15 was connected to C-5, a 
hypothesis which was challenged by Gulland and Robinson who showed, for the first 
time, the structure for morphine as 2, with C-15 connected to C-13 (Figure 1).2,3,4  
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Figure 1 
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1.2 Biosynthesis of Morphine 
 
The morphine alkaloids contain a class of structurally related compounds with 
medicinal value.7 Morphine itself has a unique clinical importance due to its superior 
broad-spectrum analgesic properties. Despite some of its detrimental side effects, it 
continues to be one of the most widely used clinical drugs for alleviation of severe 
pain.3,7  
 
Three types of mammalian opioid receptors, δ, κ and µ have been identified.8 The 
expression of morphine’s interaction with the µ receptor is thought to be the key 
contribution to its analgesic effect. The mechanisms of its action in affecting the human 
central nervous and immune systems have received a lot of attention.9 The mechanism 
for its function is thought to be similar to the body’s own painkiller endorphins, a 
family of polypeptides. Additionally, recent discoveries showed that the affinity 
between morphine and the binding site of the µ receptor is much higher.8  
 
It has been found that human bodies need morphine and produce it intracellularly at a 
nanomolar level.9 Morphine is also present in toad skin, cow brain, adrenal glands and 
various mammalian tissues.10,11,12 The biosynthesis of (–)-morphine is well studied, as 
depicted in Scheme 2, although the mechanism is still not fully elucidated. Amine 3 and 
aldehyde 4 both derive from L-tyrosine. Pictet–Spengler reaction of 3 with 4 gives (S)-
norcodaurine, which provides all the non-N-methyl carbon atoms required in morphine. 
Subsequent oxidation, methylation and epimerisation gave (R)-reticuline 5. The next 
key carbon–carbon bond formation was achieved by a diphenolic coupling via 
intermediate 6 to give salutaridine. Following the syntheses of several analogues, 
morphine is obtained in an extremely concise manner.13  
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1.3 Total Synthesis of Morphine 
 
The distinctive architecture of morphine, which possesses five rings, five contiguous 
stereocentres and a compact arrangement of functionality, has attracted synthetic 
chemists for decades.13,14,15 Since the first total synthesis was accomplished by Gates in 
1952,16 over 20 others have been published.13,14,15  
 
1.3.1 Rice’s Approach to Morphine 
 
The biomimetic route of Rice, published in 1980, has offered the most efficient and 
probably the only synthetically feasible route to produce morphine in bulk (Scheme 
3).17 Homologation of benzaldehyde 7 gave acid 8, which was coupled with amine 9 to 
give the corresponding amide. Subsequent Bischler–Napieralski reaction mediated by 
POCl3 followed by reduction of the tetrahydroisoquinolinium intermediate gave 
tetrahydroisoquinoline 10. Compound 10 was subjected to Birch reduction followed by 
formylation, ketalisation and regioselective bromination. The resulting ketal was then 
deprotected to give ketone 11. Compound 11 was then converted to morphinan 12 after 
a Grewe cyclisation, initiated by hydrogen fluoride-ammonia complex in 
trifluoromethanesulfonic acid, which is a very practical way to construct the tetracyclic 
ring structure of morphine. The bromine substituent acts as a blocking group to prevent 
the undesired coupling. After hydrolysis of amide 12, the dihydrofuran ring of 13 was 
formed via regioselective α-bromination of the ketone followed by base-induced ring 
closure. Finally, dihydrocodeinone 13 was prepared after cleavage of the aryl bromide 
bond and methylation of the resulting amine simultaneously by hydrogenation over 
palladium in a mixture of aqueous formaldehyde and acetic acid. Morphine was then 
synthesised in another five steps from 13. 
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Scheme 3  
 
Having a sequence of 16 steps and total yield of 16%, Rice’s method is highly efficient. 
However, the main disadvantage of this synthesis was that it required a final resolution 
of (±)-morphine. 
 
1.3.2 Overman’s Approach to Morphine 
 
The first asymmetric total synthesis of (–)-morphine was achieved by Overman et al. 
(Scheme 4).18 Cyclohexenol 16 was synthesised in 93% yield and over 96% ee by 
enantioselective reduction of cyclohexanone 14 with catechol borane in the presence of 
(R)-oxazaborolidine catalyst 15. The introduction of chirality in this step allows the 
final product (–)-morphine to be produced without any resolution. Allylic alcohol 16 
was then transformed to allylsilane 17 in five steps involving a condensation with 
phenyl isocyanate, transformation of the terminal olefin to the corresponding acetonide, 
SN2′ displacement of the carbamate, deprotection of the acetonide followed by cleavage 
of the resulting diol, and treatment of the resulting aldehyde with dibenzosuberylamine 
(DBS-NH2). Condensation of 17 and aldehyde 18 resulted in the formation of 19 in 
which (E)-iminium ion is orientated towards to the face opposite to the silyl group. 
Subsequent cyclisation gave product 20, which upon treatment with a palladium 
catalyst underwent a Heck reaction to give unsaturated morphinan 21.  After cleavage 
of the benzyl ether of 21, the final ring of the core skeleton was formed by treatment 
 15
with camphorsulfonic acid and 3,5-dinitroperoxybenzoic acid. Intermediate 22 was then 
converted into 23 in three steps, from which (–)-morphine was prepared in another five 
steps following Rice’s route. 
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Scheme 4  
 
Overman’s asymmetric method also allowed the synthesis of the other enantiomer by 
adopting the enantiomeric form of the proline-derived catalyst 15. The success of the 
iminium ion-allylsilane cyclisation and the formation of the quaternary stereocentre by 
an intramolecular Heck reaction also highlighted the efficiency of this approach. This 
route, like many others, primarily focused on the construction of the N-norreticuline 
moiety. Several phenanthrene-based approaches to morphine have been reported, such 
as Ginsburg in 1954,19 Mulzer20 and White21, both in the 1990s. 
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1.3.3 White’s Approach to Morphine 
 
Due to the interest of the pharmacological properties of the unnatural enantiomer, 
White’s synthesis focused on (+)-morphine (Scheme 5).21 Stobbe condensation22  of 
isovanillin 24 and dimethyl succinate 25, followed by a chiral rhodium catalysed 
asymmetric hydrogenation 23  and bromination gave intermediate 26. Intramolecular 
Friedel–Crafts reaction of 26, hydrogenolysis of the resulting aryl bromide and 
saponification gave 27. Condensation of 27 with methyl formate was followed by 
treatment with methyl vinyl ketone to give 28, which was subjected to a Robinson 
annulation to yield the phenanthrene framework 29. Substrate 29 was then transformed 
into tetracyclic intermediate diazo ketone 30 in nine steps. The formation of the 
quaternary carbon centre 13 of the pentacyclic nucleus of 31 was achieved by 
rhodium(II)-catalysed carbenoid C–H insertion from diazo ketone 30. (+)-Morphine 
was then synthesised from 31 in another ten steps. The overall yield of White’s 
approach is moderate (ca. 3%). This synthesis can be easily used to prepared the natural 
(–)-morphine by controlling the stereochemistry of 26. 
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1.3.4 Parker’s Approach to Morphine 
 
Parker et al. made use of a tandem radical ring closure to construct the morphine core 
structure in an extremely efficient manner (Scheme 6).24 Mono-protected diol 33 was 
obtained from aryl amine 32 in a seven-step transformation. Mitsunobu coupling of 33 
and phenol 34 followed by deprotection of the resulting alcohol yielded substrate 35 
with the aromatic ring placed behind the cyclohexene. When treated with Bu3SnH and 
AIBN, aryl bromide 35 underwent the planned cascade sequence to afford 38. The final 
ring of morphine, the piperidine ring, was formed when tosylamide 38 was exposed to 
dissolving metal conditions. It was believed that the ring closure was facilitated by N-
centred radicals. Swern oxidation of 39 gave ketone 40, which was transformed to (–)-
morphine according to literature procedures.17,25 
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Morphine is currently produced mostly by extraction from the natural plant opium.26 
Although India and Australia are the two biggest legal suppliers for morphine, a large 
proportion of opium is grown in the world’s politically unstable areas and in order to 
secure the supply of morphine alternative means should be explored. However, 
synthetic manufacturing of morphine will only be favourable if a short sequence (6–8 
steps) is achieved.26 This may seem almost unobtainable given the state-of-the-art 
chemistry, but from that point of view this molecule still provides a major challenge. In 
addition, given the unique structure of morphine, many synthetic chemists continue to 
use this molecule as a test ground for different methodologies. 
 
1.4 The Craig Group Proposed Route to Morphine Synthesis 
 
The Craig group has a keen interest in natural product synthesis27,28,29 and has been very 
active in exploring the synthesis of morphine in recent years. 30,31 Our current proposal 
intends to take advantage of the methodologies of regioselective vinylaziridine ring-
opening mediated by sulfones and ring-rearrangement metathesis (RRM) (Scheme 7). 
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It was envisaged that (±)-morphine could be constructed from cyclopentenyl sulfone 45 
and vinylaziridine 46. The synthesis of sulfone 45 has been reported via a π-allyl 
palladium-mediated nucleophilic addition of sodium phenylsulfinate to cyclopentadiene 
monoxide.32  The preparation of aziridine 46 has been achieved via two routes,30,31 
developed by former group members, both starting from butadiene monoxide 47 and the 
Grignard reagent (4-methoxyphenyl)magnesium bromide 48.  
 
It was believed that the three-membered N-ring of aziridine 46 would undergo a 
regioselective ring-opening reaction when treated with the α-sulfonyl carbanion of 45. 
The sulfonyl cyclopentene product 44 would then be subjected to metathesis conditions 
in an attempt to synthesise sulfonyl cyclohexene 43 via a ring-rearrangement metathesis 
(RRM). Subsequently, we hoped to form the C12–C13 bond of phenanthrene 42 by a 
Lewis acid-mediated intramolecular desulfonylative cationic cyclisation of 43. 
Hydroboration–oxidation of the terminal double bond of 42 followed by an 
intramolecular Mitsunobu reaction should furnish the piperidine ring of 41. When 
successful, it would result in the dihydrofuran ring formation. This was expected to 
include an oxidation of the allylic alcohol of substrate 41 and a hydroxylation of its enol 
tautomer. After bromination of the aromatic ring, this process would then be concluded 
by an aromatic substitution by the resulting alcohol to give the pentacyclic skeleton of 
morphine. 
 
One of the attractive characteristics of this retrosynthesis is that RRM of cyclopentenyl 
sulfone 44 to cyclohexenyl sulfone 43, arranging the functionality required for the 
formation of the next two rings. A major aspect of this project also aimed to develop 
further the methodology of regioselective aziridine ring-opening. 
 
The following reviews intend to give some literature evidence for the feasibility of the 
unprecedented RRM step proposed, and an overview of recent developments in the area 
of regioselective aziridine ring-opening. 
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1.5 Ring-rearrangement Metathesis 
 
Metathesis chemistry has gained tremendous attention from synthetic chemists in recent 
years.33 Its unique and easy way of forming and redistributing carbon–carbon bonds 
makes it one of the most powerful tools in organic chemistry.33 Moreover, with 
increasingly robust catalysts being discovered (Figure 2), its impact will continue to 
expand.34 
 
Mo
N
O
OF3C
F3C
CF3F3C
Ph
Ru
PCy3
PCy3
PhCl
Cl
49                                  50                                                     51                                         52
Ru
PCy3
Ph
Cl
Cl
NN
Ru
O
Cl
NN
Cl
 
 
Figure 2 - Well-defined olefin metathesis catalysts 
 
1.5.1 RRM of Carbocycles to Heterocycles 
 
Amongst the three fundamental types of metathesis, ring-closing metathesis (RCM), 
cross metathesis (CM) and ring-opening metathesis polymerisation (ROMP), RCM and 
ROMP have been most widely used.33,35 In recent years the combined intramolecular 
use of ring-opening metathesis (ROM) and RCM, also recognised as ring-
rearrangement metathesis (RRM), has grown rapidly. Investigations have shown that 
RRM reactions are generally governed by thermodynamic factors. 36  It provides an 
effective way of forming heterocycles such as 54a, b from their corresponding 
carbocycles 53a, b by an increase in thermodynamic stability (Figure 3).34,36b, 37  
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Figure 3 
 
Blechert and Schaudt have successfully synthesised the first natural cis-cinnamoyl 
alkaloid (+)-astrophylline utilising RRM chemistry (Scheme 8).38 The RRM reaction 
precursor 57 came from a Mitsunobu substitution of the alcohol of 56 with N-Ns allyl 
amine. Alcohol 56 derived from optically pure acetate 5539 in four steps involving: 
Pd(0) π-allyl substitution; epimerisation; stannation and [2,3]-Wittig–Still 
rearrangement. Stereospecific RRM reaction of cyclopentene 57 with catalyst 50 gave 
bi-tetrahydropyridine 58, which was converted to compound 59 after N-Ns deprotection 
and acylation. Subjection of 59 to N-Boc deprotection followed by alkyne syn-reduction 
gave (+)-astrophylline 60. 
 
OHAcO
55
N
N
H
H
Boc
Ns
95%
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H
O
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Scheme 8 
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1.5.2 RRM of Carbocycles to Carbocycles 
 
In contrast to the transformations described above, converting one carbocyle into 
another by RRM is more challenging, especially when the ring strain of the product is 
close to the starting material.40 Norborenes are good substrates for RRM owing to their 
highly strained bridged bicyclic system.41 Blechert and co-workers have reported the 
first application of RRM for the synthesis of [X.3.0] carbo-bicycles using olefin 
substituted norborenes 61a–d (Scheme 9).42 Rearranged products 62a–d were easily 
obtained under mild reaction conditions. The presence of ethylene was necessary in 
order to suppress polymerisation. Notably, even the relatively strained 
bicyclo[6.3.0]undecene 62d was synthesised in good yield. 
 
R1
R2
n
catalyst (0.5 mol%)
ethylene, rt
n
R1 R2
61a      n = 0, R1 = H, R2 = OTBS                                                    62a  80%
61b      n = 1, R1 = H, R2 = OTBS                                                    62b  88%
61c      n = 2, R1 = H, R2 = OTBS                                                    62c  75%
61d      n = 3, R1 = OTBS, R2 = H                                                    62d  83%
[a]
[b]
[a]
[a]
 
 
Scheme 9 [a] catalyst 49 used; [b] catalyst 52 used  
 
A highly efficient synthesis of fused tricyclic enones from norborene derivatives has 
been achieved by Holtsclaw and Koreeda using tether-directed RRM (Scheme 10).41b In 
the presence of catalyst 49, norborene 63 underwent the desired rearrangement to give 
tricyclic compound 64 in an excellent yield. 
 
catalyst 49 (5 mol%)
CH2Cl2, 23 °CO
Me
H
H
O
> 90%
63                                                                                               64  
 
Scheme 10 
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The rearrangement of cyclohexenes under metathesis conditions is rarely reported. 
However, Mehta and Nandakumar have successfully applied this strategy in a domino 
process (Scheme 11).43 By using 30 mol% of catalyst 49, they were able to convert 
cyclohexenyl diene 65 into a mixture of tertiary alcohol 66 as the major product and 
secondary alcohol 67. After purification by silica gel column chromatography, 66 
almost completely rearranged to the more stable 67. 
 
a. 49 (30 mol%)
   CH2Cl2, 40 °C
HO HO
+
OH65                                                                66, 8%                                 67, 62%
b. Silica gel
 
 
Scheme 11 
 
Ring-rearrangement metathesis process can also be carried out stereoselectively. 
Hoveyda, Schrock and co-workers have successfully converted achiral homoallylic 
cyclopentene 69 into cyclohexene 70 using chiral molybdenum based catalysts 68.44 
Depending on the reaction conditions the ee of the desired product can reach up to 96% 
in a reaction yield of 94%. This ring shuffling encouragingly proved the feasibility of 
interconversion from cyclopentenes to cyclohexenes where the ring strains are very 
similar.45 
 
Mo
N
OO
O
iPr
Pr
iPr Cl
Cl
iPr
Pr
iPr
RO
5 mol% 68
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i
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69                                                                70
 
 
Scheme 12 
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1.6 Regioselective Ring-opening of Aziridines 
 
The aziridine functionality, or alternatively recognised as azaethylene or ethylenimine 
unit, is one of the most important three-membered ring moieties in organic synthesis.46 
Structurally, aziridines are analogous to epoxides with the nitrogen group replacing the 
oxygen. The chemistry of aziridines has been increasingly researched over the last few 
decades and their application has been greatly broadened.47 Aziridines have become 
important building blocks in synthetic chemistry, especially for nitrogen-containing 
bioactive natural compounds.48  
 
The utility of aziridines is profoundly dependent on their ability to undergo nucleophilic 
ring-opening, both stereo- and regioselectively.49 It is widely accepted that aziridines 
with nitrogen bearing electron-withdrawing substituents, such as sulfonyl, sulfinyl, 
phosphoryl, phosphinyl and carbonyl, are more reactive towards ring-opening than their 
nitrogen unsubstituted counterparts.50  
 
Regarding the regiochemistry, the intrinsic properties of the aziridine and the nature of 
the incoming nucleophile can both affect the outcome.51 In general, 1,2-disubstituted 
aziridines mirror that of similarly substituted epoxides, in that they suffer attack at the 
less substituted 3-position. This regioselectivity may be changed when the two C–N 
bonds are polarised unsymmetrically and there is significant positive charge 
development at the 2-carbon atom, eg: 2-benzyl substituted aziridines in acidic media. 
When both carbon atoms are substituted, competing steric and electronic effects may be 
such that the regioselectivity of nucleophilic ring-opening is eroded, though many 
examples of selective reactions are documented.46,49,50,52  
 
2-Phenyl substituents are powerful directing groups for regioselective ring-opening of 
aziridines by both carbon and hetero nucleophiles. Two possible mechanisms may be 
proposed as outlined in Figure 4. Firstly, as above mentioned, there is a partial positive 
character developed on the C-2 induced by the electron withdrawing phenyl group, as 
shown in structure 71. Secondly, the resulting C-2 p orbital of the nucleophilic ring-
opening transition state is stabilised through overlapping with the aromatic system of 
the phenyl ring, as depicted in structure 72. 
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Figure 4 - nucleophilic ring-opening of 2-benzyl substituted aziridines 
 
A comprehensive review on the subject of nucleophilic ring-opening of aziridines was 
offered by Hu,53 together with many others.48a,49,51 The following review intends to give 
an overview of regioselective ring-opening of aziridines organised by class of 
nucleophile, focused mainly on reports from the year 2000 onwards. 
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1.6.1 Carbon Nucleophiles 
 
Hodgson and co-workers have established a general process to access allylic N-
sulfonylamines by regio-controlled opening of 2,3-disubstituted N-sulfonylaziridines 
with dimethylsulfonium methylide 7454 (Scheme 13).55 Initial attack on the benzylic or 
allylic carbon of the aziridines 73a–d by 74 generated intermediates 75, which could 
then undergo elimination to give the desired products 76a–d through either path A or B 
with another equivalent of 74. 
 
As shown in Scheme 13, both N-Ts and N-Bus (Bus = tert-butylsulfonyl) aziridines 
gave the corresponding allylic amines in good yields. With the exception of substrate 
73b that gave the other regioisomer in 12% yield, all others produced exclusively the 
expected compounds. Diene 76d is also potentially useful for cycloaddition chemistry.55 
R1
NSO2R
3
R2
SMe2
R1
NHSO2R
3
R2
Entry               aziridine                                         product                      yield(%)
NBus
NHBus
NTs
OR4
NHTs
OR4
R4 = H,  85
        TES, 79
R4 = H, TES
NBus
NHBus
81
95
NTs
NHTs
75
1
2
3
4
R1
R2
NSO2R
3
S
H
H
S
A
B
73                                                                        75                         76
74
73a
73b
73c
73d
76a
76b
76c
76d
 
 
Scheme 13 
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The use of Lewis acids, such as Cu, Zn, B, Sc, In, Bi, Ce, Au and Ag in promoting 
aziridine ring-opening has attracted much attention.53 Yadav et al. examined the use of 
In(OTf)3 as catalyst in the reaction of aryl aziridines 77 and arenes 78 (Scheme 14).
56 
This was the first report on regioselective aziridine ring-opening with arenes. Despite 
the fact that there is no substitution on C-3, nucleophilic additions almost exclusively 
occur on C-2. With short reaction times of 1–2 hours for activated arenes, and slightly 
longer for unactivated arenes (4–6.5 hours), β-diaryl amines 79 were prepared in high 
yields and excellent regioselectivity. In addition, they also investigated other metal 
triflates and found that 5% Sc(OTf)3 and 10% Yb(OTf)3 gave similar results for 
activated arenes but In(OTf)3 was the only catalyst effective for unactivated arenes. 
Additionally, without the use of catalyst, no reaction was observed.  
 
Ts
N
R1
In(OTf)3 (5mol%)+ R2
Activated arenes:
  R2 = OMe, 1,2-(OMe)2, 1,4-(OMe)2
            1,2,3-(OMe)3, 1,2-OMeO
Unactivated arenes:
  R2 = H, F, Me, iPr, Ar
R1 = H, 4-Cl, 4-Me
NHTs
R1
R2
Yield: 68−92%
Regioselectivity: > 95:5
77                                             78                                        79
 
 
Scheme 14 
 
Interestingly, when metal halide catalysts were used, a mixture of β-diaryl amines and 
β-chloro amines 80 were obtained (Scheme 15). 
 
Ts
N
R1 MCln+ R
2
NHTs
R1
R2
M = In, Zr, Bi,
       Yb, Fe
+
Cl
NHTs
R1
8077 78 79
 
 
Scheme 15 
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This methodology was extended by Wu et al.57  and Roy et al.58  In the interest of 
applying gold and silver catalysts in organic synthesis, Wu and co-workers 
demonstrated that the combination use of AuCl3 and AgOTf had similar results as that 
of Yadav (Scheme 16), whereas poor yields were resulted when only one of them was 
used. Except when R2 = OMe obtained with a selectivity of 5.2:1, all other reactions 
gave 100% regioselectivity. However, when switching R2 to electron withdrawing 
groups such as –Cl, –CF3 and –NO3, complex, unidentified mixtures were obtained. 
 
Activated arenes:
  R2 = OMe, 1,2-(OMe)2, 1,4-(OMe)2
            1,2-OMeO, Me, Ar
R1 = H, 4-Cl, 4-Me
Ts
N
R1
AuCl3 (1mol%)
+ R
2
NHTs
R1
R2
AgOTf (3mol%)
77                              78                                                         79
Yield: 70−95%
Regioselectivity: 100% 
(except when R2 = OMe)  
 
Scheme 16 
 
This type of process is not restricted to arenes. Heteroarenes are also susceptible to 
Lewis acid mediated nucleophilic addition to aziridines. In addition to Yadav’s earlier 
work, 59  Roy et al. recently showed that in the presence of AgPF6, furans 81 and 
thiophenes 82 are good nucleophiles for the regioselective ring-opening of aziridines 77 
to yield exclusively 83 (Scheme 17).58 The authors believed that the well-known 
binding ability of Ag(I) towards arenes60  and aziridines61  might contribute to such 
reactivity. 
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      S, 82
R2 = H, Me
R1 = H, 4-Cl, 4-Me
Ts
N
R1 +
NHTs
R1
AgPF6 (2mol%)
77                                                                                          83
Yield: 80−85%
Regioselectivity: 100%
X R2
X
R2
 
 
Scheme 17 
 
Aziridines have also been found to undergo ring-opening reactions with nonactivated 
alkenes in the presence of BF3·Et2O. This remarkable work was published by Man and 
co-workers (Scheme 18). 62 , 63  They described this process as a formal [3+2] 
cycloaddition involving a 1,3-dipole 2-phenyl aziridine precursor. Building on the 
success of reacting aziridine with allylsilanes,62 they were able to extend this 
methodology to a variety of other alkenes.63 They suggested that the reaction occurred 
via a rather unusual zwitterionic 1,3-dipole, as depicted in intermediate 86, stabilised 
externally by the aromatic ring and the tosyl group. It is so electron deficient that it can 
react with nonactivated alkenes to generate 88. Intermediated 88 can then undergo 
either β-hydride elimination to give 89 or nucleophilic attack of the nitrogen anion on 
the carbocation to afford pyrrolidine 90. 
 
N
Ts
Ph
+ BF3·Et3O
NTs
Ph
dipole with external
stabilisation
84                                86            87          88                                          89            90
85
R
R NTs
Ph R
R
H
β-hydride 
elimination
N
Ts
R
RPh
R
R
Ph
TsHN
+
R = alkyl  
 
Scheme 18 
 
Results showed that the ratio of 89 and 90 depends on the stability of the carbocation of 
88 (Scheme 19). When cyclopentene and cyclohexene 91 were used, a 1:1 mixture of 
92 and 93 was observed. The yields of these two reactions were low, which was 
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probably also due to the stability of the carbocation. This hypothesis was supported by 
the outcome of the reactions using geminal disubstituted alkenes 94, in which more 
stable tertially carbocations were formed. As shown in Scheme 19, only the cyclised 
products 95 were prepared in good yields.  
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n
n
N
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         n = 3, 75%
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          n= 2, 50%
 
 
Scheme 19 
 
Boron trifluoride etherate 85 is an excellent Lewis acid for mediating regioselective 
aziridine ring-openings. A key step in Farr’s synthesis of the GnRH antagonist GnRH-1 
is the unprecedented BF3·Et2O-catalysed enantio- and regioselective reaction between 
2-arylindole 96 and nosyl aziridine 97 (Scheme 20).64 The use of BF3·Et2O resulted 
from the screening of a series of Lewis acids. Indole 96 was prepared in a nine-step 
sequence starting from 4-nitrophenyl acetic acid, involving a palladium-catalysed 
coupling of iodo aniline with phenyl acetylene followed by a 5-endo-dig indole 
formation triggered by CuI. Aziridine 97 could be obtained in a one-step transformation 
by treating L-alaninol with 2.1 equivalents of nosyl chloride in the presence of 
triethylamine. As illustrated in Scheme 20, the reaction of 96 with 97 gave a very good 
yield of 98, with perfect regio- and enantioselectivity. The stereochemistry of 98 was 
determined by direct comparison with that previously prepared by Walsh.65 
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Scheme 20 
 
Effective boron-based Lewis acids are not limited to just BF3·Et2O. Pineschi et al. 
adopted the use of electron-rich aryl borates to achieve highly chemo-, stereo- and 
regioselective carbon–carbon bond formations from aziridines 99 and phenols 100 
(Scheme 21) with retention of configuration at the C-2 of the aziridines.66 When Ar is 
phenyl, a 1:1 mixture of C- and O-alkylated products 101 and product 102 was 
obtained. Interestingly, the amount of C-alkylated product was dramatically increased 
when Ar was more electron rich, with a ratio of >95:5 over their O-alkylated 
counterparts. Changing the protecting groups of the aziridine had very little effect on 
the outcome. During all these transformations, no alternative regioisomer was observed. 
 
N
Ph
PG
+
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R1
(ArO)3B
Ph
NHPG
Ph
NHPG
OHO
R1
R1
+
99a, PG = Ts
99b, PG = Cbz
99c, PG = P(O)Ph2
R1 = 3,5-(Me)2
     2,3.5-(Me)3
     3,5-(OMe)2
Ar = 3,5-dimethyl-o-phenyl
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     3,5-dimethoxy-o-phenyl
         4-methyoxy-o-phenyl
100
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Yields: > 99%
101
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Scheme 21 
 
Having successfully accessed aminophenol derivatives 101, Pineschi also managed to 
convert them into aryl indolines 104 using intramolecular amination of aryltriflates 103 
with CuI and CsOAc.  
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Scheme 22 
 
Another group of substrates capable of directing regioselective attack on the benzylic 
carbon of the aziridine is α-indole aziridines. Tse et al. have developed a very efficient 
method of furnishing highly functionalised bisindoles 106 from 105 on a solid support 
under solvent free conditions (Scheme 23).67 The advantage of employing activated 
silica as the solid support was not only enhanced regioselectivity but also it cleaved the 
two N-Boc groups whereas clay (Montmorillonite K-10) gave both regioisomers and 
neutral alumina only yielded a small amount of the deprotected products.  
 
Many functionalities on the indole nucleophile including halides, alkoxy groups and 
esters, were tolerated under these conditions. However, 1-nitroindole only gave a poor 
yield of less than 20% and 1,2-dimethylindole yielded a substantial amount of the 
undesired regioisomer. 
 
In addition to indole carbon nucleophiles, others such as N-, O- and H-nucleophiles also 
gave similar results.  
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Scheme 23 
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In addition to investigations of regioselective nucleophilic additions at the aziridine C-2 
centre, interest in C-3 attack has also been aroused. Unsurprisingly, when R are alkyl 
groups, ring-opening on the 3-carbon is favoured due to steric factors (Figure 5). 
 
N
R
PG
R = alkyl Nu  
 
Figure 5 
 
However, this limits the synthetic utility of the ring-opening product, considering the 
difficulties of further functionalising the R group α to the resulting amine. Introduction 
of other functionalities will complicate the electronic effect, as a result, both C-3 and C-
2 attacks are possible due to steric and electronic reasons. For example, when using 2-
carboxylate ester aziridines in the course of the study to provide new amino acids, 
Baldwin et al. observed some interesting regioselectivities (Scheme 24). 68   When 
carbonyl stabilised reagent 108 was used to react with aziridine 107 and the protecting 
group of the nitrogen was either of the strongly electron withdrawing groups, –
COC6H4NO2 and –Ts, both isomers 109 and 110 were obtained with the C-3–N-1 
cleavage product 109 favoured. Whereas when the protecting group was –
COCH2C6H4NO2  or –COCH2Ph, only 109 was isolated with yields of 30%. 
 
N
MeO2C
PG
+ PPh3EtO2C
MeO2C
HN
CO2Et
PPh3
PG
+
MeO2C
NHPG
Ph3P CO2Et
107                        108                                         109                                110  
Scheme 24 
 
They also tested organolithium and Grignard reagents, such as 112, in the reactions with 
aziridine 111 and found that nucleophilic attacks on both carbons took place (Scheme 
25).69 The ratio between products 113 and 114 is affected by the size of the nucleophile. 
When R is methyl, compound 114 was obtained as the major isomer at a ratio of 4:1. 
However, when R is isopropyl, only compound 113 was observed.  
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Scheme 25 
 
To overcome this problem, Young and co-workers examined the reaction of 2-
carboxylic acid aziridine 115 with a variety of organocuprate nucleophiles, where 
completely regioselective C-3 attack was achieved to furnish α-amino acids 116 
(Scheme 26).70 Nevertheless, the reaction of 3-methyl substituted aziridine 117 gave a 
~1:3 mixture of isomers 118 and 119 with the β-amino acid as the preferred product 
(Scheme 27).  
 
Ts
N
HO2C
+
HO2C
NHTs
R2CuCNLi2 R
R = Ph, tBu, nBu,
       iPr, -allyl, Me,
yield: 48-94%
115                                                                           116
 
 
Scheme 26 
 
Ts
N
HO2C
+
HO2C
NHTs
R2CuCNLi2 +
R
HO2C
R
NHTs
117                                                       118                         119
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         R = Me, 36%
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Scheme 27 
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1.6.2 Heteroatom Nucleophiles 
 
2-Phenyl aziridines are also often used to effect regioselective attack by heteroatom 
nucleophiles, similar to carbon nucleophiles, on the benzylic carbon.71 Diamines and 
amino sulfides are biologically and synthetically important classes of compounds in the 
pharmaceutical industry.72 Rao et al. have devised an approach to synthesise these two 
groups of substrates (Scheme 28).72 In the presence of β-cyclodextin (β-CD) in H2O, the 
reaction of hydroxy phenylaziridine 120 and amines/sulfides yielded only single 
regioisomers 121 and 122. β-Cyclodextins are cyclic oligosaccharides possessing 
hydrophobic cavities, which bind substrates selectively. 
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N
Ph
OR1
β-CD/H2Oβ-CD/H2OPh
NHTs
OR1
S
120 121122
R1 = H, TBDMS
SH
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Ph
NHTs
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n
n = 0,1
yield: 86−94% yield: 84−92%  
 
Scheme 28 
 
Ring-opening of pyridyl-substituted aziridine with N-, S- and O-nucleophiles was tested 
by Savoia et al. (Scheme 29). Intriguingly, in contrast to phenyl-substituted aziridines, 
it did not produce good selectivity. Prepared by addition of chloromethyllithium to 
pyridineimine derived from (S)-valinol, aziridine 122 was allowed to react with a series 
of nucleophiles in the presence of Lewis acids. Except when NaN3 was used which gave 
100% C-2 addition isomer 123, all other reagents gave mixtures of 123 and 124 with 
ratios varied from 96:4–40:60. 
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Scheme 29 
 
Nucleophilic addition of heteroatoms to carboxylate aziridines is of particular interest 
due to the ease of accessing the precursor natural or unnatural amino acids, which are 
themselves useful building blocks for synthesis. In their work towards indolizidine 
alkaloid syntheses, the Dhavale group developed an efficient approach for the synthesis 
of pentahydroxylated indolizidine derivatives by using regioselective ring-opening of 
aziridine 125 with H2O to give 126, promoted by TFA (Scheme 30).
73 Following a six-
step sequence from 126, compound 127 and 128 were prepared. 
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Scheme 30 
 
The importance of fluorinated compounds has been well documented.74 This class of 
substrates has attracted increasing attention in recent years, especially in the 
pharmaceutical industry.74,75 The introduction of fluorine atoms into organic molecules 
often results in profound changes in their chemical and biological properties.75 One 
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important family is fluorine-substituted amino acids. 76  Many methods for their 
preparation have been reported.75,76 However, few methodologies for the synthesis of 
fluorinated diamino acid have been developed.77  
 
Bonnet-Delpon et al. have achieved the synthesis of fluoro-alkyl α,β-diamino acids by 
ring-opening of 2-carboxy-3-trifluoromethyl aziridines 129 and  131 with nitrogen 
nucleophiles (Schemes 31, 32).78 2,3-cis-Aziridines 129 were prepared form CF3-imines 
reacting with ethyl diazoacetate in the presence of a sub-stoichiometric amount of 
BF3·Et2O.
79  When treated with amines or NaN3, ring-opening products 130 were 
obtained with complete stereo- and regioselectivity without Lewis acid catalysis 
(Scheme 31). 2,3-trans-Aziridine 131 was synthesised by bromination of (E)-ethyl 
4,4,4-trifluorobut-2-enoate followed by aminative cyclisation with tosylamine. 80 
Regioselective nucleophilic attack of 131 was accomplished with benzylamine 132 to 
give the α,β-diamino ester 133 (Scheme 32). The stereochemistry of 133 was 
determined by X-ray crystallography. 
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Scheme 31 
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Scheme 32 
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Bonnet-Delpon believed that the regioselectivity of these reactions was due to the 
strongly electronegative nature of the fluorine atoms, resulting in electrostatic repulsion 
between the trifluoromethyl group and the incoming nucleophiles. Additionally, it may 
also be explained by the theory that the –CF3 substituent is less able than the –COOEt 
group to stabilise the p orbital of the transition state on the adjacent carbon in an SN2 
process. 
 
The Joullié group has reported a thorough investigation of ring-opening reactions of 
highly substituted alkynyl aziridines with oxygen nucleophiles (Schemes 33, 34).81 
Remarkably, addition of phenol nucleophiles 134 occurred exclusively on the more 
substituted C-2 of both aziridine carboxamide 135 and aziridine ester 137. The yields of 
products 136 were low, typically around 50%. It was found that, under these conditions, 
the sulfonamide anion intermediate further reacted with the terminal alkyne undergoing 
a 5-endo-dig cyclisation to give the corresponding pyrroles. This was avoided when 
stronger base TBD (1,5,7-triazabicyclo[4.4.0]dec-5-ene or 2,3,4,6,7,8-hexahydro-
1Hpyrimido[1,2-a]pyrimidine) was used in the absence of copper catalyst. When these 
optimised conditions were later applied to the reactions of 137, the yields of products 
138 were dramatically increased.  
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To probe the mechanism of these reactions, aziridine 139 was used to investigate 
whether the regioselectivity was dictated by the alkynyl substituent (Scheme 35), as 
literature precedent suggested that alkynyl aziridine ring-opening processes could occur 
through an allene carbenoid intermediate.82 However, as shown in Scheme 35, with 
absence of the C2 alkynyl group, aziridine 139 underwent a regio-controlled 
nucleophilic addition with phenol at the more hindered C2 to give 140. This 
unanticipated result prompted the authors to carry out computational studies which 
showed that, in both alkyl and alkynyl aziridines, the C2–N bond was longer that the 
C3–N bond. Additionally there was a partially positive charge on C2. Further X-ray 
analysis of aziridine 141 (Figure 5) confirmed that C2–N bond length was 1.552 Å, 
longer than 1.496 Å of the C3–N, implying that it was indeed the weaker bond. 
Furthermore, the ethynyl–C2–methyl bond angle is greater than that of a normal 
tetrahedral carbon making it more susceptible towards nucleophilic attacks. 
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Figure 5 
 
Halides are another good class of nucleophiles in the reactions with aziridines.83 Righi 
et al. found that N-Boc-alkenyl aziridines 142 underwent regioselective ring-opening 
with lithium halides when catalysed by Amberlyst-15 (Scheme 36).84 With various R 
substituents, only single regioisomers 143 were observed. Interestingly, when purified 
by silica gel column chromatography, the bromo- and iodo-products underwent 
intramolecular SN2 reactions to give oxazolidinones 144, whereas no conversion 
occurred on the chloro-derivatives.  
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Nevertheless, when aziridine 145 was used, with a methyl group replacing the 
carboxylate group of 143, the reactions gave a complex mixture of products (Scheme 
37). 
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1.6.3 via Aziridinium Ion 
 
Aziridinium ion chemistry has gained increasing interest from synthetic chemists.85 
They are useful intermediates in facilitating aziridine ring-opening processes and 
proved to be valuable for the synthesis of chiral diamines.85 A general strategy in 
forming aziridinium ions such as 148, as shown in path A in Scheme 38, relies on an 
intramolecular SN2 reaction of hydroxyamine 146.
85,86 Subsequent regioselective attack 
of 148 with amine 147 will give C2 and/or C3 addition adducts 149 and/or 150. The 
regioselectivity depends on the R1 and R5 substituents, or sometimes the 
nucleophiles.85,86,87 
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Scheme 38 
 
However, as illustrated in path B, direct intermolecular SN2 reaction of 146 with amine 
147 can occur under the same conditions. This gives diamine 151, which is 
diastereomeric to 149. Since the difficulties in differentiating between 149 and 150 by 
common analytical techniques, such as NMR, questions arise whether the aziridinium 
intermediates have indeed been formed during the reaction. 
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The O’Brien group has probed the evidence of the aziridinium ion formation using a 
novel deuterium substitution approach.88 During their investigation for the synthesis of 
1,2-chiral diamines, they observed that varying the R group of 152 affected the 
regioselectivity (Scheme 39). When R = Me, Bn or iPr, 153a–c were favoured against 
154a–c. Whereas when R = Ph, 154d was synthesised with an excellent 
regioselectivity. They argued that the formation of 154d must have proceeded via an 
aziridinium ion intermediate whereas it was not conclusive for the formations of 153a–c 
since direct SN2 substitution on 152a–c with MeNH2 would also give 153a–c. 
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Scheme 39 
 
To clear this ambiguity, they decided to prepare the deuterated adduct syn-155 by 
incorporating a deuterium atom onto the α-hydroxy carbon of 152b and determine the 
mechanism of nucleophilic addition of NH2Me by analysing the stereochemistry of the 
products. As depicted in Scheme 40, compound syn-155 was prepared via a Swern 
oxidation of 152b followed by reduction with sodium borodeuteride. Subsequent 
methanesulfonate formation with MsCl followed by treatment with MeNH2 gave a 94:6 
C1/C2 addition regioisomeric mixture with C1 addition products 156 as the major 
isomer. Further experimental and NMR analyses revealed that 156 consisted of an 
85:15 diastereomeric mixture of syn-156 and anti-156. The retention of the C1 
stereocentre of syn-156 indicated that this process went through an aziridinium ion 
intermediate whereas the C1 inversion conformation of anti-156 came from a direct SN2 
process.  
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Scheme 40 
 
Ha et al. have reported a novel synthesis of oxazolidinones via aziridinium ion species 
(Scheme 41).89 Acylation of the nucleophilic nitrogen of carboxylate aziridines 157 
gave aziridinium ions 158, which were more reactive and regioselectively attacked by 
the resulting chloride anion to give chlorides 159. Chloro-substituted intermediates 159 
were then converted into oxazolidinone 160 through intramolecular SN2 reactions. The 
formation of the aziridinium intermediate was also evidenced by the isolation of 
compound 159 when the reaction was performed in toluene instead of acetonitrile. 
Furthermore, when 159 was heated under reflux in acetonitrile, it gave oxazolidinone 
160 in excellent yield. 
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Scheme 41 
 
In addition to carboxylate aziridines, Ha also investigated vinylaziridines 162 and 164, 
prepared from aldehyde 161 via Horner-Wadsworth-Emmons reaction and Wittig 
reaction respectively (Scheme 42). When exposed to standard conditions, 
oxazolidinones 163 and 165 were isolated in good yields and excellent regioselectivity. 
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Wang and co-workers extended this methodology to the synthesis of 1,4-
benzodiazepine derivatives 170 (Scheme 43).90 This process began with N-benzylation 
of aziridines 166 with benzyl bromides 167 followed by a highly regioselective ring-
opening of the aziridinium intermediates 168 by the resulting bromide anion to generate 
bromoesters 169. The regioselectivity was ca. 10:1, as determined by 1H-NMR, in 
favour of attack on the more substituted carbon adjacent to the ester group. Although 
compounds 169 could be isolated by silica gel column chromatography, they were used 
in a one-pot process by addition of triethylamine under reflux to furnish the desired 
products 170. The overall yield was respectable, typically around 50–60%, with the 
exception of where R is 3-Cl and Ar is phenyl giving a yield of 25%. This tandem 
method provides an efficient way of preparing 1,4-benzodiazepines with easy 
availability of starting materials and simple procedure.  
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1.7 Conclusion 
 
The current Craig group retrosynthetic approach to morphine was proposed (Scheme 7), 
together with examples of some classical total syntheses of morphine. Our strategy 
includes two key steps: 1) an unprecedented RRM of allyl cyclopentene 44 to vinyl 
cyclohexene 43; 2) regioselective ring-opening of vinyl aziridine 46 with anionic 
sulfone 45. The RRM step was considered to be challenging since the relatively similar 
ring-strain of the starting material and the desired product. Some reported examples 
were provided to prove the feasibility of this transformation. A brief review in the area 
of nucleophilic regioselective ring-opening of aziridines was presented. It demonstrates 
the unique value of this methodology in constructing carbon–carbon bonds stereo- and 
regioselectively and incorporating nitrogen into molecules. The foregoing discussion 
shows that, in general, phenyl substituents are particularly effective for directing 
regioselective attack, both for carbon and heteroatom nucleophiles. Some interesting 
results with carboxylate-substituted aziridines have been observed where the control 
elements are less obvious. Additionally, the presence of Lewis acids proved to be 
essential in some cases and their effects were fascinating. Finally, aziridinium rings 
have significant potential in directing regio-controlled attack, which allows rapid 
formation of a variety of heterocycles. 
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2. Results and Discussion 
 
Application of aziridine chemistry in natural products synthesis: 
Previous results from the Craig group 
 
The Craig group is actively involved in the application of aziridine chemistry directed 
towards natural product synthesis. Previous research has successfully accomplished the 
synthesis of (±)-lepadiformine 179 via two key reactions: aziridine ring-opening and 5-
endo-trig pyrrolidine formation mediated by a phenylsulfonyl group, as shown in 
Scheme 44. 91  The natural form (–)-lepadiformine, a decahydro-1H-pyrrolo[1,2-
j]quinoline isolated in 1994 by Biard et al. from the tunicate Clavelina lepadiformis92, 
has moderate in vitro cytotoxic activity towards varioustumor cell lines, including 
nonsmall-cell lung carcinoma (NSCLCN6), and is also a cardiac-K+-channel blocker.93 
 
N-SES Protected aziridine 174 was prepared from N-cyclohexylidenecyclohexanamine 
171 and 2-(2-bromoethyl)-1,3-dioxolane 172 in a four-step sequence. Alkylation of the 
lithium enolate of 171 with 172 gave ketone 173 94 , as described by Minor and 
Overman.95 Epoxidation of 173 with dimethylsulfoxonium methylide, prepared from 
Me3S(O)I and NaH in situ, yielded a single epoxide, which reacted with SESNH2 to 
give the corresponding amino alcohol. Subjection of this amino alcohol to modified 
Mitsunobu conditions [1,1’-(azodicarbonyl)dipiperidine (ADDP), Me3P] furnished 174 
with inversion of configuration at the tertiary alcohol stereocentre. Completely 
regioselective attack at the less hindered site of the aziridine of 174 was achieved by 
treatment with lithiated PhSO2Me, giving 175 in 97% yield. Exposure of the dianion of 
175 to BnOCH2CHO followed by quenching with PhCOCl furnished pyrrolidine 176. 
This process proceeds through a 5-endo-trig cyclisation of the resulting E-vinylic 
sulfone intermediate. 
 
The tetracyclic intermediate 177 contains the tricyclic skeleton of lepadiformine 179, 
which was constructed by deprotection of the benzyl and SES group of 176 followed by 
cleavage of the acetal triggering aminal formation. Reaction of 177 with hex-1-
ynylmagnesium bromide in an SN1-like substitution gave alkyne 178, which was 
transformed into 179 in another seven steps. 
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Scheme 44 
 
A modified approach to the previously established route96 in the group that has achieved 
the pentacyclic framework of (–)-alstonerine97 187, a macroline-related alkaloid, was 
also investigated, as outlined in Scheme 45. 98 This involves the synthesis and ring-
opening reaction of the 1,2,3-trisubstituted indole hydroxyl-methyl-substituted aziridine 
184.  
 
Mono-protection of diol 180 followed by aziridination gave cis-aziridine 181. This 
substrate was then converted to cis-aziridine 184 in a four-step sequence involving: 
NaH-mediated aza-Payne rearrangement to yield the epoxide 182;99 BF3·OEt2-assisted 
ring-opening of 182 by 1-methylindole and cyclisation of amino alcohol 183 under 
Mitsunobu conditions followed by silyl deprotection. Reaction of O-lithio-aziridine 184 
with lithiated tosyl acetal 185 gave a 1:1 mixture of adducts 186 in 83% yield, with 
none of the alternative regioisomers observed. However, in an attempt to convert 186 
into the corresponding tetrahydropyridine by treatment with Lewis acids such as 
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BF3·Et2O and TMSI, a Pictet–Spengler reaction occurred involving the indole C2. 
Current effort is focused on the use of alternative nucleophiles for ring-opening of 184. 
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2.1 Previous Approaches to Morphine Synthesis 
 
The approach to morphine synthesis shown in Scheme 46 has been investigated 
previously in the group.31 In this route, a key step was the preparation of acetal 
tosamide 191, by reaction of acetal 185 and 2,3-trans-vinylaziridine 46. Aziridine 46 
may in principle react at either of the aziridine ring carbon atoms, or in an SN2' sense at 
the terminal alkene carbon atom, as depicted in Figure 6. Additionally, it has acidic 
benzylic protons whose removal could trigger styrene formation through eliminative 
ring-opening. 
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Despite all these possible side-reactions, lithio-185 was combined with aziridine 46 
with complete chemo- and regio-selectivity to give acetal tosamide 191 in an excellent 
yield (Scheme 47). When treated with the Lewis acid BF3·Et2O, 191 cyclised to yield N-
tosyl tetrahydropyridines 190. 
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It was also discovered that under the same conditions the reaction of aziridine 46 with a 
more hindered nucleophile sulfone 192 gave allyl tosamide 193, the product of an SN2' 
addition at the terminal olefin, in a poor yield of 28% (Scheme 48). 
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Intriguingly, when the 2,3-cis-benzyl vinyl aziridine 194 was treated with lithio-192, 
the desired products 195 were obtained with once again complete chemo- and regio-
selectivity, albeit in a low yield of 50% (Scheme 49).  
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With tetrahydropyridine 191 in hand, its C-4 alkylation was investigated in an attempt 
to access the next key intermediate 189. However, after extensive experimentation, no 
direct alkylations were realised, although carboxylation was achieved when lithio-191 
was treated with methyl chloroformate, giving 196 (Scheme 50). 
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2.2 Investigation of the Current Retrosynthesis of Morphine 
 
2.2.1 Synthesis of 2-(4-Methoxybenzyl)-1-tosyl-3-vinylaziridine 46 
 
The work presented herein follows the current proposed retrosynthetic route to 
morphine synthesis, as previously described in Scheme 7, and its modifications as 
appropriate.  
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Scheme 7 
 
At the outset of the new work described in this thesis, the synthesis of key 
vinylaziridine 46 was re-investigated. Two methods were available before the 
commencement of the project, both developed by former group members, Hyland30 and 
Carballares.31  
 
Initially the shorter approach uncovered by Hyland was examined. As depicted in 
Scheme 51, aziridine 46 was prepared stereoselectively in a four-step sequence starting 
from butadiene monoxide 47. Conjugate addition of (4-methoxyphenyl)magnesium 
bromide 48 to the terminal olefinic position of 47 was achieved in the presence of sub-
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stoichiometric CuCN. The resulting allyl alcohol 197 was exposed to Sharpless 
aziridination100 conditions to produce hydroxylaziridine 198 with the desired 2,3-trans 
configuration, together with 8% of the 2,3-cis isomer. No alternative reactions for the 
synthesis of 198 were carried out using another common aziridination procedure with 
PhI=NTs and Cu(OTf)2
101 since it was found by Hyland that only starting material and 
tosylamide were recovered.  
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i) (4-methoxyphenyl)magnesium bromide 48 (1.2 equiv), CuCN (0.1 equiv), THF, –78 °C-rt, 3 h; ii) 
anhydrous chloramine-T® (1.1 equiv), PhNMe3Br3 (0.1 equiv), dry MeCN, rt, 20 h; iii) IBX (1.1 equiv), 
DMSO, rt, 22 h; iv) Ph3PCH3Br (1.1 equiv), KHMDS (1.1 equiv), THF 
 
Scheme 51 
 
The proposed pathway for this bromine-catalysed aziridination process is shown in 
Figure 7. Initial addition of Br+ to trans-olefin 199 gave bromonium ion 200 which 
reacts with TsNCl– to give β-bromo-N-chloro-N-toluene sulfonamide 201. Attack of Br– 
on the Cl–N group generates substrate 203 and Br– resource species entering the 
catalytic cycle. Intermediate 203 undergoes an intramolecular substitution of Br with 
NTs yields aziridine 204. 
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Figure 7 
 
The subsequent oxidation of alcohol 198 was achieved using IBX to give the 
corresponding aldehyde in typically above 95% yields.102 However, the final Wittig 
olefination step was problematic. It was poor yielding and not reproducible. This was 
believed to be due to the instability of the aldehyde as decomposition was observed 
when it was passed through a silica gel column. Steric hindrance from the N-Ts group 
may also contribute to this outcome. 
 
Although this approach gave access to aziridine 46, low yields rendered it impractical. 
As a result, the longer but more robust route of Carballares was adopted as shown in 
Scheme 52. Epoxidation of allyl alcohol 197, prepared as described previously in 
Scheme 51, yielded hydroxy epoxide 205, which was converted into vinyl epoxide 206 
after oxidation and Wittig olefination. Microwave assisted ammonolysis of 206 gave 
amino alcohol 207 together with its regioisomer in a 10:1 ratio. This transformation 
could also be performed by conventional methods. However, a reaction time of 12 days 
was required to obtain similar results. Subsequent tosylation of 207 followed by 
Mitsunobu cyclisation of tosamide 208 furnished aziridine 46.  
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This method gave an overall yield of 52% compared to 11% for the route shown in 
Scheme 51. Furthermore, it gave good consistency when scaling up. It is noteworthy 
that only four column chromatography purifications were necessary as substrates 197, 
205 and 207 could be used crude. 
 
OMe
OH
O
OMeOMe
O
HO
H2N
OMe
HO
TsHN
OMe
OH
96%
OMe
TsN
83% 84% 81%
i
96%
ii, iii iv
vi
v
   197                    205                                     206                                         207
208                                     46  
 
i) m-CPBA (1.3 equiv), CH2Cl2, –78 °C-rt, 4 h, 96%; ii) (COCl)2 (1.2 equiv), DMSO (2.4 equiv), Et3N 
(5.0 equiv), CH2Cl2, –78 °C-rt, 1h, 85%; iii) Ph3PCH3Br (2.0 equiv), KHMDS (2.0 equiv), THF,   –20 °C, 
1.5 h, 83% over two steps; iv) NH4OH (28% NH3), microwave, 110 °C, 35 min, 84%; v) TsCl (1.5 
equiv), DMAP (0.12 equiv), Et3N (3.1 equiv), CH2Cl2, –5-0 °C, 3 h, 81%; vi) DIAD (2.0 equiv), PPh3 
(2.6 equiv), THF, –25 °C then –5 °C, 13 h, 96% 
 
Scheme 52 
 
2.2.2 Synthesis of 4-(Phenylsulfonyl)cyclopent-2-enol 45 
 
Having successfully synthesised aziridine 46, the focus shifted to the synthesis of 
another key intermediate, 4-(phenylsulfonyl)cyclopent-2-enol 45 (Scheme 53). It has 
previously been prepared from epoxide 210 via a palladium(0) π-allyl addition process 
with two equivalents of PhSO2Na. This method employed 0.5 mol% Pd(acac)2 in THF 
to give 57% yield after five hours.32 
 
Encouraged by this report, cyclopentadiene monoxide 210 was prepared from 
cyclopentadiene 209 following a literature described procedure.103  In an attempt to 
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improve the reaction yield, an alternative epoxidising reagent m-CPBA was tested. 
However, both TLC profiles and crude NMRs suggested that undesired by-products 
were produced and the expected compound was synthesised only in a very small 
amount.  Nevertheless, with sufficient quantity of this substrate in hand, the synthesis of 
sulfone 45 was investigated. Disappointingly, when the literature conditions were 
repeated only a trace amount of sulfone 45 was isolated. Therefore other conditions 
were investigated (Table 1). 
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             i) CH3COOOH (1.0 equiv), Na2CO3 (3.97 equiv), NaOAc (0.04 equiv), CH2Cl2, 20 °C 
 
Scheme 53 
 
By increasing the loading of the catalyst Pd(acac)2 to 5 mol%  and reaction time to four 
days, the yield of this reaction was improved to 37% (Entry 1). Interestingly, when 
switching the solvent from THF to DMF, no reaction occurred after six hours (Entry 2). 
When Pd(PPh3)4 was used in THF (Entry 3), no product was detected despite the fact 
that all the starting material of 210 had been consumed. Finally, when Pd2(dba)3 was 
employed in DMF, the highest yield of 42% was obtained (Entry 4) compared to 20% 
in THF. This was likely to be because the solubility of PhSO2Na salt is much greater in 
DMF than THF. 
 
 
Entry          solvent         catalyst (mol %)              time           temp. (°C)  yield (%) 
   1                THF             Pd(acac)2 (0.5→5)          4 days            60              37        
   2                DMF            Pd(acac)2  (5)                   6 h                 60              – 
   3                THF             Pd(PPh3)4 (5)                  2 days             90              – 
  4                THF             Pd2(dba)3  (5)                   6 h                 60              20 
   5                DMF            Pd2(dba)3  (5)                   6 h                 90              42 
 
Table 1 
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Although cyclopentenyl sulfone 45 could be made via this route, low yields hindered its 
practicality. In order to overcome this unsatisfactory outcome, alternative methods were 
considered. There are many examples of synthesising cyclopentenes using RCM 
chemistry.33a,34 It was expected that compound 45 could be derived from RCM of diene 
precursor 211 (Scheme 54). Diene 211 was anticipated to come from a regioselective 
ring-opening of epoxide 47 on C3 by lithiated allyl sulfone 212 that in turn could be 
prepared from inexpensive starting materials allyl bromide 213 and PhSO2Na.  
 
Br
O
PhO2S OHOHPhO2S
+
PhSO2Na
RCM
+
45                                            211                             47                         212
213
SO2Ph23
 
Scheme  54 
 
As planned, allyl sulfone 212 was obtained after an SN2 reaction of allyl bromide 213 
and sodium phenylsulfinate (Scheme 55). The low yield of this step was likely due to 
the quality of reagent 213. Surprisingly, the subsequent ring-opening of epoxide 47 by 
lithiated anion of 212104 resulted in olefin migrated products 216 and 217 with a 1.7:1 
ratio according to 1H NMR analysis of the crude mixture. 
213                                                              212
Br PhSO2Na+
i SO2Ph ii
OHPhO2S
+ PhO2S
OH
OPhO2S
PhO2S
+
O
216, 29%                           217, 17%
70%
214
215
 
 
i) DMF, rt, 4 h; ii) a) nBuLi (1.2 equiv), Et2O, –20 °C-rt, 45 min; b) butadiene monoxide 47 (1.0 equiv),  
–20 °C-rt, 2.5 h 
Scheme 55 
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These results are probably due to the relative lack of stability of intermediates 214 and 
215, induced by the strong electron withdrawing ability of the β-sulfone and the 
products being more stable α-sulfonyl tri-substituted olefins. The geometry of the 
double bonds was not proved. However, we believed that the E isomers were favoured 
because this process was considered to be driven by thermodynamic effect. Similar 
results were also reported by Cheng et al.105  
 
According to this hypothesis, it was speculated that the migration could be prevented if 
the β-sulfonyl olefin was stabilised by being more substituted such as 218 and/or having 
an electron withdrawing substituent such as 219 (Scheme 56). More importantly, the 
subsequent RCM would give the same product. 
 
PhO2S
EWG
OHOHPhO2S
R1
R2
RCMRCM OHPhO2S
218                                               45                                                      219  
 
Scheme 56 
 
Work by Hoveyda et al. has shown that RCM of diene 220 gave the corresponding 
cyclopentenol 221 in excellent yields (Scheme 57).106  
 
OH
Ru-based metathesis catalysts OH
> 98%
220                                                                               221  
 
Scheme 57 
 
Encouraged by this, prenyl sulfone 223 was prepared from prenyl bromide 222 and 
PhSO2Na similar to that previously described in Scheme 55 (Scheme 58).
104 Pleasingly, 
when butadiene monoxide 47 was treated with lithio-223, the expected products 224 
and 225 were synthesised, both with dr >100:1. However, the regioselectivity of this 
reaction was poor. It gave 36% yield of the desired diene 224, less than that of the 
undesired diene 225 42%. Therefore RCM was not carried out at this point and the 
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stereochemical relationship between the phenylsulfonyl and hydroxyl substituents was 
not investigated. 
Br
PhSO2Na SO2Ph
OHPhO2S
SO2Ph
HO
+ i ii +
92%
222                                                          223
224, 36%
225, 42%  
 
i) DMF, rt, 6 h; ii) a) nBuLi (1.2 equiv), THF/TMEDA (1:1), –78-20 °C, 45 min; b) butadiene monoxide 
47 (1.2 equiv), –78 °C, 1 h 45 min 
 
Scheme 58 
 
As depicted in Scheme 56, in line with the theory of having a more substituted double 
bond, introduction of an electron-withdrawing group such as phenyl was also expected 
to have a similar stabilising effect. Therefore, cinnamyl sulfone 227 was prepared from 
cinnamyl bromide 226 and PhSO2Na.
107  Indeed, when butadiene monoxide 47 was 
treated with lithio-227, the expected products 228 and 229 were obtained in around 
3.5:1 ratio according to 1H NMR analysis of the crude mixture. A number of conditions 
were tested in attempts to improve the yield and regioselectivity of this reaction, such as 
utilising co-solvent TMEDA, varying the reaction concentrations and temperatures. It 
was found that the yields for 228 and 229 were typically 55%–62% and 15–18% 
respectively. Compounds 228 were obtained as a 3:1 diastereomeric mixture, favouring 
the 3-phenylsulfonyl-5-hydroxyl-syn isomer, as determined later on in the RCM step. 
These two diastereoisomers were inseparable by column chromatography. However, a 
fraction of the syn isomer was isolated by slow recrystallisation. 
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Ph Br
PhSO2Na+ Ph SO2Ph
PhO2S
Ph
OH
SO2Ph
Ph
HO
iii
93% +
226                                                              227
228, 55−62%
229, 15−18%
dr = 3:1
dr > 100:1  
 
i) DMF, rt, 2 h; ii) a) nBuLi (1.05 equiv), THF, –20-0 °C, 45 min; b) butadiene monoxide 47 (1.1 equiv),  
–20 °C- rt, 1 h 45 min 
 
Scheme 59 
 
With dienes 228 in hand, the subsequent RCM reactions were investigated. As had been 
hoped, when mixture 228 was treated with catalyst 50 in parallel with the small amount 
of 3,5-syn-228 isolated, they underwent facile ring-closing reactions to furnish 45 and 
1,4-syn-45 in excellent yields and short reaction times (Scheme 60). Intriguingly, the 
reaction of 3,5-syn-228 was completed in just one minute, as monitored by TLC, 
whereas ten minutes were required for mixture 228. It is noteworthy that higher reaction 
temperature was crucial for these reactions. At room temperature the reaction proceeded 
very slowly and did not reach completion. Finally, the stereochemistry of syn-228 was 
determined by comparison of its RCM product syn-45 with that previously prepared via 
the palladium π-allyl nucleophilic addition strategy as illustrated in Scheme 53. 
 
PhO2S
Ph
OH
OHPhO2Si
PhO2S
Ph
OH
OHPhO2Si
228                                                                  45
93%
93%
syn-228                                                          syn-45  
                         
                          i) Catalyst 50 (1 mol%), CH2Cl2, 40 °C, 10 min for 228; 1 min for 3,5-syn-228 
 
Scheme 60 
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Due to difficulties in separating regioisomers 228 and 229 on large scales, a two-step 
experiment was devised by using the crude isomeric mixture for the subsequent RCM 
step. An overall yield of 54% for 45 was obtained when the reaction was carried out 
with 45 grams of cinnamyl sulfone 227. 
 
In parallel with the investigation of the RCM of 228, its hydroxy-protected counterpart 
230 was also subjected to metathesis conditions (Scheme 61). Protection of alcohol 228 
with TBDMSCl under standard conditions cleanly afforded 230. Interestingly, RCM of 
230 demanded higher catalyst loadings and longer reaction times compared to 228. 5 
mol% Catalyst 50 and 16 hours were required in order to obtain 231 in 79% yield. 
 
OTBDMSPhO2S
PhO2S
Ph
OTBDMSPhO2S
Ph
OH
i ii
228                                            230                                                    231
95%                                                  79%
 
 
i) TBDMSCl (1.8 equiv), Et3N (3.0 equiv), DMAP (7.5 mol%), CH2Cl2, 40 °C, 24 h; ii) catalyst 50 (5 
mol%), CH2Cl2, 40 °C, 16 h 
 
Scheme 61 
 
Overall, a satisfactory route to access cyclopentenyl sulfone 45 was discovered. 
Cinnamylsulfone 227 was the ideal starting material. It first of all precluded the double 
bond from migrating. Secondly it gave a regioselectivity of 3.5:1 in favour of the 
desired product. The explanation of the regioselectivity is believed to be that the steric 
hindrance of the phenyl group enhances the difficulties of attacking the more hindered 
C2 position of the epoxide. 
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2.2.3 Investigation of the Reactivity of Cyclopentenyl Sulfone 45 
 
Having developed an efficient route to large quantities of cyclopentenyl sulfone 45, it 
was considered to be beneficial to investigate the reactivity of 45 prior to the reaction 
with aziridine 46. This section details the investigation of the stability of 45, α-SO2Ph 
alkylation and RRM of its derivatives.  
 
2.2.3.1 Stability Test of 45 
 
The stability of 45 was considered to be crucial for subsequent transformations in the 
planned synthetic sequence. A major concern was that an elimination reaction would 
occur when 45 was treated with base, generating a more stable sulfonylcyclopentadiene 
232 (Figure 8).  
 
OHPhO2S
H
B
PhO2S
elimination
45 232  
 
Figure 8 
 
Therefore, a simple deprotonation experiment was carried out in which compound 45 
was exposed to two equivalents of nBuLi in THF at –78 °C (Scheme 62). The resulting 
solution was warmed to 0 °C over a period of two hours. After stirring at that 
temperature for one hour followed by two hours at room temperature, the reaction was 
quenched with a 1M solution of AcOH in THF. Gratifyingly 100% of 45 as 1:1 
diastereomixture were recovered. 
 
OHPhO2S
45, dr = 3.5:1
OHPhO2S
1a. nBuLi (2.0 equiv), THF
      −78°C → rt
1b. AcOH, THF
45, dr = 1:1, 100%  
 
Scheme 62 
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2.2.3.2 α-SO2Ph Alkylation of 45 
 
As set out in the retrosynthetic route, our plan to access cyclohexene 43 entailed 
subjection to RRM of the cyclopentene-containing ring-opening adduct 44 (Scheme 
63). This kind of RRM is unprecedented. In order to understand the RRM reactivity of 
this type of allyl cyclopentene moiety, it was considered to be useful to synthesise 
analogous cyclopentenes 234 in order to find out whether RRM would lead to 
cyclohexenes 235. The plan for synthesis of 234 involved treatment of lithio-45 with 
allylic bromides 233.  
 
OMe
TsHN
PhO2S
OH
PhO2S
OR3
PhO2S
OR3
OMe
TsHN
OH
H
RRM?
PhO2S
OMe
TsN
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+
RRM?
 46                                          44                                                     43
litiho-45
234                                                 235
OPhO2S
lithio-45                         233
+
Br R1
R2 R1
R2
 
 
Scheme 63 
 
Alkylations of cyclopentene 45 proved to be facile. When lithio-45 was treated with 
allylic bromides 233, 1-allyl-1-phenylsulfonyl cyclopentenes 234a–d were obtained 
(Scheme 64). 
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OHPhO2S i OHPhO2S
234a: R1 = H,    R2 =H;    61%
234b: R1 = Me,  R2 =H;    67%
234c: R1 = Ph,   R2 =H;   49%
234d: R1 = Me,  R2 =Me; 40%
R1R2
45
 
 
i) a) nBuLi (2.1 equiv), THF, –78 °C, 30 min; b) R1R2C=CHCH2Br 233 (1.0 equiv), THF,      
–78 °C-rt, 1.5-2.5 h 
 
Scheme 64 
 
Remarkably, with the exception of 234a obtained with a 10:1 dr, these transformations 
gave complete diastereoselectivities favouring the 1-phenylsulfonyl-4-hydroxy-cis 
isomers as depicted in Scheme 64. This was determined by the X-ray crystallographic 
structure of 234d (Appendix I). 
 
This fascinating selectivity may be attributed to the chelating effect between lithium 
and oxygen atoms.108 As illustrated in Figure 9, the lithium cation coordinates with the 
oxy-anion and the proximal oxygen of the PhSO2 group.
108 This configuration leaves 
only the least hindered opposite face for the electrophiles to approach. This explanation 
is supported by X-ray crystallographic analysis of 234d, which shows a distinctive 
intramolecular H-bond between the –OH and the –SO2 groups (Appendix I). 
 
 
 
 
 
 
                                                  
                                                              X–ray structure of 234d 
 
Figure 9 
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The yields of these reactions might be explained by steric effects. When the size of the 
electrophiles increased, the yields decreased. This was most marked by that the yields 
dropped from 61% for allyl bromide to 40% for prenyl bromide.  
 
2.2.3.3 Investigation of RRM of 234a–d 
 
Having acquired substrates 234a–d, their RRM reactivity was investigated. As 
previously mentioned, RRM of this kind is unprecedented. Two possible mechanisms 
may be proposed (Schemes 65, 66).  
 
Mechanism 1 begins with an initially attack of the catalyst on the side chain olefin of 
234 to give 236 followed by the interaction with the cyclic double bond in an attempt to 
undergo an intramolecular ring-opening of the cyclopentene (Scheme 65). However, as 
the Ru atom has to be bonded to the unsaturated cyclic carbon β to the sulfone, as 
depicted in intermediate 237, ring strain impedes its viability.  
 
 
LnRu=CHPh
OR3
PhO2S
LnRu
OR3
PhO2S
LnRu
(strained intermediate)
+
PhO2S
OR3
R1
R2
PhO2S
OR3
RuLn
234                                         236                                  236
237
 
 
Scheme 65 
 
In mechanism 2, cyclopentene 234 is opened by the catalyst, generating intermediate 
238 that then undergoes a ring-closing metathesis involving the side chain olefin 
(Scheme 66). Expulsion of LnRu=CHR1R2 240 from 239 yields the expected 
cyclohexene 235. The regenerated ruthenium carbene species 240 is ready to initiate 
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another reaction cycle. This pathway avoids the ring strain seen in mechanism 1 and 
would therefore be the suitable mechanism for these reactions. 
 
 
LnRu=CHPh
R3O SO2Ph
R3O SO2Ph
LnRu
R3O SO2Ph
LnRu
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Scheme 66 
 
Additionally, since RRM reactions were rationalised to be thermodynamically driven,109 
to ascertain whether cyclohexene was favoured, the following experiments were carried 
out (Scheme 67). Triene 241 was prepared from 228 via an SN2 reaction with allyl 
bromide. Treatment of 241 with catalyst 50 in dilute CH2Cl2 afforded cyclohexene 242 
as the only product isolated.  
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Ph
OHPhO2S OH
Ph
PhO2S
ii
228                                                     241                                                  242Ph
OHPhO2S
i
57%                                                   59%
 
i) nBnLi (2.1 equiv), CH2=CHCH2Br (1.0 equiv), THF, –78 °C-rt, 1 h; ii) catalyst 50 (3 mol%), CH2Cl2, 
rt, 24 h 
 
Scheme 67 
 
Encouraged by this outcome, compounds 234a–c were subjected to metathesis 
conditions. Unexpectedly cyclopentenones 243a–c were isolated (Scheme 68). The 
yields of these ketones were directly proportional to the loadings of the catalyst. It was 
therefore rationalised that the ruthenium catalyst acted as an oxidant in a non-catalytic 
manner, thus incompatible with the hydroxyl group of these substrates.  
 
i
2 3
4
OHPhO2S
R1H
234a-c: R1 = H, Me, Ph                                             243a-c
+ SM
2 3
4
OPhO2S
R1H
 
 
                   i) catalyst 50 (5 mol%), CH2Cl2, rt, 24 h 
 
Scheme 68 
 
The structures of 243a–c were determined by their 1H NMR and IR spectra. All IR 
spectra of products 243a–c showed absorptions at ~1726 cm-1 for the cyclic α,β-
unsaturated ketones. Figure 10 compares the key differences of the 1H NMR spectra of 
the starting material 234a and the product 243a. Olefinic H–2 of 243a is significantly 
more downfield than that of 234a.  α-Hydroxyl H–4 of 234a is not observed in 243a 
and cyclic olefinic H–3 changed from a dd in 234a to a d in 243a.  
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Figure 10 
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In light of the above results, attention was turned towards the investigation of the RRM 
of hydroxy-protected derivative 244, synthesised by protection of compound 234a with 
TBDMSCl (Scheme 69). When 244 was treated with catalyst 50, however, 10% of the 
dimerised adduct 245 and 3% of compound 234c were isolated, together with recovered 
SM. Compound 234c was believed to come from a cross metathesis between 244 and 
catalyst 50. Similar results were obtained using TES as an alternative protecting group.  
 
OTBDMSPhO2S
234a                                       244
OHPhO2S
i                                                    ii
87%
245, ca. 10%
+
OTBDMSPhO2S
Ph
234c, 3%
OTBDMSPhO2S
PhO2S
OTBDMS
 
i) TBDMSCl (1.8 equiv), Et3N (2.5 equiv), DMAP (15 mol%), CH2Cl2, 40 °C, 24 h; ii) catalyst 50 (10 
mol%), CH2Cl2, 40 °C, 20 h                   
 
Scheme 69 
 
2.2.3.4 Attempt at Relay RRM Mediated by Dihydrofuran 
 
The above experiments indicate the inability of the catalyst to access the cyclic alkene. 
According to this rationale, an alternative strategy was designed to facilitate the ring-
opening of the cyclopentene by an allyl ether side chain (Scheme 70). Initial RRM of 
246 involves the allyl ether side chain alkene and the cyclic alkene forming the 
dihydrofuran of 247 ready to undergo a second metathesis to give 248. 
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Scheme 70 
 
The feasibility of RRM of cyclopentenes bearing allyl ether side chains has been 
demonstrated by Grubbs et al.110 and Hoveyda et al.111 (Scheme 71). They showed that 
when treated with catalyst 49, cyclopentenyl allyl ethers 249, 251, 253, and 254 were 
converted to their corresponding dihydrofurans 250, 253 and 255. Grubbs proposed that 
mechanisms of initial attack of the catalyst at the acyclic olefin or the cyclic olefin were 
both possible. 
 
OO O O
5 mol% catalyst 49
0.1 M C6H6, 60 °C  2h
90%
O
O
O O5 mol% catalyst 49
0.04 M C6H6, 60 °C  3h
92%
O
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0.1 M C6H6, 22 °C  20h
O
O
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33%
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249                                                                                           250
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Scheme 71 
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In addition, Hoveyda et al. investigated the reaction equilibrium between 
cyclohexenyl allyl ether 256 and dihydrofuran 257 (Scheme 72).111 They showed that 
under the metathesis conditions as shown in Scheme 72 256 was only poorly 
converted to 257 in 24% yield. They argued that the inefficiency was due to the 
relatively strain-free cyclohexene. In contrast, exposure of 257 under the same 
conditions led to a ca. 2:1 mixture of 256/257. 
 
O
5 mol% catalyst 49
0.1 M C6H6
 22 °C, 20h
ethylene O
5 mol% catalyst 49
0.1 M C6H6
 22 °C, 37h
ethylene
24%
O
256                                                     257                                                         256
 
 
Scheme 72 
 
Encouraged by these precedents, allyl ether 246 was prepared by O-allylation of 234d 
with allyl bromide (Scheme 73). The choice of 234d was in hope to increase the 
chemoselectivity of the initial metathesis on the allyl ether olefin. However, subjection 
of 246 to metathesis conditions led to alkene migrated adducts 258 with a 2:1 ratio of E/ 
Z isomers.  
 
OHPhO2S OPhO2S OPhO2S
i ii
95% 10%
234d                                              246                                                   258  
 
i) NaH (1.1 equiv), CH2=CHCH2Br (1.7 equiv), DMF, 0 °C-rt, 16 h; ii) catalyst 50 (0.07 equiv), toluene, 
rt, 16 h 
 
Scheme 73 
 
Many explanations have been proposed for Ru-based metathesis catalyses induced 
alkene isomerisations, such as metal-based hydride, π-allyl, or other pathways.112,113 
Although the exact mechanism is unknown, Grubbs and co-workers have shown that 
ruthenium hydride species, formed from the decomposition of the ruthenium metathesis 
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catalysts, could cause migration of olefins.114 Additionally, they managed to suppress 
this type of unwanted transformation by deploying benzoquinone based additives.115  
 
Many people also take advantage of this methodology for their syntheses.113c,116 For 
example, Schmidt and co-workers have synthesised various 6-deoxy glycols by 
adopting a tandem process of RCM followed by isomerisation of the newly formed 
alkene.117 
 
Comparing the structural similarities of 246 (Scheme 73) and 249 (Scheme 71), these 
results seemed to indicate that the highly encumbered nature of the cyclic olefin of 246, 
primarily caused by the 1-SO2Ph substituent, was deleterious to its reactivity. 
Additionally, the electron-withdrawing effect from the sulfone might further decrease 
its reactivity. 
 
2.2.4 Attempted Synthesis of Aziridine Ring-opening Product 44 
 
In light of the above results, it was considered to be necessary to change the original 
proposal, in which reaction of aziridine 46 and sulfone 45 was followed by a RRM of 
the product 44 (Scheme 6). Compound 44 would then undergo a cationic induced 
desulfonylative cyclisation31 to give 42. It was now believed that removal of the PhSO2 
group of 44 prior to RRM was essential. This would reveal the less hindered and more 
electron rich cyclic alkene of 259, which would be subjected to metathesis conditions to 
furnish 42 (Scheme 74).  
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Scheme 74 
 
Attention was focused on the synthesis of substrate 44, by reaction of regioselective 
ring-opening of vinyl aziridine 46 with sulfone 45 (Scheme 75). However, after testing 
various conditions including the use of excessive sulfone 45 and different bases, none 
of the desired product was observed (Table 2). Other methods were also tested, 
including deploying co-solvents TMEDA or DMPU, raising reaction temperatures to 60 
°C, microwave irradiation and utilising Lewis acid additives such as Zn(OTf)2. 
However, only starting materials were recovered in most cases. It was reasoned that the 
sterically congested α-sulfonyl carbanion centre of 45 and the insufficient 
electrophilicity of 46 both contributed to the outcome. 
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Scheme 75 
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 Entry      Comp. 45 (equiv)       Base (equiv)      Comp. 46 (equiv)          result 
  1                1.0                         nBuLi (2.1)               1.0                           SMs 
  2                1.0                             KH (2.2)               1.0            SMs + unidentified 
                                                                                                     new product     
  3                1.0               nBuLi (1.0) + KH (1.0)      1.0            SMs + unidentified 
                                                                                                     new product  
  4                2.2                         nBuLi (4.4)               1.0                          SMs          
  5                5.0                         nBuLi (10.0)             1.0       SM(45) + unidentified 
                                                                                                     new products 
                                                                                                                     
 
Table 2 
 
To overcome this problem, the analogous hydroxyaziridine 198 was deployed to react 
with sulfone 45 in an attempt to synthesise adduct 260, which would then be converted 
to 44 by oxidation of the primary alcohol followed by olefination  (Scheme 76). 
However, after trying similar reaction conditions, no desired product was isolated. 
Instead, when the reaction temperature was increased to ambient temperature, O-
lithiated aziridine 198 underwent an aza-Payne rearrangement118 to give epoxide 261 
(Scheme 76). 
 
OH
TsHN
PhO2S
OH
OHPhO2S TsN
+
45                                       198
OH
OMe
OMe
260  
 
TsN
TsHN
O
   nBuLi, rt
33%
OH
OMe OMe
198                                                                       261  
 
Scheme 76 
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2.2.5 Revised Route for Morphine Synthesis 
 
Direct introduction of the cyclopentene moiety onto the vinylaziridine 46 or 
hydroxyaziridine 198 proved to be difficult. To overcome this problem, two revised 
approaches to morphine synthesis were proposed (Schemes 77, 78). Route A aimed at 
the synthesis of alkene 262 (Scheme 77), which would then be converted into morphine 
in a manner similar to that described in the initial retrosynthesis. Alkene 262 would be 
prepared from alcohol 263 by oxidation and olefination. The cyclopentene ring of 263 
could be constructed by RCM of diene 264, which derived from C-α-SO2Ph alkylation 
of tosamide 265 with β,γ-unsaturated aldehyde 266. Tosamide 265 would be 
synthesised by reaction of allylsulfone 212 and hydroxyaziridine 198.  
 
Revised Route A: 
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Scheme 77 
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Route B diverged from route A by beginning with the reaction of allylsulfone 212 and 
vinylaziridine 46 to give tosamide 269. C-α-SO2Ph Alkylation of 269 with β,γ-
unsaturated aldehyde 266 would give triene 268. Subjection of 268 to RCM should 
yield cyclohexene 267, which would then be converted into morphine along lines 
similar to those described in the initial retrosynthesis. 
 
Revised Route B: 
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Scheme 78 
 
2.2.5.1 Regioselective Ring-opening of Aziridines 198 and 46 
 
Both routes A and B required aziridine ring-opening reactions, and subsequent C-α-
SO2Ph alkylations of 265 and 269 with aldehyde 266. Therefore the syntheses of 265 
and 269 were first investigated. Intriguingly, reaction of lithio-212 and O-lithiated 
aziridine 198 gave disulfone 271 in 25% yield with no desired product tosamide 265 
isolated (Scheme 79). Disulfone 271 was believed to come from a self-coupling 
reaction of allyl sulfone 212 with possible vinyl sulfone intermediate 270. Such process 
has been reported by Bauld and co-workers.119 
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Scheme 79 
 
This result indicates that isomerisation of the allylsulfone is such a rapid process. As 
previously described, the reaction of lithio-212 with butadiene monoxide 47 resulted in 
migration of the terminal olefins of the allyl sulfone intermediates to give vinyl sulfones 
216 and 217 (Scheme 55). The experiment reported in Scheme 79 suggests that when 
212 reacts with a less reactive electrophile such as hydroxylaziridine 198, self-coupling 
is preferred.  
 
To overcome this problem, a similar strategy as aforementioned in Scheme 59 was 
adopted employing cinnamylsulfone 227120. More importantly, the subsequent RCM 
step would give the same product 263. As shown in Scheme 80, reaction of lithio-227 
with O-lithiated 198 gave a 10:1 mixture of diastereoisomers of tosamide 272, 
according to 1H NMR analysis, as single regioisomer in 52% yield. No aza-Payne 
rearrangement or olefin isomerisation side products were detected. Treatment of the 
major isomer with paraformaldehyde under acidic conditions gave N-tosyl aminal 
273,121 whose identity was established by X-ray crystallographic analysis (Appendix 
II).  
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i) nBuLi (1.1 equiv) added to 198, THF, –78 °C, 5 min, then  PhCH:CHCHLiSO2Ph (generated from 227 
+ nBuLi, THF), –78 °C-rt: 52%;; ii) (HCHO)n (1.3 equiv), p-TsOH·H2O (0.065 equiv), benzene, 90 °C, 6 
h 
 
Scheme 80 
 
The unprotected hydroxyl group of 198 was considered to be crucial for the 
regioselectivity, supported by previous observations in the group (Scheme 81).98 
Reaction of O-MOM protected aziridine 184 with lithio-185 gave a mixture of 
regioisomers, whereas a single regioisomer 186 was obtained after the reaction of lithio-
185 with O-lithiated 184. 
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Scheme 81 
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The observed regioselectivity for hydroxyl aziridines 198 and 184 may be explained by 
that the lithiated oxygen moiety in 198 and 184 interacts in an attractive sense with 
lithiated 227 and 185 respectively, directing ring-opening to the proximal aziridine 
carbons.122  
 
Following the successful ring-opening of aziridine 198, lithio-227 was reacted with 
vinylaziridine 46.123 Pleasingly, this reaction gave a single regioisomers 274 as a 10:1 
diastereomeric mixture according to 1H NMR analysis. The configuration of the major 
isomer as shown in Scheme 82 was determined by X-ray crystallographic analysis 
(Appendix III). Intriguingly, this reaction exhibited the opposite diastereoselectivity to 
that of the hydroxyaziridine counterpart 198. A major unidentified by-product (38% 
yield by weight) was also isolated from this reaction. It was believed to be derived from 
an SN2′ addition of the sulfone at the terminal olefin of 46. It is also noteworthy that, in 
order for this transformation to reach completion, higher reaction concentrations and 
use of co-solvent TMEDA were essential.   
 
i
OMe
TsHN
PhO2S
OMe
TsN
Ph
45%
+
SO2Ph
Ph
227
46                                                             274  
 
i) vinylaziridine 46 (0.7 equiv) in THF added to PhCH:CHCHLiSO2Ph [generated from 227 + nBuLi  
(1.1equiv), THF/TMEDA, –20 °C-rt, 0.5 h], 0 °C-rt, 16 h 
 
Scheme 82 
 
The observed regioselectivity in the above reaction may be attributed to the strong 
directing effect of the vinyl group, primarily through selective weakening of the allylic 
C–N bond of the aziridine by πC=C–σ*C–N overlap, as illustrated in Figure 11 and 
analogous to that depicted in Figure 3.  
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Figure 11 
 
2.2.5.2 Attempted Alkylation of Sulfones 273 and 274 
 
With aziridine ring-opening derivatives 273 and 274 in hand, focus shifted towards the 
preparation of the alkylating reagent β,γ-unsaturated aldehydes 266. The synthesis of 
aldehyde 266a was accomplished in a three-step sequence beginning with the protection 
of 3-butene-1,2-diol 275 with benzaldehyde 276 to yield a 1:1 diastereomeric mixture 
of acetals 277 (Scheme 83).124 Regioselective deprotection of 277 was achieved by 
treatment with excessive DIBAL-H giving a 4:1 mixture of regioisomeric alcohols 278 
and 279. 125  Finally oxidation of primary alcohol 278 with IBX gave the desired 
aldehyde 266a. 126  However, attempted purification of 266a by silica gel column 
chromatography induced an isomerisation to give α,β-unsaturated aldehyde 280. 
Therefore substrate 266a was used crude in subsequent reactions. 
 
HO
OH
+ H
O
O
O
Ph
BnO
OH
HO
OBn
+
O
OBn
iii
i                                      ii
275                               276                                277                                 278                             279
266a
90% 73%
86%
silica gel
O
OBn
280
4    :    1
 
 
i) p-TsOH·H2O (0.02 equiv), toluene, reflux, 5 h; ii) DIBAL (3.0 equiv), CH2Cl2, –78 ºC-rt, 16 h; iii) IBX 
(1.3 equiv), EtOAc, 80 ºC, 2 h 
 
Scheme 83 
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Unfortunately, treatment of aldehyde 266a with lithio-273 and lithio-274 resulted in 
isomerisation of 266a to 280 (Scheme 84). A similar outcome was observed in a test 
reaction with lithiated cinnamyl sulfone 227. 
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Scheme 84 
 
In light of these results, it was anticipated that introduction of a γ-phenyl substituent to 
the aldehyde 266a would stabilise the double bond and prevent it from migrating. 
Therefore, attention was turned towards the synthesis of γ-phenyl-β,γ-unsaturated 
aldehyde 266b (Scheme 85). Acetals 282 were synthesised via a cross metathesis127 of 
acetals 277 and styrene 281. Subsequent deprotection of 282 gave 1:4 separated 
regioisomeric alcohols 283 and 284. Oxidation of alcohol 284 with Dess–Martin 
periodinate (DMP)128 proceeded smoothly at ambient temperature gave aldehyde 266b.  
O
O
Ph
+
O
O
Ph
Ph
HO
OBn
BnO
OH
+
PhPh
O
OBn
Ph
iii
277                              281                                               282
283                               284                                     266b
i                                                            ii
46%                                                      82%
93%
1   :   4  
 
i) catalyst 50 (0.03 equiv), styrene 281 (2.0 equiv) CH2Cl2, reflux, 16 h; ii) DIBAL (3.0 equiv), CH2Cl2, –
78 ºC-rt, 16 h; iii) Dess-Martin periodinane (1.15 equiv), CH2Cl2, rt, 2 h 
 
Scheme 85 
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Acetals 282 were also synthesised by cross-metathesis of diol 275 with styrene 281 
followed by protection of the resulting diol 285 with benzaldehyde 276 (Scheme 86). 
 
O
O
Ph
Ph
HO
OH
+ HO
OH
275                        281                                 285                                      282
i                                                ii
55%                                          84%Ph
 
 
i) catalyst 50 (0.01 equiv), styrene 281 (2.9 equiv), CH2Cl2, reflux, 16 h; ii) p-TsOH·H2O (0.05 equiv), 
benzaldehyde 276 (1.1 equiv), toluene, reflux, 5 h 
 
Scheme 86 
 
With aldehyde 266b in hand, alkylations of lithio-227, 273 and 274 were investigated. 
Disappointingly, all of these reactions gave the isomerisation product, α,β-unsaturated 
aldehyde 286 (Figure 12).  
 
O
OBn
Ph 286  
 
Figure 12 
 
The highly conjugating tendency of β,γ-unsaturated aldehydes suggested that double 
bond introduction at a later stage was necessary. It was envisaged that the double bond 
could be masked by a 2-phenyl-1,3-dioxane moiety as found in 289 (Scheme 87). 
Compound 289 was expected to derive from alkylation of 274 with aldehyde 
290
129 , 130 , 131 , 132 . Regioselective deprotection of the acetal of 289 should give the 
corresponding primary alcohol, which could then be converted to a leaving group. 
Finally compound 288 would be subjected to E2 elimination to reveal the desired 
alkene in 287. 
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Scheme 87 
 
Thus, aldehyde 290 was prepared via a literature procedure (Scheme 88).129,131 
Reduction of (S)-malic acid 291 with borane and trimethoxy borate gave optically pure 
1,2,4-triol 292. Subsequent regioselective protection of 292 followed by DMP oxidation 
of the resulting alcohol 293 yielded aldehyde 290 in good overall yield. This aldehyde 
was prepared freshly and used crude in subsequent reactions since attempted 
purification by column chromatography resulted in material of inferior quality. 
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291                                    292                                            293                               290
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O
O Ph
O
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O Ph
i                                        ii                                       iii
90%                                  89%                                  84%
 
 
i) BH3·SMe2 (3.1 equiv), B(OMe)3 (3.3 equiv), THF, 0 ºC-rt, 16 h; ii) PhCH(OMe)2 (1.07 equiv), (R)-(–)-
CSA (0.05 equiv), CH2Cl2 rt, 16 h; iii) Dess-Martin periodinane (1.28 equiv), CH2Cl2, rt, 2 h 
 
Scheme 88 
 
Unfortunately, when aldehyde 290 was treated with lithio-274, only starting materials 
were recovered (Scheme 89). This unexpected result prompted us to carry out test 
reactions of lithio-274 with other electrophiles such as benzaldehyde, benzoyl chloride 
and iodomethane, no desired products were detected. It was concluded that both the 
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poor nucleophilicity and highly hindered nature of the α-SO2Ph carbanion of 274 
rendered it unsuitable for the proposed reaction with 290. 
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Scheme 89 
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2.2.6 Alkylation of Sulfide Stabilised Carbanions Approach to Morphine Synthesis 
 
In light of the above conclusion, it was proposed that the problems could be overcome 
by adopting the sulfide analogue of sulfone 274. It was believed that the α-SPh 
carbanion has the advantages of being less hindered and more nucleophilic than the α-
SO2Ph carbanion. This section details the synthesis of sulfide nucleophiles prepared 
from regioselective ring-opening of vinyl aziridine 46 by appropriate sulfides, and 
investigation of their alkylation reactions in an approach to morphine synthesis. 
 
2.2.6.1 Ring-opening of Vinyl Aziridine 46 with Allyl Phenyl Sulfide 
 
The first sulfide investigated in aziridine ring-opening reactions was allyl phenyl sulfide 
294. A major concern for 294 is that its delocalised anion can undergo both α- and γ-
addition to give the corresponding α- and γ-adducts,133,134 as depicted in Scheme 90. 
The ratio between the two regioisomers depends on a number of factors such as: the 
base/the counter cation, the electrophile and additives used.133,134 It has been reported 
that HMPA is an excellent additive to enhance α-attack.135  
 
SPh
E+
SPh
E
SPhE
α-adduct
γ-adduct
E = electrophiles
294
Mαγ
 
 
Scheme 90 
 
Despite this concern, the reaction of vinyl aziridine 46 with lithio-294, prepared from 
PhSH and allyl bromide,134 gave only the α-addition adducts (Scheme 91). 
Interestingly, when the reaction temperature was warmed up to 20 ºC, migration of the 
β-alkene occurred to give the unwanted α,β-unsaturated sulfides 295 as a 5:1 olefin 
isomeric mixture according to 1H NMR analysis. This was avoided when the 
temperature was kept at –78 ºC, in which case the desired β,γ-unsaturated sulfide 296 
was synthesised. Later experiments showed that sulfide 296 was the only product 
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obtained when the reaction temperatures were kept below 0 ºC. Similar phenomena 
were observed by Enholm and co-workers in the reaction of lithio-294 with ethylene 
oxide.136 
TsN+
TsHN
TsHN
SPh
Li
Ar
Ar
i. −78°C→20 °C, THF
295, 67%
ii. −78 °C, 15 min, THF
296, 76%
lithio-294 46
SPh
SPh
Ar
 
 
i) CH2CHCHLiSPh generated from 294 + nBuLi, THF, –78-0 ºC, 30 min, then aziridine 46 in THF 
added, 20 ºC, 16 h; ii) CH2CHCHLiSPh generated from 294 + nBuLi, THF, –78-0 ºC, 30 min, recooled 
to –78 ºC, then aziridine 46 in THF added, –78 ºC, 15 min, dr = 5:1 
 
Scheme 91 
 
With sulfide 296 in hand, the subsequent C-α-SPh alkylation of lithio-296 with 
aldehyde 290 was investigated. Disappointingly, no reaction occurred. A number of 
other electrophiles were tested, such as benzaldehyde, benzoyl chloride, 1-iodo-3-
butene and iodomethane, but no expected products were detected. Instead, the reaction 
of lithio-296 with MeI gave the N-methylated adduct 297 (Scheme 92),137 whose major 
isomer was assigned by X-ray crystallographic analysis (Appendix IV). The yield of 
297 was increased to 82% when tBuOK was used as the base.  
 
TsHN
Ar
SPh
N
Ts
Ar
SPh
i
296                                                                         297  
 
i) nBuLi (2.0 equiv), –78 ºC, 30 min, then MeI, 0.5 h, 53% or tBuOK (1.0 equiv),  
       tBuOH, MeI, 4 h, 82% 
 
Scheme 92 
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2.2.6.2 Synthesis of Thiophenyl Tetrahydropyridine 299 
 
Although the alkylation of the α-sulfide carbanion of 296 was not successful, the ring-
opening reaction of aziridine 46 by the anion of allyl phenyl sulfide 290 demonstrated 
the superior reactivity of the sulfide anion compared to its sulfone counterpart, 
evidenced by the higher yield, significantly shorter reaction time and lower reaction 
temperature. In light of this observation, it was decided to re-visit a route previously 
pursued in the group, as described in Scheme 46. This approach was hindered by the 
reactivity of the C-4 centre of the tosyl tetrahydropyridine 190, as indicated by 
unsuccessful direct alkylation, and the low yield of the Lewis acid-mediated 
desulfonylative cation-assisted cyclisation shown in Scheme 93.  
 
N
Ts
OMe
N
Ts
OMe
Ts
SnCl4, CH2Cl2
−78°C-20 °C
56%
190                                                            298
4
 
Scheme 93 
 
It was now hoped that the reactivity of the C-4 centre could be improved by employing 
the thiophenyl-substituted tetrahydropyridine analogue 299 (Scheme 94). The alkylation 
derivative 300 would then be subjected to a cation-mediated cyclisation similar to that 
of tosyl tetrahydropyridine 190 to give diene 188. If diene 188 could be made via this 
route, the later-stage chemistry would remain the same, as described in Scheme 46. 
Following this plan, focus shifted to the synthesis of tetrahydropyridine 299. 
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Scheme 94 
 
2.2.6.2.1 Attempted approach via acetal 
 
It was anticipated that thiophenyl-substituted tetrahydropyridine 299 could be accessed 
via a route similar to that used for tosyl-substituted analogue 190 as shown in Scheme 
47. Therefore, aldehyde 303138 was made by conjugate addition of thiophenol 302 to 
acrolein 301 (Scheme 95). Acetal protection of 303 with trimethyl orthoformate yielded 
304.139 Unexpectedly, the subsequent aziridine opening reaction gave acetal tosamide 
305 in only 18% yield. This was believed to be caused by the instability of the lithiated 
anion of 304, since the by-product 308 was also isolated (Figure 13), indicating the 
generation of significant amounts of thiophenolate anion. The attempt of 
tetrahydropyridine formation by exposing 305 to Lewis acidic conditions resulted in a 
Pictet–Spengler type reaction giving 307 via 306. This was thought to be due to the 
lower electron-withdrawing ability of the thiophenyl substituent of intermediate 306 
compared to the sulfone analogue. 
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i) Et3N (0.1 equiv), CH2Cl2, 0 °C, 30 min; ii) (MeO)3CH (2.0 equiv), p-TsOH·H2O (0.03 equiv), MeOH, 
50 °C, 16 h; iii) nBuLi (1.0 equiv), THF/TMEDA, –78 °C, 40 min, then aziridine 46 in THF, rt, 16 h, dr 
= 5:1; iv) BF3·Et2O (15.0 equiv), CH2Cl2; –78 °C-rt, 16 h 
 
Scheme 95 
 
PhS OMe
TsHN
308  
 
Figure 13 
 
2.2.6.2.2 Attempted approach via γ-lactam 
 
This unexpected result indicated the need for alternative approaches for the synthesis of 
thiophenyl-substituted tetrahydropyridine. It was proposed that the route shown in 
Scheme 96 via γ-lactam 310 would provide the desired tetrahydropyridine 314. Ring-
opening of aziridine 46 by sulfide ester 309 followed by lactamisation in one step 
would give γ-lactam 310. Subsequent alkylation of the α-SPh carbanion, reduction of γ-
lactam 311 and protection of the resulting alcohol would give 312. Ozonolysis of diene 
312 should furnished C4 alkylated tetrahydropyridine 314 via tosamide aldehyde 313. 
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Scheme 96 
 
However, in an attempt to form γ-lactam 310 from the reaction of KH deprotonated 
sulfide ester 309140 with aziridine 46, tosamide esters 315 were obtained (Scheme 97). 
The production of 315 suffered from poor reproducibility and low yielding. These were 
again likely due to the lack of stability of the anion of 309 as by-product 308 was also 
isolated. A series of other conditions were tested but no γ-lactam 310 was detected 
(Table 3).  
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                   i) KH (1.0 equiv), DMF, 0 °C, 20 min, then aziridine 46 in DMF added, 60 °C, 16 h 
 
Scheme 97 
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Entry               base                                        solvent                      yield(%)
1                  nBuLi                                         THF                             −
2                  tBuO K                                       DMSO                        −
3                  tBuO K/18-crown-6                   THF                            − 
4                  KH                                             toluene                         −
5                  KHMDS/18-crown-6                  toluene                        −
6                  NaH                                            DMF                           5
7                  DBU                                          toluene                         −
 
 
Table 3 
 
2.2.6.2.3 Attempted approach via propargylic sulfide  
 
Two alternative approaches for the synthesis of tetrahydropyridine 299 from propargyl 
sulfide aziridine ring-opening product 317 were also proposed, as outlined in Scheme 
98. The reaction of propargylic sulfide 316 with aziridine 46 should give alkynyl 
tosamide 317. Path A converts substrate 317 into Z-vinyl halide 318, which will be 
subjected to an intramolecular N-vinylation mediated by appropriate transition metals to 
give 299. Path B involves a direct 6-endo-dig cyclisation of 317 to afford 299. 
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Scheme 98 
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Path A 
 
Ullmann–Goldberg-type reactions mediated by copper reagents are valuable for 
construction of sp2-C–N bonds from amines and aryl or vinyl bromides.141 However, 
intramolecular N-vinylations under these conditions have rarely been reported, 
especially for small rings. Joyeau et at. 142  in 1989 and Li et al. 143  in 2006 have 
published their independent work for intramolecular enamide/enamine formations using 
modified Ullmann–Goldberg conditions. Joyeau et al. treated the azetidinone 319 with 
copper powder at 110 °C in DMF to produce carbacephem 320 (Scheme 99).142 The 
yield of this reaction, albeit low (20–30%), depended on the amount of Z isomer 
contained in the starting material mixture, which was considered to be the reactive 
isomer. 
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319                                                                    320  
 
Scheme 99 
 
Li et al. have demonstrated the high efficiency of 4-exo-trig cyclisation of N-tosyl-3-
halo-3-butenylamines 321 to yield 2-alkylideneazetidines 322 in the presence of 
stoichiometric amount of CuI and TMEDA (Scheme 100).143 The reaction times were 
typically under two hours. 
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Ts
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321                                                                             322
94 − 99%
 
 
Scheme 100 
 
Another method for sp2-C–N bond formations is Buchwald–Hartwig palladium-
catalysed cross coupling. 144 It has been wildly adopted for the synthesis of aryl amines 
from amines and aryl halides.144,145 Intramolecular enamine/enamide formation between 
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a vinyl halide and an amine, however, is less well documented.146 One example is from 
Mori and co-workers who successfully applied this methodology to the synthesis of 3-
ethoxycarbonyl-1β-methylcarbapenem 324 (Scheme 101).147 They found that DPEphos 
was the optimum ligand for this reaction and better yield was obtained when vinyl 
iodide 323 was used instead of the corresponding vinyl bromide. 
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Scheme 101 
 
Encouraged by these precedents, the synthesis of tetrahydropyridine 299 was explored. 
Propargylic sulfide 316 was prepared from a biphasic reaction of propargylic bromide 
325 and thiophenol 302 as described by Bäckwell et al. (Scheme 102). 148  It was 
subsequently doubly deprotonated149 and combined with aziridine 46 to give a mixture 
of alkynyl tosamide 317 with a 3:1 dr. Iodination of the terminal alkynes of 317 was 
accomplished by treatment with NIS in the presence of AgNO3
150  to yield alkynyl 
iodides 326. Following syn-reduction with diimine, generated from dipotassium 
azodicarboxylate150b,151,152 (PADA) 328, and acetic acid,153 Z-vinyl iodides 327 were 
formed. The geometry of the double bond was assigned by 1H NMR analysis, where the 
Z-alkene protons have a J value of 7.5 Hz. An alternative reducing agent, 2-
nitrophenylsulfonylhydrazide154 (2-NBSH), was also tested for the preparation of 327 
and gave similar results. Both of these two reagents were easy to prepare from cheap 
starting materials.151,152,154  
 
A number of conditions were investigated for the formation of tetrahydropyridine 295 
from 327 with palladium and copper catalysts (Table 4). Unfortunately, no desired 
product was detected. Only starting material was recovered. 
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i) NaOH (1.7 equiv), nBu4NBr (0.15 equiv), H2O, benzene, 0 °C, 3 h; ii) a) nBuLi (2.4 equiv), 1.5 h, b) 
aziridine 46 (1.0 equiv), THF, –78-0 °C, 3.5 h, dr = 3:1; iii) NIS (1.22 equiv), AgNO3 (0.5 equiv), DMF, 
rt, 16 h;. iv) potassium azodicarboxylate 328 (5.1 equiv), AcOH (15.0 equiv), dioxane/iPrOH (0.3 mL), 
18 h 
 
Scheme 102 
 
 
Entry           solvent                     catalyst/ligand               base              temp. (°C)   
   1                PhMe                     Pd(acac)2/BINAP       Cs2CO3               rt                
   2                PhMe                     Pd(dba)3/P
nBu3           Cs2CO3               rt         
   3                PhMe                     Pd(dba)3/BINAP         Cs2CO3             rt–60               
   4                DMF                      Pd2(OAc)2/PPh3            Et3N                  rt   
   5          DMSO/PhH                         CuI                       Cs2CO3             60 
 
Table 4 
 
Path B 
 
This disappointing outcome led us to investigate path B of Scheme 98, 6-endo-dig 
cyclisation of alkynyl tosamide 317. Whilst 6-endo-dig cyclisation between a terminal 
alkyne and an amine or tosamide is unprecedented, reported literature indicated that, in 
general, the selectivity between 5-exo-dig and 6-endo-dig cyclisation can be markedly 
dependent on the reaction conditions.155 Work by Georg and co-workers has uncovered 
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a remarkably simple protocol for preparing enaminones via 6-endo-dig ring closures 
(Scheme 103).156 
 
Amino–ynones 329 were prepared from the corresponding N-Boc protected β-amino 
acids via Weinreb amide formation and subsequent addition of the appropriate alkynyl 
magnesium bromide. N-Boc Deprotection of 329 under acidic conditions followed by 
treatment of the crude with methanol and K2CO3 gave enaminones 332 in only 15 
minutes (Scheme 103). This process is thought to go through either intermediate 330 
with a conjugated π-orbital or 331 with the filled σ-orbital stabilised by the carbonyl 
group. 
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Scheme 103 
 
Encouraged by this facile ring-closure process alkynyl tosamide 317 was exposed to 
similar cyclisation conditions (Scheme 104). When heated to 50 °C, 100% conversion 
was observed. However, only 5-exo-dig cyclised product pyrroles 335 were isolated in 
almost quantitative yield. Interestingly, when pyrroles 335 were left in a NMR tube 
with deuterated chloroform for two days, complete isomerisation occurred to give 
dihydropyrrole 336. This was thought be induced by the trace amounts of acid in the 
solvent.  
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           i) K2CO3, MeOH, 50 °C, 16 h 
 
Scheme 104 
 
Many transition metals are reported to be capable of activating triple bonds for 
cyclisation reactions, such as: Pd157, Rh155, Au158, Ir159 and Cu160. Therefore, our focus 
was shifted towards cyclisation mediated by organometallic catalysis. Disappointingly, 
after evaluating the cyclisation of 317 under a number of conditions, either no reaction 
occurred or only the 5-exo-dig ring-closure adduct was formed (Table 5). For example, 
compounds 335 were isolated when 317 was exposed to the conditions described by 
Luo et al.157b (Entry 2). These workers had synthesised a range of 2-
alkylidenetetrahydrofurans and pyrans by treatment of alkyl or aryl acetylenic alcohols 
with nBuLi in THF, followed by addition of a solution of Pd(OAc)2 and PPh3 in THF 
and one equivalent of an organic halide. Modifying their conditions by employing DMF 
as a co-solvent only resulted in higher yields of 335 (Entry 3). When the reaction was 
attempted without prior deprotonation with nBuLi, only starting materials were 
recovered (Entries 1 and 4). Surprisingly, substrate 317 decomposed when treated with 
sub-stoichiometric CuI (Entries 5 and 6). Many iridium catalysts were reported to be 
effective reagents to induce 6-endo-dig reactions selectively over 5-exo-dig.159 However 
when iridium catalyst 336 (Figure 14) was used, no reaction was observed (Entry 7).  
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Entry              catalyst                             conditions                              result
1                  Pd(OAc)2                    PPh3, THF, 50 °C                          SM 
2                  Pd(OAc)2                    nBuLi, THF, PPh3
                                                           −78 °C - rt                           SM + 335 (3%)
3                  Pd(OAc)2                    nBuLi, THF/DMF, PPh3
                                                           −78 °C - rt                           SM + 335 (15%)
4                  PdCl2                          PPh3, toluene, 40 °C                      SM 
5                   CuI                                  DMF, 70 °C                       decomposition 
6                   CuI                                  DMF, rt                              decomposition
7                    [Ir]                                CH2Cl2, 40 °C                            SM
 
 
Table 5 
 
Ir
P
P
Ph
Ph
Me
Ph
Me
Ph
PF6
 
 
Figure 14 
 
 
2.3.6.2.4 Approach via an unexpected enal  
 
In order to reverse the selectivity to favour 6-endo-dig cyclisation of alkynyl tosamides 
317, it was considered that activation of the terminal carbon of the alkyne was required. 
It was proposed that this could be achieved by exposure of the corresponding sulfoxide 
of 317 to organometallic catalysts (Scheme 105). Initial coordination between the metal 
and the oxygen of the sulfoxide of 337 would direct the interaction of the metal with the 
alkyne. 
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Scheme 105 
 
Following this plan, the synthesis of sulfoxide 337 was carried out. Intriguingly, when 
alkynyl tosamide 317 was treated with mCPBA, enal 339 was isolated (Scheme 106).  
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TsHN
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Ar Ar
i
317                                                              339
52%
 
 
                             i) mCPBA (1.1 equiv), CH2Cl2, rt, 16 h 
 
Scheme 106 
 
A mechanism for this process is proposed in Scheme 107. Oxidation of 317 yields the 
sulfoxide intermediate 337, which undergoes [2,3]-sigmatropic rearrangement to give 
the unstable allenylsulfinate intermediate 340.161 Following hydrolysis of the enol ether 
group in 340, product 339 is formed. In an attempt to improve the yield of this reaction, 
many other oxidants were tested, including IBX, DMP, NaIO4, Oxone
® and DMDO. 
However, no reaction was observed with the exception of Oxone®, which gave a small 
amount of 339 as evidence by 1H NMR analysis of the crude product. 
 
 100
TsHN
SPh
TsHN
O
Ar
Ar
TsHN
SPh
Ar
O
TsHN
Ar
O
PhS
317
337 340
339
hydrolysis
 
 
Scheme 107 
 
To take advantage of this unexpected outcome, enal 339 was used for the synthesis of 
tetrahydropyridine 299, as shown in Scheme 108. 1,4-Addition of PhSH to enal 339 
triggered a spontaneous cyclisation of the tosamide nitrogen and the resulting aldehyde 
to give thiophenyl-substituted piperidinol 341. Subsequent syn-elimination of H2O from 
341 was effected by converting the alcohol to the corresponding mesylate with MsCl in 
the presence of excessive Et3N. This sequence was also performed in a one-pot process 
from enal 339 giving similar yields. 
.  
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Ar Ar
339                                                                341                                                   299
73% 93%
 
 
i) PhSH (3.0 equiv), Et3N (5.0 equiv), CH2Cl2, 0 °C – rt, 16 h; ii) MsCl (10.0 equiv), Et3N (5.0 equiv), 
CH2Cl2, –20 °C, 2 h 
 
Scheme 108 
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2.2.6.2.5 Approach via tosyl tetrahydropyridine 190 
 
Although the above approach gave access to tetrahydropyridine 299, it was impractical 
due to overall low yields. It was proposed that 299 could be constructed by treatment of 
tosyl tetrahydropyridine 190 with (Me)2AlSPh
162 . Therefore, 190 was prepared as 
previously described in Scheme 47. Aziridine 46 was combined with lithiated 
tosylacetal 185 followed by cyclisation of the resultant acetal tosamide 191 under Lewis 
acidic conditions (Scheme 109). When 190 was exposed to (Me)2AlSPh in CH2Cl2, 
generated in situ from AlMe3 and PhSH,
162 thiophenyl-substituted tetrahydropyridine 
299 was obtained in good yield.  
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OMe OMe OMe
i ii iii
83% 89%
46                                       191                                 190                                   299  
 
i) (MeO)2CHCH2CHLiTs(1.5 equiv) [generated from (MeO)2CHCH2CH2Ts 185 and nBuLi (1.5 equiv)], 
THF, –78-–30 °C, 40 min then added to 46 (1.0 equiv), THF, –30 °C-rt, 16 h, dr = 3:1; ii) BF3·Et2O (10.0 
equiv), CH2Cl2, –78 °C for 30 min then –55 °C for 16 h; iii) AlMe3 (4.5 equiv), PhSH (4.5 equiv), CH2Cl2, 
rt, 1 h 
 
Scheme 109 
 
The unprecedented aluminium-mediated conversion of 190 into 299 was also applicable 
to the syntheses of other sulfides such as 342 and 343, by treatment of 190 with 
(Me)2AlSPy
163  and (Me)2AlSMe
164  respectively (Scheme 110). Reagent (Me)2AlSPy 
was prepared in a similar manner to that of (Me)2AlSPh whereas (Me)2AlSMe was 
prepared from AlMe3 and sulfur powder. Interestingly, in the reaction of 190 with 
(Me)2AlSMe, C6 attack was favoured to give 344 as the major isomer. These results 
seemed to suggest that sterically bulky sulfide groups such as –SPh and –SPy favour C4 
addition, whereas small sulfide groups such as –SMe favour C6 attack. When substrate 
342 was treated with AgOTf, the elimination triene adduct 345 was isolated. 
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i) (Me)2AlSPy (5.0 equiv) [prepared from AlMe3 (5.0 equiv)and pyridine-2-thiol (5.0 equiv)in CH2Cl2,  rt, 
45 min) added to 190 in CH2Cl2, rt, 16 h, dr = 2.5:1. ii) ) 190 in toluene added to (Me)2AlSMe (4.0 equiv) 
[prepared from AlMe3 (4.o equiv)and sulfur powder (5.0 equiv) in toluene under reflux, 2 h, then to rt], rt, 
16 h, dr = 2:1for 331, 1.2:1 for 223. iii) AgOTf (1.5 equiv), 4 Å molecular sieves, CH2Cl2, –40 °C, 2 h 
 
Scheme 110 
 
2.2.6.3 Attempted Alkylation of Tetrahydropyridine 299 
 
Having developed an efficient route for the synthesis of the thiophenyl 
tetrahydropyridine 299, attention was turned towards its subsequent C4 alkylation in 
attempts to prepare diene 300 as described in Scheme 94. Compound 299 was treated 
with nBuLi followed by an electrophile. Disappointingly, after examining a range of 
electrophiles as shown in Scheme 111, no alkylated products were observed. 
Lactaldehyde 346165  was prepared from ethyl-L-lactate 347 after alcohol protection 
with TBDPSCl to give ester 348166 followed by a DIBAL-H reduction (Scheme 112). 
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Scheme 111 
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i) TBDPSCl (1.8 equiv), DMAP (0.15 equiv), Et3N (2.5 equiv), CH2Cl2, 50 °C, 16 h; ii) DIBAL-H (1.15 
equiv), CH2Cl2, –78 °C, 1.5 h 
 
Scheme 112 
 
In addition to alkylation, C4 α-sulfide halogenations of 299 were also investigated with 
NIS167, NBS168, NCS169 and SO2Cl2
170
 in attempts to synthesise halides 349 (Scheme 
113). However, no desired products were observed. Furthermore, attempted cyclisation 
of 299 to give compound 350 mediated by Pummerer rearrangement induced by 
MeSSMe2BF4 (DMTSF)
171 gave only recovered starting materials. 
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Scheme 113 
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2.2.7 Alternative Strategies for C4 Alkylation 
 
The failure of attempts to effect C4 alkylation of tetrahydropyridine 299 led us to 
consider alternative strategies. It was considered that sulfide- or sulfone-substituted 
unsaturated lactam 354 might be a suitable precursor for C4 alkylation via conjugate 
addition (Scheme 114). It was envisaged that 354 could be derived from allyl 
sulfone/sulfide 351 and aziridine 46. Reaction of 351 and 46 would give 352, which 
would be subjected to cyclisation to give lactam 353. Oxidation of 353 would give 
unsaturated lactam 354. Subsequent 1,4-addition followed by desulfurative cyclisation 
of 355 would give 356, which could ultimately lead to morphine. 
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Scheme 114 
 
2.2.7.1 Attempted Synthesis of Allyl Sulfone 351 
 
Following the above proposal, focus shifted to the preparation of allyl sulfone 351, 
which was anticipated to be accessed via isomerisation of vinyl sulfone 358. Two routes 
were examined for the synthesis of 358 (Schemes 115, 116). The first approach 
involved the synthesis of α,β-unsaturated acetal 357172 , which was synthesised by 
protection of acrolein 301 with (CH3O)3CH (Scheme 115). Subjection of 357 to either 
cross-metathesis with vinylsulfone 212173 or selenosulfonation with PhSeSO2Tol 359
174
 
followed by oxidation–elimination with H2O2 resulted in no desired product. 
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i) CH(CH3O)3 (1.33 equiv), NH4NO3 (0.05 equiv), MeOH, rt, 16 h; ii) catalyst 50 (0.05 equiv), 
CH2=CHSO2Ph 212 or PhSeSO2Tol 359 hv, CCl4, 2.5 h, H2O2, 2 h 
 
Scheme 115 
 
In the second approach, bromination of 301 with Br2 gave dibromide 360, which was 
treated with PhSO2Na in DMF to give sulfonyl acrolein 361 (Scheme 116).
175 
Subsequent acetal protection of 361 furnished vinyl sulfone 358a. Disappointingly, no 
desired product 351 was detected when 358a was treated with either Et3N or DBU or 
tBuOK in tBuOH despite the fact that all smarting materials were consumed. It was 
speculated that this was due to the instability of compound 351. This was supported by 
the work of Tasaki et al. who demonstrated that vinyl sulfones 362 underwent facile 
isomerisations to give allyl sulfones 363 (Scheme 117).176 However, no products were 
isolated when similar conditions were applied to acetal vinyl sulfones 364 and 365 
although all the starting materials were consumed. They reasoned that this was caused 
by the instability of the desired products. 
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i) Br2 (1.0 equiv), CCl4, 0°C, 4 h; ii) PhSO2Na (1.5 equiv), DMF, rt, 30 h; iii) (CH3O)3CH (2.0 equiv), 
NH4NO3 (0.05 equiv), MeOH, rt, 96 h 
 
Scheme 116 
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Scheme 117 
 
2.2.7.2 Synthesis of Lactam 353 
 
The above results meant that alternative synthesis of lactam 353 was required. It was 
expected that a one-step cyclisation–oxidation of acetal tosamide 191 would provide the 
desire product. Indeed, when 191 was exposed to Jones oxidation conditions,177 lactam 
353 was obtained, albeit in low yield (Scheme 118). In an attempt to improve the yield 
by employing other acidic oxidising reagents such as PCC and PDC, only starting 
materials were recovered. The identity of 353 was firmly established by X-ray 
crystallographic analysis (Appendix V). 
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               i) CrO3 (5.0 equiv), H2SO4 (11.0 equiv), H2O, acetone 
 
Scheme 118 
 
Although the exact mechanism of this transformation is unknown, two possible 
pathways are proposed, as outlined in Scheme 119.177 Both pathways starts from 
deprotection–cyclisation of 191 to give hemi-aminal intermediate 366. In path A, hemi-
aminal 366 converts into piperidinium 367 under acidic conditions. Subsequent 
interception of the oxygen of the HCrO4
– ion to 367 generates chromate ester 368, 
which suffers elimination of the Cr(IV) HCrO3
– to give the observed compound 353 and 
Cr(IV) H2CrO3. This Cr(IV) substrate reacts with a Cr(VI) species to yield two Cr(V) 
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molecules, and can oxidise 367 in a similar manner, and which are ultimately reduced 
to Cr(III). In pathway B, hemi-aminal 366 reacts with Cr(VI) CrO3 to give chromate 
ester intermediate 369, which decomposes by elimination of Cr(IV) MeOCrO2H to 
yield 353. Similarly, these Cr(IV) species will convert into Cr(III). 
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Scheme 119 
 
It was believed that piperidinium intermediate 367 could be generated by treatment with 
TFA, since double bond reduction of the tetrahydropyridine of compound 190 has been 
achieved previously by group members with TFA and reductant Et3SiH (Scheme 
120).31 Therefore, other potential oxidants were used in combination with TFA, such as: 
DMSO, N-hydroxy succinamide, Dess–Martin periodinate, IBX, PCC and NMO. 
However no desired product was detected under any of these conditions. 
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Scheme 120 
 
2.2.7.3 Tosyl Elimination of Lactam 353 
 
The final phase of research was devoted to the investigation of 4-tosyl elimination of 
lactam 353 by exposure to basic conditions. This was expected to give unsaturated 
lactam 373 (Scheme 121). Intriguingly, when compounds 353 were treated with DBU, a 
2.7:1 olefin isomeric mixture of dienone 371 were isolated in quantitative yield. 
Whereas when the weaker base Et3N was used, dienone 372 was obtained in 28% yield 
together with 63% 371. The conversion of lactam 353 to dienone 371 was believed to 
go via intermediate 373. 
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i) DBU (1.67 equiv), CH2Cl2, rt, 20 h; ii) Et3N (0.1 equiv), CH2Cl2, rt, 16 h 
 
Scheme 121 
 
In an attempt to trap the elimination intermediate 373 with cuprate 374, generated from 
allylmagnesium bromide and CuCN, a 2:1 isomeric mixture of alcohols 375 was 
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isolated (Scheme 122). Further study is needed to determine the mechanism for this 
remarkable result. 
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i) CH2=CHCH2CuMgBr 374 (generated from CH2=CHCH2MgBr 2.0 equiv and CuCN 2.0 equiv), Et3N 
(0.3 equiv), THF, rt, 16 h, aqueous work-up 
 
Scheme 122 
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2.3 Future Work 
 
In addition to further optimisation of the reaction to afford lactam 353, the remaining 
chemistry as described in Scheme 114 will need to be pursued. Oxidation of 353 to give 
α,β-unsaturated lactam 354 is key to the success of this route. Although Saegusa–Ito 
palladium-catalysed oxidation178 can give access to α,β-unsaturated ketone from silyl 
enol ether, generated from the corresponding ketone, oxidation to give a α,β-
unsaturated lactam or amide is foreseen to be challenging. Subsequently, it will be 
interesting to see if compound 354 is susceptible to 1,4-addition to give 355. Lewis acid 
mediated cationic-cyclisation of 355 to give 356 will then be investigated. 
 
Alternatively, it is envisaged that intermediate 356 could also be constructed by a route 
shown in Scheme 123. Aryl iodide 377 should be derived from aziridine 376 similar to 
the synthesis 354. Nucleophilic addition–elimination of compound 377 will give 378, 
which will be subjected to an intramolecular reductive Heck cyclisation179 to furnish 
379. 
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Scheme 123 
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2.4 Conclusion 
 
During the investigation of the initial retrosynthetic plan (Scheme 7), an extremely short 
and robust synthesis of 4-(phenylsulfonyl)cyclopent-2-enol 45 has been developed by 
application of RCM chemistry. However, attempts of incorporating 45 into 
vinylaziridine 46 were not realised after intensive studies. Therefore alternative 
strategies of morphine synthesis were explored. During these investigations, it was 
observed that functionally diverse sulfone- or sulfide-stabilised carbanionic species 
react with vinylaziridine 46 with complete regioselectivity. Furthermore, analogous 
sulfones and sulfides have exhibited markedly different reactivities under the same 
reaction conditions. For example, poor yields resulted when thiophenyl acetal 304 
(Scheme 95) and thiophenyl methyl ester 309 (Scheme 97) were used. On the contrary, 
their sulfone counterparts gave good yields.  
 
A practical synthesis of highly substituted N-tosyl thiophenyl-substituted 
tetrahydropyridine 299 was developed through a Me2AlSPh mediated trans-
sulfurisation from tosyl-substituted tetrahydropyridine 190. Extensive studies into C-4 
alkylation of 299 led to the proposal of nucleophilic 1,4-addition of the N-tosyl α,β-
unsaturated δ-lactam 354, which is foreseen to derive from oxidation of δ-lactam 353 
(Scheme 114). The synthesis of 353 was achieved by an unusual cyclisation–oxidation 
of acetal tosamide 191 under Jones oxidation conditions. Future endeavours will focus 
on the synthesis of 354 and its subsequent alkylations, towards a total synthesis of 
morphine. 
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3. Experimental 
 
General Laboratory Procedure 
 
Unless otherwise stated, all reactions were carried out under nitrogen; Melting points 
were determined using Stuart Scientific SMP1 melting point apparatus and are 
uncorrected. Infrared spectra were recorded on a Mattson 5000 FTIR spectrometer and 
on a Perkin-Elmer Spectrum RX FT-IR System. Proton magnetic resonance (1H NMR) 
and carbon magnetic resonance (13C NMR) spectra were recorded in CDCl3 unless 
otherwise stated on a Jeol GSX-270, a Bruker DRX-300, a Bruker AV-400 or a Bruker 
AV-500 spectrometer. Chemical shifts are in part per million (ppm) and are referenced 
relative to the residual proton-containing solvent (1H NMR: 7.26 ppm for CDCl3; 
13C 
NMR: 77.0 ppm for CDCl3). The following abbreviations are used to indicate the 
multiplicities: s, singlet, bs, broad signal; d, doublet; t, triplet; m, multiplet. Mass 
spectra (CI) were recorded using Micromass AutoSpec-Q, Micromass Platform II or 
Micromass AutoSpec Premier instruments. Elemental analyses were performed at the 
microanalytical laboratory of the London Metropolitan University. Analytical thin layer 
chromatography (TLC) was performed on pre-coated aluminium-backed Merck 
Kiesegel 60 F254 plates. Visualisation was effected with ultraviolet light, potassium 
permanganate or vanillin as appropriate. Flash chromatography was performed using 
BDH (40-63 µm) silica gel unless otherwise stated. Standard solvents were distilled 
under nitrogen prior to use: Et2O and THF from sodium-benzophenone ketyl; DMSO, 
CH2Cl2 and DMPU from CaH2; toluene from sodium, TMEDA from sodium or CaH2. 
All other solvents were reagent-grade. Petrol refers to the fraction with bp760 40–60 °C. 
All liquid reagents except HCl and Me2S were distilled prior to use. All other reagents 
were purchased from Aldrich, Fluka, Acros, Alfa Aesar Lancaster and used as such 
unless otherwise stated. Microwave reactions were performed using a Biotage Initiator 
instrument. 
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(E)-4-(4-Methoxyphenyl)but-2-en-1-ol
30,31 197 
O
OMe
OH
+
MgBr
OMe
47
48 197  
 
To a solution of butadiene monoxide 47 (5.00 g, 71.4 mmol, 1.0 equiv) and CuCN (639 
mg, 7.14 mmol, 0.1 equiv) in THF (130 mL) at –78 °C a freshly prepared solution of 
(4-methoxyphenyl)magnesium bromide 48 (17 mL of a ca. 0.5 M solution in THF, 8.40 
mmol, 0.1 equiv) in THF (17 mL) was added dropwise. After 15 min the solution was 
warmed to –20 °C then re-cooled to –78 °C for 20 min and a further amount of (4-
methoxyphenyl)magnesium bromide 48 (153 mL of a ca. 0.5 M solution in THF, 76.6 
mmol, 1.1 equiv) added. After 45 min, the resulting solution was warmed to rt. After 1 
h sat. NH4Cl(aq.) (13 mL) and NH3 (10 mL of a 17% aqueous solution) were added. 
After 15 min the solution was diluted with sat. NH4Cl(aq.) (53 mL), H2O (36 mL) and the 
mixture was extracted with EtOAc (3 × 100 mL). The combined organic layers were 
washed with brine (2 × 100 mL) and dried (Na2SO4). Concentration under reduced 
pressure and column chromatography (20% EtOAc–petrol) gave the alcohol 197 (11.6 
g, 91%) as a colourless oil; Rf 0.30 (20% EtOAc–petrol); vmax (film) 3357, 3029, 3002, 
2952, 1670, 1610, 1583, 1463, 1463, 1440, 1299, 1176, 1108, 1089, 1035, 998, 971, 
817 cm–1; δH (270 MHz) 7.08 (2H, d, J 8.0 Hz, meta ArOMe), 6.28 (2H, d, J 8.0 Hz, 
ortho ArOMe), 5.85-5.68 (2H, m, CH=CH), 4.10 (2H, d, J 5.0 Hz, CH2OH), 3.79 (3H, 
s, OMe), 3.35 (2H, d, J 6.0 Hz, CH2Ar); δC (67.5 MHz) [158.1, 132.2 (q Ar)], [132.1, 
130.0 (ortho & meta ArOMe)], [114.0, 113.9 (CH=CH)], 63.6 (OMe), 55.4 (CH2OH), 
37.8 (CH2ArOMe); m/z (CI) 196 [M+NH4]
+, 179 [M+H]+, 161; data in agreement with 
that previously reported.30,31   
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[(2S*,3R*)-3-(4-Methoxybenzyl)-1-tosylaziridin-2-yl]methanol
30
 198 
 
OMe
OH
OMe
OH
TsN
197 198  
                                          
To a mixture of allylic alcohol 197 (4.10 g, 23.0 mmol, 1.0 equiv) and anhydrous 
Chloramine-T® (5.76 g, 25.3 mmol, 1.1 equiv) MeCN (115 mL) at rt was added 
phenyltrimethylammonium tribromide (0.860 g, 2.30 mmol, 0.1 equiv). After 20 h the 
suspension was concentrated to ca. 40 mL and filtered through a short pad of silica gel 
with Et2O. Concentration under reduced pressure and column chromatography 
(25%→35% EtOAc–petrol) gave the hydroxyaziridine 198 (4.60 g, 57%) as a white 
solid; mp 71-72 °C; Rf  0.32 (40% EtOAc–petrol); vmax (film) 3511, 2935, 1612, 1514, 
1443, 1304, 1248, 1157, 1088, 1034, 976, 943, 816, 710 cm–1; δH (270 MHz) 7.65 (2H, 
d, J 8.0 Hz, ortho Ts), 7.22 (2H, d, J 8.0 Hz, meta Ts), 6.89 (2H, d, J 8.0 Hz, meta 
ArOMe), 6.67 (2H, d, J 8.0 Hz, ortho ArOMe), 4.12-3.89 (2H, m, CH2OH), 3.73 (3H, s, 
OMe), 3.19-3.03 (2H, m, CHCHCH2OH), 2.90 (1H, dd, J 16.5, 13.0 Hz, CHHArOMe), 
2.63 (1H, dd, J 16.5, 13.0 Hz, CHHArOMe), 2.43 (3H, s, Me of Ts); δC (125 MHz) 
158.4, 144.1,  136.9, 129.9, 129.6, 129.5, 127.4, 113.9, 60.8, 55.2, 51.7, 47.1, 35.8, 
21.6; m/z (CI) 365 [M+NH4]
+, 348 [M+H]+, 189; data in agreement with that previously 
reported.30   
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(2R*,3R*)-2-(4-Methoxybenzyl)-1-tosyl-3-vinylaziridine
30
 46 
 
OMe
OH
TsN
OMe
TsN
OMe
TsN
O
198 46  
 
To a solution of hydroxyaziridine 198 (4.54 g, 13.1 mmol, 1.0 equiv) in DMSO (140 
mL) at rt was added IBX (4.06 g, 14.5 mmol, 1.1 equiv). After 22 h the reaction was 
diluted with Et2O (400 mL), washed with sat. NaHCO3(aq.) (4 × 100 mL), H2O (4 × 100 
mL) and extracted with Et2O (3 × 100 mL). The combined organic layers were washed 
with brine (4 × 50 mL) and dried (Na2SO4). Concentration under reduced pressure and 
drying under high vacuum for 1 h gave the corresponding crude aldehyde (4.14 g).  
 
To a suspension of Ph3PCH3Br (5.20 g, 14.3 mmol, 1.1 equiv) in THF (104 mL) at –20 
°C was added KHMDS (28.6 mL of a 0.5 M solution in toluene, 14.3 mmol, 1.1 equiv). 
After 15 min the suspension was warmed to rt for 45 min and re-cooled to –20 °C and 
the solution of aldehyde (4.14 g, 11.9 mmol, 0.9 equiv) in THF (7.5 mL) added. After 
45 min the solution was warmed to rt. After 35 min the solution was quenched with 
brine (300 mL) and extracted with Et2O (3 × 100 mL). The combined organic layers 
were dried (Na2SO4). Concentration under reduced pressure and column 
chromatography (25% EtOAc–petrol) gave vinylaziridine 46 (1.00 g, 22%) as a gum; Rf 
0.72 (25% EtOAc–petrol); vmax (film) 3061, 3030, 2996, 2955, 2837, 1611, 1598, 1585, 
1512, 1462, 1440, 1398, 1323, 1302, 1247, 1178, 1116, 1089, 989, 928, 906, 814 cm–1; 
δH (270 MHz) 7.65 (2H, d, J 8.0 Hz, ortho Ts), 7.20 (2H, d, J 8.0 Hz, meta Ts), 6.90 
(2H, d, J 8.0 Hz, meta ArOMe), 6.67 (2H, d, J 8.0 Hz, ortho ArOMe), 6.11-6.04 (1H, 
m, CH=CH2), 5.50 (1H, d, J 16.5 Hz, cis CH=CHH), 5.35 (1H, d, J 12.0 Hz, trans 
CH=CHH), 3.77 (3H, s, OMe), 3.27-3.14 (2H, m, CHNCH), 2.90 (1H, dd, J 14.5, 5.0 
Hz, CHHArOMe), 2.69 (1H, dd, J 14.5 Hz, 6.5 Hz, CHHArOMe), 2.42 (3H, s, Me of 
Ts); δC (125 MHz) [158.4 , 143.8, 137.1 (q Ar)], 131.8 (CH=CH2), [129.7, 129.4 (4C, 
Ar)], 129.4 (q Ar), [127.4 (2C, Ar)], 122.0 (CH=CH2), [114.0, 113.9 (Ar)], 60.4 (OMe), 
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[55.2, 51.5 (CHNCH)], 36.0 (CH2ArOMe), 21.6 (Me of Ts); m/z (CI) 344 [M+NH4]
+, 
196, 173, 163, 121; data in agreement with that previously reported.30   
 
 
[(2R*,3R*)-3-(4-Methoxybenzyl)oxiran-2-yl]methanol
31 205 
 
OMe
OH
OMe
OH
O
197 205  
 
To a solution of allylic alcohol 197 (21.0 g, 118 mmol, 1.0 equiv) in CH2Cl2 (170 mL) 
at –20 ºC was added m-CPBA [~26.5 g (45.7 g of a mixture of ~58% with water), 153 
mmol, 1.3 equiv]. The suspension was warmed to rt over 2h. After another 1 h, it was 
re-cooled to –20 ºC and 10% Na2SO3(aq.) (10 mL) added. It was then warmed to rt and a 
further amount of 10% Na2SO3(aq.) (290 mL) added. After 1 h, it was diluted with H2O 
(200 mL) and the aqueous phase extracted with CH2Cl2 (4 × 100 mL). The combined 
organic layers were washed with 10% Na2CO3(aq.) (2 × 100 mL), sat. NaHCO3(aq.) (3 × 
100 mL), brine (3 × 150 mL) and dried (Na2SO4). Concentration under reduced 
pressure cleanly gave the crude epoxide 205 (22.0 g, 96%) as an oil; Rf 0.24 (50% 
EtOAc–petrol); vmax (film) 3415, 2993, 2931, 2836, 1612, 1583, 1513, 1463, 1442, 
1301, 1247, 1180, 1081, 1033 cm–1; δH (400 MHz) 7.16 (2H, d, J 8.5 Hz, meta MeOAr), 
6.87 (2H, d, J 8.5 Hz, ortho MeOAr), 3.93 (1H, dd, J 12.5, 2.5 Hz, CHHOH), 3.80 (3H, 
s, OMe), 3.65 (1H, dd, J 12.5, 4.5 Hz, CHHOH), 3.20 (1H, ddd, J 8.5, 5.5, 3.0 Hz, 
CHCH2OH), 3.00 (1H, ddd, J 4.5, 4.5, 3.0 Hz, ArCH2CH), 2.86 (1H, dd, J 12.0, 6.5 Hz, 
ArCHHCH), 2.84 (1H, dd, J 12.0, 6.5 Hz, ArCHHCH); δC (125 MHz) 158.4 (Ar ipso to 
MeO), 130.0 (meta MeOAr), 128.9 (para MeOAr), 114.3 (ortho MeOAr), 61.6 (MeO), 
58.4 (CH2OH), 56.2 (CHCH2OH), 55.3 (ArCH2CH), 36.9 (ArCH2); m/z (CI) 212 
[M+NH4]
+, 195 [M+H]+, 177, 121; data in agreement with that previously reported.31 
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(2S*,3R*)-3-(4-Methoxybenzyl)oxirane-2-carbaldehyde
31 380 
 
OMe
O
O
OMe
OH
O
205 380  
 
To a solution of (COCl)2 (1.05 mL, 12.1 mmol, 1.20 equiv) in CH2Cl2 (15 mL) at –78 
ºC was added a solution of DMSO (1.72 mL, 24.2 mmol, 2.4 equiv) in CH2Cl2 (7 mL) 
dropwise. After 5 min, a solution of hydroxyl epoxide 205 (1.96 g, 10.1 mmol, 1.0 
equiv) in CH2Cl2 (23 mL) was added. After 25 min, Et3N (7.0 mL, 50.5 mmol, 5.0 
equiv) in CH2Cl2 (7 mL) was added slowly. After 10 min it was warmed to rt over 15 
min and sat. NaHCO3(aq.) (15 mL) added. The aqueous phase was extracted with Et2O (3 
× 50 mL). The combined organic layers were washed with H2O (2 × 50 mL), brine (2 × 
50 mL) and dried (Na2SO4). Concentration under reduce pressure and column 
chromatography (20→40% EtOAc–petrol) gave aldehyde 380 (1.74 g, 85%) as an oil; 
Rf 0.35 (40% EtOAc–petrol); vmax (film) 3000, 2956, 2913, 1836, 2738, 1725, 1612, 
1514, 1464, 1440, 1301, 1249, 1180, 1143, 1112, 1033 cm–1; δH (270 MHz) 8.90 (1H, d, 
J 6.5 Hz, CHO), 7.13 (2H, d, J 8.5 Hz, meta ArOMe), 6.84 (2H, d, J 8.5 Hz, ortho 
ArOMe), 3.77 (3H, s, OMe), 3.42 (1H, dt, J 5.0, 1.5 Hz, CHCH2Ar), 3.14 (1H, dd, J 
6.5, 1.5 Hz, CHCHO), 2.96 (1H, dd, J 15.5, 5.0 Hz, CHHAr), 2.88 (1H, dd, J 15.0, 5.5 
Hz, CHHAr); δC (67.5 MHz) 198.3 (CHO), 158.8 (q ArOMe), 130.2 (3º), 127.5 (q 
ArOMe), 114.2 (3º), [58.4, 57.0 (CHCH)], 55.3 (OMe), 36.4 (CH2Ar); m/z (CI) 210 
[M+NH4]
+, 193 [M+H]+, 175, 163, 147, 138, 121, 71, 52 (Found: [M+H]+, 193.0862. 
C11H12O3 requires [M+H]
+, 193.0865); data in agreement with that previously 
reported.31 
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(2R*,3R*)-2-(4-Methoxybenzyl)-3-vinyloxirane
31
 206 
 
OMe
O
O
OMe
O
308 206  
 
To a mixture of Ph3PCH3Br (43.6 g, 121.9 mmol, 2.0 equiv) in THF (140 mL) at –20 ºC 
was added KHMDS (243.8 mL of a 0.5 M solution in toluene, 121.9 mmol, 2.0 equiv). 
After 30 min, it was warmed to rt then re-cooled to –20 ºC after 30 min and aldehyde 
308 (11.7 g, 60.9 mmol, 1.0 equiv) in THF (30 mL) was added slowly. After 1 h at that 
temperature the reaction was quenched with brine (400 mL) was poured in and the 
aqueous phase extracted with Et2O (3 × 200 mL). The combined organic layers were 
washed with H2O (3 × 150 mL), brine (4 × 150 mL) and dried (Na2SO4). Concentration 
under reduced pressure gave a the brown liquid, which was cooled down to give 
P(O)PPh3 precipitate that was filtered. Column chromatography of the filtrate gave 
vinyl epoxide 206 (11.1 g, 96%) as an oil; Rf 0.55 (10% EtOAc–petrol); vmax (film) 
2992, 2949, 2913, 2844, 1611, 1583, 1512, 1461, 1445, 1246, 1034, 923, 806 cm–1; δH 
(400 MHz) 7.18 (2H, d, J 8.5 Hz, meta MeOAr), 6.88 (2H, d, J 8.5 Hz, ortho MeOAr), 
5.58 (1H, ddd, J 17.0, 10.0, 7.5 Hz, CH=CH2), 5.47 (1H, dd, J 17.0, 1.5 Hz, cis 
CH=CHH), 5.25 (1H, dd, J 10.0, 1.5 Hz, trans CH=CHH), 3.82 (3H, s, MeO), 3.18 
(1H, dd, J 7.5, 2.0 Hz, CHCH=CH2), 3.06 (1H, ddd, J 5.5, 5.5, 2.0 Hz, ArCH2CH), 2.89 
(1H, dd, J 10.0, 5.5 Hz, ArCHH), 2.87 (1H, dd, J 10.0, 5.5 Hz, ArCHH); δC (125 MHz) 
158.4 (ipso MeOAr), 135.5 (CH=CH2), 130.0 (meta MeOAr), 128.9 (para MeOAr), 
119.3 (CH=CH2), 114.3 (ortho MeOAr), 60.6 (MeO), [58.4, 55.3 (CHOCH)], 37.4 
(ArCH2); m/z (CI) 208 [M+NH4]
+, 192, 173, 161, 147, 134, 121, 107; data in agreement 
with that previously reported.31 
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(2R*,3S*)-3-Amino-1-(4-methoxyphenyl)pent-4-en-2-ol
31 207 
 
OMe
O
OMe
HO
H2N
206 207  
 
The mixture of vinyl epoxide 206 (2.00 g, 10.4 mmol, 1.0 equiv) and NH4OH (17 mL 
of a 28% A.C.S. reagent, 251 mmol, 24.1 equiv) was irradiated under microwave at 110 
ºC for 35 min. Water (20 mL) was added to the reaction mixture, extracted with ether (3 
× 20 mL). The combined organic layers were washed with brine (3 × 10 mL) and dried 
(Na2SO4). Concentration under reduced pressure cleanly gave crude hydroxyamine 207 
(1.8 g, 84%) as an oil; Rf 0.17 (15% EtOAc–petrol); vmax (film) 3355, 3289, 3099, 3031, 
2935, 1612, 1582, 1511, 1463, 1442, 1423, 1299, 1246, 1178, 1108, 1035 cm–1; δH (400 
MHz) 7.16 (2H, d, J 8.5 Hz, meta MeOAr), 6.87 (2H, d, J 8.5 Hz, ortho MeOAr), 6.03-
5.94 (1H, m, CH=CH2), 6.29-5.25 (2H, m, CH=CH2), 3.83-3.78 (4H, m, MeO & 
CHOH), 3.45 (1H, dd, J 7.0, 3.0 Hz, CHNH2), 2.74 (1H, dd, J 14.0, 4.5 Hz, ArCHH), 
2.65 (1H, dd, J 14.0, 8.5 Hz, ArCHH), 1.77 [2H, s (br), NH2]; δC (125 MHz) 158.2 (Ar 
para to MeO), 138.2 (CH=CH2), 130.6 (Ar ipso to MeO), 130.4 (Ar meta to MeO), 
116.7 (CH=CH2), 114.0  (Ar ortho to MeO), 75.3 (CHOH), 58.0 (CHNH2), 38.4 
(ArCH2); m/z (CI) 208 [M+H]
+, 189, 168, 150, 135, 123, 121, 109; data in agreement 
with that previously reported.31 
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N-[(3S*,4R*)-4-Hydroxy-5-(4-methoxyphenyl)pent-1-en-3-yl]-4-
methylbenzenesulfonamide
31
 208 
 
OMe
HO
H2N
OMe
HO
TsHN
207 208  
 
To a solution of hydroxyamine 207 (7.10 g, 34.3 mmol, 1.0 equiv), DMAP (503 mg, 
4.1 mmol, 0.12 equiv) and TsCl (13.0 g, 68.2 mmol, 2.0 equiv) in CH2Cl2 (61 mL) at 0 
ºC was added Et3N. After 3 h at that temperature, the resulting solution was diluted with 
CH2Cl2 (200 mL), washed with 10% NaHCO3(aq.) (130 mL) and the aqueous phase 
extracted with CH2Cl2 (2 × 50 mL). The combined organic layers were washed with 
brine (3 × 30 mL) and dried (Mg2SO4). Concentration under reduced pressure and 
column chromatography (35→60% EtOAc–petrol) gave tosamide 208 (10.1 g, 81%) as 
a gum; Rf 0.3 (30% EtOAc–petrol); vmax (film) 3447, 3356, 3291, 1511, 1322, 1288, 
1153, 1077, 1025, 813, 675 cm–1; δH (400 MHz) 7.70 (2H, d, J 8.0 Hz, ortho Ts), 7.28 
(2H, d, J 8.0 Hz, meta Ts), 7.05 (2H, d, J 8.5 Hz, meta ArOMe), 6.85 (2H, d, J 8.5 Hz, 
ortho ArOMe), 6.74 (1H, ddd, J 17.5, 10.5, 7.5 Hz, CH=CH2), 6.19-5.08 (2H, m, 
CH=CH2), 3.86-3.79 (5H, m, OMe, CHNHTs & CHOH), 2.67 (1H, dd, J 14.0, 4.5 Hz, 
ArCHH), 2.58 (1H, dd, J 14.0, 9.0 Hz, CHHAr), 2.65 (1H, dd, J 14.0, 8.5 Hz, CHHAr), 
2.44 (3H, s, Me of Ts), 1.88 (1H, d, J 4.5 Hz, NHTs); δC (100 MHz) [158.2, 143.4, 
137.7 (q Ar)], 132.5 (CH=CH2), [130.2, 129.6, (ArH)], 129.1 (q ArOMe), 127.2 (ArH), 
119.4 (CH=CH2), 114.2 (ArH), 74.7 (CHOH), 59.9 (CHNH2), 55.3 (OMe), 39.0 
(CH2Ar), 21.6 (Me of Ts); m/z (CI) 379 [M+NH4]
+, 362 [M+H]+, 344, 300, 251, 228, 
227, 207, 189, 150, 148, 140, 134, 122, 120, 109; data in agreement with that 
previously report.31 
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(2R*,3R*)-2-(4-Methoxybenzyl)-1-tosyl-3-vinylaziridine
31
 46 
 
OMe
HO
TsHN
OMe
TsN
208 46  
 
To a solution of tosamide 208 (7.20 g, 19.9 mmol, 1.0 equiv) and PPh3 (13.6 g, 51.9 
mmol, 2.6 equiv) in THF (200 mL) at –15 ºC was added DIAD (8.1 g, 39.9 mmol, 2.0 
equiv) dropwise. The solution was warmed to –5 ºC. After 14 h at that temperature, the 
solvent was removed under reduced pressure. The liquid was cooled down and the 
resulting solid was filtered off. The filtrate was purified by column chromatography 
(25% EtOAc–petrol) to give vinylaziridine 46 (6.4 g, 94%); data identical to that 
previously reported.31 
 
 
(1R*,5S*)-6-Oxabicyclo[3.1.0]hex-3-ene
103  
 
O
209 210  
 
To a mixture of anhydrous sodium carbonate (65.0 g, 613 mmol, 4.0 equiv) and 
cyclopentadiene 209 (10.2 g, 154 mmol, 1.0 equiv) in CH2Cl2 (169 mL) at 0 °C was 
added dropwise the solution of peracetic acid (28.8 mL of a 40 wt% solution in dilute 
acetic acid, 154 mmol, 1.0 equiv) and sodium acetate trihydrate (0.80 g, 5.9 mmol, 0.04 
equiv) over 20 min with vigorous stirring. After 10 min the mixture was stirred in a 
water bath at 20 °C until a negative result was obtained from starch-iodide paper test 
then filtered. Concentration under reduced pressure and distillation under vacuum (46 
mmHg) gave the epoxide 210 (3.20 g, 25%) as a colourless liquid; Rf 0.60 (90% 
EtOAc–petrol); vmax (film) 3492, 3459, 3401, 2958, 2922, 2873, 2105, 1837, 1463, 
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1361, 1182, 1122, 1072, 1041 cm–1; δH (270 MHz) 6.15-5.93 (2H, m, CH=CH), 3.92-
3.80 (2H, m, CHOCH), 2.63-2.59 (1H, m, CHHCHOCH), 2.41-2.32 (1H, m, 
CHHCHOCH); δC (125 MHz) [138.5, 131.3 (CH=CH)], [59.2, 56.9 (CHOCH)], 35.6 
(CH2); m/z (CI) 100 [M+NH4]
+, 83 [M+H]+, 71, 56; data in agreement with that 
previously reported.103  
 
 
(1R*,4S*)-4-(Phenylsulfonyl)cyclopent-2-enol
32 45 
 
210
O PhO2S OH
45  
 
Method 1: Pd(acac)2 in THF preparation 
 
To a mixture of epoxide 210 (50.0 mg, 0.76 mmol, 1.0 equiv) and sodium 
benzenesulfinate (313 mg, 1.91 mmol, 2.5 equiv) in THF (2.5 mL) was added a solution 
of Pd(acac)2 (1.2 mg, 0.004 mmol, 0.005 equiv) in THF (1 mL). The mixture was 
heated to 60 °C. After 16 h a further amount of Pd(acac)2 (11.0 mg, 0.04 mmol, 0.05 
equiv) in THF (1 mL) was added. After 3 days the mixture was quenched with sat. 
NH4Cl(aq.) (0.5 mL). After 15 min the solution was diluted with sat. NH4Cl (aq.) (1 mL), 
H2O (10 mL) and the mixture extracted with CH2Cl2 (3 × 10 mL). The combined 
organic layers were washed with brine (2 × 5 mL) and dried (MgSO4). Concentration 
under reduced pressure and column chromatography (40% EtOAc–petrol) gave the 
(1R*,4S*)-4-(phenylsulfonyl)cyclopent-2-enol 45 (63 mg, 37%) as a colourless oil; Rf 
0.52 (80% EtOAc–petrol); vmax (film) 3428, 3000, 2985, 2956, 2921, 2850, 2815, 2802, 
2782, 1910, 1884, 1658, 1641, 1552, 1303, 1145, 1083, 989 cm–1; δH (270 MHz) 7.90 
(2H, d, J 7.0 Hz, ortho PhSO2), 7.67 (1H, t, J 7.0 Hz, para PhSO2), 7.57 (2H, t, J 7.0 
Hz, meta PhSO2), 6.36-6.35 (1H, m, CH=CHCHOH), 5.74-5.73 (1H, m, 
CH=CHCHOH), 4.72-4.70 (1H, m, CHSO2Ph), 4.16-4.01 (1H, m, CHOH), 2.26-2.21 
(2H, m, CH2); δC (125 MHz) 142.5 (ipso PhSO2), 137.7 (ortho PhSO2), 134.2 (para 
PhSO2), [129.4, 128.8 (CH=CH)], 126.3 (meta PhSO2), 74.9 (CHSO2Ph), 70.2 
(CHOH), 34.3 (CH2); m/z (CI) 242 [M+NH4]
+, 225 [M+H]+, 208 [M-OH]+; data in 
agreement with that previously reported.32  
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Method 2: Pd2(dba)3 in DMF preparation 
 
To a solution of Pd2(dba)3 (36.7 mg, 0.04 mmol, 0.05 equiv) in DMF (1 mL) at rt was 
added a solution of epoxide 210 (65.7 mg, 0.8 mmol, 1.0 equiv) in DMF (1 mL) and a 
suspension of sodium benzenesulfinate (263 mg, 1.6 mmol, 2.0 equiv) in DMF (2 mL). 
The resulting solution was heated to 90 °C. After 6 h the solution was quenched with 
sat. NH4Cl(aq.) (0.5 mL). After 15 min the solution was diluted with sat. NH4Cl(aq.) (1 
mL) and H2O (10 mL) then extracted with EtOAc (3 × 10 mL). The combined organic 
layers were washed with brine (4 × 5 mL) and dried (MgSO4). Concentration under 
reduced pressure and column chromatography (30% EtOAc–petrol) gave the compound 
45 (75.3 mg, 42%); data identical to that of method 1 preparation. 
 
 
5-(Phenylsulfonyl)hepta-1,5-dien-3-ol 216 and 3-(phenylsulfonyl)-2-vinylpent-3-en-
1-ol 217 
 
O OHPhO2S
PhO2S
+
PhO2S
OH
+
212 216 217
47
 
 
To a solution of allylic sulfone 212 (1.00 g, 5.5 mmol, 1.0 equiv) in Et2O (27 mL) at         
–20 °C was added nBuLi (2.30 mL of a 2.8 M solution in hexanes, 6.60 mmol, 1.2 
equiv) dropwise over 20 min. After 15 min the suspension was warmed for 30 min then 
re-cooled to –20 °C. Butadiene monoxide 47 (440 µL, 5.5 mmol, 1.0 equiv) was added. 
After 30 min the reaction was warmed to rt for 2 h then sat. NH4Cl(aq.) (1.0 mL) added. 
After 5 min the mixture was diluted with sat. NH4Cl(aq.) (4 mL), H2O (30 mL) and 
extracted with Et2O (3 × 30 mL). The combined organic layers were washed with brine 
(2 × 15 mL) and dried (MgSO4). Concentration under reduced pressure and column 
chromatography (20%→30% EtOAc–petrol) gave 5-(phenylsulfonyl)hepta-1,5-dien-3-
ol 216 (407 mg, 29%) and 3-(phenylsulfonyl)-2-vinylpent-3-en-1-ol 217 (232 mg, 17%) 
both as colourless gums.  
 
 124
Data for 216: Rf  0.37 (40% EtOAc–petrol); vmax (film) 3501, 3069, 2984, 2924, 1704, 
1643, 1584, 1477, 1300, 1148, 1132, 1083, 1033, 1022, 996, 926, 762, 737, 693 cm–1; 
δH (270 MHz) 7.86-7.79 (2H, m, ortho PhSO2), 7.65-7.45 (3H, m, para & meta PhSO2), 
7.12 (1H, q, J 7.0 Hz, CH=CSO2Ph), 5.86-5.72 (1H, m, CH2=CHCHOH), 5.21 (1H, d, J 
18.0 Hz, cis CHH=CH), 5.07 (1H, d, J 11.0 Hz, trans CHH=CH), 4.12-4.30 (1H, m, 
CHOH), 2.44-2.38 (2H, m, CH2CHOH), 1.89 (3H, d, J 7.0 Hz, Me), 1.20 (1H, br s, 
OH); δC (125 MHz) 140.5 (ipso PhSO2), 139.6 (CH=CSO2Ph), 138.6 (para PhSO2), 
133.4 (CH=CSO2Ph), 129.4 (CH2=CH), 129.2 (ortho PhSO2)], 128.1 (meta PhSO2), 
115.3 (CH2=CH), 71.6 (CHOH), 33.9 (CH2CHOH), 14.7 (Me); m/z (CI) 522 
[2M+NH4]
+, 270  [M+NH4]
+, 253 [M+H]+, 235 [M-OH]+, 216, 69, 52 (Found: 
[M+NH4]
+, 270.1157. C13H16O3S requires [M+NH4]
+, 270.1164) (Found: C, 61.78; H, 
6.32. C13H16O3S requires C, 61.88; H, 6.39%). 
 
Data for 217: Rf 0.23 (40% EtOAc–petrol); vmax (film) 3502, 3065, 2951, 2936, 2882, 
1640, 1584, 1476, 1446, 1416, 1376, 1289, 1200, 1149, 1084, 1070, 1045, 996, 926, 
894, 837, 762, 721, 689, 612 cm–1; δH (500 MHz) 7.90-7.87 (2H, m, ortho PhSO2), 7.64 
(1H, m, para PhSO2), 7.56-7.53 (2H, m, meta PhSO2), 7.16 (1H, q, J 7.0 Hz, 
CH=CSO2Ph), 5.71-5.64 (1H, m, CH2=CH), 4.96 (1H, dd, J 10.0, 1.5 Hz, trans 
CHH=CH), 4.79 (1H, dd, J 17.0, 1.5 Hz, cis CHH=CH), 3.79 (2H, d, J 7.5 Hz, 
CH2OH), 3.53 (1H, dt, J 14.5, 7.5 Hz, CHCH2OH), 1.95 (3H, d, J 7.0 Hz, CH3), 1.28-
1.18 (1H, m, OH);  δC (125 MHz) 140.8 (ipso PhSO2), 139.9 (CH=CSO2Ph), 139.3 
(para PhSO2), 133.8 (CH=CSO2Ph), 133.4 (CH2=CH), 129.1 (ortho PhSO2), 128.2 
(meta PhSO2), 117.4 (CH2=CH), 64.5 (CH2OH), 45.2 (CHCH2), 15.1 (Me); m/z (CI) 
270 [M+NH4]
+,  253 [M+H]+, 235 [M-OH]+, 132, 52 (Found: [M+NH4]
+, 270.1160. 
C13H16O3S requires [M+NH4]
+, 270.1164) (Found: C, 61.89; H, 6.37. C13H16O3S 
requires C, 61.88; H 6.39%). 
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(3-Methylbut-2-enylsulfonyl)benzene
104 223 
 
Br
+ PhSO2Na
SO2Ph
222 223  
 
To a solution of sodium benzenesulfinate (4.92 g, 30.0 mmol, 1.0 equiv) in DMF (20 
mL) at 70 °C was added prenyl bromide 222 (3.46 mL, 30.0 mmol, 1.0 equiv) then 
cooled to rt. After 6 h H2O (30 mL) was poured into the yellow suspension and the 
mixture extracted with EtOAc (3 × 60 mL). The combined organic layers were washed 
with brine (4 × 50 mL) and dried (MgSO4). Concentration under reduced pressure and 
recrystalisation (Et2O–petrol) gave the sulfone 223 (5.80 g, 92%) as a white crystalline 
solid; mp 49-50 ºC (lit. mp 50-51 ºC); Rf 0.76 (40% Et2O–petrol); vmax (film) 2976, 
2933, 2914, 1447, 1374, 1304, 1245, 1150, 1133, 1105, 1085, 774, 745, 689 cm–1; δH 
(270 MHz) 7.84 (2H, d, J 8.5 Hz, ortho PhSO2), 7.60 (1H, t, J 8.0 Hz, para PhSO2), 
7.54 (2H, dd, J 8.5, 8.0 Hz, meta PhSO2), 5.17 (1H, t, J 9.0 Hz, CH=C), 3.76 (2H, d, J 
9.0 Hz, CH2), 1.69 (3H, s, CH3CCH3), 1.28 (3H, s, CH3CCH3); δC (125 MHz) 143.0 
(ipso PhSO2), 138.7 (para PhSO2), 133.5 (C=CH), 128.9 (ortho PhSO2), 128.5 (meta 
PhSO2), 110.4 (C=CH), 56.2 (CH2SO2Ph), [25.8, 17.7 (2 × Me)]; m/z (CI) 228 
[M+NH4]
+, 211 [M+H]+; data in agreement with that previously reported.104  
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7-Methyl-5-(phenylsulfonyl)octa-1,6-dien-3-ol 224 and 5-methyl-3-
(phenylsulfonyl)-2-vinylhex-4-en-1-ol 225 
 
PhO2S OHPhO2S
+
PhO2S
OH
O
+
223
47
224 225  
  
To a solution of prenyl sulfone 223 (1.05 g, 5.0 mmol, 1.0 equiv) in THF/TMEDA (1:1, 
25 mL) at –78 °C was added nBuLi (2.50 mL of a 2.4 M solution in hexanes, 6.0 mmol, 
1.2 equiv). After 15 min the solution was warmed to –20 °C for 30 then  re-cooled to –
78 °C and butadiene monoxide 47 (483 µL, 6.0 mmol, 1.2 equiv) added. After 15 min 
the suspension was warmed to –20 °C then to rt after 30 min. After 1 h the reaction was 
quenched with sat. NH4Cl(aq.) (15 mL), diluted with H2O (50 mL) and extracted with 
Et2O (3 × 60 mL). The combined organic layers were washed with brine (3 × 10 mL) 
and dried (MgSO4). Concentration under reduced pressure and column chromatography 
(15% EtOAc–petrol) gave 7-methyl-5-(phenylsulfonyl)octa-1,6-dien-3-ol 224 (476 mg, 
36%) and 5-methyl-3-(phenylsulfonyl)-2-vinylhex-4-en-1-ol 225 (550 mg, 42%) both as 
colourless gums. 
 
Data for 224: Rf 0.48 (40% EtOAc–petrol); vmax (film) 3492, 3065, 2978, 2926, 2876, 
1667, 1644, 1446, 1299, 1145, 1083, 1069, 1052, 996, 924, 744, 718, 689 cm–1; δH (270 
MHz) 7.82 (2H, d, J 7.5 Hz, ortho PhSO2), 7.60 (1H, t, J 7.0 Hz, para PhSO2), 7.51 
(2H, dd, J 7.5, 7.0 Hz, meta PhSO2), 5.88 (1H, ddd, J 14.0, 9.5, 5.0 Hz, CH =CH2), 5.20 
(1H, dd, J 14.0, 7.5 Hz, cis CHH=CH), 5.12 (1H, dd, J 9.5, 7.5 Hz, trans CHH=CH), 
4.98 (1H, d, J 10.5 Hz, C=CH), 4.13-4.05 (2H, m, PhSO2CH & CHOH), 2.24 (1H, ddd, 
J 6.5, 6.0, 2.5 Hz, CHHCHOH), 1.83 (1H, ddd, J 6.5, 6.0, 2.5 Hz, CHHCHOH), 1.65 
(3H, s, CH3CCH3), 1.48 (1H, d, J 7.0 Hz, OH), 1.15 (3H, s, CH3CCH3); δC (101 MHz) 
143.1 (ipso PhSO2), 140.4 (C=CH), 137.9 (para PhSO2), 133.4 (CH2=CH), 129.1 (ortho 
PhSO2), 128.7 (meta PhSO2), 116.6 (C=CH), 115.1 (CH2=CH), 69.6 (CHSO2Ph), 61.9 
(CHOH), 34.5 (CH2), [25.9, 17.9 (2 × Me)]; m/z (CI) 298 [M+NH4]
+, 281 [M+H]+, 264, 
263 [M-OH] +, 160, 121, 83 (Found: [M+NH4]
+, 298.1472. C15H20O3S requires 
 127
[M+NH4]
+, 298.1477) (Found: C, 64.29; H, 7.13. C15H20O3S requires C, 64.26; H, 
7.19%). 
 
Data for 225: Rf 0.41 (40% EtOAc–petrol); vmax (film) 3497, 2978, 2937, 2915, 1446, 
1377, 1301, 1175, 1143, 1083, 1069, 1049, 995, 927, 777, 745, 795, 689 cm–1; δH (270 
MHz) 7.78 (2H, d, J 8.5 Hz, ortho PhSO2), 7.55 (1H, t, J 7.0 Hz, para PhSO2), 7.51 
(2H, dd, J 8.5, 7.0 Hz, meta PhSO2), 5.79-5.73 (1H, m, CH2=CH), 5.21-5.11 (2H, m, 
CH2=CH), 4.95 (1H, d, J 11.5 Hz, C=CH), 4.23-4.21 (1H, m, PhSO2CH), 3.84-3.44 
(2H, m, CH2OH), 2.39-2.33 (1H, m, CHCH2OH), 1.60 (3H, s, CH3CCH3), 1.15 (1H, m, 
OH), 1.11 (3H, s, CH3CCH3); δC (100 MHz) 142.8 (ipso PhSO2), 141.9 (C=CH), 137.9 
(para PhSO2), 134.0 (CH2=CH), 129.1 (ortho PhSO2), 128.7 (meta PhSO2), 117.3 
(C=CH), 116.4 (CH2=CH), 70.9 (CHSO2Ph), 61.7 (CH2OH), 30.3 (CHCH2OH), [25.7, 
18.0 (2 × Me)]; m/z (CI) 298 [M+NH4]
+, 281 [M+H]+, 264, 263 [M-OH]+, 160, 121, 
109, 83 (Found: [M+NH4]
+, 298.1471. C15H20O3S requires [M+NH4]
+, 298.1477) 
(Found: C, 64.37; H, 7.16; C15H20O3S requires C, 64.26; H, 7.19%). 
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Cinnamylsulfonylbenzene
107 227 
 
Ph Br + PhSO2Na Ph SO2Ph
226 227  
 
To a solution of sodium benzenesulfinate (10.0 g, 60.9 mmol, 1.0 equiv) in DMF (20 
mL) at 80 °C was added cinnamyl bromide 226 (12.0 g, 60.9 mmol, 1.0 equiv) then 
cooled to rt. After 2 h the suspension was diluted with H2O (150 mL) and extracted with 
EtOAc (3 × 70 mL). The combined organic layers were washed with brine (3 × 40 mL) 
and dried (MgSO4). Concentration under reduced pressure and recrystalisation (EtOAc–
petrol) gave cinnamylphenylsulfone 227 (14.7 g 93%) as a white crystalline solid; mp 
50-51 ºC (EtOAc–petrol) (lit.107 mp 50-51 ºC); Rf 0.62 (30% EtOAc–petrol); vmax (film) 
2974, 1445, 1403, 1317, 1237, 1160, 1135, 1084, 1058, 998, 982, 759, 697 cm–1; δH 
(270 MHz) 7.87 (2H, d, J 7.0 Hz, ortho PhSO2), 7.64 (1H, t, J 7.0 Hz, para PhSO2), 
7.54 (2H, t, J 7.0 Hz, meta PhSO2), 7.30-7.25 (5H, m, PhCH), 6.36 (1H, d, J 16.0 Hz, 
CH=CHCH2), 6.05 (1H, dt, J 16.0, 8.0 Hz, CH=CHCH2), 3.94 (2H, d, J 8.0 Hz, 
CH2SO2Ph); δC (125 MHz) 139.2 (ipso PhSO2), 138.5 (ortho PhSO2), 135.8 (ipso 
PhCH=CH), 133.7 (PhCH=CH), 130.8 (para PhCH=CH), [129.1, 128.8, 126.6 (ortho 
& meta PhCH & PhSO2), 115.2 (PhCH=CH), 60.5 (CH2SO2); m/z (CI) 276 [M+NH4]
+, 
269, 229, 175, 160; data in agreement with that previously reported.107 
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(3R*,5S*,E)-7-Phenyl-5-(phenylsulfonyl)hepta-1,6-dien-3-ol 3,5-syn-228, (E)-7-
phenyl-5-(phenylsulfonyl)hepta-1,6-dien-3-ol 228 and (E)-5-phenyl-3-
(phenylsulfonyl)2vinylpent-4-en-1-ol 229  
 
PhO2S
Ph
PhO2S
Ph
OH
+
PhO2S
Ph
OH
PhO2S
Ph
OH
+
227 3,5-syn-228 228 229  
     
To a solution of cinnamylsulfone 227 (2.10 g, 8.0 mmol, 1.0 equiv) in THF (40 ml) at –
78 °C was added nBuLi (4.54 mL of a 2.3 M solution in hexanes, 10.4 mmol, 1.3 equiv) 
dropwise over 10 min. After 15 min the solution was warmed to –20 °C for 30 min then 
re-cooled to –78 °C and butadiene monoxide (677 µL, 8.4 mmol, 1.05 equiv) added. 
The reaction was warmed to rt over a period of 1 h. After 3 h the reaction was quenched 
with sat. NH4Cl(aq.) (10 mL) then diluted with water (50 mL) and extracted with Et2O (3 
× 40 mL). The combined organic layers were washed with brine (2 × 30 mL) and dried 
(MgSO4). Concentration under reduced pressure and recrystalisation (Et2O–petrol) gave 
(3R*,5S*,E)-7-phenyl-5-(phenylsulfonyl)hepta-1,6-dien-3-ol 3,5-syn-228 (534 mg, 
20%) as a white solid, further column chromatography (20% EtOAc–petrol) gave (E)-7-
phenyl-5-(phenylsulfonyl)hepta-1,6-die-3-ol 228 (923 mg, 35%) as a yellow solid and 
(E)-5-phenyl-3-(phenylsulfonyl)-2-vinylpent-4-en-1-ol 229 (394 mg, 15%) as a gum. 
 
Data for 3,5-syn-228: mp 114-116 ºC (Et2O–petrol); Rf 0.40 (40% EtOAc–petrol); vmax 
(film) 3461, 2955, 2923, 2886, 2773, 1446, 1297, 1143, 1083, 1072, 996, 971, 734, 688 
cm–1; δH (270 MHz) 7.83 (2H, d, J 8.0 Hz, ortho PhSO2), 7.60 (1H, t, J 8.0 Hz, para 
PhSO2), 7.54 (2H, t, J 8.0 Hz, meta PhSO2), 7.26-7.24 (5H, m, PhCH), 6.30 (1H, d, J 
16.0 Hz, PhCH=CH), 5.99-5.82 (2H, m, PhCH=CH & CH2=CH), 5.23 (1H, dd, J 16.0, 
5.5 Hz, cis CHH=CH), 5.13 (1H, dd, J 10.5, 5.5 Hz, trans CHH=CH), 4.13-4.03 (2H, 
m, CHSO2Ph & CHOH), 2.33 (1H, ddd, J 20.5, 11.0, 3.0 Hz, CHHCHOH), 1.96 (1H, 
ddd, J 20.5, 11.0, 3.0 Hz, CHHCHOH), 1.55-1.52 (1H, d, J 3.5 Hz, OH); δC (101 MHz) 
140.1 (ipso PhSO2), [138.7, 137.5, 135.7 (ipso PhCH & ortho, para PhSO2)], 133.7 
(PhCH=CH), [129.1, 128.9, 128.7  (meta PhSO2 & ortho, para PhCH)], 128.5 
(PhCH=CH), 126.6 (meta PhCH), 120.5 (CH2=CH), 115.5 (CH2=CH), 69.4 
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(PhSO2CH), 66.4 (CHOH), 34.4 (CH2); m/z (CI) 346 [M+NH4]
+, 333, 332, 329 
[M+H]+, 297, 276, 206, 204, 175, 160, 134, 132, 131, 52 (Found: [M+NH4]
+, 346.1480. 
C19H20O3S requires [M+NH4]
+, 346.1477) (Found: C, 69.49; H, 6.19. C19H20O3S 
requires C, 69.48; H, 6.14%). 
 
Data for 229: Rf 0.34 (40% EtOAc–petrol); vmax (film) 3493, 3055, 2975, 2954, 2930, 
2878, 1447, 1302, 1144, 1083, 1060, 732, 689 cm–1; δH (270 MHz) 7.82 (2H, d, J 8.5 
Hz, ortho PhSO2), 7.55 (1H, t, J 8.0 Hz, para PhSO2), 7.42 (2H, dd, J 8.5, 8.0 Hz, meta 
PhSO2), 7.24-7.12 (5H, m, PhCH=CH) 6.09 (1H, d, J 16.0 Hz, PhCH=CH), 6.07 (1H, 
dd, J 16.0, 8.5 Hz, PhCH=CH), 5.27 (1H, dd, J 10.0, 1.0 Hz, trans CHH=CH), 5.25 
(1H, dd, J 15.5, 1.0 Hz, cis CHH=CH), [4.14-4.00, 3.88-3.69 (2H, m, CH2OH)], 3.59 
(1H, dd, J 11.0, 8.5 Hz, CHSO2Ph), 3.34-3.26 (1H, m, CHCH2OH), 1.24-1.19 (1H, m, 
OH); δC (101 MHz) 139.1 (ipso PhSO2), 138.1 (para PhSO2), 135.7 (ipso PhCH), 133.6 
(PhCH=CH), [129.0, 128.8, 128.6, 128.3 (ortho, meta PhSO2 & ortho, para PhCH)], 
128.3 (PhCH=CH), 126.6 (meta PhCH), 119.5 (CH2=CH), 118.6 (CH2=CH), 69.2 
(PhSO2CH), 63.3 (CH2OH), 44.6 (CH); m/z (CI) 346 [M+NH4]
+, 329 [M+H]+, 206, 
204, 287, 177, 169, 160, 157, 52 (Found: [M+NH4]
+, 346.1479. C19H20O3S requires 
[M+NH4]
+, 346.1477) (Found: C, 69.58; H, 6.12. C19H20O3S requires C, 69.48; H, 
6.14%). 
 
 
(1R*,4S*)-4-(Phenylsulfonyl)cyclopent-2-enol
32 cis-45 
 
3,5-syn-228
PhO2S
Ph
OH
PhO2S OH
cis-45
 
 
To a solution of 3,5-syn-228 (400 mg, 1.20 mmol, 1.0) in CH2Cl2 (15 mL) at 40 °C was 
added catalyst 50 (31.1 mg, 0.04 mmol, 0.03 equiv) in CH2Cl2 (2 mL). After 10 min 
concentration under reduced pressure and column chromatography (15%→50% 
EtOAc–petrol) gave cyclopentenylsulfone cis-45 (255 mg, 93%); data identical to that 
previously reported.32  
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tert-Butyldimethyl[(3R*,5S*,E), (3S*,5S*,E)-7-phenyl-5-(phenylsulfonyl) 
hepta-1,6-dien-3-yloxy]silane 230 
 
PhO2S
Ph
OTBDMSPhO2S
Ph
OH
228 230  
 
To a solution of compound 228 (311 mg, 0.95 mmol, 1.0 equiv), DMAP (8.7 mg, 0.07 
mmol, 0.08 equiv) and TBDMSCl (258 mg, 1.7 mmol, 1.8 equiv) in CH2Cl2 (1 mL) at 
40 °C was added Et3N (397 µL, 2.85 mmol, 3.0 equiv) dropwise. After 24 h the brown 
suspension was quenched with sat. NH4Cl(aq.) (2 mL), diluted with H2O (5 mL) and 
extracted with CH2Cl2 (3 × 10 mL). The combined organic layers were washed with sat. 
NaHCO3(aq.) (5 mL), brine (3 × 5 mL) and dried (MgSO4). Concentration under reduced 
pressure and column chromatography (40% ether–petrol) gave tert-
butyldimethyl[(3R*,5S*,E), (3S*,5S*,E)-7-phenyl-5-(phenylsulfonyl)hepta-1,6-dien-3-
yloxy]silane 230 (400 mg, 95%) as a colourless oil; Rf 0.67 (40% Et2O–petrol); vmax 
(film) 2953, 2929, 2902, 2856, 1470, 1447, 1360, 1316, 1305, 1254, 1083, 1028, 988, 
968, 943, 906, 873, 836, 819, 777, 753, 734, 705 cm–1; δH (270 MHz) 7.83-7.79 (2 × 
2H, m, ortho PhSO2, 2 × diast.), 7.61-7.45 (2 × 3H, m, para & meta PhSO2, 2 × diast.), 
7.30-7.19 (2 × 5H, m, PhCH=CH, 2 × diast.), 6.25 (1H, d, J 18.5 Hz, CH=CHPh, diast. 
of PhSO2 syn to OTBDMS), 6.15 (1H, d, J 18.5, CH=CHPh, diast. of PhSO2 anti to 
OTBDMS), 5.92-5.60 (2 × 2H, m, PhCH=CH & CH2=CH,    2 × diast.), 5.13-5.02 (2 × 
2H, m, CH2=CH, 2 × diast.), 4.23-3.77 (2 × 2H, m, PhSO2CHCH2CHOH, 2 × diast.), 
[2.40–2.28, 2.02–1.77 (2 × 2H, m, CHCH2CH, 2 × diast.)], 0.91 (9H, s, tBu, diast. of 
PhSO2 anti to OTBDMS), 0.86 (9H, s, tBu, diast. of PhSO2 syn to OTBDMS), {0.12, 
0.06, 0.02, -0.02, -0.04 [2 × 6H, m, Si(CH3)2, 2 × diast.]}; δC (101 MHz) 140.9, 140.2, 
138.7, 137.9, 137.6, 137.4, 135.8, 133.6, 129.2, 129.1, 128.8, 128.6, 128.4, 126.6, 
126.5, 121.5, 120.8, 115.6, 115.3, 71.8, 70.9, 66.2, 65.9, [35.9, 35.6 (2 × C, CHCH2CH, 
2 × diast.)], 25.8, 25.7, 25.6, [18.1, 18.0 (2 × C, SiC(CH3)3, 2 × diast.], {-3.6, -3.8, -4.4, 
-4.8 [2 × 2C, Si(CH3)2, 2 × diast.]}; m/z (CI) 460 [M+NH4]
+, 443 [M+H]+, 312, 311, 
301, 298, 171; 169, 132 (Found: [M+H]+, 443.2057. C25H34O3SSi requires [M+H]
+, 
443.2076) (Found: C, 67.96; H, 7.68. C25H34O3SSi requires C, 67.83; H, 7.74%). 
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tert-Butyldimethyl[(1R*,4S*), (1S*,4S*)-4-(phenylsulfonyl)cyclopent-2-enyl 
oxy]silane 213 
 
OTBDMSPhO2S
PhO2S
Ph
OTBDMS
230 231  
 
To a solution of diene 230 (350 mg, 0.79 mmol, 1.0 equiv) in CH2Cl2 (13 mL) at 40ºC 
was added a solution of catalyst 50 (20 mg, 0.024 mmol, 0.03 equiv) in CH2Cl2 (2 mL). 
After 2 h another solution of Grubbs II (13.4 mg, 0.016 mmol, 0.02 equiv) in DCM (1 
mL) was added. After 16 h concentrated under reduced pressure and column 
chromatography (5% EtOAc–petrol) gave tert-butyldimethyl[(1R*,4S*), (1S*,4S*)-4-
(phenylsulfonyl)cyclopent-2-enyloxy]silane 231 (211 mg, 79%); Rf (10% EtOAc–
petrol); vmax (film) 2953, 2935, 2882, 2856, 1725, 1470, 1447, 1367, 1307, 1256, 1179, 
1148, 1083, 897, 837, 778, 755, 718, 689 cm–1; δH (270 MHz) 7.85 (2 × 2H, d, J 7.5 Hz, 
ortho PhSO2, 2 × diast.), 7.61 (2 × 1H, t, J 7.0 Hz, para PhSO2, 2 × diast.), 7.56 (2H, 
dd, J  7.5, 7.0 Hz, meta PhSO2, 2 × diast.), [6.06-6.04, 5.93-5.91 (2H, m, CH=CH, diast. 
of PhSO2 syn to OTBDMS)],  [5.84-5.82, 5.74-5.71 (2H, m, CH=CH, diast. of PhSO2 
anti to OTBDMS)], 4.80-4.76 (2H, m, PhSO2CHCH2CHOTBDMS, 1 × diast.), [4.38-
4.35, 4.15-4.11 (2H, m, PhSO2CHCH2CHOTBDMS, 1 × diast.)], 2.70-2.52 (2H, m, 
CH2, diast. of PhSO2 syn with OTBDMS), 2.02-1.88 (2H, m, CH2, diast. of PhSO2 anti 
to OTBDMS), 0.87 (9H, s, tBu, diast. of PhSO2 anti to OTBDMS), 0.79 (9H, s, tBu, 
diast. of PhSO2 cis to OTBDMS, {0.00, –0.03, –0.05 [2 × 6H, s, Si(CH3)2, 2 × diast.]}; 
δC (125 MHz) [143.3, 141.4 (2 × ipso PhSO2, 2 × diast.)], 136.5 (para PhSO2, 1 × 
diast.), [133.8, 133.7 (2 × CH=CHCHSO2Ph, 2 × diast.)], 129.6 (para PhSO2, 1 × 
diast.), [129.4, 129.1 (2 × ortho PhSO2, 2 × diast.)], [129.0, 128.9 (2 × meta PhSO2, 2 × 
diast.)], [125.6, 125.4  (2 × CH=CHCHSO2Ph, 2 × diast.)], [76.4, 70.2, 71.4, 70.2 (2 × 
CHSO2Ph & CHOTBDMS, 2 × diast.)], [35.5, 34.4 (2 × CH2CHOTBDMS, 2 × diast.)], 
{25.8, 25.7, 25.6 [2 × (CH3)3CSi, , 2 × diast.]}, {18.1, 18.0 [2 × (CH3)3CSi, , 2 × 
diast.]}, {-4.8, -4.7 [2 × (CH3)2Si, 2 × diast.]} m/z (CI) 356 [M+NH4]
+, 339 [M+H]+, 
321, 281, 242, 240, 224, 197 [M-PhSO2]
+; (Found: [M+H]+, 339.1439. C17H26O3SSi 
requires [M+H]+, 339.1450) (Found: C, 60.23; H, 7.73. C17H26O3SSi requires C, 60.31; 
H, 7.74%). 
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(E)-5-(Phenylsulfonyl)-5-styrylocta-1,7-dien-3-ol 241 
 
PhO2S
Ph
OH
+ Br
Ph
OHPhO2S
228 241  
 
To a solution of diene 228 (405 mg, 1.23 mmol, 1.0 equiv) in THF (2.5 mL) at –78 °C 
was added nBuLi (1.05 mL of a 2.45 M solution in hexanes, 2.58 mmol, 2.1 equiv). 
After 20 min the solution was warmed to –20 °C for 20 min then re-cooled to –78 °C 
and allyl bromide (107 µL, 1.23 mmol, 1.0 equiv) added to this deep red solution. After 
15 min it was warmed to 0 °C for 15 min then to rt. After 30 min the reaction was 
quenched with sat. NH4Cl(aq.) (1.1 mL), diluted with H2O (5 mL) and extracted with 
EtOAc (3 × 10 mL). The combined organic layers were washed with brine (2 × 5 mL) 
and dried (MgSO4). Concentration under reduced pressure and column chromatography 
(30% EtOAc–petrol) gave 2:1 diastereomeric mixture of (E)-5-(phenylsulfonyl)-5-
styrylocta-1,7-dien-3-ol 241 (260 mg, 57%) as a colourless gum; Rf 0.24 (30% EtOAc–
petrol); vmax (film) 3505, 3463, 3063, 3026, 2978, 2922, 1640, 1493, 1445, 1300, 1146, 
1083, 1017, 923, 760, 740, 680 cm–1; δH (400 MHz) [7.84, 7.78 (2 × 2H, 2 × d, 2 × J 7.5 
Hz, ortho PhSO2, 2 × diast.)], 7.67-7.61 (2 × 1H, m, para PhSO2, 2 × diast.), 7.55-7.46 
(2 × 2H, m, meta PhSO2, 2 × diast.), 7.37-7.21 (2 × 5H, m, PhCH, 2 × diast.), 6.34 (1H, 
d, J 16.5 Hz, PhCH=CH, major diast.), 6.25 (1H, d, J 16.5 Hz, PhCH=CH, major 
diast.), 6.15-6.03 (1H, m, CH2=CHCH2, minor diast.), 5.95 (1H, dd, J 10.0, 6.5 Hz, 
CHH=CHCHOH, minor diast.), 5.92 (1H, dd, J 10.0, 6.5 Hz, CHH=CHCHOH, minor 
diast.), 5.82 (1H, dd, J 10.0, 4.5 Hz, CHH=CHCHOH, major diast.), 5.78 (1H, dd, J 
10.0, 6.0 Hz, CHH=CHCHOH, major diast.), 5.72-5.58 (1H, m, CH2=CHCH2, major 
diast.), [5.33-4.99 (2H, m, PhCH=CHC, minor diast.) & (2 × 3H, m, CH2=CHCH2, 2 × 
diast.)], 4.63 (1H, br s, OH, major diast.), 4.36 (1H, br s, OH, min. OH), 4.28 (1H, q, J 
6.20 Hz, CHOH, major diast.), 3.76 (1H, m, CHOH, major. diast.), 3.06 (1H, dd, J 
15.0, 6.5 Hz, CHHCH=CH2, minor diast.), 2.78 (1H, dd, J 15.0, 6.5 Hz, CHHCH=CH2, 
minor diast.), 2.65-2.46 (4H, m, CH2CH=CH2 & CH2CHOH, major diast.), 2.38 (1H, 
dd, J 14.0, 2.0 Hz, CHHCHOH, minor diast.), 2.22 (1H, dd, J 14.0, 8.5 Hz, 
CHHCHOH, minor diast.); δC (125 MHz) 147.0, 141.4, 140.8, 139.6, 139.1, 137.6, 
 134
135.2, 134.9, 134.6, 133.8, 133.5, 132.4, 130.9, 129.2, 128.9, 128.8, 128.5, 128.1, 
127.5, 127.4, 127.1, 126.7, 126.6, 119.7, 117.7, 115.4, 114.7, 71.5, 69.7, 69.2, 44.5, 
44.4, 41.1, 40.9, 38.1, 35.9, 34.7, 17.5; m/z (CI) 386 [M+NH4]
+, 368, 351, 330, 244, 
227, 171, 160, 52 (Found: [M+NH4]
+, 386.1788. C22H24O3S requires [M+NH4]
+, 
386.1782). 
 
 
(E)-5-(Phenylsulfonyl)-5-styrylcyclohex-2-enol 242 
 
Ph
OHPhO2S OH
Ph
PhO2S
241 242  
 
To a solution triene 241 (100 mg) in CH2Cl2 (12.6 mL) at rt was added a solution of 
catalyst 50 (6.90 mg) in CH2Cl2. After 24 h, concentration under reduced pressure and 
column chromatography (20% EtOAc–petrol) gave a 2:1 diastereomixture (E)-5-
(phenylsulfonyl)-5-styrylcyclohex-2-enol 242 (54.0 mg, 59%) as a gum; Rf 0.17 (30% 
EtOAc–petrol); δH (400 MHz) 7.87 (2H, d, J 7.5 Hz, ortho PhSO2, minor diast.), 7.81 
(2H, d, J 7.5 Hz, ortho PhSO2, major diast.), 7.67-7.20 (2 × 8H, m, para & meta PhSO2 
and PhCH, 2 × diast.), 6.31 (1H, d, J 16.5 Hz, PhCH=CH, major diast.), 6.05 (1H, d, J 
16.5 Hz, PhCH=CH, major diast.), [5.81-5.65 (2 × 2H, m, CH=CHCHOH, 2 × diast.) & 
(2H, m, PhCH=CH, minor diast.)], 5.60-5.54 (1H, m, CHOH, minor diast.), 4.78-4.74 
(1H, m, OH, minor diast.), 4.22-4.19 (1H, m, OH, major diast.), 3.99-3.94 (1H, m, 
CHOH, major diast.), 2.99-2.61 (2 × 2H, m, CH2CH=CH2, 2 × diast.), 2.35-2.11 (2H, 2 
× 2H, , CH2CHOH, 2 × diast.). 
 
 
 
 
 
 
 
 135
4-(Phenylsulfonyl)cyclopent-2-enol 45 
 
OHPhO2S
45
PhO2S
Ph
PhO2S
Ph
OH
227 228  
 
To a solution of cinnamylsulfone 227 (45.0 g, 174.2 mmol, 1.0 equiv) in THF (360 ml) 
at –78 °C was added nBuLi (60.0 mL of a 2.45 M solution in hexanes, 149 mmol, 0.86 
equiv) dropwise. It was warmed to –30 °C for 15 min then re-cooled to –78 °C. Another 
amount of nBuLi (10.5 mL of a 2.45 M solution in hexanes, 26.0 mmol, 0.14 equiv)  
was added dropwise. After 15 min the solution was warmed to –20 °C for 30 min then 
re-cooled to –78 °C and butadiene monoxide (14.7 mL, 182.9 mmol, 1.05 equiv) added. 
The reaction was warmed to rt over a period of 2 h. After 3 h the reaction was quenched 
with sat. NH4Cl(aq.) (200 mL) then diluted with water (300 mL) and extracted with Et2O 
(3 × 150 mL). The combined organic layers were washed with brine (3 × 100 mL) and 
dried (MgSO4). Concentration under reduced pressure and drying under high vacuum 
for 16 h gave 55g of a crude mixture of 228 and its regioisomer 229 as a gum. This 
crude mixture was then dissolved in CH2Cl2 (1.5 L). To the resulting solution was 
added catalyst 50 (750 mg). The solution was then heated under reflux. After 30 min, 
the reaction was cooled to rt. Concentration under reduced pressure and column 
chromatography (35→45% EtOAc–petrol) gave a 2:1 diastereomixture of 45 (21.0g, 
93.6mmol, 54%); δH (400 MHz) 7.95-7.88 (2 × 2H, m, ortho PhSO2, 2 × diast.), 7.67 (2 
× 3H, m, para & meta PhSO2, 2 × diast.), 6.36-6.35 (1H, m, CH=CHCHOH, major 
diast.), 6.20-6.18 (1H, app. dt, J 5.5, 2.0 Hz, CH=CHCHOH, minor diast.), 5.85-5.87 
(1H, m, CH=CHCHOH, minor diast.), 5.74-5.73 (1H, m, CH=CHCHOH, major diast.), 
4.83-4.87 (1H, m, CHSO2Ph, minor diast.), 4.72-4.70 (1H, m, CHSO2Ph, major diast.), 
4.41-4.44 (1H, m, CHOH, minor diast.), 4.16-4.01 (1H, m, CHOH, major diast.), 2.79-
2.72 (2H, m, CH2, minor diast.), 2.26-2.21 (2H, m, CH2, major diast.). 
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(1R*,4S*)-4-Allyl-4-(phenylsulfonyl)cyclopent-2-enol 234a 
 
OHPhO2S
+
Br
OHPhO2S
45 234a  
 
 
To a solution of cyclopentenol 45 (837 mg, 3.74 mmol, 1.0 equiv) in THF (15 mL) at –
78 °C was added nBuLi (3.31 mL of a 2.45 M solution in hexanes, 7.85 mmol, 2.1 
equiv). After 15 min the reaction was warmed to –20 °C for 15 min then to 0 °C. After 
15 min it was re-cooled to –78 °C and allyl bromide (326 µL, 3.74 mmol, 1.0 equiv) 
added. After 15 min the reaction was warmed to 0 °C for 0.5 h then to rt. After 2 h the 
reaction was quenched with sat. NH4Cl(aq.) (3.5 mL), diluted with H2O (40 mL) and 
extracted with EtOAc (3 × 30 mL). The combined organic layers were washed with 
brine (3 × 15 mL) and dried (MgSO4). Concentration under reduced pressure and 
column chromatography (20% EtOAc–petrol) gave (1R*,4S*)-4-allyl-4-
(phenylsulfonyl)cyclopent-2-enol 234a (603 mg, 61%) as a white crystalline solid; mp 
56-58 ºC; Rf 0.19 (30% EtOAc–petrol); vmax (film) 3490, 3416, 3209, 3069, 2978, 1445, 
1299, 1142, 1082, 1052, 1019, 732, 691   cm–1; δH (400 MHz) 7.91 (2H, d, J 8.0 Hz, 
ortho PhSO2), 7.74 (1H, t, J 7.0 Hz, para PhSO2), 7.63 (2H, dd, J 8.0, 7.0 Hz, meta 
PhSO2), 6.34 (1H, dd, J 5.5, 2.5 Hz, CH=CHCH), 5.58 (1H, d, J 5.5 Hz, CH=CHCH ), 
5.49–5.39 (1H, m, CH=CH2), 5.14–5.06 (2H, m, CH=CH2), 4.75 (1H, ddd, J 12.0 , 7.0, 
2.5 Hz, CHOH), 3.17 (1H, d, J 12.0 Hz, CHOH), [2.67–2.62, 2.52–2.47 (2H, m, 
CH2CH=CH2)], 2.42–2.26 (2H, m, CH2CHOH); δC (125 MHz) 142.2 (ipso PhSO2), 
135.6 (para PhSO2), [130.9, 130.7 (CH=CH)], [130.4, 129.2 (ortho & meta PhSO2)], 
[128.0, 120.5 (CH=CH2)], 79.0 (CSO2Ph), 75.7 (CHOH), [37.3, 37.0 (2 × CH2)]; m/z 
(CI) 282 [M+NH4]
+, 265 [M+H]+, 264, 247, 105 (Found: [M+NH4]
+, 282.1154. 
C14H16O3S requires [M+NH4]
+, 282.1164) (Found: C, 63.69; H, 6.10.  C14H16O3S 
requires C, 63.61; H, 6.10%). 
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(1R*,4S*)-4-[(E)-But-2-enyl]-4-(phenylsulfonyl)cyclopent-2-enol 234b 
 
PhO2S OHPhO2S OH
+ Br
45 234b  
                 
To a solution of cyclopentenol 45 (300 mg, 1.34 mmol, 1.0 equiv) in THF (2.7 mL) at rt 
was added nBuLi (1.15 mL of 2.45 M solution in hexanes, 2.82 mmol, 1.01 equiv). 
After 20 min to the dark red solution was added 4-bromo-2-butene (136 µL, 1.35 mmol, 
1.01 equiv). After 1.5 h the reaction was quenched with sat. NH4Cl(aq.) (1.2 mL), diluted 
with H2O (5 mL) and extracted with EtOAc (3 × 10 mL). The combined organic layers 
were washed with brine (2 × 5 mL) and dried (MgSO4). Concentration under reduced 
pressure and column chromatography (30% EtOAc–petrol) gave (1R*,4S*)-4-[(E)-but-
2-enyl]-4-(phenylsulfonyl)cyclopent-2-enol 234b (250 mg, 67%) as a white solid; mp 
64–66 ºC; Rf 0.22 (30% EtOAc–petrol); vmax (film) 3493, 3063, 3026, 2942, 2922, 2884, 
2855, 1445, 1299, 1287, 1140, 1083, 1071, 1050, 969, 793, 756, 691 cm–1; δH (400 
MHz) 7.90 (2H, d, J 8.0 Hz, ortho PhSO2), 7.73 (1H, t, J 7.0 Hz, para PhSO2), 7.63 
(2H, dd, J 8.0, 7.0 Hz, meta PhSO2), 6.33 (1H, dd, J 5.5, 3.0 Hz, CH=CHCHOH), 5.57 
(1H, d, J 5.5 Hz, CH=CHCHOH), 5.55-5.45 (1H, m, CH2CH=CH), 5.08-5.00 (1H, m, 
CH3CH=CH), 4.78-4.73 (1H, m, CHOH), 3.23 (1H, d, J 12.0 Hz, OH), 2.71–2.20 (4H, 
m, 2 × CH2), 1.63 (3H, d, J 6.5 Hz, Me); δC (125 MHz) 142.0 (ipso PhSO2), 135.8 (para 
PhSO2), [134.1, 131.3, 130.9, 123.1 (2 × CH=CH)], [130.4, 129.1 (ortho & meta 
PhSO2)], 79.0 (CSO2Ph), 75.6 (CHOH), [37.3, 35.8 (CH3CH=CHCH2)], 18.0 
(CH2CHOH); m/z (CI) 296 [M+NH4]
+, 278 M+, 261, 119 (Found: [M+NH4]
+, 296.1314. 
C15H18O3S requires [M+NH4]
+, 296.1320) (Found: C, 64.79; H, 6.60.  C15H18O3S 
requires C, 64.72; H, 6.52%). 
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(1R*,4S*)-4-Cinnamyl-4-(phenylsulfonyl)cyclopent-2-enol 234c 
 
45 234c
OHPhO2S
+ Ph Br
OHPhO2S
Ph
 
 
To a solution of cyclopentenol 45 (110 mg, 0.49 mmol, 1.0 equiv) in THF (3.4 mL) at    
–78 °C was added nBuLi (0.4 mL of a 2.45 M solution in hexanes, 0.98 mmol, 2.1 
equiv). After 15 min the reaction was warmed to –20 °C for 15 min then to 0 °C. After 
15 min the solution was re-cooled to –78 °C and cinnamyl bromide (96 mg, 0.49 mmol, 
1.0 equiv) added. After 15 min the reaction was warmed to 0 °C for 0.5 h then to rt. 
After 2 h the reaction was quenched with sat. NH4Cl(aq.) (1 mL), diluted with H2O (5 
mL) and extracted with EtOAc (3 × 5 mL). The combined organic layers were washed 
with brine (2 × 5 mL) and dried (MgSO4). Concentration under reduced pressure and 
column chromatography (20% Et2O–petrol) gave (1R*,4S*)-4-cinnamyl-4-
(phenylsulfonyl)cyclopent-2-enol 234c (80 mg, 49%) as a colourless gum; Rf 0.57 (40% 
EtOAc–petrol); vmax (film) 3488, 3428, 3060, 3027, 2924, 2852, 2359, 1737, 1498, 
1445, 1299, 1288, 1192, 1135, 1082, 1052, 998, 969, 733, 679 cm–1; δH (400 MHz) 7.92 
(2H, d, J 7.0 Hz, ortho PhSO2), 7.71 (1H, t, J 7.0 Hz, para PhSO2), 7.63 (2H, t, J 7.0 
Hz, meta PhSO2), 7.29-7.17 (5H, m, PhCH=CH), 6.39 (1H, d, J 15.5 Hz, PhCH=CH), 
6.34 (1H, dd, J 5.5, 2.5 Hz, CH=CHCH), 5.78 (1H, ddd, J 15.5, 9.0, 6.0 Hz, 
CH=CHCH2), 5.64 (1H, d, J 5.5 Hz, CH=CHCH), 4.75-4.70 (1H, m, CHOH), 3.19 (1H 
d, J 12.0 Hz, OH), 2.79 (1H, dd, J 14.0, 6.0 Hz, CHHCH=CH), 2.64 (1H, dd, J 14.0, 9.0 
Hz, CHHCH=CH), 2.44-2.29 (2H, m, CH2CHOH); δC (125 MHz) 142.4 (ipso PhSO2), 
136.4 (para PhSO2), [135.3, 134.2, 130.6 (ipso, para PhCH & CH=CHCHOH)], [130.4, 
129.2, 128.6 (ortho, meta PhSO2 & ortho PhCH)], 127.8 (PhCH=CH), 126.2 (meta 
PhCH), 122.1 (PhCH=CH), 78.9 (CSO2Ph), 75.7 (CHOH), [37.5, 36.3 (2 × CH2)]; m/z 
(CI) 358 [M+NH4]
+, 340, 323, 198, 181, 160 (Found: [M+NH4]
+, 358.1469. C20H20O3S 
requires [M+NH4]
+, 358.1477) (Found: C, 70.47; H, 5.98. C20H20O3S requires C, 70.58; 
H, 5.92%). 
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(1R*,4S*)-4-(3-Methylbut-2-enyl)-4-(phenylsulfonyl)cyclopent-2-enol 234d 
 
45 234d
PhO2S OH
Br
+
PhO2S OH
 
 
To a solution of cyclopentenol 45 (837 mg, 3.74 mmol, 1.0 equiv) in THF (15 mL) at –
78 °C was added nBuLi (3.31 mL of a 2.45 M solution in hexanes, 7.85 mmol, 2.1 
equiv). After 15 min the reaction was warmed to –20 °C for 15 min then to 0 °C. After 
15 min it was re-cooled to –78 °C and prenyl bromide (411 µL, 3.74 mmol, 1.0 equiv) 
added. After 15 min the reaction was warmed to 0 °C for 0.5 h then to rt. After 2 h the 
reaction was quenched with sat. NH4Cl(aq.) (3.5 mL), diluted with H2O (40 mL) and 
extracted with EtOAc (3 × 30 mL). The combined organic layers were washed with 
brine (3 × 15 mL) and dried (MgSO4). Concentration under reduced pressure and 
column chromatography (25% EtOAc-petrol) followed by recrystalisation (EtOAc-
petrol) gave (1R*,4S*)-4-(3-methylbut-2-enyl)-4-(phenylsulfonyl)cyclopent-2-enol 234d 
(440 mg, 40%) as a colourless crystalline solid; mp 70-72 ºC (EtOAc-petrol); Rf 0.16 
(25% EtOAc–petrol); vmax (film) 3507, 2966, 2934, 1445, 1405, 1298, 1285, 1267, 
1138, 1054, 1025, 690 cm–1; δH (400 MHz) 7.91 (2H, d, J 7.5 Hz, ortho PhSO2), 7.72 
(1H, t, J 7.0 Hz, para PhSO2), 7.61 (2H, dd, J 7.5, 7.0 Hz, meta PhSO2), 6.32 (1H, dd, J 
5.5, 2.5 Hz, CH=CHCH), 5.54 (1H, d, J 5.5 Hz, CH=CHCH), 4.77-4.72 (2H, m, 
C=CHCH2 & CHOH), 3.22 (1H, d, J 12.0 Hz, OH), 2.58 (1H, dd, J 14.0, 8.5 Hz, 
C=CHCHH), 2.46 (1H, dd, J 14.0, 6.0 Hz, C=CHCHH), 2.41 (1H, dd, J 15.5, 6.0 Hz, 
CHHCHOH), 2.21 (1H, dd, J 15.5, 7.0 Hz, CHHCHOH), 1.66 (3H, s, Me), 1.54 (3H, s, 
Me); δC (125 MHz) 141.9 (ipso PhSO2), 136.8 (para PhSO2), [135.5, 134.1 (CH=CH)], 
131.0 (C=CH), [130.4, 129.0 (ortho & meta PhSO2)], 111.3 (C=CH), 79.4 (CSO2Ph), 
75.8 (CHOH), [37.4, 30.9 (CH3CCH3)], 25.9 (C=CHCH2), 18.0 (CH2CHOH); m/z (CI) 
310 [M+NH4]
+, 293 [M+H]+, 292 M+, 133, 52 (Found: [M+NH4]
+, 310.1479. 
C16H20O3S requires [M+NH4]
+, 310.1477) (Found: C, 65.71; H, 6.90.  C16H20O3S 
requires C, 65.72; H, 6.89%). 
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(E)-(1-Phenylhepta-1,6-dien-3-ylsulfonyl)benzene 381 
 
Ph SO2Ph
+
PhO2S
Ph
Br
381
227
 
 
To a solution of cinnamylsulfone 227 (657 mg, 2.54 mmol, 1.0 equiv) in THF (12 mL) 
at –78 °C was added nBuLi (1.14 mL of a 2.45 M solution in hexanes, 2.80 mmol, 1.0 
equiv). After 15 min the solution was warmed to –20 °C for 15 min then to 0 °C, After 
15 min it was re-cooled to –78 ºC and butenyl bromide (310 µL, 3.05 mmol, 1.2 equiv) 
added. After 15 min it was gradually warmed to rt over 1 h. After 1 h the reaction was 
quenched with sat. NH4Cl(aq.) (2.2 mL), diluted with water (20 mL) and extracted with 
EtOAc (3 × 15 mL). The combined organic layers were washed with brine (2 × 10 mL) 
and dried (MgSO4). Concentration under reduced pressure and column chromatography 
(8% EtOAc–petrol) gave (E)-(1-phenylhepta-1,6-dien-3-ylsulfonyl)benzene 381 (660 
mg, 83%) as a colourless gum; Rf 0.28 (15% EtOAc–petrol); vmax (film) 3062, 3027, 
2932, 1640, 1494, 1446, 1304, 1145, 1084, 996, 969, 734, 689 cm–1; δH (400 MHz) 7.86 
(2H, d, J 7.5 Hz, ortho PhSO2), 7.64 (1H, t, J 7.5 Hz, para PhSO2), 7.53 (2H, t, J 7.5 
Hz, meta PhSO2), 7.34-7.27 (5H, m, PhCH=CH), 6.27 (1H, d, J 16.0 Hz, PhCH=CH), 
5.92 (1H, dd, J 16.0, 9.0 Hz, PhCH=CH), 5.82-5.72 (1H, m, CH2=CH), 5.06-5.02 (2H, 
m, CH2=CH), 3.71 (1H, ddd, J 11.0, 9.0, 3.0 Hz, CHSO2Ph), 2.39-2.37 (2H, m, 
CH2CH=CH2), 2.08 (1H, dt, J 15.0, 9.0 Hz, CHHCHSO2Ph), 1.95-1.85 (1H, m, 
CHHCHSO2Ph); δC (125 MHz) 138.2 (ipso PhSO2), 137.3 (ipso PhCH=CH), 136.3 
(para PhSO2), 135.6 (para PhCH=CH), 133.5 (PhCH=CH), [129.0, 128.7, 128.5, 128.3 
(ortho & meta PhSO2 & PhCH=CH)], 126.4 (PhCH=CH), [120.8, 116.1 (CH2=CH)], 
68.6 (PhSO2CH), 30.2 (CH2=CHCH2), 26.1 (CHCH2); m/z (CI) 330 [M+NH4]
+, 188, 
171, 160 (Found: [M+NH4]
+, 330.1523. C19H20O2S requires [M+NH4]
+, 330.1528) 
(Found: C, 73.11; H, 6.41.  C19H20O2S requires C, 73.04; H, 6.45%). 
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[(1R*,4S*)-4-Allyl-4-(phenylsulfonyl)cyclopent-2-enyloxy](tert-butyl) 
dimethylsilane 244 
 
OHPhO2S OTBDMSPhO2S
244234a  
 
To a solution of cyclopentenol 234a (137 mg, 0.52 mmol, 1.0 equiv), TBDMSCl (141 
mg, 0.94 mmol, 1.8 equiv) and DMAP (9.5 mg, 0.08 mmol, 0.15 equiv) in CH2Cl2 (1.0 
mL) at rt was added Et3N (181 µL, 1.3 mmol, 2.5 equiv) dropwise. The solution was 
heated under reflux for 24 h then quenched with sat. NH4Cl (aq.) (0.8 mL), diluted with 
H2O (5 mL) and extracted with CH2Cl2 (3 × 7 mL). The combined organic layers were 
washed with brine (2 × 5 mL) and dried (Na2SO4). Concentration under reduced 
pressure and column chromatography (10% EtOAc-petrol) gave [(1R*,4S*)-4-allyl-4-
(phenylsulfonyl)cyclopent-2-enyloxy](tert-butyl)dimethylsilane 244 (170 mg,  87%) as a 
colourless oil; Rf 0.57 (10% EtOAc–petrol); vmax (film) 2953, 2929, 2855, 1446, 1303, 
1146, 1088, 716 cm–1; δH (400 MHz) 7.87 (2H, d, J 8.0 Hz, ortho PhSO2), 7.63 (1H, t, J 
7.5 Hz, para PhSO2), 7.53 (2H, dd, J 8.0, 7.5 Hz, meta PhSO2), 5.83 (1H, dd, J 5.5, 2.0 
Hz, CH=CHCH), 5.78 (1H, d, J 5.5 Hz, CH=CHCH), 5.61–5.51 (1H, m, CH2CH=CH2), 
5.19-5.14 (2H, m, CH=CH2), 4.68-4.65 (1H, m, CHOTBDMS), 2.81 (1H, dd, J 14.0, 
5.5 Hz, CHHCH=CH2), 2.70 (1H, dd, J 14.0, 7.0 Hz, CHHCH=CH2), 2.33 (1H, dd, J 
14.5, 7.5 Hz, CHHCHOTBDMS), 2.12 (1H, dd, J 14.5, 4.5 Hz, CHHCHOTBDMS), 
0.77 (9H, s, tBu of TBDMS), -0.04 (3H, s, CCH3CH3Si), -0.07 (3H, s, CCH3CH3Si); δC 
(125 MHz) 140.7, 133.6, 131.4, 130.5, 130.0, 128.8, 128.5, 120.1, 77.9, 76.3, 39.8, 
36.4, 25.7, 17.9, -4.8; m/z (CI) 396 [M+NH4]
+, 379 [M+H]+, 264, 105 (Found: [M+H]+, 
379.1778. C20H30O3SSi requires [M+NH4]
+, 379.1763). 
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[(1R*,4S*)-4-Allyl-4-(phenylsulfonyl)cyclopent-2-enyloxy]triethylsilane 382 
 
234a
OHPhO2S OTESPhO2S
382  
 
To a solution of cyclopentenol 234a (137 mg, 0.52 mmol, 1.0 equiv), TESCl (141 mg, 
0.94 mmol, 1.8 equiv) and DMAP (9.5 mg, 0.08 mmol, 0.15 equiv) in CH2Cl2 (1.0 mL) 
at rt was added Et3N (181 µL, 1.3 mmol, 2.5 equiv) dropwise. After 16 h the reaction 
was quenched with sat. NH4Cl(aq.) (0.7 mL), then diluted with H2O (5 mL) and extracted 
with CH2Cl2 (3 × 7 mL). The combined organic layers were washed with brine (2 × 5 
mL) and dried (Na2SO4). Concentration under reduced pressure and column 
chromatography (5% EtOAc-petrol) gave [(1R*,4S*)-4-allyl-4-
(phenylsulfonyl)cyclopent-2-enyloxy]triethylsilane 382 (185 mg, 92%) as a colourless 
oil; Rf 0.17 (5% EtOAc–petrol); vmax (film) 2954, 2911, 2866, 1367, 1303, 1147, 1090, 
1033, 749, 714, 689 cm–1; δH (400 MHz) 7.88 (2H, d, J 8.0 Hz, ortho PhSO2), 7.65 (1H, 
t, J 7.5 Hz, para PhSO2), 7.54 (2H, dd, J 8.0, 7.5 Hz, meta PhSO2), 5.86 (1H, dd, J 5.5, 
2.0 Hz, CH=CH), 5.78 (1H, d, J 5.5 Hz, CH=CH), 5.61-5.51 (1H, m, CH=CH2), 5.20-
5.15 (2H, m, CH=CH2), 4.69-4.65 (1H, m, CHOTES), 2.81 (1H, dd, J 13.5, 6.0 Hz, 
CHHCH=CH2), 2.70 (1H, dd, J 13.5, 9.0 Hz, CHHCH=CH2), 2.32 (1H, dd, J 14.5, 7.5 
Hz, CHHCHOTES), 2.15 (1H, dd, J 14.5, 4.5 Hz, CHHCHOTES), 0.86 [9H, t, J 8.0 
Hz, (CH3CH2)3Si], 0.48 [6H, q, J 8.0 Hz,  (CH3CH2)3Si]; δC (125 MHz) 140.8 (ipso 
PhSO2), 135.4 (para PhSO2), [133.7, 131.5 (CH=CH)], [130.5, 130.1, 128.6, 120.2 
(ortho & meta PhSO2, C=CH2)], 77.9 (CSO2Ph), 76.0 (CHOH), 39.1 (CH2CH=CH2), 
36.5 (CH2CHOTES), {6.7, 4.6 [Si(CH2CH3)3]}; m/z (CI) 396 [M+NH4]
+, 379 [M+H]+, 
282, 264, 247 [M-OTES]+, 105 (Found: [M+H]+, 3791754. C20H30O3SSi requires 
[M+H]+, 379.1763) (Found: C, 63.40; H, 7.92.  C20H30O3SSi requires C, 63.45; H, 
7.99%). 
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[(1S*,4R*)-1-Allyl-4-(allyloxy)cyclopent-2-enylsulfonyl]benzene 383 
 
234a
OHPhO2S OPhO2S
383  
 
To a flask containing NaH (25.0 mg of a 60% in mineral oil, 0.64 mmol, 1.2 equiv) 
under N2 was added petrol (1 mL). The suspension was stirred vigorously then allowed 
to settle. The petrol was removed by syringe. This process was repeated twice. The 
remaining petrol was dried by flushing N2. To this flask at 0 °C was slowly added a 
solution of cyclopentenol 234a (137 mg, 0.5 mmol, 1.0 equiv) and allyl bromide (86 
µL, 0.9 mmol, 1.8 equiv) in DMF (2 mL). Upon addition the yellow solution was 
warmed to rt. After 16 h the reaction was quenched with sat. NaHCO3(aq.) (0.5 mL) then 
diluted with H2O (10 mL) and extracted with EtOAc (3 × 8 mL). The combined organic 
layers were washed with brine (3 × 5 mL) and dried (MgSO4). Concentration under 
reduced pressure and column chromatography (20% EtOAc–petrol) gave [(1S*,4R*)-1-
allyl-4-(allyloxy)cyclopent-2-enylsulfonyl]benzene 383 (110 mg, 70%) as a colourless 
oil; Rf 0.50 (25% EtOAc–petrol); vmax (film) 3071, 2980, 2920, 2850, 1445, 1360, 1301, 
1086, 1038, 997, 923, 756, 716, 690 cm–1; δH (400 MHz) 7.88 (2H, d, J 7.0 Hz, ortho 
PhSO2), 7.66 (1H, t, J 7.0 Hz, para PhSO2), 7.54 (2H, dd, J 7.0, 7.0 Hz, meta PhSO2), 
6.04 (1H, dd, J 5.5, 2.0 Hz, CH=CHCH), 5.87 (1H, d, J 5.5 Hz, CH=CHCH), 5.75 (1H, 
ddt, J 22.5, 10.5, 5.5 Hz, CH2=CHCH2OCH), 5.59-5.49 (1H, m, CH2=CHCH2C), 5.19-
5.11 (4H, m, 2 × CH2=CHCH2), 4.46-4.44 (1H, m, CHOCH2), 3.79 (1H, dd, J 7.0, 5.5 
Hz, OCHH), 3.75 (1H, dd, J 7.0, 6.0 Hz, OCHH), 2.81 (1H, dd, J 13.5, 6.0 Hz, CHHC), 
2.70 (1H, dd, J 13.5, 9.0 Hz, CHHC), 2.28 (2H, d, J 5.5 Hz, CH2CHO); δC (125 MHz) 
138.2 (ipso PhSO2), 135.4 (para PhSO2), [134.7, 133.8 (CH=CH)], [131.9, 131.3 
(CH2=CHCH2OCH)], [130.5, 128.7 (ortho & meta PhSO2)], [120.3, 116.9 (CH2=CH)], 
82.6 (CPhSO2), 77.9 (CHOCH2), 69.6 (OCH2CH=CH2), 36.7 (CH2CH=CH2), 35.4 
(CH2CHOCH2); m/z (CI) 322  [M+NH4]
+, 305 [M+H]+, 282, 264, 163, 105 (Found: 
[M+H]+, 305.1219. C17H20O3S requires [M+H]
+, 305.1211) (Found: C, 67.14; H, 6.69.  
C17H20O3S requires C, 67.08; H, 6.62%). 
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[(1S*,4R*)-4-(Allyloxy)-1-(3-methylbut-2-enyl)cyclopent-2-enylsulfonyl]benzene 
246 
 
OHPhO2S OPhO2S
234d 246  
 
To a flask containing NaH (54.0 mg of a 60% in mineral oil, 1.25 mmol, 1.1 equiv, 
washed by petrol as described above) at 0 °C was slowly added a solution of 
cyclopentenol 234d (365 mg, 1.25 mmol, 1.0 equiv) and allyl bromide (179 µL, 2.06 
mmol, 1.7 equiv) in DMF (3 mL). Upon addition the yellow solution was warmed to rt. 
After 16 h the reaction was quenched with sat. NaHCO3(aq.) (1 mL) then diluted with 
H2O (10 mL) and extracted with EtOAc (3 × 10 mL). The combined organic layers 
were washed with brine (3 × 5 mL) and dried (MgSO4). Concentration under reduced 
pressure and column chromatography (20% EtOAc–petrol) gave [(1S*,4R*)-4-
(allyloxy)-1-(3-methylbut-2-enyl)cyclopent-2-enylsulfonyl]benzene 246 (395 mg, 95%) 
as a colourless gum; Rf 0.55 (25% EtOAc–petrol); vmax (film) 3065, 2978, 2915, 2857, 
1446, 1361, 1301, 1146,1086, 1046, 924, 756, 690, 606 cm–1; δH (400 MHz) 7.89 (2H, 
d, J 7.5 Hz, ortho PhSO2), 7.65 (1H, t, J 7.5 Hz, para PhSO2), 7.55 (2H, dd, J 7.5, 7.5 
Hz, meta PhSO2), 6.03 (1H, dd, J 5.5, 2.0 Hz, CH=CHCH), 5.84 (1H, d, J 5.5 Hz, 
CH=CHCH), 5.75 (1H, ddt, J 22.5, 10.5, 5.5 Hz, CH2=CHCH2OCH), 5.16-5.11 (1H, m, 
CH2=CHCH2OCH), 4.86 [1H, app t, J 7.5 Hz, CH=C(CH3)2], 4.45-4.42 (1H, m, 
CHOCH2), 3.80-3.71 (2H, m, OCH2), 2.79 (1H, dd, J 14.0, 8.5 Hz, CHHC), 2.64 (1H, 
dd, J 14.0, 6.0 Hz, CHHC), 2.26-2.16 (2H, m, CH2CHO), 1.70 (3H, s, CH3), 1.63 (3H, 
s, CH3); δC (100 MHz) 137.8 (ipso PhSO2), 136.6 [CH=C(CH3)2], 135.5 (para PhSO2), 
[134.7, 133.7 (CH=CH)], [132.2 (CH2=CHCH2OCH)], [130.5, 128.6 (ortho & meta 
PhSO2)], 116.8 [CH=C(CH3)2], 116.6 (CH2=CH), 78.6 (CHOCH2), 69.4 
(OCH2CH=CH2), 35.4 [CH2CH=C(CH3)2], 30.4 (CH2CHOCH2), [26.0, 18.1 (2 × CH3)]. 
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[(1S*,4R*)-1-(3-Methylbut-2-enyl)-4-(prop-1-enyloxy)cyclopent-2-
enylsulfonyl]benzene 258 
 
246
OPhO2S OPhO2S
258  
 
To a solution of allyl ether 246 (80.0 mg, 0.241 mmol, 1.0 equiv) in toluene (5 mL) at rt 
in a environment of ethylene was added a solution of catalyst 50 (14.3 mg, 0.0168 
mmol, 0.07 equiv) in toluene (1 mL). After 16 h, concentration under reduced pressure 
and column chromatography (15% EtOAc–petrol) gave a 2:1 mixture of E/Z isomers of 
[(1S*,4R*)-1-(3-mmethylbut-2-enyl)-4-(prop-1-enyloxy)cyclopent-2-
enylsulfonyl]benzene 258 (8 mg, 10%) as a gum; Rf 0.35 (20% EtOAc–petrol); vmax 
(film) 3061, 2968, 2919, 1668, 1445, 1368, 1301, 1147, 1122, 768, 753 690, 606 cm–1; 
δH (400 MHz) 7.90-7.86 (2 × 2H, m, ortho PhSO2), 7.67-7.64 (2 × 1H, m, para PhSO2, 
2 × isomers), 7.58-7.54 (2 × 2H, m, meta PhSO2, 2 × isomers), 5.99-5.97 (2 × 1H, m, 
CH=CHCH, both isomers), 5.92-5.8 (2  × 1H, m, CH=CHCH, 2 × isomers), 5.83 (1H, 
dd, J 12.5, 1.5 Hz, CH=CHOCH, E isomer), 5.69 (1H, dd, J 6.5, 1.5 Hz, CH=CHOCH, 
Z isomer), 4.87-4.84 [2 × 1H, m, CH=CHOCH, 2 × isomers], 4.70-4.62 (2 × 1H, m, 
CHOCH2, 2 × isomers), 4.61-4.57 (1H, m, CH=CHOCH, E isomer), 4.35-4.27 (1H, m, , 
CH=CHOCH, Z isomer), 2.84-2.76 (2 × 1H, dd, J 14.0, 8.5 Hz, CHHCH=C, 2 × 
isomers), 2.71-2.64 (2 × 1H, m, CHHCH=C, 2 × isomers ), 2.30-2.19 (2 × 2H, m, 
CH2CHO, 2 × isomers), 1.70 (2 × 3H, s, CH3, 2 × isomers), 1.64 (2 × 3H, s, CH3, 2 × 
isomers), 1.49 (3H, dd, J 7.0, 1.5 Hz, CH3CH=CH, E isomer), 1.37 (3H, dd, J 7.0, 1.5 
Hz, CH3CH=CH, Z isomer); δC (100 MHz) 203.1, 141.9, 138.7, 138.2, 136.8, 135.9, 
134.1, 133.6, 131.6, 131.4, 131.0, 130.4, 130.4, 129.0, 126.7, 126.7, 116.6, 116.3, 
102.7, 102.6, 75.7, 37.4, 36.7, 30.9, 27.0, 26.1, 25.9, 18.1, 18.0, 9.1, 6.0. 
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N-{(R*)-2-(4-Methoxyphenyl)-1-[(R*)-oxiran-2-yl]ethyl}-4-methylbenzene 
Sulfonamide 261 
 
OMe
TsN
OMe
TsHN
OOH
198 261  
 
To a solution of hydroxyaziridine 198 (110 mg, 0.32 mmol, 1.0 equiv) in THF (1.0 mL) 
at –78 °C was added nBuLi (182 µL of a 2.28 M solution in hexanes, 0.42 mmol, 1.3 
equiv). The resulting solution was warmed to rt over a period of 1.5 h then heated to 40 
°C. After 1 h the reaction was quenched sat. NH4Cl(aq.) (0.6 mL) then diluted with H2O 
(6 mL) and extracted with EtOAc (2 × 6 mL). The combined organic layers were 
washed with brine (2 × 5 mL) and dried (MgSO4). Concentration under reduced 
pressure and column chromatography gave N-{(R*)-2-(4-methoxyphenyl)-1-[(R*)-
oxiran-2-yl]ethyl}-4-methylbenzenesulfonamide 261 (36 mg, 33%) as a brown gum; Rf 
0.43 (40% EtOAc–petrol); vmax (film) 3271, 2954, 2922, 2858, 1611, 1513, 1453, 1329, 
1304, 1247, 1160, 1117, 1092, 1058, 1050, 840, 813, 665 cm–1; δH (400 MHz) 7.51 (2H, 
d, J 8.5 Hz, ortho Ts), 7.19 (2H, d, J 8.0 Hz, meta Ts), 6.93 (2H, d, J 8.0 Hz, meta 
PhOMe), 6.73 (2H, d, J 8.5 Hz, ortho PhOMe), 4.64 (1H, d, J 6.5 Hz, NH), 3.80 (3H, s, 
OMe), 3.06 (1H, ddd, 12.0, 7.5, 4.8 Hz, CHOCH2), 2.93-2.88 (2H, m, CHNHTs & 
CHHOCH), 2.78-2.67 (3H, m, CHHOCH & CH2Ar), 2.43 (3H, s, Me of Ts); δC (125 
MHz) [158.7, 143.4,  136.9 (q Ar)], 130.3 (ortho Ts), 129.6 (meta Ts), 127.3 (q 
ArOMe), 126.9 (meta ArOMe), 114.2 (ortho ArOMe), 66.3 (OMe), [55.2, 53.5 
(CHCH2O)], 47.7 (CHNHTs), 37.3 (CH2 of Ts), 21.5 (CH2ArOMe); m/z (CI) 365 
[M+NH4]
+, 348 [M+H]+, 246, 189 [TsNH+H+NH4]
+ (Found: [M+NH4]
+, 365.1539. 
C18H21NO4S requires [M+NH4]
+, 365.1535) (Found: C, 62.38; H, 6.16; N, 4.06.  
C18H21NO4S requires C, 62.23; H, 6.09; N, 4.03%). 
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(E)-(2-Methylpent-3-ene-1,3-diyl)bis(phenylsulfone) 271 
 
SO2Ph
PhO2S SO2Ph
OMe
TsN
+
OMe
TsHN
SO2Ph
(expected)(isolated)
OH
OH
271212
198
 
 
Preparation of solution 1: To a solution of allyl sulfone 212 (68.3 mg, 0.375 mmol, 1.3 
equiv) in THF (1.0 mL) at –78 °C was added nBuLi (171 µL of a 2.19 M solution in 
hexanes, 1.87 mmol, 1.3 equiv). After 15 min it was warmed to –20 °C for 15 min then 
re-cooled to –78 °C. 
 
Preparation of solution 2: To a solution of hydroxyaziridine 198 (100 mg, 0.288 mmol, 
1.0 equiv) in THF (1 mL) at –78 °C was added nBuLi (132 µL of a 2.19 M solution in 
hexanes, 0.288 mmol, 1.0 equiv). After 5 min solution 1 was added via cannula. The 
resulting solution was warmed to 10 °C over a period of 3 h then to rt. After 1 h 40 min, 
the reaction was quenched with sat. NH4Cl(aq.) (3 mL), then diluted with H2O (10 mL) 
and EtOAc (8 mL). The organic phase was separated and the aqueous phase extracted 
with EtOAc (2 × 5 mL). The combined organic layers were washed with brine (2 × 5 
mL) and dried (Na2SO4). Concentration under reduced pressure and column 
chromatography (20% EtOAc–petrol) gave disulfone 271 (34.0 mg, 50% as to the input 
of allyl sulfone) as a colourless gum; Rf 0.31 (40% EtOAc–petrol); vmax (film) 3062, 
2981, 2923, 1612, 1512, 1446, 1301, 1149, 1086, 841, 707, 689 cm–1; δH (400 MHz) 
[7.86 (2H, d, J 7.5 Hz), 7.76 (2H, d, J 7.5 Hz), 2 × ortho PhSO2], 7.70 (1H, t, J 7.5 Hz, 
1 × para PhSO2), 7.63-7.49 (5H, m, 2 × meta PhSO2 & 1 × para PhSO2), 6.96 (1H, q, J 
7.5 Hz, CH3CH=C), 3.48-3.42 (1H, m, CH2CHCH3), 3.39-3.37 (2H, m, CH2SO2Ph), 
1.94 (3H, d, J 7.5 Hz, CH3CH=C), 1.24 (3H, d, J 7.0 Hz, CH3CHCH2); δC (100 MHz) 
[144.1, 140.3 (2 × ipso Ph)], 139.6 (CH=C), 139.4 (CH=C), [133.9, 133.3 (2 × para 
Ph)], [129.7, 129.6, 127.9, 127.8 (2 × ortho Ph & 2 × meta Ph)], 60.3 (CH2SO2Ph), 27.8 
(CH), 18.7 (CH3CH=C), 14.6 (CH3CHCH2); m/z (CI) 382 [M+NH4]
+, 365 [M+H]+, 
348, 223 (Found (ESI): [M+Na]+, 387.0710. C18H20O4S2 requires [M+Na]
+, 387.0701). 
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N-[(2R*,3R*,4S*,E)-3-(Hydroxymethyl)-1-(4-methoxyphenyl)-6-phenyl-4-
(phenylsulfonyl)hex-5-en-2-yl]-4-methylbenzenesulfonamide 272 
 
SO2Ph
OMe
TsHN
SO2Ph
OH
Ph
Ph
OMe
OH
TsN
+
227
272198  
 
Preparation of solution 1: To a solution of cinnamyl sulfone 227 (484 mg, 1.87 mmol, 
1.3 equiv) in THF (3.5 mL) at –20 °C was added nBuLi (821 µL of a 2.3 M solution in 
hexanes, 1.87 mmol, 1.3 equiv). After 5 min it was warmed to 0 °C for 30 min then re-
cooled to –20 °C. 
 
Preparation of solution 2: To a solution of hydroxyaziridine 198 (500 mg, 1.44 mmol, 
1.0 equiv) in THF (2 mL) at –78 °C was added nBuLi (632 µL of a 2.3 M solution in 
hexanes, 1.44 mmol, 1.0 equiv). After 10 min solution 1 was added via cannula. The 
resulting solution was warmed to 8 °C over a period of 2.5 h then to 25 °C. After 1 h the 
reaction was quenched with sat. NH4Cl(aq.) (4 mL), then diluted with H2O (15 mL) and 
extraction with EtOAc (3 × 8 mL). The combined organic layers were washed with 
brine (2 × 8 mL) and dried (Na2SO4). Concentration under reduced pressure and column 
chromatography (10% EtOAc–petrol) gave a 10:1 diastereomixture of N-
[(2R*,3R*,4S*,E)-3-(hydroxymethyl)-1-(4-methoxyphenyl)-6-phenyl-4-
(phenylsulfonyl)hex-5-en-2-yl]-4-methylbenzenesulfonamide 272 (453 mg, 52%) as a 
colourless gum; Rf 0.19 (43% EtOAc–petrol); vmax (film) 3582, 3298, 2954, 2932, 1513, 
1447, 1318, 1301, 1247, 1154, 1035, 735, 690 cm–1; δH (400 MHz) 7.72 (2H, d, J 8.0 
Hz, ortho Ts), 7.71 (2H, d, J 6.5 Hz, ortho PhSO2), 7.58 (1H, t, J 7.0 Hz, para PhSO2), 
7.44 (2H, dd, J 7.0, 6.5 Hz, meta PhSO2), 7.29-7.28 (3H, m, ortho & para Ph), 7.21 
(2H, d, J 8.0 Hz, meta Ts), 6.93–6.91 (2H, m, meta PhSO2), 6.89 (2H, d, J 8.6 Hz, meta 
MeOAr), 6.76 (2H, d, J 8.6 Hz, ortho MeOAr), 6.24 (1H, d, J 16.0 Hz, PhCH=CH, 
diagnostic signal of the minor diast.)5.71 (1H, d, J 16.0 Hz, PhCH=CH), 5.18 (1H, dd, J 
16.0, 9.5 Hz, PhCH=CH), 4.57-4.54 (1H, m, NH), 4.29-4.24 (1H, m, TsNHCH), 3.98 
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(1H, t, J 9.5 Hz, PhSO2CH), 3.81 (3H, s, OMe), 3.72-3.59 (2H, m, CH2OH), 2.87 (1H, 
dd, J 14.0, 4.5 Hz, MeOArCHH), 2.73 (1H, dd, J 14.0, 11.0 Hz, MeOArCHH), 2.45-
2.40 (1H, m, CHCH2OH)2.37 (3H, s, Me of Ts); δC (125 MHz) 171.2, 158.4, 143.0, 
139.7, 138.8, 137.8, 135.5, 133.9, 129.9, 129.7, 129.6, 129.1, 128.9, 128.8, 128.5, 
126.9, 126.7, 126.5, 120.1, 114.2, 113.9, 67.4, 58.9, 56.9, 55.2, 53.5, 40.3, 39.4, 21.5; 
m/z (ESI) 628.1789 [M+Na]+, 606.1971 [M+H]+, 464.1922, 304.1042, 241.1812, 
196.0183 (Found: [M+H]+, 606.1971. C33H35NO6S2 requires [M+H]
+, 606.1984) 
(Found: C, 65.48; H, 5.87; N, 2.39.  C33H35NO6S2 requires C, 65.43; H, 5.82; N, 
2.31%). 
 
 
(4R*,5R*)-4-(4-Methoxybenzyl)-5-[(S*,E)-3-phenyl-1-(phenylsulfonyl)allyl]-3-
tosyl-1,3-oxazinane 273 
 
OMe
TsHN
SO2Ph
OHPh
SO2Ph
Ph
N
Ts
OMe
O
272
273  
 
The suspension of hydroxyl tosamide 272 (496 mg, 0.82 mmol, 1.0 equiv), 
paraformaldehyde (32 mg, 1.06 mmol, 1.3 equiv) and p-TsOH·H2O (10.0 mg, 0.05 
mmol, 0.064 equiv) in benzene (2 mL) was heated to reflux for 16 h. The dark mixture 
was filtered through a short pat of cotton wool. The filtrate was extracted with EtOAc 
(5 mL) . The organic layer was washed with brine (3 × 3 mL) and dried (Na2SO4). 
Concentration under reduced pressure and column chromatography (15→25% EtOAc-
petrol) gave (4R*,5R*)-4-(4-methoxybenzyl)-5-[(S*,E)-3-phenyl-1-
(phenylsulfonyl)allyl]-3-tosyl-1,3-oxazinane 273 (316 mg, 62%) as a solid; mp 136-138 
°C (CH2Cl2-methanol); Rf  0.31 (40% EtOAc–petrol);  vmax (film) 2928, 1621, 1513, 
1447, 1341, 1304, 1248, 1178, 1146, 1084, 1034, 970, 816, 734, 693 cm–1; δH (400 
MHz) 7.65 (2H, d, J 7.5 Hz, ortho PhSO2), 7.59 (2H, d, J 8.0 Hz, ortho Ts), 7.53 (1H, 
dd, J 7.5, 7.5 Hz, para PhSO2), 7.39 (2H, dd, J 7.5, 7.5 Hz, meta PhSO2), 7.29-7.27 
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(3H, m, ortho & para PhCH=CH), 7.21 (2H, d, J 8.5 Hz, meta Ts), 6.95 (2H, d, J 8.5 
Hz, meta MeOAr), 6.91-6.89 (2H, m, meta PhCH=CH), 6.78 (2H, d, J 8.5 Hz, ortho 
MeOAr), 5.62 (1H, d, J 16.0 Hz, PhCH=CH), 5.49 (1H, d, J 10.5 Hz, NTsCHHO), 
5.14-5.05 (2H, m, PhCH=CH & CHCHHOCH2), 4.76 (1H, d, J 10.5 Hz, NTsCHHO), 
4.13-4.05 (2H, m, CHCHHOCH2 & CHNTs), 3.96 (1H, dd, J 10.5, 10.0 Hz, CHSO2Ph), 
3.82 (3H, s, OMe), 3.06 (1H, dd, J 13.5, 11.0 Hz, MeOArCHH), 2.82 (1H, dd, J 13.5, 
4.5 Hz, MeOArCHH), 2.39 (3H, s, CH3 of Ts), 2.20-2.18 (1H, m, CHCH2O); δC (125 
MHz) 158.6, 143.6, 139.6, 138.6, 137.8, 135.6, 133.4, 130.2, 129.7, 129.1, 128.8, 
128.7, 128.6, 128.5, 127.3, 126.5, 120.68, 114.3, 74.1, 66.9, 64.3, 55.4, 55.3, 36.2, 34.6, 
21.5; m/z (ESI) 640.1835 [M+Na]+, 618.1989 [M+H]+, 476.1903, 182.9854, 154.9901 
(Found: [M+Na]+, 640.1835. C34H35NO6S2 requires [M+Na]
+, 640.1804) (Found: C, 
66.00; H, 5.68; N, 2.28.  C34H35NO6S2 requires C, 66.10; H, 5.71; N, 2.27%). 
 
 
N-[(2R*,3S*,4R*,E)-1-(4-Methoxyphenyl)-6-phenyl-4-(phenylsulfonyl)-3-vinylhex-
5-en-2-yl]-4-methylbenzenesulfonamide 274 
 
SO2Ph
OMe
TsHN
SO2Ph
Ph
Ph
OMe
+
TsN
227
46 274  
 
To a mixture of cinnamyl sulfone 227 (1.58 g, 6.12 mmol, 1.4 equiv) in THF (5.0 
mL)/TMEDA (1.7 mL) at –20 °C was added nBuLi (570 µL of a 11.5 M solution in 
hexanes, 6.56 mmol, 1.5 equiv). The mixture became a red solution. It was warmed to 0 
°C for 15 min then to rt. After 15 min the reaction was re-cooled to 0 °C and 
vinylaziridine 46 (1.51 g, 4.39 mmol, 1.0 equiv) in THF (0.9 mL) added. After 16 h the 
reaction was quenched with sat. NH4Cl(aq.) (10 mL) then diluted with H2O (10 mL) and 
extracted with EtOAc (3 × 10 mL). The combined organic layers were washed with 
brine (3 × 5 mL) and dried (Na2SO4). Concentration under reduced pressure and column 
chromatography gave N-[(2R*,3S*,4R*,E)-1-(4-Methoxyphenyl)-6-phenyl-4-
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(phenylsulfonyl)-3-vinylhex-5-en-2-yl]-4-methylbenzenesulfonamide 274 (1.20 g, 45%) 
as a yellow solid; mp 120-122 °C (EtOAc–petrol); Rf 0.46 (30% EtOAc–petrol); vmax 
(film) 3260, 2954, 2952, 1611, 1512, 1446, 1302, 1247, 1147, 1032, 926, 735 cm–1; δH 
(400 MHz) 7.85 (2H, d, J 7.5 Hz, ortho PhSO2), 7.76 (2H, d, J 8.5 Hz, ortho Ts), 7.58 
(1H, t, J 7.5 Hz, para PhSO2), 7.46 (2H, t, J 7.5 Hz, meta PhSO2), 7.27-7.15 (5H, m, 
PhCH=CH), 6.88 (2H, d, J 8.5 Hz, meta MeOAr), 6.71 (2H, d, J 8.5 Hz, ortho 
MeOAr), 6.0 (1H, d, J 16.0 Hz, PhCH=CH), 6.75 (1H, dd, J 16.0, 10.5 Hz, PhCH=CH), 
5.51 (1H, ddd, J 17.0, 10.5, 7.0 Hz, CH=CH2), 5.29 (1H, dd, J 10.5, 1.5 Hz, trans 
CH=CHH), 5.16 (1H, dd, J 17.0, 1.5 Hz, cis CH=CHH), 4.63-4.58 (2H, m, CHSO2Ph & 
TsNHCH), 4.32 (1H, d, J 9.5 Hz, NH), 3.81 (3H, s, MeO), 3.11 (1H, ddd, 10.5, 10.0, 
1.5 Hz, CHCH=CH2), 2.79 (1H, dd, J 14.0, 4.5 Hz, MeOArCHH, diagnostic signal of 
the minor diast.)2.60 (1H, dd, J 14.0, 8.5 Hz, MeOArCHH), 2.45 (3H, s, Me of Ts), 
2.33 (1H, dd, J 14.0, 6.5 Hz, MeOArCHH); δC (125 MHz) 158.4, 143.6, 137.6, 136.7, 
135.9, 133.5, 132.6, 130.2, 129.8, 129.3, 128.7, 128.6, 128.2, 128.1, 127.3, 126.5, 
121.3, 113.9, 67.4, 56.4, 55.2, 44.5, 39.4, 21.6; m/z (ESI) 624.1842 [M+Na]+, 602.2050 
[M+H]+, 539.1342, 304.1051 (Found: [M+H]+, 602.2050. C34H35NO5S2 requires 
[M+H]+, 602.2035) (Found: C, 67.84; H, 6.00; N, 2.44.  C34H35NO5S2 requires C, 
67.86; H, 5.86; N, 2.33%). 
 
 
2-Phenyl-4-vinyl-1,3-dioxolane
124 
277 
 
HO
OH
+
H
O
O
O
Ph
275 276 277  
 
The solution of 3-butene-1,2-diol 275 (7.00 g, 79.5 mmol, 1.0 equiv), benzaldehyde 276 
(8.43 g, 79.5 mmol, 1.0 equiv) and p-TsOH·H2O (303 mg, 1.59 mmol, 0.02 equiv) in 
toluene (100 mL) was heated under reflux azeotropically. After 5 h, the reaction 
mixture was concentrated to ~40 mL and filtered though a short pad of cotton wool. 
Concentration of the filtrate under reduced pressure and column chromatography 
(5→12% EtOAc–petrol) gave a 1:1 diastereomixture of 2-phenyl-4-vinyl-1,3-dioxolane 
277 (12.6 g, 90%) as an oil; Rf 0.67 (10% EtOAc–petrol); vmax (film) 3067, 2986, 2879, 
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1702, 1458, 1397, 1311, 1291, 1220, 1204, 1091, 1068, 1027, 988, 759, 698 cm–1; δH 
(400 MHz) 7.55-7.41 (2 × 5H, m, Ph, 2 × diast.), 6.01 (1H, s, PhCH, 1 × dias.), 6.00-
5.92 (2 × 1H, m, CH=CH2, 2 × dias.), 5.91 (1H, s, PhCH, 1 × dias.), 5.44 (2H, dd, J 
17.0, 1.0 Hz, CH=CH2, 1 × dias.), 5.31 (2H, dd, J 10.5, 5.0 Hz, CH=CH2, 1 × dias.), 
4.72-4.66 (2 × 1H, m, CHCH=CH2, 2 × dias.), 4.35 (1H, dd, J 8.5, 6.5 Hz, CHHCH, 1 × 
dias.), 4.20 (1H, dd, J 8.5, 7.5 Hz, CHHCH, 1 × dias.), 3.82 (1H, dd, J 7.5, 7.0 Hz, 
CHHCH, 1 × dias.), 3.75 (1H, dd, J 8.0, 7.5 Hz, CHHCH, 1 × dias.); δC (125 MHz) 
138.0, 137.6, 135.5, 135.3, 129.4, 129.2, 128.4, 127.7, 126.9, 126.7, 126.4, 118.6, 
118.2, 104.4, 103.8, 78.4, 70.5, 70.0; m/z (CI) 194 [M+NH4]
+, 177 [M+H]+, 170, 164, 
106, 52; data in agreement with that previously reported.124 
 
 
2-(Benzyloxy)but-3-en-1-ol 278 & 1-(benzyloxy)but-3-en-2-ol 279 
 
O
O
Ph
HO
OBn
BnO
OH
+
277 278 279  
 
To a solution of dioxolane 277 (2.40 g, 13.6 mmol, 1.0 equiv) in CH2Cl2 (68 mL) at –78 
ºC was added DIBAL (27.2 mL of a 1.5 M solution in toluene, 40.8 mmol, 3.0 equiv) 
dropwise. The solution was warmed to rt slowly. After 12 h, the resulting solution was 
re-cooled to –78 ºC and quenched with sat. Na/K tartrate(aq.) (14 mL). After 15 min, it 
was warmed to rt for 30 min. Water (50 mL) was added and the aqueous phase was 
extracted with EtOAc (3 × 25 mL). The combined organic layers were washed with 
brine (3 × 10 mL) and dried (MgSO4). Concentration under reduced pressure and 
column chromatography (15% EtOAc–petrol) gave a 4:1 regioisomeric mixture of 2-
(benzyloxy)but-3-en-1-ol 278 and 1-(benzyloxy)but-3-en-2-ol 279 (1.77 g, 73%) as an 
oil; Rf 0.24 (15% EtOAc–petrol); vmax (film) 3382, 2916, 2880, 2853, 1719, 1686, 1598, 
1449, 1399, 1274, 1215, 1178, 1120, 1027, 816, 759, 714, 560 cm–1; δH (400 MHz) 
7.41-7.33 (m, 2 × Ph, 2 × regio.) 5.91-5.75 (m, 2 × CH=CH2, 2 × regio.), 5.43-5.37 (m, 
CH=CH2, major regio.), 5.24-5.22 (m, CH=CH2, minor regio.), 4.71 (d, J 11.5 Hz, 
PhCHH, major regio.), 4.61 (s, PhCHH, minor regio.), 4.43 (d, J 11.5 Hz, PhCHH, 
major regio.), 3.98 (dd, J 12.5, 6.5 Hz, CHCH=CH2, major regio.), 3.64-3.63 (m, 
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CH2OH, major regio.), 3.57 (dd, J 9.5, 3.5 Hz, CHOH, minor regio.), 3.41 (dd, J 9.5, 
8.0 Hz, CH2OBn); δC (125 MHz) 138.1, 137.8, 136.6, 135.1, 128.5, 127.9, 126.9, 119.4, 
116.5, 81.1, 74.0, 73.4, 71.5, 70.5, 65.3; m/z (CI) 196 [M+NH4]
+, 178 [M]+, 161, 108 
(Found: [M+NH4]
+, 196.1331. C11H14O2 requires [M+NH4]
+, 196.1338). 
 
 
2-(Benzyloxy)but-3-enal 266a & (E)-2-(benzyloxy)but-2-enal 280 
 
278 279
HO
OBn
BnO
OH
+ O
OBn
O
OBn
266a 280  
 
The suspension of a regioisomeric mixture of alcohols 278 and 279 (51.0 mg, 0.29 
mmol, 1.0 equiv) and IBX (105 mg, 0.38 mmol, 1.3 equiv) in EtOAc (3 mL) was heated 
to reflux. After 2.5 h, the resulting mixture was cooled to rt and filtered. The filtrate was 
concentrated under reduced pressure to give 2-(benzyloxy)but-3-enal  266a (44.1 mg, 
86%) as an oil. After column chromatography 266a isomerised to give (E)-2-
(benzyloxy)but-2-enal 280 as an oil. 
 
Data for 266a:  Rf  0.58 (20% EtOAc–petrol); δH (400 MHz) 9.58 (1H, d, J 1.5 Hz, 
CHO), 7.39-7.26 (5H, m, Ph), 5.80 (1H, ddd, J 17.0, 10.5, 6.5 Hz, CH=CH2), 5.55-5.48 
(2H, m, CH=CH2), 4.72 (1H, d, J 12.0 Hz, PhCHH), 4.61 (1H, d, J 12.0 Hz, PhCHH), 
4.32 (1H, dd, J 6.5, 1.5 Hz, BnOCH); δC (100 MHz) 199.6 (CHO), 137.1 (ipso Ph), 
130.7 (3º), 128.6 (meta or ortho Ph), 128.1 (3º), 128.0 (meta or ortho Ph), 120.9 
(CH=CH2), 84.7 (BnOCH), 71.4 (PhCH2). 
 
Data for 280: Rf 0.63 (20% EtOAc–petrol); δH (400 MHz) 9.26 (1H, s, CHO), 7.42-7.34 
(5H, m, Ph), 6.11 (1H, q, J 7.0 Hz, CH=C), 5.09 (2H, s, PhCH2), 1.84 (3H, d, J 7.0 Hz, 
CH3); δC (100 MHz) 189.2 (CHO), 154.8 (BnOC), 137.2 (ipso Ph), 136.9 (3º), 128.4 
(meta or ortho Ph), 128.2 (3º), 127.8 (3º), 72.9 (PhCH2), 12.0 (CH3). 
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(E)-4-Phenylbut-3-ene-1,2-diol 285 
 
HO
OH
+
HO
OH
275 281 285  
 
To a solution of catalyst 50 (210 mg, 0.247 mmol, 0.01 equiv) in CH2Cl2 (110 mL) at rt 
was added styrene (6.65 g, 63.8 mmol, 2.9 equiv) and diol 275 (1.95 g, 22.0 mmol, 1.0 
equiv). The resulting solution was heated to reflux. After 16 h, concentration under 
reduced pressure and column chromatography (5→30% EtOAc–petrol) gave (E)-4-
phenylbut-3-ene-1,2-diol 285 (1.99 g, 55%) as a gum; Rf 0.29 (10% EtOAc–petrol); vmax 
(film) 3302, 2973, 1448, 1053, 1018, 987, 971, 745, 690 cm–1; δH (400 MHz) 7.45-7.29 
(5H, m, Ph), 6.73 (1H, d, J 16.0 Hz, PhCH=CH), 6.24 (1H, dd, J 16.0, 6.5 Hz, 
PhCH=CH), 4.98-4.96 (1H, m, CH2CH), 3.81-3.78 (1H, m, CHHCH), 3.67-3.62 (1H, 
m, CHHCH), 2.27 (1H, d, J 3.5 Hz, OH), 2.01 (1H, t, J 5.5 Hz, OH); δC (100 MHz) 
136.3 (ipso Ph), 132.3 (3º), 128.6 (meta or ortho Ph), 127.9 (3º), 127.7 (3º), 126.6 (meta 
or ortho Ph), 73.2 (CHOH), 66.5 (CH2OH); m/z (CI) 182 [M+NH4]
+, 164, 147, 129, 52 
(Found: [M+NH4]
+, 182.1185. C10H12O2 requires [M+ NH4]
+, 182.1181). 
 
 
(2R*)-2-Phenyl-4-styryl-1,3-dioxolane  & (2S*)-2-phenyl-4-styryl-1,3-dioxolane 282 
 
281
O
O
Ph
+
O
O
Ph
Ph
O
O
Ph
Ph
+
277 282  
 
To a solution of catalyst 50 (127 mg, 0.15 mmol, 0.03 equiv) in CH2Cl2 (25 mL) at rt 
was added styrene (1.05 g, 10.1 mmol, 2.0 equiv) and dioxolane 277 (825 mg, 4.7 
mmol, 1.0 equiv). The resulting solution was heated to 40 ºC. After 14 h concentration 
under reduced pressure and column chromatography (5→15% EtOAc–petrol) gave a 
1:1 diastereomixture of 282 (544 mg, 46%) as a gum; 
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Data for one diastereomer: Rf 0.22 (10% EtOAc–petrol); vmax (film) 3030, 2987, 2880, 
1718, 1596, 1493, 1450, 1400, 1273, 1091, 1068, 967, 750, 698 cm–1; δH (400 MHz) 
7.56-7.27 (10H, m, 2 × Ph), 6.75 (1H, d, J 16.0 Hz, PhCH=CH), 6.28 (1H, dd, J 16.0, 
7.5 Hz, PhCH=CH), 6.08 (1H, s, PhCH), 4.85 (1H, ddd, J 7.5, 7.5, 7.5 Hz, 
CHCH=CH2), 4.04 (1H, dd, J 8.5, 7.5 Hz, CHHCH), 3.83 (1H, dd, J 8.5, 7.5 Hz, 
CHHCH); δC (125 MHz) 136.2, 133.5, 129.2, 128.6, 128.4, 128.1, 126.7, 126.4, 126.2, 
103.9, 80.9, 70.7.  
  
Data for the other diastereomer: Rf 0.19 (10% EtOAc–petrol); vmax (film) 3030, 2879, 
1720, 1599, 1494, 1450, 1400, 1272, 1219, 1092, 1068, 967, 750, 695 cm–1; δH (400 
MHz) 7.59-7.27 (10H, m, 2 × Ph), 6.73 (1H, d, J 16.0 Hz, PhCH=CH), 6.28 (1H, dd, J 
16.0, 7.5 Hz, PhCH=CH), 5.96 (1H, s, PhCH), 4.85 (1H, ddd, J 7.0, 7.0, 7.0 Hz, 
CHCH=CH2), 4.26 (1H, dd, J 8.0, 7.0 Hz, CHHCH), 3.83 (1H, dd, J 8.0, 7.0 Hz, 
CHHCH); δC (125 MHz) 137.6, 136.2, 133.8, 129.4, 128.6, 128.4, 128.1, 126.6, 126.4, 
104.5, 78.3, 70.2; m/z (CI) 270 [M+NH4]
+, 251, 164, 147 (Found: [M+NH4]
+, 253.1216. 
C17H16O2 requires [M+NH4]
+, 253.1229) (Found: C, 80.72; H, 6.32.  C17H16O2 requires 
C, 80.93; H, 6.39%). 
 
 
(E)-1-(Benzyloxy)-4-phenylbut-3-en-2-ol 283 and (E)-2-(benzyloxy)-4-phenylbut-3-
en-1-ol 284 
 
O
O
Ph
Ph
HO
OBn
BnO
OH
+
PhPh
282 283 284  
 
To a solution of a 1:1 diastereomixture of dioxolane 282 (260 mg, 1.0 mmol, 1.0 equiv) 
in CH2Cl2 (2 mL) at  –78 ºC was added DIBAL (3.1 mL of a 1 M solution in CH2Cl2, 
3.1 mmol, 3.0 equiv). The solution was warmed to rt slowly then stirred at that 
temperature for 12 h. The resulting solution was re-cooled to –78 ºC, sat. Na/K 
tartrate(aq.) (3 mL) was added slowly. After 10 min it was warmed to rt. After 30 min 
H2O (10 mL) was added and the aqueous phase extracted with EtOAc (3 × 5 mL). The 
combined organic layers were washed with brine (2 × 5 mL) and dried (MgSO4). 
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Concentration under reduced pressure and column chromatography (E)-1-(benzyloxy)-
4-phenylbut-3-en-2-ol 283 (41 mg, 16%) and (E)-2-(benzyloxy)-4-phenylbut-3-en-1-ol 
284 (167 mg, 66%). 
 
Data for 283: Rf 0.42 (25% EtOAc–petrol); vmax (film) 3424, 3062, 3029, 2864, 1495, 
1435, 1392, 1206, 1071, 932, 747, 697 cm–1; δH (400 MHz) 7.42-7.26 (10H, m, 2 × Ph), 
6.73 (1H, d, J 15.5 Hz, PhCH=CH), 6.22 (1H, dd, J 16.0, 6.0 Hz, PhCH=CH), 4.69 (1H, 
d, J 11.5 Hz, BnOCHH), 4.44 (1H, d, J 11.5 Hz, BnOCHH), 3.99 (1H, app dd, J 12.5, 
6.0 Hz, CHOH), 3.66-3.64 (2H, m, CH2OBn); δC (100 MHz) 136.1, 134.5, 128.7, 128.6, 
128.2, 127.9, 127.8, 126.6, 126.1, 80.8 (CHOH), 70.6 (CH2OBn), 65.6 (PhCH2); m/z 
(CI) 254 [M+NH4–H2O]
+, 236, 219 (Found: [M+NH4–H2O]
+, 254.1556. C17H18O2 
requires [M+NH4–H2O]
+, 254.1545). 
 
Data for 284: Rf 0.36 (25% EtOAc–petrol); vmax (film) 3331, 3029, 2872, 1495, 1435, 
1208, 1019, 734, 696 cm–1; δH (400 MHz) 7.45-7.29 (10H, m, Ph of Bn & PhCH=CH), 
6.70 (1H, d, J 16.0 Hz, PhCH=CH), 6.16 (1H, dd,  J 16.0, 8.0 Hz, PhCH=CH), 4.73 
(1H, d, J 11.5 Hz, OCHHPh), 4.48 (1H, d, J 11.5 Hz, OCHHPh), 4.18-4.13 (1H, m, 
CHOBn), 3.72-3.71 (2H, m, CH2OH); δC (125 MHz) 138.1 (ipso Ph), 136.1 (ipso Ph), 
134.5 (3º), [128.7, 128.5 (meta or ortho Ph)],  128.1 (3º), 127.9 (meta or ortho Ph), 
127.8 (3º), 126.6 (meta or ortho Ph), 126.1 (3º), 80.8 (CHOH), 70.6 (CH2OBn), 65.6 
(PhCH2); m/z (CI) 254 [M+NH4–H2O]
+ (Found: C, 80.19; H, 7.21.  C17H18O2 requires 
C, 80.28; H, 7.13%). 
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(E)-2-(Benzyloxy)-4-phenylbut-3-enal 266b & (E)-2-(benzyloxy)-4-phenylbut-2-
enal 286 
 
284
HO
OBn
Ph
O
OBn
Ph
O
OBn
Ph
266b 286  
 
To a solution of Dess–Martin periodinate (495 mg, 1.17 mmol, 1.5 equiv) in CH2Cl2 
(3.5 mL) at rt was added a solution of alcohol 284 (270 mg, 1.01 mmol, 1.0 equiv) in 
CH2Cl2 (1.5 mL). After 2.5 h, Et2O (6 mL) was added to the solution, followed by a 
solution of sat. NaHCO3(aq.) dissolving Na2S2O3 (1.5 g). After 3 min, the mixture was 
further diluted with Et2O (10 mL). The organic phase was separated, washed with sat. 
NaHCO3(aq.) (6 mL), H2O (10 mL), brine (2 × 8 mL) and dried (Na2SO4). Concentration 
under reduced pressure and drying under high vacuum cleanly gave crude (E)-2-
(benzyloxy)-4-phenylbut-3-enal 266b (250 mg, 93%); Rf 0.42 (13% EtOAc–petrol); δH 
(400 MHz) 9.64 (1H, s, CHO), 7.44-7.31 (10H, m, 2 × Ph), 6.81 (1H, d, J 16.0 Hz, 
PhCH=CH), 6.12 (1H, dd, J 16.0, 7.0 Hz, PhCH=CH), 4.77 (1H, d, J 12.0 Hz, PhCHH), 
4.67 (1H, d, J 12.0 Hz, PhCHH), 4.49 (1H, dt, J 7.0, 1.5 Hz, CHOBn). When enal 266b 
was treated with anionic nucleophiles, it isomerised to (E)-2-(benzyloxy)-4-phenylbut-2-
enal 286; δH (400 MHz) 9.29 (1H, s, CHO), 7.44-7.07 (10H, m, 2 × Ph), 6.15 (1H, t, J 
7.5 Hz, CH=COBn), 5.17 (2H, s, PhCH2O), 3.60 (2H, d, J 7.5 Hz, PhCH2CH). 
 
 
(S)-Butane-1,2,4-triol
130,132
 292 
 
HO
OH
OH
HO
OH
OH
O
O
+ BH3·SMe2
291 292  
 
To a solution of (S)-malic acid 291 (2.00 g, 14.9 mmol, 1.0 equiv) in THF (30 mL) at 0 
°C were added BH3·SMe2 (44.0 mL, 46.4 mmol, 3.1 equiv) and B(OMe)3 (5.50 mL, 
49.1 mmol, 3.3 equiv). It was then warmed to rt. After 16 h, methanol (12 mL) was 
added slowly. Concentration under reduced pressure and column chromatography 
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(5→15% MeOH–CH2Cl2) gave triol 292 as a colourless oil (1.42 g, 90%). Rf 0.22 (15% 
MeOH–CH2Cl2); vmax (film) 3355, 2941, 1422, 1059, 987, 872 cm
–1; δH (400 MHz, 
[d6]DMSO) 4.48 (1H, t, J 5.5 Hz, CHOH), 4.51-4.46 (2H, m, CH2OHCHOH), 3.56-
3.48 (3H, m, OH), 3.26 (2H, qt, J 11.0, 5.5 Hz, CH2CH2OH), 2.53-2.50 (2H, m, 
CH2CH2OH); δC (100 MHz) 69.2, 66.6, 58.5, 37.2; m/z (CI) 210, 124 [M+NH4]
+, 107 
[M+H]+, data in agreement with that previously reported.130,132 
 
 
[(2S,4S)-2-Phenyl-1,3-dioxan-4-yl]methanol
130,132 293 
 
292
HO
OH
OH HO
O
O Ph
293  
 
A solution of triol 292 (900 mg, 8.49 mmol, 1.0 equiv), benzaldehyde dimethylacetal 
(1.38 g, 9.08 mmol, 1.07 equiv) and (R)-(–)-CSA (99.0 mg, 0.427 mmol, 0.05 equiv) in 
CH2Cl2 (13 mL) was stirred at rt. After 16 h, the solution was re-cooled to –5 °C and 
Et3N (125 µL) added dropwise. Concentration under reduced pressure and column 
chromatography (30% EtOAc–petrol) gave the alcohol 293 (1.46 g, 89%) % as a 
colourless oil; Rf 0.09 (20% EtOAc–petrol); vmax (film) 3424, 2924, 2861, 1454, 1399, 
1364, 1313, 1240, 1215, 1141, 1104, 1066, 1025, 758, 699 cm–1; δH (400 MHz) 7.53-
7.51 (2H, m, ortho PhS), 7.42-7.37 (3H, m, meta & ortho PhS), 5.58 (1H, s, CHPh), 
4.35-4.32 (1H, m, CHOCHPh), 4.08-3.98 (2H, m, CH2OH), 2.02-1.91 (1H, m, 
CH2CHCHH), 1.50-1.47 (1H, m, CH2CHCHH); δC (101 MHz) 138.3 (ipso Ph), 129.0 
(para Ph), [128.3, 126.1 (meta & ortho Ph)], 101.3 (CHPh), 77.4, 66.6, 65.8, 26.8; m/z 
(CI) 212 [M+NH4]
+, 195 [M+H]+, 163; data in agreement with that previously 
reported.130,132  
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(2S,4S)-2-Phenyl-1,3-dioxane-4-carbaldehyde
130,132
 290 
 
293
HO
O
O Ph
O
O
O Ph
290  
 
To a solution of alcohol 293 (150 mg, 0.772 mmol, 1.0 equiv) in CH2Cl2 (1.0 mL) at 0 
°C was added a mixture of Dess–Martin periodinane (418 mg, 0.987 mmol, 1.28 equiv) 
in CH2Cl2 (2.0 mL). The resulting suspension was warmed to rt. After 1 h, the mixture 
was diluted with Et2O (3 mL) and washed with a solution of sat. NaHCO3(aq.) (5mL) 
dissolving Na2S2O3·5H2O (2.5 g). After 5 min, the organic phase was separated and the 
aqueous phase extracted with Et2O (5 mL). The combined organic layers were washed 
with sat. NaHCO3(aq.) (5mL), H2O (8 mL), brine (8 mL) and dried (MgSO4). 
Concentration under reduced pressure cleanly gave crude aldehyde 290 (120 mg, 84%) 
as a colourless oil; Rf 0.21 (20% EtOAc–petrol); δH (400 MHz) 9.78 (1H, s, CHO), 
7.60-7.28 (5H, m, Ph), 5.61 (1H, s, CHPh), 4.44-4.36 (1H, m, CHCH2), 4.11-4.01 (2H, 
m, CH2O), 2.07-1.80 (2H, m, CH2CH2O); δC (101 MHz) 200.1 (CHO), 137.5 (ipso Ph), 
129.0 (para Ph), [128.1, 126.3 (meta & ortho Ph)], 101.0 (CHPh), 80.1, 66.0, 25.8; m/z 
(CI) 210 [M+NH4]
+, 193 [M+H]+; data in agreement with that previously reported.130,132 
 
 
Allyl(phenyl)sulfane
135 294 
 
SH
+
Br
S
294  
 
To a flask containing NaH (1.09 g of a 60% wt% dispersion in mineral oil, 27.2 mmol, 
1.0 equiv) at 0 °C was added EtOH (40 mL). To this resulting solution were added 
thiophenol (3.00 g, 27.2 mmol, 1.0 equiv) and allyl bromide (3.62 g, 29.9 mmol, 1.0 
equiv). The resulting mixture was stirred at rt for 16 h then filtered. H2O (100 mL) was 
added to the filtrate and the aqueous phase extracted with Et2O (3 × 20 mL). The 
combined organic layers were washed with brine (2 × 15 mL) and dried (MgSO4). 
Concentration under reduced pressure cleanly gave crude product 294 (3.50 g, 86%) as 
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a colourless oil; vmax (film) 3070, 3059, 2007, 2919, 2916, 1948, 1852, 1636, 1583, 
1480, 1438, 1228, 1089, 1025, 987, 919, 737, 690 cm–1; δH (400 MHz) 7.38-7.36 (2H, 
m, ortho Ph), 7.32-7.28 (2H, m, meta Ph), 7.22-7.19 (1H, m, para Ph), 5.90 (1H, ddt, J 
17.0, 7.0, 7.0 Hz, CH=CH2), 5.18-5.14 (1H, m, cis CHH=CH), 5.11-5.08 (1H, m, trans 
CHH=CH), 5.57 (2H, d, J 7.0 Hz, CH2); δC (125 MHz) 137.5 (ipso PhS), 133.6 (para 
PhS), [129.8, 128.8 (ortho & meta PhS)], 126.2 (CH=CH2), 117.7 (CH=CH2), 37.2 
(CH2); m/z (CI) 184, 166, 149, 52; data in agreement with that previously reported.
 135 
 
 
N-[(2R*,3S*)-1-(4-Methoxyphenyl)-4-(phenylthio)-3-vinylhex-4-en-2-yl]-4-
methylbenzenesulfonamide 295 
 
TsHN
OMe
SPh
OMe
TsN
SPh +
294
46 295  
 
To a solution of allyl sulfide 294 (81.4 mg, 0.542 mmol, 1.4 equiv) in THF (0.3 ml) at  
–78 °C was added nBuLi (62 µL of a 9.4 M solution in hexanes, 0.581 mmol, 1.5 
equiv). After 15 min, it was warmed to –30 °C then to 0 °C. After 15 min, it was re-
cooled to –20 °C then a solution of aziridine 46 (100 mg, 0.387 mmol, 1.0 equiv) in 
THF (0.2 ml) was added. The resulting solution was warmed to rt. After 16 h the 
solution was quenched with sat. NH4Cl(aq.) (2 mL), diluted with H2O (5 mL) and the 
aqueous phase extracted with EtOAc (2 × 5 ml). The combined organic layers were 
washed with brine (2 × 5 ml) and dried (Na2SO4). Concentration under reduced pressure 
and column chromatography (5→15% EtOAc–petrol) gave a 5:1 olefin isomeric 
mixture of N-[(2R*,3S*)-1-(4-methoxyphenyl)-4-(phenylthio)-3-vinylhex-4-en-2-yl]-4-
methylbenzenesulfonamide 295 (97.0 mg, 67%) as a solid; data for the major isomer: Rf 
0.33% (15% EtOAc–petrol); vmax (film) 3287, 1612, 1513, 1439, 1326, 1247, 1158, 
1093, 1036, 813, 741, 690, 663 cm–1; δH (400 MHz) 7.66 (2H, d, J 8.5 Hz, ortho Ts), 
7.30 (2H, d, J 8.5 Hz, meta Ts), 7.25 (2H, d, J 8.0 Hz, ortho PhS), 7.13-7.09 (1H, m, 
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para PhS), 6.98-6.96 (2H, m, meta PhS), 6.85 (2H, d, J 8.5 Hz, meta ArOMe), 6.63 
(2H, d, J 8.5 Hz, ortho ArOMe), 6.03 (1H, q, J 6.5 Hz, CH3CH=C), 5.85 (1H, app. dt, J 
16.0, 9.5 Hz, CH2=CH, diagnostic signal of the minor isomer), 5.75 (1H, ddd, J 17.0, 
10.0, 8.5 Hz, CH2=CH), 5.16 (1H, dd, J 10.0, 1.5 Hz, trans CHH=CH), 4.91 (1H, dd, J 
17.0, 1.5 Hz, cis CHH=CH), 4.44 (1H, d, J 8.0 Hz, NH), 3.80-3.78 (4H, m, OMe & 
NCH), 2.85-2.81 (1H, m, CHCH=CH2), 2.74 (1H, dd, J 14.0, 5.0 Hz, CHH), 2.63-2.58 
(1H, m, CHH), 2.43 (3H, s, Me of Ts), 1.79 (3H, d, J 6.5 Hz, CH3CH=C); δC (125 
MHz) [158.0, 143.1, 137.5 (q Ar)], [134.9, 134.8, 133.8 (CH=C & para PhS)], [129.9, 
129.6 (q Ar)], [130.1, 129.5, 128.9, 128.7, 127.2 (ortho & meta Ar)], 125.8 (CH=CH2), 
119.2 (CH=CH2), 113.6 (ortho or meta Ar), 56.9, 55.1, 52.1, 38.5, 21.5, 15.9; m/z (ESI) 
516 [M+Na]+, 494 [M+H]+, 304, 214 (Found: [M+Na]+, 516.1642. C28H31NO3S2 
requires [M+Na]+, 516.1643). 
 
 
N-[(2R*,3S*)-1-(4-Methoxyphenyl)-4-(phenylthio)-3-vinylhex-5-en-2-yl]-4-
methylbenzenesulfonamide 296 
 
294
46 296
TsHN
OMe
SPh
OMe
TsN
SPh +
 
 
To a solution of allyl sulfide 294 (241 mg, 1.60 mmol, 1.1 equiv) in THF (1.0 mL) at –
78 °C was added nBuLi (988 µL of a 1.62 M solution in hexanes, 1.60 mmol, 1.1 
equiv). After 25 min, the reaction vessel was put into a 0 °C bath for 5 min then re-
cooled to –78 °C. To the resulting solution was added a solution of aziridine 46 (500 
mg, 1.46 mmol, 1.0 equiv) in THF (0.8 mL) at –78 °C. After 20 min, the reaction was 
quenched with a solution of AcOH (96 mg) in THF (865 mg) then warmed to rt. This 
solution was further diluted with H2O (10 mL) and the aqueous phase extracted with 
EtOAc (3 × 15 ml). The combined organic layers were washed with brine (2 × 10 mL) 
and dried (Na2SO4). Concentration under reduced pressure and column chromatography 
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(15% EtOAc–petrol) gave a 5:1 diastereomixture of N-[(2R*,3S*)-1-(4-
methoxyphenyl)-4-(phenylthio)-3-vinylhex-5-en-2-yl]-4-methylbenzenesulfonamide 296 
(547 mg, 76%) as a gum; data for major diastereomer: Rf 0.33 (15% EtOAc–petrol); 
vmax (film) 3280, 1612, 1513, 1440, 1325, 1247, 1158, 1093, 1035, 923 cm
–1; δH (500 
MHz) 7.79 (2H, d, J 8.5 Hz, ortho Ts, diagnostic signal of the minor diast.), 7.73 (2H, 
d, J 8.5 Hz, ortho Ts), 7.33-7.19 (7H, m, meta Ts and PhS), 6.88 (2H, d, J 8.5 Hz, meta 
ArOMe), 6.77 (2H, d, J 8.5 Hz, ortho ArOMe), 5.74 (1H, ddd, J 15.5, 10.0, 8.5 Hz, 
CH2=CHCHCHN), 5.40 (1H, dd, J 10.0, 1.5 Hz, trans CHH=CHCHCHN), 5.29-5.17 
(2H, m, CH2=CHCHS & cis CHH=CHCHCHN), 4.89 (1H, dd, J 10.0, 1.0 Hz, trans 
CHH=CHCHS), 4.65 (1H, dd, J 17.0, 1.0 Hz, cis CHH=CHCHS), 4.34 (1H, m, NH), 
3.83-3.76 (4H, m, OMe & NCH), 2.62-2.49 (2H, m, CH2CHN), 2.44 (3H, s, Me of Ts), 
2.22-2.17 (1H, m, CHCHN); δC (125 MHz) [158.3, 143.5 137.7 (q Ar)], [136.7, 134.4, 
134.2 (para PhS & CH=CH2 & CH=CH2)], [133.1, 130.2, 129.7 (meta & ortho Ar)], 
[128.9, 128.8 (q Ar)], [128.6, 127.1 (meta & ortho Ar)], [120.9, 117.9 (CH=CH2 & 
CH=CH2)], 113.9 (meta or ortho Ar), 56.0, 55.2, 53.0, 48.6, 39.1, 21.6; m/z (ESI) 516 
[M+Na]+, 494 [M+H]+, 384, 304 (Found: [M+Na]+, 516.1646. C28H31NO3S2 requires 
[M+Na]+, 516.1643). 
  
 
N-[(2R*,3S*)-1-(4-Methoxyphenyl)-4-(phenylthio)-3-vinylhex-5-en-2-yl]-N,4-
dimethylbenzenesulfonamide 297 
 
TsHN
OMe
SPh
TsMeN
OMe
SPh
+ MeI
296 297  
 
To a diastereomixture of sulfide 296 (207 mg, 0.42 mmol, 1.0 equiv), MeI (168 µL, 
2.69 mmol, 6.4 equiv) and tBuOK (48.0 mg, 0.42 mmol, 1.0 equiv) at rt was added 
tBuOH (0.6 mL). The suspension was heated to 70 °C. After 4 h, it was concentrated 
under reduced pressure. Then, H2O (5 mL) was added to the crude mixture and 
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extracted with EtOAc (3 × 5 mL). The combined organic layers were washed with brine 
(2 × 5 mL) and dried (Na2SO4). Concentration under reduced pressure and column 
chromatography (5→20% EtOAc–petrol) gave N-[(2R*,3S*)-1-(4-methoxyphenyl)-4-
(phenylthio)-3-vinylhex-5-en-2-yl]-N,4-dimethylbenzenesulfonamide 297 (173 mg, 
82%) as a gum; data for major diastereomer only: Rf 0.62 (25% EtOAc–petrol); vmax 
(film) 3072, 2933, 2835, 1720, 1612, 1513, 1439, 1333, 1303, 1247, 1157, 1088, 1035, 
932, 815, 740, 655 cm–1δH (400 MHz) 7.46 (2H, d, J 8.5 Hz, ortho Ts), 7.35-7.17 (7H, 
m, meta Ts and PhS), 6.96 (2H, d, J 8.5 Hz, meta ArOMe), 6.74 (2H, d, J 8.5 Hz, ortho 
ArOMe), 5.91-5.81 (1H, m, CH2=CHCHCHN), 5.40 (1H, td, J 17.0, 9.5 Hz, 
CH2=CHCHS), 5.32-4.82 (4H, m, CH2=CHCHCHN & CH2=CHCHS), 3.87-3.81 (5H, 
m, OMe & NCH & CHS), 3.83 (3H, s, OMe, diagnostic signal of minor diast.), 2.76-
2.73 (5H, m, NMe & CH2Ar), 2.43-2.37 (4H, m, Me of Ts & CHCHN); δC (125 MHz) 
[158.4, 142.7 (q Ar)], 137.6 (CH=CH2), 136.7 (q Ar), 135.6 (CH=CH2), 134.7 (q Ar), 
[132.8, 130.3 (3º Ar)], 130.1 (q Ar), [129.5, 128.6, 127.1 (3º Ar)], [118.9, 116.4 (2 × 
CH=CH2)], 113.8 (3º Ar)], 59.8 (OMe), [55.2, 54.3 (MeNMe)], 51.9 (CHSPh), 35.9 
(CH2ArOMe), 30.2 (CHCHS), 21.5 (Me of Ts); m/z (ESI) 530 [M+Na]
+, 508 [M+H]+, 
465, 318 (Found: [M+Na]+, 530.1816. C29H33NO3S2 requires [M+Na]
+, 530.1800) 
(Found: C, 68.65; H, 6.67; N, 2.71.  C29H33NO3S2 requires C, 68.60; H, 6.55; N, 
2.76%). 
 
 
5-(Phenylthio)hepta-1,6-dien-3-ol 384 
 
PhS +
O PhS OH
384
47294
 
 
To a solution of allyl sulfide 294 (300 mg, 2.0 mmol, 1.0 equiv) in THF (1 mL) at –78 
°C was added nBuLi (230 µL of a 8.7 M solution in hexanes, 2.0 mmol, 1.0 equiv). 
After 20 min, the reaction vessel was put in a 0 °C bath for 10 min then re-cooled to –
78 °C. Butadiene monoxide 47 (154 mg, 2.2 mmol, 1.1 equiv) was added. After 15 min, 
AcOH (120 mg) in THF (1 mL) was added and the solution warmed to rt. 
Concentration under reduced pressure and column chromatography (10% EtOAc–
petrol) gave diene 384 (82 mg, 19%) as a colourless oil; Rf 0.59 (20% EtOAc–petrol); 
 164
δH (400 MHz) 7.40-7.42 (2H, m, ortho Ph, 2 × dias.), 7.33-7.26 (3H, m, para & meta 
Ph), 5.95-5.68 (2H, m, CH2=CH & CH2=CH, 2 × dias.), [5.33-5.28, 5.19-5.15, 5.04-
4.89 (4H, m, CH2=CH & CH2=CH, 2 × dias.)], 4.49-4.23 (1H, m, CHOH), 3.89-3.78 
(1H, m, CHSPh), 1.99-1.76 (2H, m, CH2, 2 × dias.); δC (125 MHz) [140.6, 140.4, 138.7, 
138.2, 133.1, 132.9, 128.7, 127.4, 127.3, 116.4, 115.6, 115.4, 115.1 (Ph &  2 × 
CH2=CH, 2 × dias.)], [70.8 70.7 (CHOH, 2 × dias.), [48.9, 48.8 (CHSPh, 2 × dias.)], 
[41.0, 40.9 (CH2, 2 × dias.)]; m/z (CI) 238 [M+NH4]
+, 221 [M+H]+, 203, 149 (Found: 
[M+H]+, 221.1007. C13H16OS requires [M+H]
+, 221.1007). 
 
 
3-(Phenylthio)propanal
138
 303 
 
O
+
O
PhSH
PhS
301
302
303  
 
To a solution of thiolphenol 302 (2.20 g, 20.0 mmol, 1.0 equiv) and Et3N (0.28 mL, 2.0 
mmol, 0.1 equiv) and CH2Cl2 (20 mL) at 0 °C was added acrylaldehyde 301 (2.67 mL, 
40 mmol, 2.0 equiv). After 30 min, concentration under reduced pressure and dried 
under high vacuum gave aldehyde 303 (3.32 g, 100%) as a colourless oil; Rf  0.59 (50% 
EtOAc–petrol); δH (400 MHz) 9.79 (1H, s, CHO), 7.39-7.25 (5H, m, Ph), 3.21 (2H, t, J 
7.0 Hz, CH2CHO), 2.80 (2H, t, J 7.0 Hz, PhSCH2); δC (125 MHz) 200.3 (CHO), 135.1 
(ipso PhS), 130.0 (ortho PhS), 129.1 (meta PhS), 126.7 (para PhS), 43.3 (CH2CHO), 
26.4 (CH2PhS); m/z (CI) 184 [M+NH4]
+, 166, 52; data in agreement with that 
previously reported.138 
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(3,3)-Dimethoxypropyl)(phenyl)sulfane
139
 304 
 
303
O
PhS PhS
OMe
OMe
304  
 
The solution of aldehyde 303 (2.90 g, 17.5 mmol, 1.0 equiv), CH(MeO)3 (3.71 g, 34.9 
mmol, 2.0 equiv), p-TsOH·H2O (100 mg, 0.526 mmol, 0.03 equiv) and MeOH (35 mL) 
was heated to 50 °C. After 16 h, the resulting solution was concentrated under reduced 
pressure. Then, EtOH (15 mL) was added to the crude, washed with sat. NaHCO3(aq.) (3 
× 30 mL), H2O (3 × 10 mL), brine (2 × 15 mL) and dried (Na2SO4).  Concentration 
under reduced pressure and column chromatography (5% EtOAc–petrol with 1% Et3N) 
gave acetal 304 (3.90 g, 96%) as a colourless oil; Rf 0.51 (23% Et2O–petrol); vmax (film) 
3057, 2933, 2830, 1944, 1870, 1724, 1686, 1583, 1400, 1438, 1382, 1366, 1281, 1192, 
1160, 1123, 1073 cm–1; δH (400 MHz) 7.38-7.19 (5H, m, Ph), 4.53 (1H, t, J 5.0 Hz, 
CH), 3.35 (6H, s, OMe), 2.99 (2H, t, J 7.0 Hz, CH2SPh), 1.96 (2H, dt, J 7.0, 5.0 Hz, 
CH2CH); δC (125 MHz) 136.2 (ipso PhS), 129.2 (ortho PhS), 128.9 (meta PhS), 125.9 
(para PhS), 103.2 (CH), 53.2 (OMe), 32.3 (CH2PhS), 28.8 (CH2CH); compound not 
suitable for CI and ESI mass spectroscopic technologies; data in agreement with that 
previously reported.139 
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N-[(2R*,3S*)-6,6-Dimethoxy-1-(4-methoxyphenyl)-4-(phenylthio)-3-vinylhexan-2-
yl]-4-methylbenzenesulfonamide 305 
 
304
OMe
TsN
SPh
+
MeO
OMe TsHN
OMe
SPh
MeO
OMe
46 305  
 
To a solution of acetal 304 (403 mg, 1.90 mmol, 1.3 equiv) in THF (0.7 mL) at –78 °C 
was added nBuLi (905 µL of a 2.1 M solution in hexanes, 1.90 mmol, 1.3 equiv). After 
20 min, it was warmed to 0 °C. After 20 min it was re-cooled to –78 °C, then a solution 
of vinylaziridine 46 (500 mg, 1.46 mmol, 1.0 equiv) in THF (0.7 mL) was added. The 
resulting solution was allowed to warmed to rt slowly. After 16 h, the reaction was 
quenched with sat. NaHCO3(aq.) (10 mL) and the aqueous phase extracted with EtOAc (3 
× 7 mL). The combined organic layers were washed with brine (3 × 5 mL) and dried 
(Na2SO4). Concentration under reduced pressure and column chromatography 
(10%→25% EtOAc–petrol) gave a 5:1 diastereomixture of N-[(2R*,3S*)-6,6-
dimethoxy-1-(4-methoxyphenyl)-4-(phenylthio)-3-vinylhexan-2-yl]-4-
methylbenzenesulfonamide 305 (100 mg, 12%) as a gum; data for major diastereomer: 
Rf 0.21 (25% EtOAc–petrol); vmax (film) 3277, 2938, 2833, 1161, 1583, 1513, 1439, 
1324, 1302, 1248, 1178, 1157, 1124 cm–1; δH (400 MHz) 7.69 (2H, d, J 8.0 Hz, ortho 
Ts), 7.65–7.14 (7H, m, SPh & meta Ts), 6.95 (2H, d, J 8.5 Hz, meta ArOMe), 6.73 (2H, 
d, J 8.5 Hz, ortho ArOMe), 5.58 (1H, app. dt, J 17.0, 10.0 Hz, CH=CH2, diagnostic 
signal of the minor diast.), 5.47 (1H, app. dt, J 17.0, 10.0 Hz, CH=CH2), 5.18 (1H, dd, J 
10.0, 1.5 Hz, trans CH=CHH), 5.01 (1H, dd, J 17.0, 1.5 Hz, cis CH=CHH), 4.54 [1H, t, 
J 5.5 Hz, CH(OMe) 2], 4.42 (1H, d, J 7.5 Hz, NH), 3.92-3.89 (1H, m, CHN), 3.79 (3H, 
s, ArOMe), 3.54 (1H, dt, J 7.0, 4.0 Hz, CHS), 3.25 (3H, s, MeOCHOMe), 3.23 (3H, s, 
MeOCHOMe), 2.76 (1H, dd, J 14.0, 6.0 Hz, CHHArOMe), 2.55 (1H, dd, J 14.0, 4.5 
Hz, CHHArOMe), 2.44 (3H, s, Me of Ts), 2.30-2.25 (1H, m, CHCH=CH2), 1.85 (2H, 
dd, J 7.0, 5.5 Hz, CH2CHS); δC (100.7 MHz) [158.3, 143.2, 137.6, 135.6 (q Ar)], 134.9 
(3º Ar), [131.4, 130.9, 129.6, 128.9 (3º Ar)], 128.1 (q Ar), 127.2 (3º Ar), 126.9 
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(CH=CH2), 120.8 (CH=CH2), 113.8 (3º Ar), 102.5 [CH(OMe)2], 55.3 [CH(OMe)2], 
53.1 (ArOMe), 50.7 (CHN), 47.1 (CHSPh), [37.6, 37.4 (CH2)], 23.9 (Me of Ts), 21.6 
(CHCH=CH2); m/z (ESI) 578 [M+Na]
+, 556 [M+H]+, 554, 492 (Found: [M+NH4]
+, 
578.1995. C30H37NO5S2 requires [M+NH4]
+. 578.2011) (Found: C, 65.00; H, 6.71; N, 
2.58.  C30H37NO5S2 requires C, 64.84; H, 6.71; N, 2.52%). 
 
 
(2S*)-6,7-(3-Methoxyphenyl)-3-(phenylthio)-9-tosyl-2-vinyl-9-azabicyclo[3.3.1]non-
6-ene 307 
 
305
N
Ts
MeO
PhS
TsHN
OMe
SPh
MeO
OMe
307
 
 
To a solution of tosamide 305 (16.0 mg, 0.029 mmol, 1.0 equiv) in CH2Cl2 (0.6 mL) at 
–78 °C was added BF3·Et2O (0.06 mL, 0.44 mmol, 15.0 equiv). The solution was 
warmed to rt slowly. After 16 h, sat. NaHCO3 (aq.) (1.0 mL) was added. The mixture was 
extracted with CH2Cl2 (2 × 2 mL). The combined organic layers were washed with 
brine and dried (Na2SO4). Concentration under reduced pressure and purified by prep–
TLC to obtain the major diastereomer of pyridine 307 (10.0 mg, 73%) as a gum; Rf 0.74 
(30% EtOAc–petrol); δH (400 MHz) 7.50 (2H, d, J 8.5 Hz, ortho Ts), 7.26–7.23 (5H, m, 
SPh), 7.05 (2H, d, J 8.5 Hz, meta Ts), 6.75 (1H, d, J 8.5 Hz, meta ArOMe), 6.67 (1H, 
dd, J 8.5, 2.5 Hz, ortho MeOAr), 6.50 (1H, d, J 2.5 Hz, ortho MeOAr), 5.76 (1H, ddd, J 
17.0, 10.5, 8.5 Hz, CH=CH2), 5.34-5.27 (2H, m, CH=CH2), 5.07 (1H, m, ArCHN), 
4.29-4.27 (1H, m, CHCHN), 3.79 (3H, s, OMe), 2.91-2.84 (1H, m, CHSPh), 2.69-2.56 
(3H, m, CH2ArOMe & CHCH=CH), 2.33 (3H, s, Me of Ts), 2.07-2.00 (2H, m, 
CH2CHS); δC (100.7 MHz) [157.9, 143.0 (q Ar)], 137.7 (3º), [137.2, 135.9 (q Ar)], 
133.6 (3º), 131.8 (q Ar), [129.1, 129.0 (3º)], 128.8 (3º), 127.7 (3º), 126.9 (3º), 125.5 (q 
Ar), 119.2 (CH=CH2), 113.5, 110.5, 55.4 (OMe), [53.8, 53.6 (CHNCH)], 50.1 
(PhSCH), 41.1 (CHCH=CH2), 40.4 (CH2ArOMe), 25.4 (CH2CHS), 21.4 (Me of Ts); 
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m/z (EI) 491 [M]+, 382, 314, 227, 160, 91 (Found: [M]+, 491.1583. C28H29NO3S2 
requires [M]+, 491.1589). 
 
 
Methyl 2-(phenylthio)acetate
140
 309 
 
302
Br
O
O
+ PhSH SPhO
O
309  
 
To a solution of methyl bromoacetate (8.30 g, 54.4 mmol, 2.0 equiv) and thiophenol 
302 (3.00 g, 27.2, 1.0 equiv) in MeOH (7 mL) at 40 °C was added NaOMe (2.20 g, 40.8 
mmol, 1.5 equiv). After 2 h, the resulting mixture was cooled to rt and filtered. The 
filtrate was concentrated under reduced pressure. Distillation under high vacuum gave 
sulfide ester 309 (9.61 g, 97%) as a colourless oil; Rf 0.47 (15% Et2O–petrol); vmax 
(film) 3058, 3002, 2952, 2842, 1743, 1583, 1482, 1437, 1407, 1279, 1194, 1153, 1009, 
894, 741, 690 cm–1; δH (400 MHz) 7.43 (2H, d, J 7.5 Hz, meta Ph), 7.35-7.26 (3H, m, 
ortho & para Ph), 3.75 (3H, s, CH3), 3.68 (2H, s, CH2); δC (125 MHz) 170.2 (COO), 
135.0 (ipso Ph), [129.8, 129.1 (meta & ortho Ph)], 126.9 (para Ph), 52.5 (SCH2CO), 
36.4 (CH3O); m/z (CI) 279, 217, 200 [M+NH4]
+, 182 [M+ NH4–H2O]
+, 140, 123, 52; 
data in agreement with that previously reported.140 
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 (S*)-Methyl 3-[(R)*-2-(4-methoxyphenyl)-1-(4-methylphenylsulfonamido)ethyl]-2-
(phenylthio)pent-4-enoate 315 
 
46
309
OMe
TsHN
SPh
O
OMe
+
TsN
SPh
O
O O
315  
 
A solution of sulfide ester 309 (64.0 mg, 0.35 mmol, 1.3 equiv) in DMF (0.2 mL) was 
added dropwise to KH (27 mg, from a 35% mixture in oil washed with petrol three 
times, 0.673 mmol, 2.6 equiv) at 0°C. After 30 min, a solution of aziridine 46 in DMF 
(0.8 mL) was added. After 2 h at that temperature, the reaction mixture was heated to 60 
°C. After 16 h, the reaction was quenched with MeOH (2 mL). The resulting mixture 
was concentrated under reduced pressure to remove the excess MeOH, then diluted with 
EtOAc (3 mL) and brine (5 mL). The organic phase was separated and aqueous phase 
extracted with EtOAc (2 × 5 mL). The combined organic layers were washed with brine 
(3 × 5 mL) and dried (MgSO4). Concentration under reduced pressure and column 
chromatography (10→25% EtOAc–petrol) gave a separated 3:1 diastereomeric of (S*)-
methyl 3-[(R)*-2-(4-methoxyphenyl)-1-(4-methylphenylsulfonamido)ethyl]-2-
(phenylthio)pent-4-enoate 315 (93.0 mg, 68%) as gums; 
 
 Data for minor diastereomer: 22 mg, 16%; Rf 0.73 (40% EtOAc–petrol); vmax (film) 
3522, 3275, 3061, 2988, 2958, 2836, 1728, 1612, 1584, 1513, 1438, 1326, 1248, 1159, 
1091, 1036, 998, 928, 814, 738, 665 cm–1; δH (400 MHz) 7.55 (2H, d, J 8.0 Hz, ortho 
Ts), 7.38-7.36 (2H, m, meta SPh), 7.27-7.25 (3H, m, ortho & para SPh), 7.17 (2H, d, J 
8.0 Hz, meta Ts), 6.81 (2H, d, J 8.5 Hz, meta ArOMe), 6.67 (2H, d, J 8.5 Hz, ortho 
ArOMe), 5.66 (1H, td, J 17.0, 10.0 Hz, CH=CH2), 5.40 (1H, dd, J 10.0, 1.5 Hz, trans 
CH=CHH), 5.14 (1H, dd, J 17.0, 1.5 Hz, cis CH=CHH), 4.57 (1H, d, J 8.5 Hz, NH), 
3.96 (1H, d, J 11.0 Hz, CHSPh), 3.77 (3H, s, CH3OOC), 3.70 (1H, m, NCH), 3.64 (3H, 
s, CH3OAr), 2.66 (1H, ddd, J 11.5, 11.5, 2.0 Hz, CHCH=CH2), 2.55 (1H, dd, J 14.0, 8.5 
Hz, CHHArOMe), 2.42-2.37 (4H, m, Me of Ts & CHHArOMe); δC (125 MHz) 171.9 
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(COO), [158.3, 143.2, 137.3 (q Ar)], [133.2, 133.0 (3°)], 132.9 (q Ar), [130.1, 129.9, 
128.8 (3°)], 128.4(q Ar), [127.9, 126.9 (3°)], 121.7 (CH=CH2), 113.8 (3°), 55.3, 55.1, 
52.1, 51.2, 47.0, 39.2 (CH2), 21.5; m/z (ESI) 548.1555 [M+Na]
+,  526.1734 [M+H]+, 
469.3163, 208.0410 (Found: [M+Na]+, 526.1734. C28H31O5S2 requires [M+Na]
+, 
526.1722). 
 
Data for major diastereomer: 71 mg, 52%; Rf 0.65 (40% EtOAc–petrol); vmax (film) 
3510, 3273, 3060, 2951, 2837,1732, 1612, 1513, 1439, 1326, 1248, 1159, 1048, 1035, 
931, 815, 737, 664 cm–1; δH (400 MHz) 7.78 (2H, d, J 8.0 Hz, ortho Ts), 7.29-7.19 (7H, 
SPh & meta Ts), 6.87 (2H, d, J 8.5 Hz, meta ArOMe), 6.76 (2H, d, J 8.5 Hz, ortho 
ArOMe), 5.70 (1H, td, J 17.0, 10.0 Hz, CH=CH2), 5.29 (1H, dd, J 10.5, 1.0 Hz, trans 
CH=CHH), 5.14 (1H, dd, J 17.0, 1.0 Hz, cis CH=CHH), 4.81 (1H, d, J 9.0 Hz, NH), 
4.27-4.21 (1H, m, NCH), 3.99 (1H, d, J 11.0 Hz, CHSPh), 3.80 (3H, s, CH3OOC), 3.48 
(3H, s, CH3OAr), 2.51-2.39 (6H, m, CHCH=CH2 & CH2ArOMe & Me of Ts); δC (125 
MHz) 171.7 (COO), [158.4, 143.5, 137.3 (q Ar)], [133.5, 132.6 (3°)], 131.9 (q Ar), 
[130.1, 129.7 (3°)], 129.4 (q Ar), [128.7, 128.1, 127.2 (3°)], 121.8 (CH=CH2), 114.1 
(3°), 55.2, 54.6, 52.0, 51.7, 45.6, 39.2 (CH2), 21.5; m/z (ESI) 548.1540 [M+Na]
+, 
526.1730 [M+H]+, 494.1479, 344.1046 (Found: [M+Na]+, 526.1730. C28H31O5S2 
requires [M+Na]+, 526.1722). 
 
 
Phenyl(prop-2-ynyl)sulfane
148
 316 
 
+ PhSHBr SPh
325
302
316  
 
To a solution of sodium hydroxide (5.72 g, 143 mmol, 1.7 equiv) in H2O (70 mL) at rt 
was added thiophenol 302 (9.26 g, 84.1 mmol, 1.0 equiv). After 40 min, it was cooled 
to 0 °C and a solution of propargylic bromide 325 (15.0 g, 126 mmol, 1.5 equiv) in 
benzene (100 mL) added dropwise followed by tetra-nbutylammonia bromide (4.19 g, 
13.0 mmol, 0.15 equiv). After 2.5 h vigorously stirring, the reaction was diluted with 
H2O (50 mL). The organic phase was separated, washed with H2O (2 × 20 mL), brine (2 
× 30 mL) and dried (MgSO4). Concentration under reduced pressure and distillation 
(105 °C at 7 mmHg) gave propargylic sulfide 316 (10.7 g, 85%) as a colourless oil; Rf 
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0.42 (100% petrol); vmax (film) 3292, 3058, 3019, 2947, 2914, 2118, 1949, 1878, 1670, 
1585, 1480, 1438, 1407, 1299, 1233, 1086, 1025, 740, 689, 643 cm–1; δH (400 MHz) 
7.48 (2H, d, J 7.5 Hz, ortho SPh), 7.38-7.26 (3H, m, meta & para SPh), 3.64 (2H, d, J 
2.5 Hz, CH2), 2.27 (1H, t, J 2.5 Hz, CH); δC (125 MHz) 135.0 (q Ph), 130.0 (ortho Ph), 
129.0 (meta Ph), 127.0 (para Ph), 79.9 (CHC), 71 (CHC), 22.6 (CH2); compound not 
suitable for CI and ESI mass spectroscopic technologies; data in agreement with that 
previously reported.148 
 
 
N-[(2R*,3S*)-1-(4-Methoxyphenyl)-4-(phenylthio)-3-vinylhex-5-yn-2-yl]-4-
methylbenzenesulfonamide 317 
 
316
OMe
TsHN
OMe
+
TsN
SPh
SPh
46 317  
 
To a solution of propargylic sulfide 316 (1.25 g, 8.4 mmol, 1.2 equiv) in THF (9 mL) at 
–78 °C was added nBuLi (6.72 mL of a 2.5 M solution in hexanes, 16.8 mmol, 2.4 
equiv) dropwise. It was warmed to –30 °C over a period of 1.5 h then re-cooled to –78 
°C. A solution of aziridine 46 (2.30 g, 6.7 mmol, 1.0 equiv) in THF (5.0 mL) was added 
via cannula. The resulting red solution was warmed to 5 °C over a period of 3 h then to 
rt. After 30 min, it was cooled to 0 °C, quenched with sat. NH4Cl(aq.) (19 mL) then 
diluted with H2O (10 mL). The organic phase was separated and the aqueous phase 
extracted with EtOAc (3 × 10 mL). The combined organic layers were washed with 
brine (3 × 5 mL) and dried (Na2SO4). Concentration under reduced pressure and column 
chromatography (15→20% EtOAc–petrol) gave a 3:1 diastereomeric mixture of N-
[(2R*,3S*)-1-(4-methoxyphenyl)-4-(phenylthio)-3-vinylhex-5-yn-2-yl]-4-
methylbenzenesulfonamide 317 (2.50 g, 76%) as a solid; Rf 0.42 (25% EtOAc–petrol); 
vmax (film) 3285, 2925, 1731, 1612, 1512, 1439, 1326, 1303, 1248, 1158, 1081, 1034, 
927, 815, 742, 691, 663 cm–1; δH (400 MHz) 7.78 (2H, d, J 8.0 Hz, ortho Ts, minor 
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diast.), 7.73 (2H, d, J 8.0 Hz, ortho Ts, major diast.), 7.36-7.21 (2 × 7H, m, SPh & meta 
Ts, 2 × diast.), 6.98 (2H, d, J 8.5 Hz, meta ArOMe, minor diast.), 6.89 (2H, d, J 8.5 Hz, 
meta ArOMe, major diast.), 6.78-6.72 (2 × 2H, m, ortho ArOMe, 2 × diast.), 5.73-5.61 
(2 × 1H, m, CH=CH2, 2 × diast.), 5.44-5.38 (2 × 1H, m, trans CH=CHH, 2 × diast.), 
5.15 (1H, dd, J 17.0, 1.0 Hz, cis CH=CHH, major diast.), 5.13 (1H, dd, J 17.0, 1.0 Hz, 
cis CH=CHH, minor diast.), 4.69-4.59 (2 × 1H, m, NH, 2 × diast.), 4.14-3.91 (2 × 2H, 
m, NCH & CHSPh, 2 × diast.), 3.82 (3H, s, Me of ArOMe, minor diast.), 3.79 (3H, s, 
Me of ArOMe, major diast.), 2.79-2.52 (2 × 3H, m, CHCH=CH2 & CH2ArOMe, 2 × 
diast.), 2.44 (3H, s, Me of Ts, minor diast.), 2.41 (3H, s, Me of Ts, major diast.), 2.37 
(1H, d, J 2.0 Hz, CHCCHSPh, major diast.), 2.32 (1H, d, J 2.5 Hz, CHCCHSPh, minor 
diast.); δC (125 MHz) [158.5, 158.3, 143.6, 143.4 (q Ar, 2 × diast.)], 137.5, 134.2, 
133.6, 133.3, 133.2, 132.9, 132.2, 130.1, 130.4, 130.1, 129.7, 129.6, 129.5, 128.9, 
128.7, 128.2, 127.4, 127.3, 126.9, [121.6, 121.4 (CH=CH2, 2 × diast.)], 114.1, 113.9, 
89.6, 82.8, 74.6, 73.6, 56.8, 56.4, 55.8, 55.2, 51.6, 49.6, 40.4, 39.8, 39.7, 39.6, 21.9, 
21.6; m/z (ESI) 514.1473 [M+Na]+, 492.1661 [M+H]+ (Found: [M+H]+, 492.1661. 
C28H29NO3S2 requires [M+H]
+, 492.1667). 
 
 
N-[(2R*,3S*)-1-(4-Methoxyphenyl)-4-(phenylthio)-3-vinylhex-5-yn-2-yl]-N,4-
dimethylbenzenesulfonamide 384 
 
317
OMe
TsHN
SPh
OMe
TsMeN
SPh
384  
 
To a mixture of tosamides 317 (100 mg, 0.204 mmol, 1.0 equiv), tBuOK (23.0 mg, 
0.204 mmol, 1.0 equiv) and MeI (17 µL, 1.23 mmol, 6.0 equiv) at rt was added tBuOH 
(1.0 mL). After 16 h, the reaction mixture was heated to 60 °C. After 1.5 h, 
concentration under reduced pressure, the crude product was diluted with H2O (5 mL), 
extracted with EtOAc (3 × 5 mL). The combined organic layers were washed with brine 
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(2 × 5 mL) and dried (Na2SO4). Concentration under reduced pressure and column 
chromatography (5→20% EtOAc–petrol) gave a 2:1 diastereomeric mixture of N-
[(2R*,3S*)-1-(4-methoxyphenyl)-4-(phenylthio)-3-vinylhex-5-yn-2-yl]-N,4-
dimethylbenzenesulfonamide 384 (70 mg, 68%) as a solid; Rf 0.43 (25% EtOAc–petrol); 
vmax (film) 3286, 2924, 1611, 1513, 1439, 1334, 1304, 1247, 1157, 1088, 1034, 931, 815 
cm–1; δH (400 MHz) 7.52-7.46 (2 × 4H, m, ortho Ts & meta SPh, 2 × diast.), 7.37-7.27 
(2 × 5H, m, ortho & para SPh & meta Ts, 2 × diast.), 6.98-6.93 (2 × 2H, m, meta 
ArOMe, 2 × diast.), 6.76-6.72 (2 × 2H, m, ortho ArOMe, 2 × diast.), 5.93-5.78 (2 × 1H, 
m, CH=CH2, 2 × diast.), 5.28 (1H, dd, J 10.0, 1.5 Hz, trans CH=CHH, major diast.), 
5.25 (1H, dd, J 11.0, 1.5 Hz, trans CH=CHH, minor diast.), 5.19 (1H, dd, J 17.0, 1.5 
Hz, cis CH=CHH, major diast.), 5.18 (1H, dd, J 17.0, 1.5 Hz, cis CH=CHH, minor 
diast.), 4.74 (1H, q, J 7.5 Hz, NCH, major diast.), 4.68 (1H, q, J 7.5 Hz, NCH, minor 
diast.), 4.15 (1H, dd, J 7.5, 2.5 Hz, CHSPh, major diast.), 4.06 (1H, dd, J 5.5, 2.5 Hz, 
CHSPh, minor diast.), 3.81 (3H, s, OMe, minor diast.), 3.79 (3H, s, OMe, major diast.), 
2.83-2.73 (2 × 4H, m, NMe & CHCH=CH2, 2 × diast.), 2.58-2.37 (2 × 6H, m, Me of Ts 
& CH2ArOMe & CHCCHSPh, 2 × diast.); δC (100 MHz) [158.5, 158.4, 142.9, 142.8, 
136.8, 136.4 (q Ar, 2 × diast.)], 135.0, 134.7, [134.1, 133.7 (q Ar, 2 × diast.)], 132.9, 
132.0, 130.2, 130.1, 129.5, 129.4, 128.8, 127.8, 127.4, 127.2, [119.6, 119.6 (2 × 
CH=CH2, 2 × diast.)], 114.1, 114.0, 113.9, 83.1, 81.1, 74.8, 73.2, 65.9, 60.3, 59.8, 55.2, 
51.3, 50.7, 41.0, 40.7, 35.9, 35.6, 30.7, 30.1, 22.0, 21.5; m/z (ESI) 528.1654 [M+NH4]
+, 
506.1837 [M+H]+, 318.1166, 224.0127, 196.0175 (Found: [M+H]+, 506.1824. 
C29H31NO3S2 requires [M+H]
+, 506.1824). 
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(2R*,3S*)-2-(4-Methoxybenzyl)-5-methyl-4-(phenylthio)-1-tosyl-3-vinyl-2,3-
dihydro-1H-pyrrole 336 
 
OMe
TsHN
SPh
OMe
N
Ts
PhS
OMe
N
Ts
PhS
+
OMe
N
Ts
PhS
317 335 336 336  
 
To a solution of diastereomers (68.0 mg, 0.138 mmol, 1.0 equiv) in MeOH (6 mL) at rt 
was added K2CO3 (227 mg, 1.60 mmol, 11.6 equiv). The mixture was then heated to 50 
°C. After 16 h, the reaction mixture was filtered. The filtrate was concentrated under 
reduced pressure. Water (5 mL) was added and the aqueous phase extracted with 
EtOAc (3 × 5 mL). The combined organic layers were washed with brine (2 × 5 mL) 
and dried (Na2SO4). Concentration under reduced pressure and column chromatography 
(5→10% EtOAc–petrol) gave a 3:1 mixture of 335 and 336 (68.0 mg, 100%) as a gum. 
Upon standing in CDCl3 in an NMR tube for 48 h, 335 isomerised to 336 (68.0 mg, 
100%) as a gum; Rf 0.76 (25% EtOAc–petrol); vmax (film) 2925, 1612, 1582, 1512, 
1439, 1354, 1247, 1167, 1089, 1035, 815 cm–1; δH (400 MHz) 7.67 (2H, d, J 8.5 Hz 
ortho Ts), 7.34 (2H, d, J 8.5 Hz meta Ts), 7.17 (2H, d, J 8.5 Hz meta ArOMe), 7.08-
7.07 (3H, m, ortho & para SPh), 6.84 (2H, d, J 8.5 Hz ortho ArOMe), 6.74-6.72 (3H, 
m, meta SPh), 5.60 (1H, dt, J 17.0, 10.0 Hz, CH=CH2), 5.00 (1H, dd, J 10.0, 1.5 Hz, 
trans CH=CHH), 4.74 (1H, ddd, J 17.0, 1.5, 1.0 Hz, cis CH=CHH), 4.51 (1H, dd, J 6.0, 
1.5 Hz, CHNTs), 3.80 (3H, s, OMe), 3.30 (1H, dt, J 10.0, 1.5 Hz, CHCH=CH2), 2.91 
(2H, d, J 6.0 Hz, CH2ArOMe), 2.49 (3H s, Me of Ts), 2.25 (3H, d, J 2.5 Hz, 
CH3CNTs); δC (100 MHz) [158.1, 145.4, 143.9, 136.2, 135.0 (4°)], 133.7 (CH=CH2), 
130.9, 129.9, 128.6, 127.5, 127.3 (3° Ar), 125.6 (3°), 120.0 (CH=CH2), 118.6 (4°), 
113.8, 113.4, 67.1 (CHNTs), 55.2 (OMe), 51.8 (CHCH=CH2), 36.4 (CH2ArOMe), 21.7 
(Me of Ts), 15.2 (CH3CNTs); m/z (ESI) 514.1487 [M+Na]
+, 492.1678 [M+H]+, 
337.1508 (Found: [M+Na]+, 514.1495; [M+H]+, 492.1678. C28H29NO3S2 requires 
[M+Na]+, 514.1487; [M+H]+, 492.1667). 
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N-[(2R*,3R*,E)-1-(4-Methoxyphenyl)-6-oxo-3-vinylhex-4-en-2-yl)]-4-methyl- 
Benzenesulfonamide 339 
 
OMe
TsHN
SPh
OMe
TsHN
O
317 339  
 
To a solution of tosamides 317 (1.47 g, 2.99 mmol, 1.0 equiv) in CH2Cl2 (3 mL) at rt 
was added a solution of mCPBA (1.07 g of a 53% mixture of m-chlorobenzoic acid and 
H2O, 3.29 mmol, 1.1 equiv) in CH2Cl2 (5 mL). After 16 h, concentration under reduced 
pressure and column chromatography (20% EtOAc–petrol) gave N-[(2R*,3R*,E)-1-(4-
methoxyphenyl)-6-oxo-3-vinylhex-4-en-2-yl)]-4-methylbenzene- 
sulfonamide  339 (622 mg, 52%) as a gum; Rf 0.21 (25% EtOAc–petrol); vmax (film) 
3275, 2923, 1687, 1612, 1513, 1442, 1324, 1303, 1248, 1158, 1093, 1034, 814 cm–1; δH 
(400 MHz) 9.37 (1H, d, J 8.0 Hz, CHO), 7.60 (2H, d, J 8.0 Hz, ortho Ts), 7.23 (2H, d, J 
8.0 Hz, meta Ts), 6.89 (2H, d, J 8.5 Hz, meta ArOMe), 6.75-6.69 (3H, m, ortho ArOMe 
& CHOCH=CH), 6.03 (1H, ddd, J 16.0, 8.0, 1.5 Hz, CHOCH=CH), 5.77 (1H, ddd, J 
17.0, 10.5, 8.0 Hz, CH=CH2), 5.37 (1H, d, J 10.5 Hz, trans CH=CHH), 5.21 (1H, d, J 
17.0 Hz, cis CH=CHH), 4.43 (1H, d, J 8.0 Hz, NH), 3.80 (3H, s, OMe), 3.59-3.53 (1H, 
m, NCH), 3.28-3.24 (1H, m, CHCH=CH2), 2.73 (1H, dd, J 14.0, 7.5 Hz, CHHArOMe), 
2.54 (1H, dd, J 14.0, 7.0 Hz, CHHArOMe), 2.44 (3H, s, Me of Ts); δC (125 MHz) 193.4 
(CHO), 158.6 (q Ar), 155.7, [143.6, 139.9 (q Ar)], 134.1, 132.9, 129.9, 129.6, 128.2 (q 
Ar), 128.1,  121.3 (CH=CH2), 114.1, 58.5, 55.1, 48.9, 37.9 (CH2), 21.5, 15.3; m/z (ESI) 
422.1422 [M+Na]+, 417.1865, 400.1585 [M+H]+, 382.1478, 338.3427, 245.0269 
(Found: [M+H]+, 400.1585. C22H25NO4S requires [M+H]
+, 400.1583) (Found: C, 66.20; 
H, 6.30; N, 3.50.  C22H25NO4S requires C, 66.14; H, 6.31; N, 3.51%). 
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(2R*,3S*)-2-(4-Methoxybenzyl)-4-(phenylthio)-1-tosyl-3-vinyl-1,2,3,4-
tetrahydropyridine 299 
 
339
OMe
TsHN
O
N
Ts
SPh
HO
OMe
N
Ts
SPh
OMe
341 299  
 
To a solution of enal 339 (244 mg, 0.561 mmol, 1.0 equiv) in CH2Cl2 (2.3 mL) at 0 °C 
was added thiophenol (173 µL, 1.68 mmol, 3.0 equiv) and Et3N (391 µL, 2.80 mmol, 
5.0 equiv). The solution was then warmed to rt gradually. After 16 h, TLC showed 
complete conversion of enal to piperidinol 341. The mixture was cooled to –20 °C 
followed by addition of Et3N (391 µL, 2.80 mmol, 5.0 equiv) and mesylchloride (434 
µL, 5.61 mmol, 10.0 equiv). After 2 h, concentration under reduced pressure and 
column chromatography (5% EtOAc–petrol) gave a 2:1 diastereomeric mixture of 
(2R*,3S*)-2-(4-methoxybenzyl)-4-(phenylthio)-1-tosyl-3-vinyl-1,2,3,4-
tetrahydropyridine 299 (182 mg, 66%) as a solid; Rf 0.47 (18% EtOAc–petrol); vmax 
(film) 2930, 1721, 1640, 1612, 1512, 1440, 1353, 1302, 1247, 1165, 1091, 1035, 991, 
927, 815, 749, 675 cm–1; δH (400 MHz) 7.57 (2H, d, J 8.5 Hz, ortho Ts, minor diast.), 
7.48 (2H, d, J 8.5 Hz, ortho Ts, major diast.), 7.41-7.24 [(2 × 5H, m, SPh, 2 × diast.) & 
(2H, meta Ts, minor diast.)], 7.19 (2H, d, J 8.5 Hz, meta Ts, major diast.), 7.14 (2H, d, J 
8.5 Hz, meta ArOMe, minor diast.), 7.08 (2H, d, J 8.5 Hz, meta ArOMe, major diast.), 
6.88-6.82 (2 × 2H, d, J 8.5 Hz, ortho ArOMe, 2 × diast.), 6.65-6.12 (2 × 1H, m, 
CH=CHNTs, 2 × diast.), 5.70 (1H, ddd, J 17.5, 10.5, 8.0 Hz, CH=CH2, major diast.), 
5.49-5.43 (1H, m, CH=CH2, minor diast.), 5.28-5.22 [(2 × 1H, m, CH=CHNTs, 2 × 
diast.) & (1H, m, trans CH=CHH, major diast.)], 5.16 (1H, dd, J 10.5, 1.5 Hz, trans 
CH=CHH, minor diast.), 4.99-4.92 (2 × 1H, m, cis CH=CHH, 2 × diast.), 4.09-4.03 (2 × 
1H, m, NTsCHCH2, 2 × diast.), 3.83 (3H, s, OMe, minor diast.), 3.82 (3H, s, OMe, 
major diast.), 3.55-3.48 (2 × 1H, m, CHSPh, 2 × diast.), [2.98-2.85 & 2.78-2.65 (2 × 
2H, m, CH2ArOMe, 2 × diast.), 2.44 (3H, s, Me of Ts, major diast.), 2.43 (3H, s, Me of 
Ts, minor diast.), 1.73-1.68 (2 × 1H, m, CHCH=CH2, 2 × diast.); δC (125 MHz) (major 
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diast.) [158.3, 143.4 (q Ar)], 137.4, 135.7 (q Ar), 133.7 (3° Ar), 132.0 (q Ar), [130.6, 
129.7 (3° Ar)], 129.6 (q Ar), 128.7 (3° Ar), 127.7, 126.8 (3° Ar), 124.2, 118.7 
(CH=CH2), 113.6 (3° Ar), 112.1, 60.9, 55.1, 43.9, 42.9, 32.4 (CH2ArOMe), 21.6; m/z 
(ESI) 555.1768, 530.1248, 514.1501 [M+Na]+, 509.1948, 492.1668 [M+H]+, 382.1476 
(Found: [M+H]+, 514.1668. C28H29NO3S2 requires [M+H]
+, 492.1667). 
 
 
(2R*,3S*)-2-(4-Methoxybenzyl)-4-(phenylthio)-1-tosyl-3-vinylpiperidine 385 
 
 
299
N
Ts
SPh
OMe
N
Ts
SPh
OMe
385  
 
To a solution of tetrahydropyridines 299 (70.0 mg, 0.143 mmol, 1.0 equiv) in CH2Cl2 
(0.5 mL) at rt were added Et3SiH (36.5 mg, 0.314 mmol, 2.2 equiv) and TFA (36.0 mg, 
0.314 mmol, 2.2 equiv). After 16 h, further amounts of Et3SiH (36.5 mg, 0.314 mmol, 
2.2 equiv) and TFA (36.0 mg, 0.314 mmol, 2.2 equiv) were added. After 3 h, 
concentration under reduced pressure and column chromatography (8% EtOAc–petrol) 
gave (2R*,3S*)-2-(4-methoxybenzyl)-4-(phenylthio)-1-tosyl-3-vinylpiperidines 385 (54 
mg, 77%) as a gum; data for major diastereomer only: Rf 0.44 (18% EtOAc–petrol); 
vmax (film) 2926, 1725, 1677, 1611, 1512, 1440, 1320, 1247, 1154, 1093, 1034, 814 cm
–
1; δH (400 MHz) 7.45-7.41 (3H, m, SPh), 7.33-7.31 (2H, m, SPh), 7.18 (2H, d, J 8.0 Hz, 
ortho Ts), 7.03 (2H, d, J 8.0 Hz, meta Ts), 6.96 (2H, d, J 8.5 Hz, meta ArOMe), 6.73 
(2H, d, J 8.5 Hz, ortho ArOMe), 5.87 (1H, ddd, J 18.5, 9.5, 9.5 Hz, CH=CH2), 5.68-
5.59 (1H, m, CH=CH2, diagnostic signal of the minor diast.), 5.35-5.31 (2H, m, 
CH=CH2), 4.38 (1H, ddd, J 11.0, 4.5 Hz, NTsCH), 3.81 (3H, s, OMe), 3.69-3.64 (1H, 
m, CHSPh), 3.34-3.25 (1H, m, CHHNTs), 3.13-3.05 (1H, m, CHHNTs), 2.88 (1H, dd, J  
14.0, 4.0 Hz, CHHArOMe), 2.74 (1H, dd, J 14.0, 11.5 Hz, CHHArOMe), 2.61-2.54 
(1H, m, CHCH=CH2), 2.38 (3H, s, Me of Ts), 1.71-1.54 (2H, m, CH2CHSPh); δC (125 
MHz) [158.3, 142.6, 137.9, 137.5 (q Ar)], 134.1 (3° Ar), [132.7, 130.1 (q Ar)], [129.9, 
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129.3, 128.9 (3° Ar)], 127.8 (CH=CH2), 127.1 (3° Ar), 118.6 (CH=CH2), 113.8 (3° Ar), 
60.8 (OMe), 55.2 (CHNTs), 49.5, 44.9, 40.2, 32.8, 30.7, 29.7, 21.5; m/z (ESI) 516.1662 
[M+Na]+, 494.1827 [M+H]+, 406.1471, 384.1657 (Found: [M+H]+, 494.1827. 
C28H31NO3S2 requires [M+H]
+, 494.1824). 
 
 
(S)-Ethyl 2-(tert-butyldiphenylsilyloxy)propanoate
166
 348 
 
OEt
O
OH
OEt
O
OTBDPS
347 348  
 
To a solution of ethyl-L-lactate 347 (250 mg, 2.12 mmol, 1.0 equiv) and DMAP (38.9 
mg, 0.318 mmol, 0.15 equiv) in CH2Cl2 at 0 °C was added TBDPSCl (1.05 g, 3.81 
mmol, 1.8 equiv) followed by Et3N (697 mg, 5.30 mmol, 2.5 equiv). The cloudy 
suspension was warmed to rt then heated to 50 °C. After 16 h, the reaction was 
quenched with sat. NH4Cl(aq.) (1 mL) then diluted with sat. NaHCO3(aq.) (4 mL). After 5 
min, the mixture was further diluted with H2O (3 mL) and the aqueous phase extracted 
with Et2O (3 × 8 mL). The combined organic layers were washed with brine (2 × 5 mL) 
and dried (Na2SO4). Concentration under reduced pressure and column chromatography 
(5→15% Et2O–petrol) gave ester 348 (739 mg, 98%) as a colourless liquid; Rf 0.63 (5% 
EtOAc–petrol); [α]D22 –41.5 (c 2.0, CHCl3); {Lit.
166a [α]D20 –41.1 (c 2.0, CHCl3)}; vmax 
(film) 3071, 3050, 2932, 2894, 2858, 1753, 1734, 1589, 1473, 1428, 1372, 1273, 1195, 
1137, 1111, 1060, 1023, 974, 822, 739, 702, 611 cm–1; δH (400 MHz) 7.72-7.67 (4H, m, 
ortho Ph), 7.45-7.36 (6H, m, meta & para Ph), 4.29 (1H, q, J 7.0 Hz, CHOTBDPS), 
4.04 (1H, dq, J 7.0, 1.0 Hz, CH2), 1.39 (3H, d, J 7.0 Hz, CH3CH), 1.17 (3H, d, J 7.0 Hz, 
CH3CH2), 1.12 (9H, s, tBu); δC (125 MHz) 173.7 (COO), 135.8, 133.6, 129.7, 127.6, 
68.9 (CHOTBDPS), 60.6 (CH2), 26.8 (Me of tBu), 21.3, 19.3, 14.1; data in agreement 
with that previously reported.166  
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 (S)-2-(tert-Butyldiphenylsilyloxy)propanal
165
 346 
 
348
OEt
O
OTBDPS
H
O
OTBDPS
346  
 
To a solution of ester 348 (100 mg, 0.28 mmol, 1.0 equiv) in CH2Cl2 at –78 °C was 
added DIBAL-H (322 µL of a 1.0 M solution in CH2Cl2, 0.322 mmol, 1.15 equiv) 
dropwise. After 50 min, MeOH (0.07 mL) was added to the solution, then Et2O (1.2 
mL) slowly, followed by Na/K tartrate (0.9 mL), Et2O (2.2 mL). After 5 min, the 
mixture was warmed to rt. After 90 min, brine (2 mL) was added to the mixture. The 
organic layer was then separated and dried (Na2SO4).  Following concentration under 
reduce pressure, the crude product was azotroped with toluene three times. Further 
drying under high vacuum cleanly gave aldehyde 346 (76 mg, 87%) as a colourless 
liquid; Rf 0.31 (25% EtOAc–petrol); [α]D20 –10.2 (c 1.2, ethanol); {Lit.
166b [α]D20 –10.2 (c 
1.2, ethanol)}; δH (400 MHz) 9.67 (1H, d, J 1.0 Hz, CHO), 7.69-7.66 (4H, m, ortho Ph), 
7.49-7.39 (6H, m, meta & para Ph), 4.12 (1H, dq, J 7.0, 1.0 Hz, CHOTBDPS), 1.25 
(3H, d, J 7.0 Hz, CH3CH), 1.14 (9H, s, tBu); δC (125 MHz) 203.9 (CHO), 135.7, 132.9, 
130.0, 127.8, 74.4 (CHOTBDPS), 26.9 (Me of tBu), 19.2, 18.4; data in agreement with 
that previously reported.165 
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N-[(2R*,3S*)-6-Iodo-1-(4-methoxyphenyl)-4-(phenylthio)-3-vinylhex-5-yn-2-yl]-4-
methylbenzenesulfonamide 326 
 
317
OMe
TsHN
SPh
OMe
TsHN
SPh
I
326  
 
To a solution of tosamides 317 (118 mg, 0.240 mmol, 1.0 equiv) in DMF (0.9 mL) at rt 
was added NIS (60.0 mg, 0.27 mmol, 1.22 equiv) and AgNO3 (20.1 mg, 0.12 mmol, 0.5 
equiv). After 16 h, the yellow mixture was quenched with sat. NH4Cl(aq.) (0.8 mL), 
diluted with H2O (2 mL) and Et2O (5 mL). The organic phase was separated and the 
aqueous phase was extracted with Et2O (3 × 8 mL). The combined organic layers were 
washed with brine (3 × 5 mL) and dried (Na2SO4). Concentration under reduced 
pressure and column chromatography (15→20% EtOAc–petrol) gave 2:1 
diastereomeric mixture of N-[(2R*,3S*)-6-iodo-1-(4-methoxyphenyl)-4-(phenylthio)-3-
vinylhex-5-yn-2-yl]-4-methylbenzenesulfonamide 326 (111 mg, 75%) as a solid; Rf 0.41 
(25% EtOAc–petrol); vmax (film) 3274, 2931, 1710, 1611, 1513, 1439, 1325, 1303, 
1248, 1158, 1092, 1035, 927, 814 cm–1; δH (400 MHz) 7.80 (2H, d, J 8.0 Hz, ortho Ts 
of minor diast.), 7.75 (2H, d, J 8.0 Hz, ortho Ts of major diast.), 7.42-7.14 (2 × 7H, m, 
SPh & meta Ts, 2 × diast.), 6.89 (2H, d, J 8.5 Hz, meta ArOMe of minor diast.), 6.86 
(2H, d, J 8.5 Hz, meta ArOMe of major diast.), 6.79-6.75 (2 × 2H, m, ortho ArOMe, 2 
× diast.), 5.68-5.45 (2 × 1H, m, CH=CH2), 5.40 (1H, dd, J 10.5, 1.5 Hz, trans 
CH=CHH, major diast.), 5.34 (1H, dd, J 10.5, 1.5 Hz, trans CH=CHH, minor diast.), 
5.16-5.09 (2 × 1H, m, cis CH=CHH, 2 × diast.), 4.60-4.56 (2 × 1H, m, NH, 2 × diast.), 
4.06-4.97 (2 × 2H, m, CHNHTs & CHSPh, 2 × diast.), 3.83 (3H, s, OMe, minor diast.), 
3.82 (3H, s, OMe, major diast.), 2.71-2.54 (2 × 2H, m, CH2ArOMe, 2 × diast.), 2.46 
(3H, s, Me of Ts, minor diast.), 2.44 (3H, s, Me of Ts, major diast.), 2.30-2.21 (2 × 1H, 
m, CHCH=CH2, 2 × diast.); δC (100 MHz) [158.4, 158.3, 143.6, 143.5, 137.1, 136.9 (q 
Ar, 2 × diast.)], 134.9, 133.8, 133.3, 133.1, 132.7, 131.7, 130.4, 130.1, 130.0, 129.8, 
129.7, 129.5, 129.4, 127.6, 127.5, 127.4, 127.2, 12
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(C–I, major diast.), 91.9 (C–I, minor diast.), 67.2 (CCHSPh, minor diast), 65.9 
(CCHSPh, major diast.), 56.3, 55.6, 55.2, 55.2, 49.5, 48.6, 42.2, 41.9, 39.7, 38.7, 21.6, 
21.6; m/z (ESI) 681.0728, 656,0203, 640.0463 [M+Na]+, 618.0645 [M+H]+ (Found: 
[M+Na]+, 640.0463; [M+H]+, 618.0645. C28H28INO3S2 requires [M+Na]
+, 640.0453; 
[M+H]+, 618.0634). 
 
 
N-[(2R*,3S*,Z)-6-Iodo-1-(4-methoxyphenyl)-4-(phenylthio)-3-vinylhex-5-en-2-yl]-
4-methylbenzenesulfonamide 327 
 
326
OMe
TsHN
SPh
I
OMe
TsHN
SPhI
327  
 
To a mixture of alkynl iodide 326 (70.0 mg, 0.113 mmol, 1.0 equiv) and dipotassium 
azodicarboxylate (42.0 mg, 0.216 mmol, 1.9 equiv) in dioxane (1.5 mL) and iPrOH (1.0 
mL) at rt was added a solution of AcOH (34.0 mg, 0.565 mmol, 5.0 equiv) in iPrOH 
(0.3 mL) dropwise over 15 min. After 1 h, potassium azodicarboxylate (35.0 mg, 0.180 
mmol, 1.6 equiv) was added followed by another solution of AcOH (34.0 mg, 0.565 
mmol, 5.0 equiv) in iPrOH (0.3 mL). This procedure was repeated after 1 h. The 
mixture was stirred for 16 h and was then quenched with 1 M HCl (0.7 mL) and diluted 
with Et2O (15 mL) and H2O (20 mL). The organic phase was separated and the aqueous 
phase extracted with Et2O (3 × 5 mL). The combined organic layers were washed with 
brine (2 × 10 mL) and dried (Na2SO4). Concentration under reduced pressure and 
column chromatography (10% EtOAc–petrol) gave a 2:1 diastereomeric mixture of N-
[(2R*,3S*,Z)-6-iodo-1-(4-methoxyphenyl)-4-(phenylthio)-3-vinylhex-5-en-2-yl]-4-
methylbenzenesulfonamide 327 (62.0 mg, 88%) as a solid; Rf 0.61 (25% EtOAc–petrol); 
vmax (film) 3059, 2957, 1654, 1654, 1512, 1465, 1337, 1247, 1159, 1094, 1037, 904, 812 
cm–1; δH (400 MHz) 7.87 (2H, d, J 8.0 Hz, ortho Ts, minor diast.), 7.64 (2H, d, J 8.0 
Hz, ortho Ts, major diast.), 7.59 (2H, d, J 8.0 Hz, meta Ts, minor diast.), 7.41 (2H, d, J 
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8.0 Hz, meta Ts, major diast.), 7.33-7.15 (2 × 3H, m, SPh, 2 × diast.), 6.99 (2H, d, J 8.5 
Hz, meta ArOMe, minor diast.), 6.96 (2H, d, J 8.5 Hz, meta ArOMe, major diast.), 
6.89-6.82 (2 × 2H, m, SPh, 2 × diast.), 6.72 (2H, d, J 8.5 Hz, ortho ArOMe, major 
diast.), 6.68 (2H, d, J 8.5 Hz, ortho ArOMe, minor diast.), 6.27 (1H, d, J 7.5 Hz, 
ICH=CH, major diast.), 6.23 (1H, d, J 7.5 Hz, ICH=CH, minor diast.), 6.19-6.13 (2 × 
1H, m, ICH=CH, 2  × diast.), 5.75-5.64 (1H, m, CH=CH2, major diast.), 5.54 (1H, ddd, 
J 17.0, 10.0, 8.5 Hz, CH=CH2, minor diast.), 5.30 (1H, dd, J 10.0, 1.5 Hz, trans 
CH=CHH, major diast.), 5.28 (1H, dd, J 10.0, 1.5 Hz, trans CH=CHH, minor diast.), 
5.15 (1H, dd, J 17.0, 1.0 Hz, cis CH=CHH, major diast.), 5.06 (1H, dd, J 17.0, 1.0 Hz, 
cis CH=CHH, minor diast.), 4.45 (1H, d, J 10.0 Hz, NH, minor diast.), 4.33 (1H, d, J 
8.5 Hz, NH, major diast.), 4.15-3.99 (2 × 1H, m, NTsCH, 2 × diast.), 3.84-3.78 (2 × 4H, 
m, OMe & CHSPh, 2 × diast.), 2.81-2.53 (2 × 2H, m, CH2ArOMe, 2 × diast.), 2.44-2.43 
(2 × 3H, m, Me of Ts, 2 × diast.), 2.33-2.28 (1H, m, CHCH=CH2, major diast.), 2.01-
1.97 (1H, m, CHCH=CH2, minor diast.); δC (100 MHz) 158.4, 158.4, 143.5, 143.2, 
140.4, 140.3, 137.6, 137.6, 135.5, 134.9, 134.6, 134.4, 133.8, 130.5, 130.4, 130.0, 
129.8, 129.6, 128.8, 128.7, 128.6, 128.1, 127.8, 127.4, 127.1, 127.1, 121.1, 120.7, 
114.1, 113.9, [83.7, 83.6 CH=CHI, 2 × diast.], 56.9, 55.9, 55.2, 55.2, 49.8, 48.0, 46.0, 
39.2, 37.6, 23.7, 21.6, 21.6; m/z (ESI) 683.0884, 658.0369, 642.0631 [M+Na]+, 
620.0798 [M+H]+, 518.1794 (Found: [M+Na]+, 642.0631; [M+H]+, 620.0790. 
C28H30INO3S2 requires [M+Na]
+, 642.0610; [M+H]+, 620.0798). 
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N-[(2R*,3S*)-6,6-Dimethoxy-1-(4-methoxyphenyl)-4-tosyl-3-vinylhexan-2-yl]-4-
methylbenzenesulfonamide 191 
 
OMe
TsN
Ts OMe
OMe
+
OMe
TsHN
TsOMe
MeO
185
46
191  
 
To a solution of acetal 185 (3.25 g, 12.6 mmol, 1.5 equiv) in THF (36 mL) at –78 °C 
was added nBuLi (5.50 mL of a 2.29 M solution in hexanes, 12.6 mmol, 1.5 equiv). The 
resulting red solution was warmed to –30 °C over 40 min. A solution of vinylaziridine 
46 (2.90 g, 8.4 mmol, 1.0 equiv) in THF (3.5 mL) was added via cannula. The solution 
was warmed to rt gradually. After 16 h, the reaction was quenched with sat. 
NaHCO3(aq.) (60 mL) and diluted with H2O (50 mL) and EtOAc (20 mL). The organic 
phase was separated and the aqueous phase extracted with EtOAc (3 × 30 mL). The 
combined organic layers were washed with brine (3 × 30 mL) and dried (Na2SO4). 
Concentration under reduced pressure and column chromatography (25→40% EtOAc–
petrol) gave a 2:1 diastereomeric mixture of N-[(2R*,3S*)-6,6-dimethoxy-1-(4-
methoxyphenyl)-4-tosyl-3-vinylhexan-2-yl]-4-methylbenzenesulfonamide 191 (3.20 g, 
63.4%) as a solid; Rf 0.32 (40% EtOAc–petrol); vmax (film) 3273, 2937, 1602, 1512, 
1447, 1294, 1248, 1156, 1083, 928, 816, 664 cm–1; δH (400 MHz) 7.76-7.21 (2 × 2H, m, 
ortho Ts, 2 × diast.), 7.52 (2 × 2H, m, ortho Ts, 2 × diast.), 7.30-7.23 (4 × 2H, m, meta 
Ts, 2 × diast.), 7.03 (2H, d, J 8.5 Hz, meta ArOMe, minor diast.), 6.84 (2H, d, J 8.5 Hz, 
meta ArOMe, major diast.), 6.78 (2H, d, J 8.5 Hz, ortho ArOMe, minor diast.), 6.71 
(2H, d, J 8.5 Hz, ortho ArOMe, major diast.), 5.78 (1H, dt, J 17.0, 10.0 Hz, CH=CH2, 
minor diast.), 5.66 (1H, dt, J 17.0, 10.0 Hz, CH=CH2, major diast.), 5.34 (1H, dd, J 
10.0, 1.5 Hz, trans CH=CHH, major diast.), 5.24 (1H, dd, J 10.0, 1.5 Hz, trans 
CH=CHH, minor diast.), 5.04 (1H, dd, J 17.0, 1.5 Hz, cis CH=CHH, minor diast.), 4.98 
(1H, dd, J 17.0, 1.5 Hz, cis CH=CHH, minor diast.), 4.97 (1H, d, J 7.5 Hz, NH, minor 
diast.), 4.77 (1H, d, J 7.5 Hz, NH, major diast.), 4.26 [1H, t, J 5.5 Hz, CH(OMe)2, major 
diast.], 4.18-4.13 (2H, m, CH(OMe)2 & CHN, minor diast.), 3.99-3.93 (1H, dq, J 7.5, 
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3.0 Hz, CHN, major diast.), 3.82 (3H, s, Me of ArOMe, minor diast.), 3.81 (3H, s, Me 
of ArOMe, major diast.), 3.65 (1H, dt, 11.0, 6.0 Hz, CHTs, major diast.), 3.47-3.43 (1H, 
m, CHTs, minor diast.), 3.33 [3H, s, CH(OMe)2, major diast.], 3.29 [3H, s, CH(OMe)2, 
major diast.], 3.16 [3H, s, CH(OMe)2, minor diast.], 3.08 [3H, s, CH(OMe)2, minor 
diast.], 2.86 (1H, dd, J 14.0, 4.5 Hz, CHHArOMe, minor diast.), 2.81-2.71 (2 × 1H, m, 
CHCH=CH2 of major diast. & CHHArOMe of minor diast.), 2.67-2.61 (1H, m, 
CHCH=CH2, minor diast.), [2.56, 2.54 (2 × 3H, 2 × s, 2 × Me of 2 × Ts, minor diast.)], 
[2.46, 2.44 (2 × 3H, 2 × s, 2 × Me of 2 × Ts, major diast.)], 2.07-1.95 (3 × 1H, m, 
CH2CHTs of minor diast. & CHHArOMe of major diast.), 1.85 (1H, dt, J 15.0, 6.0 Hz, 
CHHArOMe, major diast.), 1.59-1.56 (2H, m, CH2CHTs, major diast.); δC (100 MHz) 
[158.4, 158.3, 144.6, 144.5, 143.4, 143.3, 137.7, 136.8, 135.9, 134.4 (q Ar, 2 × diast.)], 
[133.1, 132.5 (CH=CH2, 2 × diast.)], [130.8, 130.3, 129.8, 129.7, 129.7, 129.6 (3°, 2 × 
diast.)], 129.2 (q Ar, minor diast.), 129.1 (3°, major diast.), 128.7 (q Ar, major diast.), 
128.6 (3°, minor diast.), 127.4 (3°, major diast.), 127.3 (3°, minor diast.), 122.4 
(CH=CH2, major diast.), 121.4 (CH=CH2, minor diast.), [113.9, 113.8 (3°, 2 × diast.)], 
103.6 [CH(OMe)2, major diast.], 102.2 [CH(OMe)2, minor diast.], [61.8, 58.9, 57.6, 55.9 
(CHTs & CHNTs, 2 × diast.)], [55.2, 55.1, 54.9, 54.3, 53.7, 52.7 (OMe, 2 × diast.)], 
[47.5, 44.9 (CHCH=CH2)], 38.8 (2 × CH2ArOMe, 2 × diast.), [30.8, 30.5 (2 × 
CH2CHTs, 2 × diast.)], [21.7, 21.6 (2 × 2Me of Ts, 2 × diast.)]; m/z (ESI) 624.2070 
[M+Na]+, 570.1986, 538.1744, 382.1457 (Found: [M+Na]+, 624.2070. C31H39NNaO7S2 
requires [M+Na]+, 624.2070). 
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N-[(2R*,3S*)-6,6-Dimethoxy-1-(4-methoxyphenyl)-4-tosyl-3-vinylhexan-2-yl]-4-
methyl-N-(3-methylbut-2-enyl)benzenesulfonamide 386 
 
191
OMe
TsHN
TsOMe
MeO
OMe
TsN
TsOMe
MeO
386  
 
To a solution of diastereomixture of tosamides 191 (175 mg, 0.29 mmol, 1.0 equiv) in 
THF (0.4 mL) at –78°C was added nBuLi (236 µL of a 2.47 M solution in hexanes, 
0.582 mmol, 2.0 equiv). The solution was warmed to rt over 1 h and then prenyl 
bromide (101 µL, 0.873 mmol, 3.0 equiv) was added. After 20 h, the reaction was 
quenched with sat. NaHCO3(aq.) then diluted with H2O (5 mL) and EtOAc (5 mL). The 
organic phase was separated and the aqueous phase extracted with EtOAc (2 × 10 mL). 
The combined organic layers were washed with brine (2 × 5 mL) and dried (Na2SO4). 
Concentration under reduced pressure and column chromatography (20→40% EtOAc-
petrol) gave N-[(2R*,3S*)-6,6-dimethoxy-1-(4-methoxyphenyl)-4-tosyl-3-vinylhexan-2-
yl]-4-methyl-N-(3-methylbut-2-enyl)benzenesulfonamide 386 (44.0 mg, 23%) as a gum 
with a dr > 100:1; Rf 0.62 (40% EtOAc–petrol); vmax (film) 2933, 1601, 1512, 1447, 
1380, 1303, 1248, 1150, 1086, 926, 816, 729 cm–1; δH (400 MHz) 7.70 (2H, d, J 8.0 Hz, 
ortho Ts), 7.33 (2H, d, J 8.0 Hz, meta Ts), 7.19 (2H, d, J 7.5 Hz, ortho Ts), 7.03-6.98 
(4H, m, meta ArOMe & meta Ts), 6.75 (2H, d, J 8.5 Hz, ortho ArOMe), 5.89 (1H, dt, J 
17.0, 10.0 Hz, CH=CHH), 5.31 (1H, dd, J 10.0, 1.5 Hz, trans CH=CHH), 5.18 (1H, dd, 
J 17.0, 1.0 Hz, cis CH=CHH), 5.09-4.95 [1H, m, (CH3)2=CH)], 4.49-4.69 [2H, m, CHN 
& CH(OMe)2], 3.94 (1H, dd, J 16.0, 7.0 Hz, CHHN), 3.83 (3H, s, ArOMe), 3.57 (1H, 
dd, J 16.0, 4.0 Hz, CHHN), 3.45 (1H, dt, J 6.0, 2.0 Hz, CHTs), 3.33 (3H, s, OMe), 3.28 
(3H, s, OMe), 3.18-3.13 (1H, m, CHCH=CH2), 2.84 (1H, dd, J 14.5, 4.5Hz, 
CHHArOMe), 2.49-2.45 (4H, m, Me of Ts & CHHArOMe), 2.34 (3H, s, Me of Ts), 
2.24-2.17 (1H, m, CHHCHTs), 2.12-2.07 (1H, m, CHHCHTs), 1.66 (3H, s, CH3CCH3), 
1.63 (3H, s, CH3CCH3); δC (100 MHz) [158.4, 144.7, 142.7, 138.5 (q Ar)], [135.3, 
134.1 (q)], 133.5 (CH=CH2), 130.4 (3°), 130.1 (q), [129.8, 129.0, 128.9, 127.2 (3°)], 
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121.7 (CH3CCH3), 121.5 (CH=CH2), 113.8 (3°), 101.9 [CH(OMe)2], 62.1 (CHN), 61.3 
(CHTs), 55.2 (ArOMe), 55.0 (MeOCHOMe), 51.8 (MeOCHOMe), 45.4 (CHCH=CH2), 
42.3 (CH2N), 36.5 (CH2ArOMe), 29.5 (CH2CHTs), 25.7 (CH3CCH3), [21.7, 21.4 (2 × 
Me of 2 × Ts)], 17.8 (CH3CCH3); m/z (ESI) 692.2662 [M+Na]
+, 638.2621, 304.1006 
(Found: [M+Na]+, 692.2662. C36H47NO7S2 requires [M+Na]
+, 692.2692). 
 
 
(2R*,3S*)-2-(4-Methoxybenzyl)-1,4-ditosyl-3-vinyl-1,2,3,4-tetrahydropyridine 190 
 
191
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To a solution of diastereomeric mixture of tosamide 191 (3.10 g, 5.16 mmol, 1.0 equiv) 
in CH2Cl2 (55 mL) at –78 °C was added BF3·Et2O (6.53 mL, 51.6 mmol, 10.0 equiv) 
dropwise. After 30 min, the reaction was warmed to –55 °C. After 16 h, the reaction 
was quenched with sat. NaHCO3(aq.) (55 mL). The resulting mixture was warmed to rt 
gradually then stirred for 15 min. The organic phase was separated and the aqueous 
phase extracted with CH2Cl2 (3 × 50 mL). The combined organic layers were washed 
with brine (3 × 30 mL) and dried (Na2SO4). Concentration under reduced pressure and 
column chromatography (15→20% EtOAc–petrol) gave a 2:1 diastereomeric mixture of 
(2R*,3S*)-2-(4-methoxybenzyl)-1,4-ditosyl-3-vinyl-1,2,3,4-tetrahydropyridine 190 
(2.31g, 83%) as a solid; Rf 0.60 (40% EtOAc–petrol); vmax (film) 2922, 1640, 1512, 
1461, 1317, 1248, 1164, 1087, 1034, 814, 671 cm–1; δH (400 MHz) 7.75 (2H, d, J 8.0 
Hz, ortho Ts, major diast.), 7.57 (2H, d, J 8.0 Hz, ortho Ts, major diast.), 7.54 (2H, d, J 
8.0 Hz, ortho Ts, minor diast.), 7.40 (2H, d, J 8.0 Hz, ortho Ts, minor diast.), 7.34 (2H, 
d, J 8.0 Hz, meta Ts, major diast.), 7.29-7.27 (2 × 2H, m, meta Ts, 2 × diast.), 7.13 (2H, 
d, J 8.0 Hz, meta Ts, minor diast.), 7.03 (2H, d, J 8.5 Hz, meta ArOMe, major diast.), 
7.00 (2H, d, J 8.5 Hz, meta ArOMe, minor diast.), 6.94 (1H, dd, J 8.5, 2.5 Hz, 
NTsCH=CH, major diast.), 6.89-6.87 (1H, m, NTsCH=CH, minor diast.), 6.83 (2H, d, J 
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8.5 Hz, ortho ArOMe, major diast.), 6.82 (2H, d, J 8.5 Hz, ortho ArOMe, minor diast.), 
6.20 (1H, ddd, J 17.0, 10.0, 8.5 Hz, CH=CH2, major diast.), 5.76 (1H, ddd, J 17.0, 10.0, 
8.5 Hz, CH=CH2, minor diast.), 5.36 (1H, dd, J 8.0, 2.5 Hz, NTsCH=CH, minor diast.), 
5.25 (1H, dd, J 10.0, 2.5 Hz, trans CH=CHH, major diast.), 5.14 (1H, d, J 10.0 Hz, 
trans CH=CHH, minor diast.), 5.07 (1H, dd, J 17.0, 1.0 Hz, cis CH=CHH, major 
diast.), 4.93 (1H, dd, J 8.5, 3.5 Hz, NTsCH=CH, major diast.), 4.73 (1H, d, J 17.0 Hz, 
cis CH=CHH, minor diast.), 3.92-3.88 (2 × 1H, m, NTsCHCH2, 2 × diast.), 3.82 (3H, s, 
OMe, major diast.), 3.81 (3H, s, OMe, minor diast.), 3.74-3.71 (2 × 1H, m, CHSPh, 2 × 
diast.), 3.24 (1H, dd, J 14.5, 7.5 Hz, CHHArOMe, major diast.), 2.96 (1H, dd, J 14.5, 
6.5 Hz, CHHArOMe, major diast.), 2.75 (1H, dd, J 14.0, 4.5 Hz, CHHArOMe, minor 
diast.), 2.63-2.58 (2 × 1H,  m, CHHArOMe of minor diast. & CHCH=CH2 of major 
diast.), 2.52 (3H, s, Me of Ts, minor diast.), 2.47 (3H, s, Me of Ts, major diast.), 2.44 
(3H, s, Me of Ts, major diast.), 2.43 (3H, s, Me of Ts, minor diast.), 1.82-1.77 (1H, m, 
CHCH=CH2, minor diast.); δC (100 MHz) 158.4, 158.2, 144.7, 144.4, 143.7, 136.7, 
136.4, 135.9, 135.3, 133.4, 132.9, 130.5, 130.4, 130.1, 129.9, 129.8, 129.7, 129.6, 
129.4, 129.4, 128.8, 128.6, 127.3, 126.9, 126.8, 120.1, 118.1, 117.4, 114.2, 113.8, 
113.7, 63.3, 62.1, 60.9, 60.5, 55.2, 55.1, 43.9, 40.9, 34.3, 32.5, 21.8, 21.6, 21.6, 21.6; 
m/z (ESI) 601.1808, 576.1287, 560.1536 [M+Na]+, 538.1725 [M+H]+, 382.1481, 
318.0590 (Found: [M+Na]+, 560.1536; [M+H]+, 538.1725. C29H31NO5S2 requires 
[M+Na]+, 560.1541; [M+H]+, 538.1722). 
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8-Methoxy-3-(toluene-4-sulfonyl)-11-vinyl-1,2,3,6-tetrahydro-2,6-methano-
benzo[d]azocine
31
 298 
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To a solution of 2:1 diastereomixture of tetrahydropyridines 190 (150 mg, 0.28 mmol, 
1.0 equiv) in CH2Cl2 (2 mL) at –78 °C was added SnCl4 (86 µL, 0.73 mmol, 2.6 equiv) 
dropwise. It was warmed to –20 °C over a period of 2 h then to 0 °C. After 1 h, the 
resulting red solution was quenched with sat. NaHCO3(aq.) (15 mL). After 5 min, it was 
diluted with H2O (5 mL) and extracted with EtOAc (3 × 10 mL). The combined organic 
layers were washed with brine (2 × 10 mL) and dried (Na2SO4). Concentration under 
reduced pressure and column chromatography (5→10% EtOAc–petrol) gave 8-
methoxy-3-(toluene-4-sulfonyl)-11-vinyl-1,2,3,6-tetrahydro-2,6-methano-
benzo[d]azocine 298 (60.0 mg, 56%) as a gum; Rf 0.72 (20% EtOAc–petrol); vmax (film) 
3067, 2917, 2835, 1642, 1610, 1503, 1395, 1363, 1341, 1304, 1248, 1167, 1092, 1051, 
986, 711, 680 cm–1; δH (400 MHz) 7.74 (2H, d, J 8.0 Hz, ortho Ts), 7.35 (2H, d, J 8.0 
Hz, meta Ts), 7.00 (1H, d, J 8.5 Hz, CHCHCOMe), 6.70-6.66 (2H, m, CHCHCOMe & 
NCH=CH), 6.59 (1H, d, J 2.5 Hz, CCHCOMe), 5.55 (1H, ddd, J 17.5, 10.5, 7.5 Hz, 
CH=CHH), 5.31 (1H, dd, J 7.5, 7.0 Hz, NCH=CH), 4.99-4.92 (2H, m, CH=CH2), 4.30 
(1H, m, NCHCH2), 3.78 (3H, s, OMe), 3.22 (1H, dd, J 18.5, 6.0 Hz, CHHArOMe), 
3.11-3.10 (1H, m, NCH=CHCH), 2.98 (1H, d, J 18.5 Hz, CHHArOMe), 2.47 (3H, s, 
Me of Ts), 2.14-2.12 (1H, m, CHCH=CH2); δC (100 MHz) [157.8, 143.8, 139.4 (q Ar)], 
136.7 (3°), 136.4 (q Ar), 130.2 (3°), [129.9, 126.9 (ortho & meta Ts)], 124.6 (q Ar), 
123.1 (3°), 117.4 (CH=CH2), [113.3, 113.0, 111.9 (3°)], 55.3 (OMe), 52.8 (NCHCH2), 
[39.5, 37.1 (CH2=CHCHCH)], 33.8 (CH2ArOMe), 21.7 (Me of Ts); m/z (ESI) 382.1483 
[M+H]+, 292.6040, 226.1265 (Found: [M+H]+, 382.1483. C22H23NO3S requires 
[M+H]+, 382.1477); data in agreement with that previously reported.31 
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(2R*,3S*)-2-(4-Methoxybenzyl)-4-(phenylthio)-1-tosyl-3-vinyl-1,2,3,4-
tetrahydropyridine 299 
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To a solution of PhSH (924 mg, 8.38 mmol, 4.5 equiv) in CH2Cl2 at rt was added 
AlMe3 (4.20 mL of a 3 M solution in hexanes, 8.38 mmol, 4.5 equiv). After 30 min, the 
resulting solution was added to a solution of tetrahydropyridines 190 in CH2Cl2 via 
cannula. After 1 h, the solution was cooled to 0 °C and sat. Na/K tartrate(aq.) (15 mL) 
added dropwise, followed by H2O (10 mL) and EtOAc (10 mL). The organic phase was 
separated and aqueous phase extracted with EtOAc (3 × 10 mL). The combined organic 
layers were washed with brine (2 × 10 mL), dried (Na2SO4) and concentrated under 
reduced pressure. Purification by column chromatography (5→10% EtOAc–petrol) 
followed by recrystallisation gave a 2:1 diastereomixture of (2R*,3S*)-2-(4-
methoxybenzyl)-4-(phenylthio)-1-tosyl-3-vinyl-1,2,3,4-tetrahydropyridine 299 (810 
mg, 89%) as a solid; data in agreement with that previously reported. 
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(2R*,3S*)-2-(4-Methoxybenzyl)-4-(methylthio)-1-tosyl-3-vinyl-1,2,3,4-
tetrahydropyridine 343 and (2R*,3R*)-2-(4-methoxybenzyl)-6-(methylthio)-1-
tosyl-3-vinyl-1,2,3,6-tetrahydropyridine 344 
 
N
Ts
Ts
OMe
N
Ts
OMe
MeSN
Ts
OMe
SMe
+
190 343 344  
 
To a mixture of sulfur powder (27.0 mg, 0.842 mmol, 4.5 equiv) in toluene (1.3 mL) at 
rt was added AlMe3 (373 µL of a 2 M solution in hexanes, 0.745 mmol, 4.0 equiv). The 
mixture was heated to reflux for 2 h then cooled to rt. To the resulting mixture was 
added via cannula a solution of 2:1 diastereomixture of tetrahydropyridines 190 (100 
mg, 0.186 mmol, 1.0 equiv) in toluene (0.6 mL). After 16 h, it was quenched with H2O 
(5 mL), diluted with sat. Na/K tartrate(aq.) (5 mL) and EtOAc (5 mL). After stirring for 5 
min, the organic phase was separated and the aqueous phase extracted with EtOAc (2 × 
5 mL). The combined organic layers were washed with brine (3 × 5 mL) and dried 
(Na2SO4). Concentration under reduced pressure and column chromatography (5→10% 
EtOAc–petrol) gave a 1.2:1 diastereomeric mixture of (2R*,3S*)-2-(4-methoxybenzyl)-
4-(methylthio)-1-tosyl-3-vinyl-1,2,3,4-tetrahydropyridine 343 (11.1 mg, 14%) as a gum 
and a 2:1 diastereomeric mixture of (2R*,3R*)-2-(4-methoxybenzyl)-6-(methylthio)-1-
tosyl-3-vinyl-1,2,3,6-tetrahydropyridine 344 (55.1 mg, 69%) as a gum. 
 
Data for 1.2:1 diastereomixture of (2R*,3R*)-2-(4-methoxybenzyl)-6-(methylthio)-1-
tosyl-3-vinyl-1,2,3,6-tetrahydropyridine 343: Rf 0.76 (30% EtOAc–petrol); vmax (film) 
3035, 2922, 2837 1609, 1512 1442, 1339, 1247, 1159, 1094, 1036, 914, 816 cm–1; δH 
(400 MHz) 7.60 (2H, d, J 8.0 Hz, ortho Ts, major diast.), 7.55 (2H, d, J 8.0 Hz, ortho 
Ts, minor diast.), 7.28-7.19 (2 × 4H, m, meta Ts & meta ArOMe, 2 × diast.), 6.87 (2H, 
d, J 8.5 Hz, ortho ArOMe, major diast.), 6.77 (2H, d, J 8.5 Hz, ortho ArOMe, minor 
diast.), 5.89-5.63 (2 × 3H, m, CH=CH2 & CH=CH, 2 × diast.), 5.19-5.02 (2 × 2H, m, 
CH=CH2, 2 × diast.), 4.57-4.52 (1H, m, NCHSMe, minor diast.), 4.39-4.34 (1H, m, 
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NCHSMe, major diast.), 3.83 (3H, s, OMe, minor diast.), 3.81 (3H, s, OMe, major 
diast.), 3.51-3.44 (1H, m, NCHCH2, major diast.), 3.22 (1H, dd, J 15.0, 10.0 Hz, 
CHHArOMe, major diast.), 3.09 (1H, dd, J 14.5, 9.0 Hz, CHHArOMe, minor diast.), 
2.76-2.68 (2 × 1H, m, CHHArOMe, 2 × diast. & 1H, m, NCHCH2, minor diast.), 2.44-
2.39 (2 × 4H, m, Me of Ts & CHCH=CH2, 2 × diast.), 2.14 (3H, s, SMe, major diast.), 
1.66 (3H, s, SMe, minor diast.);  δC (100 MHz) 158.2, 157.8, 143.6, 143.4, 137.3, 136.9, 
134.8, 130.9, 130.8, 130.6, 130.5, 130.2, 129.6, 129.4, 129.3, 128.1, 127.7, 127.3, 
125.3, 124.8, 118.4, 117.1, 113.8, 113.3, 64.0, 59.8, 58.8, 57.7, 57.1, 56.5, 55.3, 55.2, 
43.8, 40.2, 35.2, 32.5, 21.5, 15.5; m/z (ESI) 425.1346 [M+Na]+, 382.1488 [M+H]+, 
318.0591, 253.5798, 227.1316 (Found: [M+Na]+, 452.1346. C23H27NO3S2 requires 
[M+Na]+, 452.1330). 
 
Data for 2:1 diastereomixture of (2R*,3S*)-2-(4-methoxybenzyl)-4-(methylthio)-1-
tosyl-3-vinyl-1,2,3,4-tetrahydropyridine 344: Rf 0.71 (30% EtOAc–petrol); vmax (film) 
3034, 2920, 2835, 1636, 1611, 1598, 1584, 1513, 1464, 1440, 1420, 1347, 1303, 1247, 
1161, 1092, 1036, 913, 814 cm–1; δH (400 MHz) 7.61 (2H, d, J 8.0 Hz, ortho Ts, major 
diast.), 7.57 (2H, d, J 8.0 Hz, ortho Ts, minor diast.), 7.30-7.26 (2 × 2H, m, meta Ts, 2 
× diast.), 7.12-7.09 (2 × 2H, m, meta ArOMe, 2 × diast.), 6.87-6.84 (2 × 2H, m, ortho 
ArOMe, 2 × diast.), 6.69 (1H, d, J 8.0 Hz, NCH=CH, major diast.), 6.62 (1H, d, J 8.0 
Hz, NCH=CH, minor diast.), 6.18 (1H, ddd, J 17.5, 10.0, 8.0 Hz, CH=CHH, minor 
diast.), 5.66 (1H, ddd, J 17.5, 10.0, 8.0 Hz, CH=CHH, major diast.), 5.47 (1H, dd, J 8.0, 
4.5 Hz, NCH=CH, minor diast.), 5.28-5.15 (2 × 1H, m, CH=CHH, 2 × diast. & 1H, m, 
NCH=CH, major diast.), 5.01-4.94 (2 × 1H, m, CH=CHH, 2 × diast), 4.14-4.07 (2 × 
1H, m, NCHCH2, 2 × diast), 3.83 (2 × 3H, s, OMe, 2 × diast), 3.14-3.11 (1H, m, 
CHSMe, major diast.), 3.03-3.00 (1H, m, CHSMe, minor diast.), 2.92 (1H, dd, J 14.0, 
4.0 Hz, CHHArOMe, minor diast.), 2.84 (1H, dd, J 14.0, 10.0 Hz, CHHArOMe, minor 
diast.), 2.72 (1H, dd, J 14.0, 4.0 Hz, CHHArOMe, major diast.), 2.65 (1H, dd, J 14.0, 
10.0 Hz, CHHArOMe, major diast.), 2.43 (3H, s, Me of Ts, major diast.), 2.25-2.20 
(1H, m, CHCH=CH2, minor diast.), 2.18 (3H, s, Me of Ts, minor diast.), 1.77-1.72 (1H, 
m, CHCH=CH2, major diast.), 1.59 (3H, s, SMe, minor diast.), 1.56 (3H, s, SMe, major 
diast.); δC (100 MHz) 158.3, 158.1, 143.8, 143.6, 137.6, 136.5, 136.1, 135.6, 130.7, 
130.5, 129.7, 129.6, 127.1, 127.0, 125.5, 125.4, 123.2, 118.4, 117.9, 113.7, 113.6, 
113.1, 60.8, 60.1, 55.2, 45.7, 44.3,42.6, 39.5, 33.8, 32.1, 31.8, 29.7, 21.5, 18.4, 9.7; m/z 
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(ESI) 452.1334 [M+Na]+, 447.1773, 430.1506 [M+H]+, 382.1479, 242.1179, 227.1312 
(Found: [M+Na]+, 452.1334. C23H27NO3S2 requires [M+Na]
+, 452.1330). 
 
 
2-[(2R*,3S*)-2-(4-Methoxybenzyl)-1-tosyl-3-vinyl-1,2,3,4-tetrahydropyridin-4-
ylthio]pyridine 342 
 
190
342
N
Ts
Ts
OMe
N
Ts
S
OMe
N
+
N SH
 
 
To a solution of 2-mercaptapyridine (207 mg, 1.86 mmol, 5.0 equiv) in CH2Cl2 (2 mL) 
at rt was added AlMe3 (930 µL of a 2 M solution in hexane, 1.86 mmol, 5.0 equiv). 
After 45 min, it was added to a solution of a 2:1 diastereomixture of tetrahydropyridines 
190 (200 mg, 0.372 mmol, 1.0 equiv) in CH2Cl2 (0.7 mL) at rt. After 16 h, the reaction 
was quenched with sat. Na/K tartrate(aq.) and stirred for 5 min. The organic phase was 
separated and the aqueous phase extracted with EtOAc (3 × 10 mL). The combined 
organic layers were washed with brine (2 × 10 mL), dried (Na2SO4) and concentrated 
under reduced pressure. Purification by column chromatography (5→10% EtOAc–
petrol) followed by recrystallisation gave a 2.5:1 diastereomixture of 2-[(2R*,3S*)-2-
(4-methoxybenzyl)-1-tosyl-3-vinyl-1,2,3,4-tetrahydropyridin-4-ylthio]pyridine 342 (125 
mg, 68%) as a solid; Rf 0.69 (30% EtOAc–petrol); vmax (film) 3044, 2922, 2850, 1637, 
1613, 1597, 1577, 1558, 1512, 1453, 1416, 1354, 1302, 1247, 1165, 1122, 1091, 1035, 
986, 927, 891, 815, 760, 684 cm–1; δH (400 MHz) 8.42 (1H, ddd, J 4.0, 1.5, 1.0 Hz, 2-
pyH, minor diast.), 8.35 (1H, ddd, J 4.0, 1.5, 1.0 Hz, 2-pyH, major diast.), 7.61-7.57 (2 
× 2H, m, ortho Ts, 2 × diast.), 7.48-7.43 (2 × 1 H, m, 6-pyH, 2 × diast.), 7.29-7.26 (2 × 
2H, m, meta Ts, 2 × diast.), 7.16-7.09 (2 × 3H, m, meta ArOMe & 1-pyH, both diast.), 
6.98-6.95 (2 × 1H, m, 5-pyH, 2 × diast.), 6.86-6.82 (2 × 2H, m, ortho ArOMe, 2 × 
diast.), 6.67 (1H, ddd,  J 6.5, 1.5, 1.0 Hz, CH=CHNTs, major diast.), 6.60 (1H, ddd, J 
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6.5, 1.5, 1.0 Hz, minor diast.), 5.99 (1H, ddd, J 14.0, 8.5, 6.0 Hz, CH=CH2, major 
diast.), 5.63 (1H, ddd, J 14.5, 8.5, 6.5 Hz, CH=CH2, minor diast.), 5.46 (1H, dd, J 6.5, 
4.0 Hz, CH=CHH, major diast.), 5.38-5.36 (1H, dd, J 6.5, 2.0 Hz, CH=CHH, minor 
diast.), 5.11-5.09 (1H, m, CH=CHH, minor diast.), 5.06-5.04 (1H, m, CH=CHH, major 
diast.), 4.97-4.92 (2 × 1H, m, CH=CHNTs, 2 × diast.), 4.83-4.81 (1H, m, CHNTs, 
major diast.), 4.62-4.59 (1H, m, CHNTs, minor diast.), [3.80, 3.79 (2 × 3H, 2 × s, OMe, 
2 × diast.)], 2.88-2.76 (2 × 2H, m, CH2ArOMe, 2 × diast.), [2.43, 2.42 (2 × 3H, 2 × s, 
Me of Ts, 2 × diast.)], 2.39-2.36 (1H, m, CHCH=CH2, major diast.), 2.87-2.82 (1H, m, 
CHCH=CH2, minor diast.); δC (100 MHz) 157.9, 157.9, 149.6, 149.4, 149.1, 143.7, 
137.4, 137.1, 136.1, 135.9, 135.8, 130.8, 130.6, 130.5, 130.4, 129.8, 129.7, 129.7, 
127.0, 126.9, 123.9, 123.6, 122.8, 122.6, 121.1, 119.7, 118.5, 117.5, 113.8, 113.6, 
113.3, 60.9, 59.9, 55.1, 44.4, 38.6, 38.2, 33.7, 31.9, 29.7, 21.6; m/z (ESI) 531.1200, 
515.1447, 493.1632 [M+Na]+, 382.1485, 221.0214 (Found: [M+Na]+, 493.1632. 
C27H28N2O3S2 requires [M+Na]
+, 493.1620). 
 
 
(R*)-2-(4-Methoxybenzyl)-1-tosyl-3-vinyl-1,2-dihydropyridine  
 
342
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To a mixture of AgOTf (16.0 mg, 0.061 mmol, 1.5 equiv), 4 Å molecular sieves and 
CH2Cl2 (1.5 mL) in the dark at –40 °C was added a solution of a 2.5:1 diastereomixture 
of 2-[(2R*,3S*)-2-(4-methoxybenzyl)-1-tosyl-3-vinyl-1,2,3,4-tetrahydropyridin-4-
ylthio]pyridines 342 (20.0 mg, 0.041 mmol, 1.0 equiv) in CH2Cl2 (0.2 mL). After 2 h, 
the reaction was quenched with sat. NaHCO3(aq.) (2 mL). After stirring for 2 min, it was 
diluted with H2O (2 mL), CH2Cl2 (2 mL) and EtOAc (5 mL). The organic phase was 
separated and the aqueous phase extracted with EtOAc (2 × 5 mL). The combined 
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organic layers were washed with brine (2 × 5 mL) and dried (Na2SO4). Concentration 
under reduced pressure and column chromatography (5→10% EtOAc–petrol) gave 
(R*)-2-(4-methoxybenzyl)-1-tosyl-3-vinyl-1,2-dihydropyridine 345 (10.0 mg, 64%) as a 
gum; Rf 0.67 (20% EtOAc–petrol); δH (400 MHz) 7.55 (2H, d, J 8.0 Hz, ortho Ts), 7.19 
(2H, d, J 8.0 Hz, meta Ts), 7.14 (2H, d, J 8.5 Hz, meta ArOMe), 6.85 (2H, d,  J 8.5 Hz, 
ortho ArOMe), 6.57 (1H, d, J 6.5 Hz, NCH=CH), 6.13 (1H, dd, J 17.5, 11.0 Hz, 
CH=CHH), 5.73 (1H, d, J 5.5 Hz, NCH=CHCH), 5.59 (1H, dd, J 6.5, 5.5 Hz, 
NCH=CH), 5.14-5.08 (2H, m, CH=CH2), 4.98 (1H, d, J 11.0 Hz, NCHCH2), 3.82 (3H, 
s, OMe), 2.78-2.75 (2H, m, CH2ArOMe), 2.38 (3H, s, Me of Ts); δC (100 MHz) [158.4, 
143.5, 136.7 (q Ar)], 135.3 (3°), 131.3 (q), [130.9, 129.4 (ortho or meta Ar)], 128.8 (q), 
126.2 (ortho or meta Ar), 124.4 (3°), 121.4 (CH=CH2), 113.5 (ortho ArOMe), [112.5, 
112.2 (3°)], [55.2, 54.8 (OMe & NCHCH2)], 37.7 (CH2ArOMe), 21.5 (Me of Ts); m/z 
(ESI) 404.1299 [M+Na]+, 398.1432, 382.1489 [M+H]+, 226.1230 (Found: [M+H]+, 
382.1489. C22H23NO3S requires [M+H]
+, 382.1477). 
 
 
3,3-Dimethoxyprop-1-ene
172
 357 
 
301
O OMe
MeO
357  
 
To a solution of NH4NO3 (357 mg, 4.46 mmol, 0.05 equiv) in MeOH (3mL) at rt was 
added acrylaldehyde 301 (5.00 g, 89.2 mmol, 1.0 equiv) and CH(CH3O)3 (12.6 g, 118.8 
mmol, 1.33 equiv). After 16 h, the reaction mixture was filtered. Solid Na2CO3 (241 
mg) was added to the filtrate. Distillation gave 3,3-dimethoxyprop-1-ene 357 (3.8 g, 
42%) as a colourless liquid; bp: 88-89 °C; Rf 0.61 (15% EtOAc–petrol); δH (400 MHz) 
5.83 (1H, dd, J 17.5, 10.5, 5.0 Hz, CH=CH2), 5.43 (1H, dt, J 17.5, 1.0 Hz, CH=CHH), 
5.35 (1H, dt, J 10.5, 1.0 Hz, CH=CHH), 4.79 [1H, dt, J 5.0, 1.0 Hz, CH(OMe)2], 3.36 
[6H, s, (OMe)2]; δC (100 MHz) 134.5 (CH=CH2), 118.9 (CH=CH2), 103.1 [CH(OMe)2], 
[52.7, 50.7 (OMe)2]; compound not suitable for CI and ESI mass spectroscopic 
technologies; data in agreement with that previously reported.172 
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2,3-Dibromopropanal
175
 360 
 
O
O
Br
Br
301 360  
 
To a solution of acrylaldehyde 301 (2.80 g, 50.0 mmol, 1.0 equiv) in CCl4 (5mL) at 0°C 
was added Br2 (2.56 mL, 50.0 mmol, 1.0 equiv) dropwise. After 4 h, the reaction was 
quenched with sat. Na2S2O3(aq.) (25 mL). The organic layer was separated and the 
aqueous phase extracted with Et2O (3 × 15 mL). The combined organic layers were 
washed with H2O (20 mL), brine (3 × 15 mL) and dried (Na2SO4). Concentration 
cleanly gave crude dibromide 360 (10.7 g, 100%) as an oil, used without further 
purification; Rf 0.78 (43% EtOAc–hexane); vmax (film) 3504, 2938, 1731, 1425, 1396, 
1125 cm–1; δH (400 MHz) 9.40 (1H, d, J 2.5 Hz, CHO), 4.55 (1H, ddd, J 10.5, 4.5, 2.5 
Hz, CHBrCHO), 3.89 (1H, t, J 10.5 Hz, CHHBr), 3.74 (1H, dd, J 10.5, 4.5 Hz, 
CHHBr); δC (100 MHz) 189.0 (CHO), 48.9 (CHBrCHO), 26.8 (CH2Br); compound not 
suitable for CI and ESI mass spectroscopic technologies; data in agreement with that 
previously reported.175 
 
 
(E)-3-(Phenylsulfonyl)acrylaldehyde
175 361 
 
360
O
Br
Br
O
SO2Ph
361  
 
To a solution of dibromide 360 (10.7 g, 50.0 mmol, 1.0 equiv) in DMF (28 mL) at rt 
was added PhSO2Na (12.3 g, 75.0 mmol, 1.5 equiv). After 30 h, the reaction was 
quenched with H2O (30 mL) and extracted with EtOAc (3 × 20 mL). The combined 
organic layers were washed with brine (4 × 50 mL) and dried (Na2SO4). Concentration 
under reduced pressure and column chromatography (20→30% EtOAc–petrol) gave 
(E)-3-(phenylsulfonyl)acrylaldehyde 361 (3.40 g, 35%) as a gum; Rf 0.46 (43% EtOAc–
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hexane); vmax (film) 3476, 3062, 2928, 2852, 1729, 1700, 1584, 1448, 1308, 1150, 1083, 
964, 819, 753, 687 cm–1; δH (400 MHz) 9.67 (1H, d, J 7.0 Hz, CHO), 7.88-7.86 (2H, m, 
ortho SO2Ph), 7.66-7.64 (1H, m, para SO2Ph), 7.57-7.54 (2H, m, meta SO2Ph), 7.31 
(1H, d, J 15.5 Hz, CHSO2Ph), 6.83 (1H, dd, J 15.5, 7.0 Hz, CHCHO); δC (100 MHz) 
190.3 (CHO), 147.9, 137.8, 136.2, 134.7, [129.8, 128.5 (ortho & meta Ph)]; m/z (CI) 
214 [M+NH4]
+, 160, 125 (Found: [M+NH4]
+, 214.0548. C9H8O3S requires [M+NH4]
+, 
214.0538); data in agreement with that previously reported.175 
 
 
(E)-(3,3)-Dimethoxyprop-1-enylsulfonyl)benzene 358a 
 
361
O
SO2Ph SO2Ph
OMe
MeO
358a  
 
To a solution of (E)-3-(phenylsulfonyl)acrylaldehyde 361 (2.00 g, 9.50 mmol, 1.0 
equiv) in MeOH (1 mL) at rt was added a solution of NH4NO3 (38.4 mg, 0.480 mmol, 
0.05 equiv) and (CH3O)3CH (2.02 g, 19.0 mmol, 2.0 equiv) in MeOH (1 mL). After 96 
h, concentration under reduced pressure and column chromatography (15→20% 
EtOAc–petrol with 1.5% Et3N) gave (E)-(3,3-dimethoxyprop-1-enylsulfonyl)benzene 
358a (1.93 g, 84%) as a crystalline solid; mp 59–61°C: Rf 0.56 (30% EtOAc–petrol); 
vmax (film) 3058, 2939, 2834, 1448, 1359, 1332, 1277, 1172, 1150, 1061, 986, 822, 763, 
688, 614 cm–1; δH (400 MHz) 7.91 (2H, d, J 7.5 Hz, ortho Ph), 7.65 (1H, t, J 7.5 Hz, 
para Ph), 7.57 (2H, t, J 7.5 Hz, meta Ph), 6.81 (1H, dd, J 15.0, 3.0 Hz, CH=CHSO2Ph), 
6.71 (1H, dd, J 15.0, 0.5 Hz, CH=CHSO2Ph), 5.02 [1H, dd, J 3.0, 0.5 Hz, CH(OMe)2], 
3.32 [6H, s, CH(OMe)2]; δC (100 MHz) 140.6 (3°), 139.8 (ipso Ph), [134.6, 133.7 (3°)], 
[129.4, 127.9 (ortho & meta Ph)], 99.1 [CH(OMe)2], 52.9 [CH(OMe)2]; m/z (CI) 260 
[M+NH4]
+, 101, 86 (Found: [M+NH4]
+, 260.0961. C11H14O4S requires [M+NH4]
+, 
260.0957). 
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(4S*,5S*,6R*)-6-(4-Methoxybenzyl)-1,4-ditosyl-5-vinylpiperidin-2-one 353 
 
OMe
TsHN
TsOMe
MeO
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N
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O
191 353  
 
To a solution of tosamides 191 (1.15g, 1.90 mmol, 1.0 equiv) in acetone (3.1 mL) at rt 
was added dropwise a solution of CrO3 (950 mg, 9.50 mmol, 5.0 equiv) in H2O (2.8 
mL) and concentrated H2SO4 (1.58 mL, 30.5 mmol, 16.0 equiv). After 40 h, 
concentration under reduced pressure and column chromatography (30→40% EtOAc–
petrol) gave a 20:1 diastereomixture of (4S*,5S*,6R*)-6-(4-methoxybenzyl)-1,4-ditosyl-
5-vinylpiperidin-2-one 353 (242 mg, 23%) as a colourless solid; data for major 
diastereomer only: Rf 0.31 (35% EtOAc–petrol); vmax (film) 2963, 2934, 1709, 1598, 
1509, 1355, 1295, 1251, 1148, 1089, 1030, 927, 816, 668, 550 cm–1; δH (400 MHz) 7.76 
(2H, d, J 8.5 Hz, ortho Ts), 7.57 (2H, d, J 8.5 Hz, ortho Ts), 7.33-7.28 (4H, m, 2 × meta 
Ts), 7.11 (2H, d, J 8.5 Hz, meta ArOMe), 6.85 (2H, d, J 8.5 Hz, ortho ArOMe), 5.90 
(1H, ddd, J 17.0, 10.0, 8.5 Hz, CH=CH2), 5.38-5.31 (2H, m, CH=CH2), 4.89 (1H, app q, 
J 5.0 Hz, CHNTs), 3.82 (3H, s, OMe), 3.29 (1H, ddd, J 11.0, 8.5, 7.0 Hz, CHTs), 3.19 
(1H, dd, J 15.0, 5.0 Hz, CHHArOMe), 3.05-2.99 (1H, m, CHCH=CH2), 2.90 (1H, dd, J 
15.0, 5.0 Hz, CHHArOMe), 2.60 (1H, dd, J 18.5, 7.0 Hz, COCHH), [2.46, 2.45 (2 × 
3H, 2 × s, 2 × Me of Ts)], 2.22 (1H, dd, J 18.5, 8.5 Hz, COCHH); δC (100 MHz) 166.5 
(CO), 159.1 (ipso Ts), [145.5, 145.1, 135.7 (4º)], 134.9 (3º), 133.6 (4º), [131.0, 129.9, 
129.3 (meta or ortho Ar)], 129.0 (2 × meta or ortho Ar), , 127.9 (4º), 119.9 (CH=CH2), 
114.4 (meta or ortho Ar), 61.5 (CHNTs), 58.4 (CHTs), 55.2 (OMe), 44.5 
(CHCH=CH2), [36.2, 32.6 (CH2ArOMe & CH2CO)], 21.7 (2 × Me of 2 × Ts); m/z (ESI) 
576.1489 [M+Na]+,  554.1674 [M+H]+, 420.1237, 358.0995 (Found: [M+Na]+, 
576.1489. C29H31NO6S2 requires [M+Na]
+, 576.1490). 
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(R*)-5-Ethylidene-6-(4-methoxybenzyl)-1-tosyl-5,6-dihydropyridin-2(1H)-one 371 
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To a solution of (5S*,6R*)-6-(4-methoxybenzyl)-1,4-ditosyl-5-vinylpiperidin-2-one 353 
(18.0 mg, 0.0325 mmol, 1.0 equiv) in CH2Cl2 (0.1 mL) at rt was added DBU (8 µL). 
After 20 h, the resulting solution was concentrated to half volume by flushing with N2. 
The crude product was purified by prep-TLC (35% EtOAc–petrol) to give a 2.7:1 
isomeric mixture of (R*)-5-ethylidene-6-(4-methoxybenzyl)-1-tosyl-5,6-dihydropyridin-
2(1H)-one 371 (12.9 mg, 100%) as a solid; Rf 0.72 (40% EtOAc–petrol); vmax (film) 
2923, 1682, 1640, 1611, 1513, 1447, 1402, 1346, 1302, 1247, 1166, 1116, 1087, 1033, 
1006, 912, 614, 680, 650, 608, 550 cm–1; δH (400 MHz) 8.01-7.98 (2 × 2H, m, ortho Ts, 
2 × isomers), 7.34-7.32 (2 × 2H, m, meta Ts, 2 × isomers), 7.06 (1 × 2H & 1 × 1H, m, 
meta ArOMe, major isomer CH=CHCO, minor isomer), 7.00 (2H, d, J 8.5 Hz, meta 
ArOMe, minor isomer), 6.83-6.79 (2 × 2H, m, ortho ArOMe, 2 × isomers), 6.61 (1H, d, 
J 9.5 Hz, CH=CHCO, major isomer), 5.90 (1H, t, J 7.5 Hz, C=CHCH3, major isomer), 
5.69-5.66 (2 × 1H, m, CHNTs, major isomer & CH=CHCO, minor isomer), 5.53 (1H, 
d, J 9.5 Hz, CH=CHCO, major isomer), 5.32 (1H, d, J 7.5 Hz, C=CHCH3, minor 
isomer), 5.19 (1H, dd, J 9.0, 3.5 Hz, CHNTs, minor isomer), [3.82, 3.80 (2 × 3H, 2 × s, 
OMe, 2 × isomers), 3.14 (1H, dd, J 13.0, 3.5 Hz, CHHArOMe, major isomer), 2.95-
2.90 (2 × 2H & 1 × 1H, m, CHHArOMe, 2 × isomers and CHHArOMe, minor isomer), 
2.44 (2 × 3H, s, Me of Ts, 2 × isomers), 1.72 (3H, d, J 7.5 Hz, C=CHCH3, minor 
isomer), 1.35 (3H, d, J 7.5 Hz, C=CHCH3, major isomer); δC (100 MHz) 162.6, 158.7, 
144.7, 143.2, 136.6, 135.8, 134.9, 132.7, 131.1, 130.9, 129.3, 129.0, 128.5, 127.9, 
121.4, 119.5, 113.7, 63.2, 56.9, 55.3, 42.7, 41.6, 21.6, 14.1, 13.4; m/z (ESI) 817.2614, 
461.1540, 420.1264 [M+Na]+, 398.1433 [M+H]+, 300.6002 (Found: [M+H]+, 398.1433. 
C22H23NO4S requires [M+H]
+, 398.1426). 
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(R*)-6-(4-Methoxybenzyl)-1-tosyl-5-vinyl-1,6-dihydropyridin-2(3H)-one 372 
 
353
N
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OMe
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N
Ts
OMe
O
Ts
372
 
 
To a solution of (5S*,6R*)-6-(4-methoxybenzyl)-1,4-ditosyl-5-vinylpiperidin-2-one 353  
(20.0 mg, 0.036 mmol, 1.0 equiv) in CH2Cl2 (0.3 mL) at rt was added Et3N (1 µL, 
0.0072 mmol, 0.2 equiv). After 16 h, the solution was concentrated to ~0.1 mL by 
flushing with N2. The crude was purified by prep-TLC (30% EtOAc–petrol) to give 
(R*)-6-(4-methoxybenzyl)-1-tosyl-5-vinyl-1,6-dihydropyridin-2(3H)-one 372 (4.0 mg, 
28%) and 371 (9.0 mg, 63%) as a gum. 
 
Data for 372: Rf 0.66 (40% EtOAc–petrol); vmax (film) 2920, 1698, 1513, 1351, 1251, 
1169, 1046, 821, 674 cm–1; δH (400 MHz) 7.93 (2H, d, J 8.5 Hz, ortho Ts), 7.30 (2H, d, 
J 8.5 Hz, meta Ts), 7.00 (2H, d, J 8.5 Hz, meta ArOMe), 6.75 (2H, d, J 8.5 Hz, ortho 
ArOMe), 6.34 (1H, dd, J 17.5, 11.0 Hz, CH=CH2), 5.66-5.64 (1H, m, NTsCH), 5.58 
(1H, dd, J 5.5, 2.0 Hz, C=CH), 5.42 (1H, d, J 17.5 Hz, CH=CHH), 5.28 (1H, d, J 11.0 
Hz, CH=CHH), 3.79 (3H, s, OMe), 3.35 (1H, dd, J 14.0, 5.0 Hz, CHHArOMe), 3.04 
(1H, dd, J 14.0, 2.5 Hz, CHHArOMe), 2.41-2.36 (5H, m, Me of Ts & CH2CO); δC (100 
MHz) 168.6 (CO), 158.9 (ipso Ts), [144.9, 136.3 (4°)], 134.4 (3°), 134.2 (4°), [132.2, 
129.2, 129.0 (ortho or meta Ar)], 126.4 (4°), 124.7 (3°), 113.8 (CH=CH2), 113.5 (ortho 
or meta Ar), [57.4, 55.2 (NTsCH & OMe)], [39.6, 34.0 (CH2CO & CH2ArOMe)], 21.7 
(Me of Ts); m/z (ESI) 461.1503, 420.1251 [M+Na]+, 398.1441 [M+H]+, 300.6017 
(Found: [M+Na]+, 420.1251. C22H23NO4S requires [M+Na]
+, 420.1245) (Found: C, 
66.50; H, 5.77; N, 3.47.  C22H23NO4S requires C, 66.48; H, 5.83; N, 3.52%). 
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(R*)-5-(2-Hydroxyethylidene)-6-(4-methoxybenzyl)-1-tosyl-5,6-dihydropyridin-
2(1H)-one 375 
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To a mixture of allylmagnezium bromide (0.18 mL of a 1 M solution in Et2O, 0.18 
mmol, 2.0 equiv) and CuCN (16.0 mg, 0.18 mmol, 2.0 equiv) in THF (0.3 mL) was 
added a solution (5S*,6R*)-6-(4-methoxybenzyl)-1,4-ditosyl-5-vinylpiperidin-2-one  
(50.0 mg, 0.090 mmol, 1.0 equiv) 353 in THF (0.3 mL), followed by Et3N  (4 µL, 0.027 
mmol, 0.3 equiv). After 16 h, the reaction was diluted with sat. NH4Cl(aq.) (2 mL) and 
THF (2 mL). The organic phase was separated and the aqueous phase extracted with 
EtOAc (3 × 2 mL). The combined organic layers were washed with brine (2 × 5 mL) 
and dried (Na2SO4). Concentration under reduced pressure and purification by prep-
TLC (55% EtOAc–petrol) gave separable isomers of (R*)-5-(2-hydroxyethylidene)-6-
(4-methoxybenzyl)-1-tosyl-5,6-dihydropyridin-2(1H)-one 375 as gums. 
 
Data for minor isomer: (4 mg, 11%); Rf 0.14 (40% EtOAc–petrol); vmax (film) 3457, 
2925, 1682, 1611, 1597, 1514, 1443, 1402, 1347, 1169, 1103, 1088, 1030, 914, 815, 
730, 689 cm–1; δH (400 MHz) 8.00 (2H, d, J 8.5 Hz, ortho Ts), 7.34 (2H, d, J 8.5 Hz, 
meta Ts), 7.10 (1H, d, J 10.0 Hz, CH=CHCO), 7.04 (2H, d, J 8.5 Hz, meta ArOMe), 
6.84 (2H, d, J 8.5 Hz, ortho ArOMe), 5.74 (1H, d, J 10.0 Hz, CH=CHCO), 5.34 (1H, 
app. t, J 6.5 Hz, C=CH), 5.23 (1H, dd, J 9.0, 3.5 Hz, NTsCH), 4.24-4.18 (2H, m, 
CH2OH), 3.81 (3H, s, OMe), 3.23 (1H, dd, J 13.0, 3.5 Hz, CHHArOMe), 2.95 (1H, dd, 
J 13.0, 9.0 Hz, CHHArOMe), 2.45 (3H, s, Me of Ts). 
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Data for major isomer: 8 mg, 22%; Rf  0.18 (40% EtOAc–petrol); vmax (film) 3455, 
2924, 1682, 1611, 1596, 1513, 1442, 1402, 1347, 1166, 1107, 1086, 1031, 913, 815, 
730, 686 cm–1; δH (400 MHz) 8.01 (2H, d, J 8.5 Hz, ortho Ts), 7.34 (2H, d, J 8.5 Hz, 
meta Ts), 7.11 (2H, d, J 8.5 Hz, meta ArOMe), 6.87 (2H, d, J 8.5 Hz, ortho ArOMe), 
6.77 (1H, d, J 9.5 Hz, CH=CHCO), 5.90 (1H, app. t, J 6.0 Hz, C=CH), 5.75 (1H, d, J 
9.5 Hz, CH=CHCO), 5.63 (1H, dd, J 10.0, 3.5 Hz, NTsCH), 3.93-3.86 (1H, m, 
CHHOH), 3.82 (3H, s, OMe), 3.34-3.31 (1H, m, CHHOH), 3.24 (1H, dd, J 13.0, 3.5 
Hz, CHHArOMe), 2.89 (1H, dd, J 13.0, 10.5 Hz, CHHArOMe), 2.45 (3H, s, Me of Ts); 
δC (100 MHz) 162.3 (CO), 158.9 (ipso Ts), 144.9, 142.3, 137.2, 136.9, 131.2 (ortho or 
meta Ar), 130.7, [129.4, 129.1 (ortho or meta Ar)], 127.8, 122.0, 113.9 (ortho or meta 
Ar), 58.8, 57.3, 55.3, 42.1, 21.7; m/z (ESI) 477.1458, 452.0938, 436.1154 [M+Na]+, 
414.1374 [M+H]+, 308.5988 (Found: [M+H]+, 436.1154. C22H23NO5S requires [M+H]
+, 
436.1175) (Found: C, 63.85; H, 5.50; N, 3.32.  C22H23NO5S requires C, 63.90; H, 5.61; 
N, 3.39%). 
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Appendices-Crystal Structures 
 
Appendix I-compound 234d 
 
 
 
PhO2S OH
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Crystal data and structure refinement for 234d. 
 
Identification code DC0602 
Empirical formula C16 H20 O3 S 
Formula weight 292.38 
Temperature 173(2) K 
Diffractometer, wavelength OD Xcalibur PX Ultra, 1.54248 Å 
Crystal system, space group Monoclinic, P2(1)/c 
Unit cell dimensions a = 17.906(4) Å α = 90° 
 b = 6.3895(18) Å β = 99.06(2)° 
 c = 12.901(4) Å γ = 90° 
Volume, Z 1457.6(7) Å3, 4 
Density (calculated) 1.332 Mg/m3 
Absorption coefficient 2.012 mm-1 
F(000) 624 
Crystal colour / morphology Colourless blocky needles 
Crystal size 0.31 x 0.12 x 0.06 mm3 
θ range for data collection 6.95 to 71.24° 
Index ranges -21<=h<=21, -7<=k<=7, -15<=l<=15 
Reflns collected / unique 33681 / 2800 [R(int) = 0.0316] 
Reflns observed [F>4σ(F)] 2359 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.06087 and 0.86647 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2800 / 1 / 188 
Goodness-of-fit on F2 1.106 
Final R indices [F>4σ(F)] R1 = 0.0313, wR2 = 0.0910 
R indices (all data) R1 = 0.0369, wR2 = 0.0929 
Extinction coefficient 0.0011(4) 
Largest diff. peak, hole 0.292, -0.328 eÅ-3 
Mean and maximum shift/error 0.000 and 0.001 
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Bond lengths [Å] and angles [°] for 234d. 
 
C(1)-C(5) 1.5020(19) 
C(1)-C(15) 1.5412(18) 
C(1)-C(2) 1.5483(19) 
C(1)-S(6) 1.8249(13) 
C(2)-C(3) 1.540(2) 
C(3)-O(20) 1.4305(18) 
C(3)-C(4) 1.494(2) 
C(4)-C(5) 1.319(2) 
S(6)-O(7) 1.4359(12) 
S(6)-O(8) 1.4454(11) 
S(6)-C(9) 1.7609(14) 
O(8)-O(20) 2.9949(18) 
C(9)-C(10) 1.386(2) 
C(9)-C(14) 1.391(2) 
C(10)-C(11) 1.386(2) 
C(11)-C(12) 1.381(2) 
C(12)-C(13) 1.383(2) 
C(13)-C(14) 1.388(2) 
C(15)-C(16) 1.5001(19) 
C(16)-C(17) 1.329(2) 
C(17)-C(18) 1.499(2) 
C(17)-C(19) 1.501(2) 
 
C(5)-C(1)-C(15) 114.33(11) 
C(5)-C(1)-C(2) 103.11(11) 
C(15)-C(1)-C(2) 115.21(11) 
C(5)-C(1)-S(6) 108.66(8) 
C(15)-C(1)-S(6) 108.19(9) 
C(2)-C(1)-S(6) 106.94(9) 
C(3)-C(2)-C(1) 106.17(11) 
O(20)-C(3)-C(4) 112.20(12) 
O(20)-C(3)-C(2) 114.02(12) 
C(4)-C(3)-C(2) 103.21(11) 
C(5)-C(4)-C(3) 112.96(13) 
C(4)-C(5)-C(1) 112.18(12) 
O(7)-S(6)-O(8) 117.84(6) 
O(7)-S(6)-C(9) 108.73(7) 
O(8)-S(6)-C(9) 108.20(7) 
O(7)-S(6)-C(1) 108.56(6) 
O(8)-S(6)-C(1) 107.47(6) 
C(9)-S(6)-C(1) 105.33(6) 
C(10)-C(9)-C(14) 121.49(13) 
C(10)-C(9)-S(6) 119.28(11) 
C(14)-C(9)-S(6) 119.22(11) 
C(9)-C(10)-C(11) 118.87(13) 
C(12)-C(11)-C(10) 120.17(14) 
C(11)-C(12)-C(13) 120.63(14) 
C(12)-C(13)-C(14) 120.10(14) 
C(13)-C(14)-C(9) 118.73(14) 
C(16)-C(15)-C(1) 111.66(11) 
C(17)-C(16)-C(15) 127.53(14) 
C(16)-C(17)-C(18) 124.41(15) 
C(16)-C(17)-C(19) 120.85(15) 
C(18)-C(17)-C(19) 114.69(14) 
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Appendix II-Compound 273 
 
 
N
Ts
SO2Ph
Ph O
OMe  
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Crystal data and structure refinement for 273. 
 
Identification code DC0606 
Empirical formula C34 H35 N O6 S2 
Formula weight 617.75 
Temperature 173(2) K 
Diffractometer, wavelength OD Xcalibur PX Ultra, 1.54248 Å 
Crystal system, space group Orthorhombic, Pccn 
Unit cell dimensions a = 15.99710(10) Å α = 90° 
 b = 30.5236(2) Å β = 90° 
 c = 12.73420(10) Å γ = 90° 
Volume, Z 6217.97(7) Å3, 8 
Density (calculated) 1.320 Mg/m3 
Absorption coefficient 1.932 mm-1 
F(000) 2608 
Crystal colour / morphology Colourless tablets 
Crystal size 0.22 x 0.20 x 0.06 mm3 
θ range for data collection 2.90 to 71.05° 
Index ranges -19<=h<=19, -36<=k<=37, -15<=l<=15 
Reflns collected / unique 165242 / 6002 [R(int) = 0.0504] 
Reflns observed [F>4σ(F)] 4796 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.76604 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6002 / 0 / 390 
Goodness-of-fit on F2 1.071 
Final R indices [F>4σ(F)] R1 = 0.0375, wR2 = 0.1052 
R indices (all data) R1 = 0.0469, wR2 = 0.1111 
Largest diff. peak, hole 0.631, -0.292 eÅ-3 
Mean and maximum shift/error 0.000 and 0.001 
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Bond lengths [Å] and angles [°] for 273. 
 
N(1)-C(6) 1.463(2) 
N(1)-C(2) 1.475(2) 
N(1)-S(7) 1.6183(15) 
C(2)-C(17) 1.544(2) 
C(2)-C(3) 1.550(2) 
C(3)-C(4) 1.526(2) 
C(3)-C(26) 1.545(2) 
C(4)-O(5) 1.4326(19) 
O(5)-C(6) 1.404(2) 
S(7)-O(9) 1.4339(13) 
S(7)-O(8) 1.4343(13) 
S(7)-C(10) 1.7671(18) 
C(10)-C(15) 1.385(2) 
C(10)-C(11) 1.392(2) 
C(11)-C(12) 1.380(3) 
C(12)-C(13) 1.390(3) 
C(13)-C(14) 1.387(3) 
C(13)-C(16) 1.505(3) 
C(14)-C(15) 1.386(3) 
C(17)-C(18) 1.505(2) 
C(18)-C(23) 1.383(3) 
C(18)-C(19) 1.385(3) 
C(19)-C(20) 1.397(3) 
C(20)-C(21) 1.374(3) 
C(21)-O(24) 1.379(2) 
C(21)-C(22) 1.383(3) 
C(22)-C(23) 1.386(3) 
O(24)-C(25) 1.425(2) 
C(26)-C(36) 1.520(2) 
C(26)-S(27) 1.8167(16) 
S(27)-O(28) 1.4378(12) 
S(27)-O(29) 1.4382(12) 
S(27)-C(30) 1.7630(18) 
C(30)-C(31) 1.383(3) 
C(30)-C(35) 1.385(2) 
C(31)-C(32) 1.382(3) 
C(32)-C(33) 1.387(3) 
C(33)-C(34) 1.371(3) 
C(34)-C(35) 1.387(3) 
C(36)-C(37) 1.305(3) 
C(37)-C(38) 1.480(2) 
C(38)-C(43) 1.370(3) 
C(38)-C(39) 1.393(3) 
C(39)-C(40) 1.402(3) 
C(40)-C(41) 1.370(3) 
C(41)-C(42) 1.369(3) 
C(42)-C(43) 1.379(3) 
 
C(6)-N(1)-C(2) 117.75(14) 
C(6)-N(1)-S(7) 122.21(11) 
C(2)-N(1)-S(7) 119.78(11) 
N(1)-C(2)-C(17) 111.61(14) 
N(1)-C(2)-C(3) 110.08(13) 
C(17)-C(2)-C(3) 112.91(14) 
C(4)-C(3)-C(26) 116.02(13) 
C(4)-C(3)-C(2) 109.84(13) 
C(26)-C(3)-C(2) 109.27(13) 
O(5)-C(4)-C(3) 111.09(13) 
C(6)-O(5)-C(4) 108.82(13) 
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O(5)-C(6)-N(1) 110.46(13) 
O(9)-S(7)-O(8) 119.22(8) 
O(9)-S(7)-N(1) 107.86(7) 
O(8)-S(7)-N(1) 106.48(8) 
O(9)-S(7)-C(10) 106.97(8) 
O(8)-S(7)-C(10) 107.77(8) 
N(1)-S(7)-C(10) 108.13(8) 
C(15)-C(10)-C(11) 120.55(17) 
C(15)-C(10)-S(7) 119.89(13) 
C(11)-C(10)-S(7) 119.53(14) 
C(12)-C(11)-C(10) 119.17(17) 
C(11)-C(12)-C(13) 121.57(17) 
C(14)-C(13)-C(12) 118.01(18) 
C(14)-C(13)-C(16) 120.57(18) 
C(12)-C(13)-C(16) 121.42(18) 
C(15)-C(14)-C(13) 121.71(18) 
C(10)-C(15)-C(14) 118.98(16) 
C(18)-C(17)-C(2) 110.66(14) 
C(23)-C(18)-C(19) 116.96(17) 
C(23)-C(18)-C(17) 123.10(17) 
C(19)-C(18)-C(17) 119.94(16) 
C(18)-C(19)-C(20) 121.92(17) 
C(21)-C(20)-C(19) 119.53(18) 
C(20)-C(21)-O(24) 123.80(17) 
C(20)-C(21)-C(22) 119.82(18) 
O(24)-C(21)-C(22) 116.38(16) 
C(21)-C(22)-C(23) 119.57(17) 
C(18)-C(23)-C(22) 122.20(18) 
C(21)-O(24)-C(25) 116.85(15) 
C(36)-C(26)-C(3) 108.56(13) 
C(36)-C(26)-S(27) 108.01(11) 
C(3)-C(26)-S(27) 111.36(11) 
O(28)-S(27)-O(29) 118.39(8) 
O(28)-S(27)-C(30) 109.43(8) 
O(29)-S(27)-C(30) 107.42(8) 
O(28)-S(27)-C(26) 107.47(8) 
O(29)-S(27)-C(26) 109.44(8) 
C(30)-S(27)-C(26) 103.72(8) 
C(31)-C(30)-C(35) 121.69(17) 
C(31)-C(30)-S(27) 119.73(13) 
C(35)-C(30)-S(27) 118.56(14) 
C(32)-C(31)-C(30) 118.81(18) 
C(31)-C(32)-C(33) 120.1(2) 
C(34)-C(33)-C(32) 120.45(19) 
C(33)-C(34)-C(35) 120.43(19) 
C(30)-C(35)-C(34) 118.53(18) 
C(37)-C(36)-C(26) 124.98(17) 
C(36)-C(37)-C(38) 126.15(18) 
C(43)-C(38)-C(39) 118.67(19) 
C(43)-C(38)-C(37) 118.60(18) 
C(39)-C(38)-C(37) 122.7(2) 
C(38)-C(39)-C(40) 120.4(2) 
C(41)-C(40)-C(39) 119.4(2) 
C(42)-C(41)-C(40) 120.0(2) 
C(41)-C(42)-C(43) 120.7(2) 
C(38)-C(43)-C(42) 120.8(2) 
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Appendix III-compound 274 
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Crystal data and structure refinement for 274. 
 
Identification code DC0604 
Empirical formula C34 H35 N O5 S2 
Formula weight 601.75 
Temperature 173(2) K 
Diffractometer, wavelength OD Xcalibur 3, 0.71073 Å 
Crystal system, space group Orthorhombic, Pbca 
Unit cell dimensions a = 16.4268(6) Å α = 90° 
 b = 13.8616(6) Å β = 90° 
 c = 26.447(5) Å γ = 90° 
Volume, Z 6021.9(11) Å3, 8 
Density (calculated) 1.327 Mg/m3 
Absorption coefficient 0.220 mm-1 
F(000) 2544 
Crystal colour / morphology Colourless tablets 
Crystal size 0.39 x 0.29 x 0.15 mm3 
θ range for data collection 3.85 to 28.54° 
Index ranges -21<=h<=21, -17<=k<=17, -35<=l<=34 
Reflns collected / unique 56392 / 7131 [R(int) = 0.0460] 
Reflns observed [F>4σ(F)] 5759 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.09029 and 0.91578 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7131 / 7 / 385 
Goodness-of-fit on F2 1.218 
Final R indices [F>4σ(F)] R1 = 0.0664, wR2 = 0.1400 
R indices (all data) R1 = 0.0830, wR2 = 0.1444 
Largest diff. peak, hole 0.723, -0.436 eÅ-3 
Mean and maximum shift/error 0.000 and 0.000 
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Bond lengths [Å] and angles [°] for 274. 
 
C(1)-C(2) 1.319(5) 
C(2)-C(3) 1.497(4) 
C(3)-C(4) 1.536(4) 
C(3)-C(6) 1.548(4) 
C(4)-N(32) 1.471(3) 
C(4)-C(5) 1.511(4) 
C(5)-C(24) 1.504(4) 
C(6)-C(16) 1.484(4) 
C(6)-S(7) 1.808(3) 
S(7)-O(8) 1.424(2) 
S(7)-O(9) 1.432(2) 
S(7)-C(10) 1.753(3) 
C(10)-C(11) 1.377(4) 
C(10)-C(15) 1.385(4) 
C(11)-C(12) 1.376(4) 
C(12)-C(13) 1.372(5) 
C(13)-C(14) 1.383(5) 
C(14)-C(15) 1.372(4) 
C(16)-C(17) 1.322(4) 
C(17)-C(18) 1.461(4) 
C(18)-C(23) 1.391(5) 
C(18)-C(19) 1.392(5) 
C(19)-C(20) 1.381(5) 
C(20)-C(21) 1.378(6) 
C(21)-C(22) 1.362(6) 
C(22)-C(23) 1.367(5) 
C(24)-C(25) 1.380(4) 
C(24)-C(29) 1.384(4) 
C(25)-C(26) 1.377(4) 
C(26)-C(27) 1.381(4) 
C(27)-O(30) 1.360(4) 
C(27)-C(28) 1.384(4) 
C(28)-C(29) 1.368(4) 
O(30)-C(31) 1.419(5) 
N(32)-S(33) 1.606(2) 
S(33)-O(35) 1.429(2) 
S(33)-O(34) 1.4346(19) 
S(33)-C(36) 1.743(3) 
C(36)-C(37) 1.385(4) 
C(36)-C(41) 1.391(4) 
C(37)-C(38) 1.373(5) 
C(38)-C(39) 1.365(5) 
C(39)-C(40) 1.390(5) 
C(39)-C(42) 1.504(5) 
C(40)-C(41) 1.370(5) 
 
C(1)-C(2)-C(3) 123.1(4) 
C(2)-C(3)-C(4) 110.4(2) 
C(2)-C(3)-C(6) 111.5(3) 
C(4)-C(3)-C(6) 112.8(2) 
N(32)-C(4)-C(5) 110.3(2) 
N(32)-C(4)-C(3) 109.9(2) 
C(5)-C(4)-C(3) 109.8(2) 
C(24)-C(5)-C(4) 117.3(2) 
C(16)-C(6)-C(3) 114.5(2) 
C(16)-C(6)-S(7) 107.91(19) 
C(3)-C(6)-S(7) 110.01(19) 
O(8)-S(7)-O(9) 118.56(14) 
O(8)-S(7)-C(10) 108.62(14) 
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O(9)-S(7)-C(10) 108.79(14) 
O(8)-S(7)-C(6) 108.10(14) 
O(9)-S(7)-C(6) 108.97(13) 
C(10)-S(7)-C(6) 102.64(13) 
C(11)-C(10)-C(15) 121.3(3) 
C(11)-C(10)-S(7) 120.3(2) 
C(15)-C(10)-S(7) 118.4(2) 
C(12)-C(11)-C(10) 119.2(3) 
C(13)-C(12)-C(11) 119.7(3) 
C(12)-C(13)-C(14) 121.0(3) 
C(15)-C(14)-C(13) 119.6(3) 
C(14)-C(15)-C(10) 119.1(3) 
C(17)-C(16)-C(6) 122.8(3) 
C(16)-C(17)-C(18) 126.6(3) 
C(23)-C(18)-C(19) 118.3(3) 
C(23)-C(18)-C(17) 123.0(3) 
C(19)-C(18)-C(17) 118.6(3) 
C(20)-C(19)-C(18) 120.4(4) 
C(21)-C(20)-C(19) 119.9(4) 
C(22)-C(21)-C(20) 119.9(4) 
C(21)-C(22)-C(23) 120.9(4) 
C(22)-C(23)-C(18) 120.5(4) 
C(25)-C(24)-C(29) 117.6(3) 
C(25)-C(24)-C(5) 121.7(3) 
C(29)-C(24)-C(5) 120.5(3) 
C(26)-C(25)-C(24) 122.1(3) 
C(25)-C(26)-C(27) 119.2(3) 
O(30)-C(27)-C(26) 124.4(3) 
O(30)-C(27)-C(28) 116.1(3) 
C(26)-C(27)-C(28) 119.5(3) 
C(29)-C(28)-C(27) 120.2(3) 
C(28)-C(29)-C(24) 121.4(3) 
C(27)-O(30)-C(31) 117.2(3) 
C(4)-N(32)-S(33) 124.65(18) 
O(35)-S(33)-O(34) 118.89(12) 
O(35)-S(33)-N(32) 108.38(12) 
O(34)-S(33)-N(32) 104.71(12) 
O(35)-S(33)-C(36) 107.62(13) 
O(34)-S(33)-C(36) 107.06(13) 
N(32)-S(33)-C(36) 110.02(13) 
C(37)-C(36)-C(41) 120.2(3) 
C(37)-C(36)-S(33) 120.3(2) 
C(41)-C(36)-S(33) 119.5(2) 
C(38)-C(37)-C(36) 119.3(3) 
C(39)-C(38)-C(37) 121.5(3) 
C(38)-C(39)-C(40) 118.8(3) 
C(38)-C(39)-C(42) 121.0(4) 
C(40)-C(39)-C(42) 120.2(4) 
C(41)-C(40)-C(39) 121.1(3) 
C(40)-C(41)-C(36) 119.0(3) 
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Crystal data and structure refinement for 297. 
 
Identification code DC0701 
Empirical formula C29 H33 N O3 S2 
Formula weight 507.68 
Temperature 173(2) K 
Diffractometer, wavelength OD Xcalibur PX Ultra, 1.54248 Å 
Crystal system, space group Orthorhombic, Pbca 
Unit cell dimensions a = 15.6552(2) Å α = 90° 
 b = 12.3842(2) Å β = 90° 
 c = 28.0436(4) Å γ = 90° 
Volume, Z 5437.01(14) Å3, 8 
Density (calculated) 1.240 Mg/m3 
Absorption coefficient 2.009 mm-1 
F(000) 2160 
Crystal colour / morphology Colourless needles 
Crystal size 0.28 x 0.05 x 0.02 mm3 
θ range for data collection 3.15 to 52.24° 
Index ranges -15<=h<=15, -10<=k<=12, -28<=l<=28 
Reflns collected / unique 10559 / 3002 [R(int) = 0.0380] 
Reflns observed [F>4σ(F)] 1958 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.61918 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3002 / 0 / 318 
Goodness-of-fit on F2 0.995 
Final R indices [F>4σ(F)] R1 = 0.0423, wR2 = 0.0761 
R indices (all data) R1 = 0.0854, wR2 = 0.0867 
Largest diff. peak, hole 0.157, -0.198 eÅ-3 
Mean and maximum shift/error 0.000 and 0.001 
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Bond lengths [Å] and angles [°] for 297. 
 
C(1)-C(2) 1.312(4) 
C(2)-C(3) 1.490(4) 
C(3)-C(4) 1.552(4) 
C(3)-S(7) 1.845(3) 
C(4)-C(5) 1.507(4) 
C(4)-C(14) 1.557(4) 
C(5)-C(6) 1.308(4) 
S(7)-C(8) 1.768(3) 
C(8)-C(9) 1.361(4) 
C(8)-C(13) 1.388(4) 
C(9)-C(10) 1.396(5) 
C(10)-C(11) 1.368(5) 
C(11)-C(12) 1.359(5) 
C(12)-C(13) 1.375(4) 
C(14)-N(15) 1.471(3) 
C(14)-C(27) 1.536(4) 
N(15)-C(26) 1.460(3) 
N(15)-S(16) 1.619(2) 
S(16)-O(18) 1.4357(18) 
S(16)-O(17) 1.4380(19) 
S(16)-C(19) 1.756(3) 
C(19)-C(20) 1.382(4) 
C(19)-C(24) 1.387(4) 
C(20)-C(21) 1.384(4) 
C(21)-C(22) 1.381(4) 
C(22)-C(23) 1.382(4) 
C(22)-C(25) 1.511(4) 
C(23)-C(24) 1.374(4) 
C(27)-C(28) 1.505(4) 
C(28)-C(33) 1.383(4) 
C(28)-C(29) 1.388(4) 
C(29)-C(30) 1.370(4) 
C(30)-C(31) 1.377(4) 
C(31)-C(32) 1.376(4) 
C(31)-O(34) 1.384(4) 
C(32)-C(33) 1.388(4) 
O(34)-C(35) 1.413(4) 
 
C(1)-C(2)-C(3) 124.7(3) 
C(2)-C(3)-C(4) 112.3(3) 
C(2)-C(3)-S(7) 109.3(2) 
C(4)-C(3)-S(7) 109.3(2) 
C(5)-C(4)-C(3) 112.8(2) 
C(5)-C(4)-C(14) 110.3(2) 
C(3)-C(4)-C(14) 112.9(2) 
C(6)-C(5)-C(4) 124.3(3) 
C(8)-S(7)-C(3) 101.29(14) 
C(9)-C(8)-C(13) 119.2(3) 
C(9)-C(8)-S(7) 120.2(3) 
C(13)-C(8)-S(7) 120.6(3) 
C(8)-C(9)-C(10) 120.6(4) 
C(11)-C(10)-C(9) 119.3(4) 
C(12)-C(11)-C(10) 120.4(4) 
C(11)-C(12)-C(13) 120.5(4) 
C(12)-C(13)-C(8) 120.0(3) 
N(15)-C(14)-C(27) 110.7(2) 
N(15)-C(14)-C(4) 110.1(2) 
C(27)-C(14)-C(4) 112.6(3) 
C(26)-N(15)-C(14) 119.8(2) 
 216
C(26)-N(15)-S(16) 117.36(18) 
C(14)-N(15)-S(16) 122.1(2) 
O(18)-S(16)-O(17) 119.48(12) 
O(18)-S(16)-N(15) 109.01(12) 
O(17)-S(16)-N(15) 107.38(12) 
O(18)-S(16)-C(19) 105.71(14) 
O(17)-S(16)-C(19) 107.99(14) 
N(15)-S(16)-C(19) 106.60(13) 
C(20)-C(19)-C(24) 119.0(3) 
C(20)-C(19)-S(16) 120.2(3) 
C(24)-C(19)-S(16) 120.8(3) 
C(19)-C(20)-C(21) 120.2(3) 
C(22)-C(21)-C(20) 121.2(3) 
C(21)-C(22)-C(23) 117.9(3) 
C(21)-C(22)-C(25) 121.6(3) 
C(23)-C(22)-C(25) 120.5(3) 
C(24)-C(23)-C(22) 121.7(3) 
C(23)-C(24)-C(19) 120.1(3) 
C(28)-C(27)-C(14) 112.7(3) 
C(33)-C(28)-C(29) 117.2(3) 
C(33)-C(28)-C(27) 121.7(3) 
C(29)-C(28)-C(27) 121.1(3) 
C(30)-C(29)-C(28) 122.1(3) 
C(29)-C(30)-C(31) 119.4(3) 
C(32)-C(31)-C(30) 120.6(3) 
C(32)-C(31)-O(34) 124.6(3) 
C(30)-C(31)-O(34) 114.8(4) 
C(31)-C(32)-C(33) 119.0(3) 
C(28)-C(33)-C(32) 121.7(3) 
C(31)-O(34)-C(35) 116.5(3) 
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Crystal data and structure refinement for 253. 
 
Identification code DC0806 
Empirical formula C29 H31 N O6 S2 
Formula weight 553.67 
Temperature 173(2) K 
Diffractometer, wavelength OD Xcalibur 3, 0.71073 Å 
Crystal system, space group Triclinic, P-1 
Unit cell dimensions a = 7.2944(2) Å α = 
64.138(5)° 
 b = 14.0189(7) Å β = 84.419(3)° 
 c = 14.7590(7) Å γ = 85.889(3)° 
Volume, Z 1350.93(12) Å3, 2 
Density (calculated) 1.361 Mg/m3 
Absorption coefficient 0.242 mm-1 
F(000) 584 
Crystal colour / morphology Colourless needles 
Crystal size 0.44 x 0.05 x 0.03 mm3 
θ range for data collection 3.75 to 32.18° 
Index ranges -10<=h<=10, -20<=k<=20, -21<=l<=21 
Reflns collected / unique 21735 / 8763 [R(int) = 0.0521] 
Reflns observed [F>4σ(F)] 4478 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.00000 and 0.82846 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 8763 / 0 / 345 
Goodness-of-fit on F2 0.905 
Final R indices [F>4σ(F)] R1 = 0.0474, wR2 = 0.1049 
R indices (all data) R1 = 0.1057, wR2 = 0.1162 
Largest diff. peak, hole 0.536, -0.353 eÅ-3 
Mean and maximum shift/error 0.000 and 0.000 
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Bond lengths [Å] and angles [°] for 253. 
 
N(1)-C(2) 1.396(2) 
N(1)-C(6) 1.489(2) 
N(1)-S(7) 1.6858(13) 
C(2)-O(2) 1.2085(19) 
C(2)-C(3) 1.503(2) 
C(3)-C(4) 1.527(2) 
C(4)-C(5) 1.556(2) 
C(4)-S(17) 1.7945(18) 
C(5)-C(27) 1.510(2) 
C(5)-C(6) 1.539(2) 
C(6)-C(29) 1.531(2) 
S(7)-O(8) 1.4292(13) 
S(7)-O(9) 1.4292(13) 
S(7)-C(10) 1.7566(18) 
C(10)-C(11) 1.386(2) 
C(10)-C(15) 1.391(2) 
C(11)-C(12) 1.385(3) 
C(12)-C(13) 1.391(3) 
C(13)-C(14) 1.390(3) 
C(13)-C(16) 1.502(3) 
C(14)-C(15) 1.376(3) 
S(17)-O(18) 1.4357(15) 
S(17)-O(19) 1.4376(15) 
S(17)-C(20) 1.7581(19) 
C(20)-C(25) 1.380(3) 
C(20)-C(21) 1.386(3) 
C(21)-C(22) 1.377(3) 
C(22)-C(23) 1.381(3) 
C(23)-C(24) 1.381(3) 
C(23)-C(26) 1.511(3) 
C(24)-C(25) 1.378(3) 
C(27)-C(28) 1.299(3) 
C(29)-C(30) 1.509(2) 
C(30)-C(35) 1.378(3) 
C(30)-C(31) 1.391(2) 
C(31)-C(32) 1.378(3) 
C(32)-C(33) 1.389(3) 
C(33)-O(36) 1.368(2) 
C(33)-C(34) 1.387(3) 
C(34)-C(35) 1.388(2) 
O(36)-C(37) 1.421(2) 
 
C(2)-N(1)-C(6) 119.66(13) 
C(2)-N(1)-S(7) 119.01(11) 
C(6)-N(1)-S(7) 120.63(11) 
O(2)-C(2)-N(1) 122.24(14) 
O(2)-C(2)-C(3) 123.23(15) 
N(1)-C(2)-C(3) 114.52(14) 
C(2)-C(3)-C(4) 115.23(14) 
C(3)-C(4)-C(5) 114.62(13) 
C(3)-C(4)-S(17) 107.53(12) 
C(5)-C(4)-S(17) 111.06(12) 
C(27)-C(5)-C(6) 110.97(15) 
C(27)-C(5)-C(4) 112.58(13) 
C(6)-C(5)-C(4) 111.27(14) 
N(1)-C(6)-C(29) 112.61(14) 
N(1)-C(6)-C(5) 108.59(13) 
C(29)-C(6)-C(5) 114.35(13) 
O(8)-S(7)-O(9) 118.96(8) 
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O(8)-S(7)-N(1) 107.19(7) 
O(9)-S(7)-N(1) 104.78(7) 
O(8)-S(7)-C(10) 108.48(8) 
O(9)-S(7)-C(10) 108.20(8) 
N(1)-S(7)-C(10) 108.86(7) 
C(11)-C(10)-C(15) 120.15(17) 
C(11)-C(10)-S(7) 119.31(14) 
C(15)-C(10)-S(7) 120.22(13) 
C(12)-C(11)-C(10) 119.28(18) 
C(11)-C(12)-C(13) 121.33(17) 
C(14)-C(13)-C(12) 118.29(18) 
C(14)-C(13)-C(16) 120.08(18) 
C(12)-C(13)-C(16) 121.63(18) 
C(15)-C(14)-C(13) 121.18(18) 
C(14)-C(15)-C(10) 119.77(16) 
O(18)-S(17)-O(19) 118.69(10) 
O(18)-S(17)-C(20) 109.11(9) 
O(19)-S(17)-C(20) 107.10(9) 
O(18)-S(17)-C(4) 108.26(8) 
O(19)-S(17)-C(4) 107.13(9) 
C(20)-S(17)-C(4) 105.84(8) 
C(25)-C(20)-C(21) 120.36(19) 
C(25)-C(20)-S(17) 120.54(15) 
C(21)-C(20)-S(17) 118.97(15) 
C(22)-C(21)-C(20) 119.0(2) 
C(21)-C(22)-C(23) 121.6(2) 
C(22)-C(23)-C(24) 118.3(2) 
C(22)-C(23)-C(26) 121.0(2) 
C(24)-C(23)-C(26) 120.7(2) 
C(25)-C(24)-C(23) 121.2(2) 
C(24)-C(25)-C(20) 119.45(19) 
C(28)-C(27)-C(5) 125.0(2) 
C(30)-C(29)-C(6) 115.15(13) 
C(35)-C(30)-C(31) 117.82(17) 
C(35)-C(30)-C(29) 120.98(16) 
C(31)-C(30)-C(29) 121.20(17) 
C(32)-C(31)-C(30) 121.30(18) 
C(31)-C(32)-C(33) 120.00(17) 
O(36)-C(33)-C(34) 124.06(18) 
O(36)-C(33)-C(32) 116.26(16) 
C(34)-C(33)-C(32) 119.68(17) 
C(33)-C(34)-C(35) 119.10(18) 
C(30)-C(35)-C(34) 122.10(17) 
C(33)-O(36)-C(37) 117.31(15) 
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